<!DOCTYPE html>
<html lang="es">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>PCSF Network Analysis - Laura Martin Chaves</title>
  <script src="https://unpkg.com/vis-network/standalone/umd/vis-network.min.js"></script>
  <link href="https://fonts.googleapis.com/css2?family=Outfit:wght@300;400;500;600;700&family=JetBrains+Mono:wght@400;500&display=swap" rel="stylesheet">
  <style>
    * { margin: 0; padding: 0; box-sizing: border-box; }
    body {
      font-family: "Outfit", sans-serif;
      background: linear-gradient(135deg, #0a0a0f 0%, #1a1a2e 50%, #16213e 100%);
      min-height: 100vh;
      color: #e8e8e8;
      overflow-x: hidden;
    }
    .container { padding: 20px; max-width: 1700px; margin: 0 auto; }
    .header {
      text-align: center;
      padding: 30px 40px;
      background: rgba(255,255,255,0.03);
      border: 1px solid rgba(255,255,255,0.08);
      border-radius: 24px;
      margin-bottom: 25px;
      position: relative;
      overflow: hidden;
    }
    .header::before {
      content: "";
      position: absolute;
      top: 0; left: 0; right: 0;
      height: 3px;
      background: linear-gradient(90deg, #E41A1C, #377EB8, #4DAF4A);
    }
    .header h1 {
      font-size: 2.2em;
      font-weight: 700;
      background: linear-gradient(135deg, #fff 0%, #a8d8ff 100%);
      -webkit-background-clip: text;
      -webkit-text-fill-color: transparent;
      background-clip: text;
      margin-bottom: 8px;
    }
    .header .subtitle { color: #8899aa; font-size: 1em; font-weight: 300; }
    .header .citation {
      margin-top: 12px;
      padding: 12px 20px;
      background: rgba(0,0,0,0.3);
      border-radius: 12px;
      font-size: 0.8em;
      color: #667788;
      font-style: italic;
      max-width: 800px;
      margin-left: auto;
      margin-right: auto;
    }
    .condition-selector { display: flex; justify-content: center; gap: 20px; margin-bottom: 20px; }
    .cond-btn {
      background: rgba(255,255,255,0.04);
      border: 2px solid var(--color);
      color: #fff;
      padding: 18px 40px;
      border-radius: 16px;
      cursor: pointer;
      font-family: "Outfit", sans-serif;
      font-size: 1.1em;
      font-weight: 600;
      transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
      position: relative;
      overflow: hidden;
    }
    .cond-btn::before {
      content: "";
      position: absolute;
      top: 0; left: 0; right: 0; bottom: 0;
      background: var(--color);
      opacity: 0;
      transition: opacity 0.3s;
    }
    .cond-btn:hover::before, .cond-btn.active::before { opacity: 0.15; }
    .cond-btn.active {
      border-width: 3px;
      transform: scale(1.02);
      box-shadow: 0 8px 25px rgba(0,0,0,0.3), 0 0 30px var(--color-glow);
    }
    .cond-btn small { display: block; font-size: 0.7em; font-weight: 400; opacity: 0.7; margin-top: 4px; }
    .pval-selector { display: flex; justify-content: center; gap: 15px; margin-bottom: 20px; align-items: center; }
    .pval-label { color: #667788; font-size: 0.9em; margin-right: 10px; }
    .pval-btn {
      background: rgba(255,255,255,0.06);
      border: 2px solid rgba(255,255,255,0.15);
      color: #ccc;
      padding: 10px 28px;
      border-radius: 25px;
      cursor: pointer;
      font-family: "JetBrains Mono", monospace;
      font-size: 0.95em;
      font-weight: 500;
      transition: all 0.25s ease;
    }
    .pval-btn:hover { background: rgba(255,255,255,0.1); border-color: rgba(255,255,255,0.3); }
    .pval-btn.active {
      background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
      border-color: transparent;
      color: #fff;
      box-shadow: 0 4px 15px rgba(102, 126, 234, 0.4);
    }
    .stats-container { display: flex; justify-content: center; gap: 30px; margin-bottom: 20px; }
    .stat-box {
      background: rgba(255,255,255,0.05);
      padding: 12px 25px;
      border-radius: 12px;
      text-align: center;
      border: 1px solid rgba(255,255,255,0.08);
    }
    .stat-box .value {
      font-family: "JetBrains Mono", monospace;
      font-size: 1.8em;
      font-weight: 600;
      background: linear-gradient(135deg, #00d4ff 0%, #00ff88 100%);
      -webkit-background-clip: text;
      -webkit-text-fill-color: transparent;
      background-clip: text;
    }
    .stat-box .label { font-size: 0.8em; color: #778899; text-transform: uppercase; letter-spacing: 1px; }
    .main-content { display: flex; gap: 20px; height: calc(100vh - 380px); min-height: 500px; }
    .network-panel {
      flex: 1;
      background: #fff;
      border-radius: 20px;
      overflow: hidden;
      box-shadow: 0 10px 40px rgba(0,0,0,0.3);
    }
    #network { width: 100%; height: 100%; }
    .legend-panel {
      width: 280px;
      background: rgba(255,255,255,0.04);
      border: 1px solid rgba(255,255,255,0.08);
      border-radius: 20px;
      padding: 20px;
      overflow-y: auto;
    }
    .legend-panel h3 {
      font-size: 1.1em;
      font-weight: 600;
      margin-bottom: 15px;
      padding-bottom: 12px;
      border-bottom: 1px solid rgba(255,255,255,0.1);
      color: #fff;
    }
    .legend-panel h3 span { font-size: 0.75em; color: #778899; font-weight: 400; display: block; margin-top: 4px; }
    .legend-item {
      display: flex;
      align-items: center;
      gap: 12px;
      margin-bottom: 10px;
      padding: 10px 12px;
      border-radius: 10px;
      cursor: pointer;
      transition: all 0.2s ease;
      background: rgba(255,255,255,0.02);
    }
    .legend-item:hover { background: rgba(255,255,255,0.08); transform: translateX(3px); }
    .legend-item.dimmed { opacity: 0.25; }
    .legend-color { width: 20px; height: 20px; border-radius: 6px; flex-shrink: 0; }
    .legend-info { flex: 1; }
    .legend-info .cluster-name { font-weight: 500; font-size: 0.95em; }
    .legend-info .cluster-meta { font-size: 0.75em; color: #778899; font-family: "JetBrains Mono", monospace; }
    .legend-rank { background: rgba(255,255,255,0.1); padding: 3px 8px; border-radius: 5px; font-size: 0.7em; font-weight: 600; color: #aabbcc; }
    .shape-legend { margin-top: 20px; padding-top: 15px; border-top: 1px solid rgba(255,255,255,0.1); }
    .shape-legend h4 { font-size: 0.85em; color: #778899; margin-bottom: 10px; font-weight: 500; }
    .shape-item { display: flex; align-items: center; gap: 10px; margin-bottom: 8px; font-size: 0.85em; color: #aabbcc; }
    .shape-icon { width: 16px; height: 16px; }
    .tooltip {
      position: absolute;
      background: rgba(15, 15, 25, 0.98);
      color: #fff;
      padding: 0;
      border-radius: 12px;
      max-width: 380px;
      font-size: 0.85em;
      z-index: 1000;
      display: none;
      box-shadow: 0 10px 40px rgba(0,0,0,0.5);
      border: 1px solid rgba(255,255,255,0.1);
      overflow: hidden;
    }
    .no-data {
      display: flex;
      flex-direction: column;
      align-items: center;
      justify-content: center;
      height: 100%;
      color: #666;
      font-size: 1.2em;
    }
    .no-data svg { width: 80px; height: 80px; margin-bottom: 20px; opacity: 0.3; }
  </style>
</head>
<body>
  <div class="container">
    <div class="header">
      <h1>PCSF Network Analysis</h1>
      <p class="subtitle">Prize-Collecting Steiner Forest - Protein-Protein Interaction Networks</p>
      <div class="citation">
        Laura Martin Chaves; Verheul-Campos, Julia; et al. - Analisis de redes de interaccion proteina-proteina en diferentes condiciones experimentales.
      </div>
    </div>
    
    <div class="condition-selector">
      <button class="cond-btn active" data-cond="TUBULAR" style="--color: #E41A1C; --color-glow: rgba(228,26,28,0.3);">
        TUBULAR
        <small>Celulas tubulares</small>
      </button>
      <button class="cond-btn" data-cond="RAIZ" style="--color: #377EB8; --color-glow: rgba(55,126,184,0.3);">
        RAIZ
        <small>Celulas raiz</small>
      </button>
      <button class="cond-btn" data-cond="MIXTO" style="--color: #4DAF4A; --color-glow: rgba(77,175,74,0.3);">
        MIXTO
        <small>Poblacion mixta</small>
      </button>
    </div>
    
    <div class="pval-selector">
      <span class="pval-label">Umbral de significancia:</span>
      <button class="pval-btn active" data-pval="P005">p &lt; 0.05</button>
      <button class="pval-btn" data-pval="P001">p &lt; 0.01</button>
    </div>
    
    <div class="stats-container">
      <div class="stat-box">
        <div class="value" id="stat-nodos">0</div>
        <div class="label">Nodos</div>
      </div>
      <div class="stat-box">
        <div class="value" id="stat-aristas">0</div>
        <div class="label">Aristas</div>
      </div>
      <div class="stat-box">
        <div class="value" id="stat-clusters">0</div>
        <div class="label">Clusters</div>
      </div>
    </div>
    
    <div class="main-content">
      <div class="network-panel">
        <div id="network"></div>
      </div>
      <div class="legend-panel">
        <h3>Clusters <span>Ordenados por |log2FC| promedio</span></h3>
        <div id="cluster-legend"></div>
        <div class="shape-legend">
          <h4>Tipo de nodo</h4>
          <div class="shape-item">
            <svg class="shape-icon" viewBox="0 0 16 16"><circle cx="8" cy="8" r="6" fill="#667eea"/></svg>
            <span>Terminal (gen diferencial)</span>
          </div>
          <div class="shape-item">
            <svg class="shape-icon" viewBox="0 0 16 16"><polygon points="8,2 14,14 2,14" fill="#667eea"/></svg>
            <span>Steiner (conector)</span>
          </div>
        </div>
      </div>
    </div>
  </div>
  
  <div class="tooltip" id="tooltip"></div>
  
  <script>
const datosCompletos = {"TUBULAR":{"P005":{"nodos":[{"id":"ACOT1","label":"ACOT1","x":2262.6482,"y":775.6032,"size":10.2947,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"ACSM4","label":"ACSM4","x":1386.7651,"y":1794.1362,"size":5,"color":"#377EB8","shape":"triangle","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"ACTC1","label":"ACTC1","x":2683.4318,"y":953.1692,"size":9.0397,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"ACTG2","label":"ACTG2","x":128.2188,"y":1534.2503,"size":12.6247,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"AEBP1","label":"AEBP1","x":1161.0261,"y":353.5147,"size":8.4963,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"AFM","label":"AFM","x":2524.2339,"y":645.0022,"size":8.4061,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"AHNAK","label":"AHNAK","x":2655.273,"y":706.3082,"size":12.8262,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"AIP","label":"AIP","x":933.0144,"y":864.9998,"size":8.5585,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"AKAP12","label":"AKAP12","x":2883.3047,"y":1029.1004,"size":10.0642,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.524<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AKAP12, B2M, CLTB, CTNNB1, DLGAP4, H1-2, MYO1C, MYO1D, RAB8B, RILPL1, SORBS2, STXBP3, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=1.34e-03)<br>Motor proteins (p=8.29e-03)<br>Pathogenic Escherichia coli infection (p=8.78e-03)<br><br><b>BP:<\/b><br>establishment of protein localization to membrane (p=3.05e-05)<br>cellular response to type II interferon (p=3.78e-05) <br> <b>MF:<\/b><br>syntaxin-1 binding (p=6.83e-05)<br>microfilament motor activity (p=3.11e-04) <br> <b>CC:<\/b><br>phagocytic vesicle (p=2.37e-08)<br>endocytic vesicle (p=5.05e-08)<\/div>"},{"id":"AKT1","label":"AKT1","x":2012.8768,"y":800.4809,"size":9.333,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"ALB","label":"ALB","x":2353.3867,"y":2116.1699,"size":8.4632,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"ALCAM","label":"ALCAM","x":950.6307,"y":2301.6763,"size":8.6787,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"ALDH16A1","label":"ALDH16A1","x":1956.2253,"y":2315.2267,"size":16.9798,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"ALDH1L1","label":"ALDH1L1","x":355.2611,"y":1577.6519,"size":9.729,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"ALDOA","label":"ALDOA","x":2116.6571,"y":284.074,"size":11.1863,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"ANG","label":"ANG","x":269.3986,"y":1855.9437,"size":8.9817,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"ANO6","label":"ANO6","x":2409.4413,"y":2018.6079,"size":8.825,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"ANOS1","label":"ANOS1","x":496.7352,"y":1643.4468,"size":8.704,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"ANXA3","label":"ANXA3","x":2242.1118,"y":2178.5055,"size":8.6044,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"ANXA6","label":"ANXA6","x":2079.5999,"y":2258.2523,"size":9.5342,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"ANXA7","label":"ANXA7","x":295.4411,"y":740.6038,"size":11.1459,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"APEH","label":"APEH","x":1640.9479,"y":1277.4225,"size":12.2391,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.669<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>APEH, APOL1, COMT, HAAO, ITGB3, L3HYPDH, MCAM, NUCB1, PEBP1, PIPOX, PLD3, PRDX5, SLC44A2<\/span><br><br><b>KEGG:<\/b><br> Peroxisome (p=2.58e-03)<br>Tyrosine metabolism (p=3.43e-02)<br>African trypanosomiasis (p=3.43e-02)<br><br><b>BP:<\/b><br>renal filtration (p=1.83e-04)<br>angiogenesis involved in wound healing (p=2.07e-04) <br> <b>MF:<\/b><br>single-stranded DNA exodeoxyribonuclease activity (p=6.95e-03)<br>vascular endothelial growth factor receptor binding (p=9.03e-03) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"APOA1","label":"APOA1","x":1232.7285,"y":2469.9249,"size":8.3828,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"APOA4","label":"APOA4","x":2637.6808,"y":1630.4594,"size":18.5557,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"APOC1","label":"APOC1","x":2401.3959,"y":2210.755,"size":9.0828,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"APOE","label":"APOE","x":371.6805,"y":1795.7692,"size":12.7903,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"APOL1","label":"APOL1","x":2394.1843,"y":1226.625,"size":18.7416,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.669<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>APEH, APOL1, COMT, HAAO, ITGB3, L3HYPDH, MCAM, NUCB1, PEBP1, PIPOX, PLD3, PRDX5, SLC44A2<\/span><br><br><b>KEGG:<\/b><br> Peroxisome (p=2.58e-03)<br>Tyrosine metabolism (p=3.43e-02)<br>African trypanosomiasis (p=3.43e-02)<br><br><b>BP:<\/b><br>renal filtration (p=1.83e-04)<br>angiogenesis involved in wound healing (p=2.07e-04) <br> <b>MF:<\/b><br>single-stranded DNA exodeoxyribonuclease activity (p=6.95e-03)<br>vascular endothelial growth factor receptor binding (p=9.03e-03) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"ARF3","label":"ARF3","x":641.48,"y":2010.658,"size":9.5375,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"ARF4","label":"ARF4","x":1290.4178,"y":1719.4432,"size":5,"color":"#A6D854","shape":"triangle","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"ATP1A2","label":"ATP1A2","x":457.6424,"y":1928.592,"size":11.6069,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"ATP1B3","label":"ATP1B3","x":1731.5457,"y":832.3492,"size":10.2856,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"ATP2A2","label":"ATP2A2","x":517.3627,"y":1089.756,"size":8.4635,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"ATP5F1D","label":"ATP5F1D","x":899.7925,"y":354.8025,"size":17.4548,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"ATRN","label":"ATRN","x":1082.7446,"y":1543.7293,"size":10.3007,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"AZGP1","label":"AZGP1","x":2404.4559,"y":1570.5551,"size":10.2377,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"B2M","label":"B2M","x":2906.0133,"y":909.1193,"size":8.716,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.524<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AKAP12, B2M, CLTB, CTNNB1, DLGAP4, H1-2, MYO1C, MYO1D, RAB8B, RILPL1, SORBS2, STXBP3, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=1.34e-03)<br>Motor proteins (p=8.29e-03)<br>Pathogenic Escherichia coli infection (p=8.78e-03)<br><br><b>BP:<\/b><br>establishment of protein localization to membrane (p=3.05e-05)<br>cellular response to type II interferon (p=3.78e-05) <br> <b>MF:<\/b><br>syntaxin-1 binding (p=6.83e-05)<br>microfilament motor activity (p=3.11e-04) <br> <b>CC:<\/b><br>phagocytic vesicle (p=2.37e-08)<br>endocytic vesicle (p=5.05e-08)<\/div>"},{"id":"BCAP31","label":"BCAP31","x":1034.8511,"y":2179.4882,"size":11.1231,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"BLVRA","label":"BLVRA","x":1624.1195,"y":268.3191,"size":10.7954,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.469<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>BLVRA, CYB5B, CYB5R3, HMGCL, HSD17B10, HSDL2, ILF3, RAB2A, RPS18, SSBP1, TUBA1C, TXNRD1, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=1.85e-04)<br>Valine, leucine and isoleucine degradation (p=1.08e-03)<br>Selenocompound metabolism (p=1.76e-02)<br><br><b>BP:<\/b><br>branched-chain amino acid catabolic process (p=1.01e-04)<br>branched-chain amino acid metabolic process (p=1.42e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=2.95e-05)<br>FAD binding (p=2.92e-04) <br> <b>CC:<\/b><br>nucleoid (p=4.56e-04)<br>mitochondrial nucleoid (p=4.56e-04)<\/div>"},{"id":"BLVRB","label":"BLVRB","x":1846.9248,"y":2593.8907,"size":8.4929,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"BST2","label":"BST2","x":2374.3618,"y":338.9033,"size":15.5481,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"CAST","label":"CAST","x":1201.5639,"y":962.133,"size":10.0642,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"CAV1","label":"CAV1","x":1218.2952,"y":2158.9675,"size":10.3137,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"CD47","label":"CD47","x":473.8622,"y":1283.5142,"size":9.5612,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"CD59","label":"CD59","x":650.797,"y":1540.9985,"size":9.5027,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"CD74","label":"CD74","x":1651.3524,"y":2386.4451,"size":9.1854,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"CD9","label":"CD9","x":339.3666,"y":1905.9943,"size":8.4984,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"CDH13","label":"CDH13","x":949.6956,"y":1646.2514,"size":8.3342,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"CFHR3","label":"CFHR3","x":764.4128,"y":1539.8632,"size":10.5444,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"CHMP4B","label":"CHMP4B","x":2478.1861,"y":345.9028,"size":10.4217,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"CHST14","label":"CHST14","x":1092.4497,"y":434.9315,"size":10.0642,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"CKB","label":"CKB","x":1975.2673,"y":993.777,"size":12.3191,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"CLTB","label":"CLTB","x":2878.7311,"y":1122.02,"size":8.9817,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.524<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AKAP12, B2M, CLTB, CTNNB1, DLGAP4, H1-2, MYO1C, MYO1D, RAB8B, RILPL1, SORBS2, STXBP3, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=1.34e-03)<br>Motor proteins (p=8.29e-03)<br>Pathogenic Escherichia coli infection (p=8.78e-03)<br><br><b>BP:<\/b><br>establishment of protein localization to membrane (p=3.05e-05)<br>cellular response to type II interferon (p=3.78e-05) <br> <b>MF:<\/b><br>syntaxin-1 binding (p=6.83e-05)<br>microfilament motor activity (p=3.11e-04) <br> <b>CC:<\/b><br>phagocytic vesicle (p=2.37e-08)<br>endocytic vesicle (p=5.05e-08)<\/div>"},{"id":"CLTC","label":"CLTC","x":2546.5576,"y":412.2279,"size":9.4353,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"CLU","label":"CLU","x":2117.5998,"y":2402.5277,"size":11.2037,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"CNDP2","label":"CNDP2","x":164.0015,"y":1098.4684,"size":10.2008,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"COL16A1","label":"COL16A1","x":421.9892,"y":2077.4565,"size":9.6285,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"COL6A1","label":"COL6A1","x":1301.1565,"y":419.5387,"size":9.3954,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"COL6A2","label":"COL6A2","x":2553.129,"y":933.7894,"size":9.0828,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"COL6A3","label":"COL6A3","x":923.0625,"y":237.4265,"size":8.4984,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"COMT","label":"COMT","x":2027.634,"y":1186.1776,"size":9.5027,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.669<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>APEH, APOL1, COMT, HAAO, ITGB3, L3HYPDH, MCAM, NUCB1, PEBP1, PIPOX, PLD3, PRDX5, SLC44A2<\/span><br><br><b>KEGG:<\/b><br> Peroxisome (p=2.58e-03)<br>Tyrosine metabolism (p=3.43e-02)<br>African trypanosomiasis (p=3.43e-02)<br><br><b>BP:<\/b><br>renal filtration (p=1.83e-04)<br>angiogenesis involved in wound healing (p=2.07e-04) <br> <b>MF:<\/b><br>single-stranded DNA exodeoxyribonuclease activity (p=6.95e-03)<br>vascular endothelial growth factor receptor binding (p=9.03e-03) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"COPA","label":"COPA","x":2190.2921,"y":1612.0852,"size":8.5895,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"COPS6","label":"COPS6","x":1202.083,"y":682.4356,"size":13.023,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"CP","label":"CP","x":2362.1095,"y":867.5336,"size":9.2955,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"CPA3","label":"CPA3","x":428.5255,"y":2168.4645,"size":9.2896,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"CPE","label":"CPE","x":1217.237,"y":1424.1168,"size":10.2924,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"CPNE1","label":"CPNE1","x":1609.7843,"y":1458.8642,"size":9.6982,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"CTNNB1","label":"CTNNB1","x":2980.5211,"y":954.049,"size":9.0773,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.524<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AKAP12, B2M, CLTB, CTNNB1, DLGAP4, H1-2, MYO1C, MYO1D, RAB8B, RILPL1, SORBS2, STXBP3, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=1.34e-03)<br>Motor proteins (p=8.29e-03)<br>Pathogenic Escherichia coli infection (p=8.78e-03)<br><br><b>BP:<\/b><br>establishment of protein localization to membrane (p=3.05e-05)<br>cellular response to type II interferon (p=3.78e-05) <br> <b>MF:<\/b><br>syntaxin-1 binding (p=6.83e-05)<br>microfilament motor activity (p=3.11e-04) <br> <b>CC:<\/b><br>phagocytic vesicle (p=2.37e-08)<br>endocytic vesicle (p=5.05e-08)<\/div>"},{"id":"CTNND1","label":"CTNND1","x":1516.0232,"y":848.9706,"size":10.7314,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"CYB5B","label":"CYB5B","x":1796.0138,"y":281.0106,"size":8.6873,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.469<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>BLVRA, CYB5B, CYB5R3, HMGCL, HSD17B10, HSDL2, ILF3, RAB2A, RPS18, SSBP1, TUBA1C, TXNRD1, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=1.85e-04)<br>Valine, leucine and isoleucine degradation (p=1.08e-03)<br>Selenocompound metabolism (p=1.76e-02)<br><br><b>BP:<\/b><br>branched-chain amino acid catabolic process (p=1.01e-04)<br>branched-chain amino acid metabolic process (p=1.42e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=2.95e-05)<br>FAD binding (p=2.92e-04) <br> <b>CC:<\/b><br>nucleoid (p=4.56e-04)<br>mitochondrial nucleoid (p=4.56e-04)<\/div>"},{"id":"CYB5R3","label":"CYB5R3","x":1338.8194,"y":605.0316,"size":10.4576,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.469<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>BLVRA, CYB5B, CYB5R3, HMGCL, HSD17B10, HSDL2, ILF3, RAB2A, RPS18, SSBP1, TUBA1C, TXNRD1, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=1.85e-04)<br>Valine, leucine and isoleucine degradation (p=1.08e-03)<br>Selenocompound metabolism (p=1.76e-02)<br><br><b>BP:<\/b><br>branched-chain amino acid catabolic process (p=1.01e-04)<br>branched-chain amino acid metabolic process (p=1.42e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=2.95e-05)<br>FAD binding (p=2.92e-04) <br> <b>CC:<\/b><br>nucleoid (p=4.56e-04)<br>mitochondrial nucleoid (p=4.56e-04)<\/div>"},{"id":"CYTL1","label":"CYTL1","x":1394.8561,"y":1656.7124,"size":8.9567,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"DCD","label":"DCD","x":2536.2,"y":1556.2151,"size":16.5126,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"DCXR","label":"DCXR","x":1429.3051,"y":100,"size":9.6642,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"DDOST","label":"DDOST","x":2806.7486,"y":1854.618,"size":10.0804,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"DDX17","label":"DDX17","x":1959.6422,"y":453.7225,"size":10.1218,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"DDX3X","label":"DDX3X","x":583.4873,"y":739.4558,"size":9.3403,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"DDX6","label":"DDX6","x":2096.047,"y":1959.5888,"size":8.7839,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"DES","label":"DES","x":124.2206,"y":1616.1127,"size":10.5444,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"DHRS1","label":"DHRS1","x":1309.4381,"y":2322.4575,"size":8.2257,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"DLGAP4","label":"DLGAP4","x":3043.6441,"y":1196.0922,"size":12.5249,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.524<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AKAP12, B2M, CLTB, CTNNB1, DLGAP4, H1-2, MYO1C, MYO1D, RAB8B, RILPL1, SORBS2, STXBP3, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=1.34e-03)<br>Motor proteins (p=8.29e-03)<br>Pathogenic Escherichia coli infection (p=8.78e-03)<br><br><b>BP:<\/b><br>establishment of protein localization to membrane (p=3.05e-05)<br>cellular response to type II interferon (p=3.78e-05) <br> <b>MF:<\/b><br>syntaxin-1 binding (p=6.83e-05)<br>microfilament motor activity (p=3.11e-04) <br> <b>CC:<\/b><br>phagocytic vesicle (p=2.37e-08)<br>endocytic vesicle (p=5.05e-08)<\/div>"},{"id":"DMD","label":"DMD","x":2719.5162,"y":817.5182,"size":9.2661,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"DNAJC24","label":"DNAJC24","x":1327.9498,"y":134.0177,"size":5,"color":"#FF7F00","shape":"triangle","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"DNM1L","label":"DNM1L","x":2344.4634,"y":2271.0144,"size":8.892,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"DNPEP","label":"DNPEP","x":562.0667,"y":1422.6491,"size":8.5278,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"DUSP6","label":"DUSP6","x":503.535,"y":1739.7112,"size":5,"color":"#984EA3","shape":"triangle","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"ECH1","label":"ECH1","x":2148.8075,"y":775.2228,"size":5,"color":"#E41A1C","shape":"triangle","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"ECHS1","label":"ECHS1","x":367.6273,"y":831.9736,"size":14.1262,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"EDNRA","label":"EDNRA","x":2518.1727,"y":2216.4267,"size":5,"color":"#F781BF","shape":"triangle","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"EEF1D","label":"EEF1D","x":1497.563,"y":299.9921,"size":8.2257,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"EFEMP2","label":"EFEMP2","x":1042.922,"y":251.1688,"size":11.054,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"EHD1","label":"EHD1","x":686.3339,"y":1678.0443,"size":9.3503,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"EIF2S2","label":"EIF2S2","x":862.7498,"y":712.076,"size":9.7223,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"EIF2S3","label":"EIF2S3","x":2921.1508,"y":1712.0732,"size":11.054,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"EIF3B","label":"EIF3B","x":1045.1835,"y":1143.3085,"size":10.9741,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"EIF4B","label":"EIF4B","x":885.0495,"y":1189.562,"size":8.3152,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"ENPP1","label":"ENPP1","x":1234.1595,"y":491.196,"size":10.3028,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"EOGT","label":"EOGT","x":377.9434,"y":1409.5046,"size":11.5045,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='padding:10px; background:#fff; color:#333; border-radius:8px;'><h4 style='color:#666;'>Cluster 19<\/h4><b>Genes:<\/b> EOGT, POGLUT3<br><i style='color:#999;'>Cluster pequeno para enriquecimiento<\/i><\/div>"},{"id":"EPX","label":"EPX","x":2965.6169,"y":1865.2313,"size":8.7839,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"ERAP1","label":"ERAP1","x":1289.7369,"y":1008.6871,"size":12.5526,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"ERGIC1","label":"ERGIC1","x":2832.3413,"y":2048.4648,"size":8.7291,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"ERLIN2","label":"ERLIN2","x":666.4934,"y":1052.3259,"size":9.3954,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"ETF1","label":"ETF1","x":657.7471,"y":794.2904,"size":8.5921,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"FAM114A1","label":"FAM114A1","x":564.7073,"y":2261.8167,"size":10.6039,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"FASN","label":"FASN","x":1428.9383,"y":2382.0089,"size":8.8821,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"FBLIM1","label":"FBLIM1","x":824.4368,"y":1829.766,"size":10.9179,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"FBLN5","label":"FBLN5","x":2464.1861,"y":896.8639,"size":10.6526,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"FCGBP","label":"FCGBP","x":2562.5862,"y":1411.9183,"size":8.4984,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"FHL1","label":"FHL1","x":1771.2235,"y":567.7135,"size":10.4199,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"FILIP1L","label":"FILIP1L","x":1411.4671,"y":357.9783,"size":8.2257,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"FLAD1","label":"FLAD1","x":1531.6544,"y":2150.2537,"size":5,"color":"#377EB8","shape":"triangle","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"FLII","label":"FLII","x":2082.0657,"y":1425.1564,"size":9.1854,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"FLNC","label":"FLNC","x":1490.3149,"y":417.2996,"size":9.6784,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"FN3K","label":"FN3K","x":2726.9584,"y":2150.171,"size":12.3973,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"FNDC1","label":"FNDC1","x":728.554,"y":2284.9431,"size":12.1267,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"GAA","label":"GAA","x":3099.9815,"y":1497.3358,"size":8.8821,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"GALM","label":"GALM","x":2267.0649,"y":544.8866,"size":11.4567,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"GC","label":"GC","x":2531.1048,"y":1793.17,"size":8.9411,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"GCLC","label":"GCLC","x":1498.6494,"y":1949.0143,"size":8.6873,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"GGCT","label":"GGCT","x":1101.6678,"y":2448.2697,"size":8.119,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"GNA13","label":"GNA13","x":1824.2882,"y":675.8523,"size":10.2492,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"GNB2","label":"GNB2","x":1256.3038,"y":1864.1513,"size":12.1666,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"GNB4","label":"GNB4","x":1053.6423,"y":1754.3298,"size":9.9814,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"GNG12","label":"GNG12","x":656.4942,"y":1922.8812,"size":8.5746,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"GPC4","label":"GPC4","x":864.1091,"y":1366.9578,"size":8.5195,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"GSN","label":"GSN","x":2193.7986,"y":1280.5916,"size":10.732,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"GSTO1","label":"GSTO1","x":1953.6625,"y":2557.5818,"size":5,"color":"#66C2A5","shape":"triangle","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"GUK1","label":"GUK1","x":959.6723,"y":547.2947,"size":11.0402,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"GYS1","label":"GYS1","x":1511.0717,"y":2522.4296,"size":10.1305,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"H1-0","label":"H1-0","x":2472.035,"y":2130.7188,"size":8.9817,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"H1-2","label":"H1-2","x":3046.0842,"y":1034.992,"size":9.3954,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.524<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AKAP12, B2M, CLTB, CTNNB1, DLGAP4, H1-2, MYO1C, MYO1D, RAB8B, RILPL1, SORBS2, STXBP3, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=1.34e-03)<br>Motor proteins (p=8.29e-03)<br>Pathogenic Escherichia coli infection (p=8.78e-03)<br><br><b>BP:<\/b><br>establishment of protein localization to membrane (p=3.05e-05)<br>cellular response to type II interferon (p=3.78e-05) <br> <b>MF:<\/b><br>syntaxin-1 binding (p=6.83e-05)<br>microfilament motor activity (p=3.11e-04) <br> <b>CC:<\/b><br>phagocytic vesicle (p=2.37e-08)<br>endocytic vesicle (p=5.05e-08)<\/div>"},{"id":"H1-3","label":"H1-3","x":1831.2454,"y":2484.9898,"size":8.8821,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"H1-4","label":"H1-4","x":2660.3622,"y":1530.8682,"size":8.5921,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"H2AC21","label":"H2AC21","x":1868.624,"y":2391.8966,"size":9.8346,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"HAAO","label":"HAAO","x":1403.7073,"y":1407.6499,"size":14.1584,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.669<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>APEH, APOL1, COMT, HAAO, ITGB3, L3HYPDH, MCAM, NUCB1, PEBP1, PIPOX, PLD3, PRDX5, SLC44A2<\/span><br><br><b>KEGG:<\/b><br> Peroxisome (p=2.58e-03)<br>Tyrosine metabolism (p=3.43e-02)<br>African trypanosomiasis (p=3.43e-02)<br><br><b>BP:<\/b><br>renal filtration (p=1.83e-04)<br>angiogenesis involved in wound healing (p=2.07e-04) <br> <b>MF:<\/b><br>single-stranded DNA exodeoxyribonuclease activity (p=6.95e-03)<br>vascular endothelial growth factor receptor binding (p=9.03e-03) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"HADH","label":"HADH","x":2349.8118,"y":654.5752,"size":8.6187,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"HCLS1","label":"HCLS1","x":2533.6897,"y":2068.1318,"size":10.0642,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"HDGF","label":"HDGF","x":416.141,"y":581.0762,"size":9.2896,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"HEBP1","label":"HEBP1","x":890.4108,"y":1992.1269,"size":9.5227,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"HLA-B","label":"HLA-B","x":2317.6457,"y":283.2948,"size":12.6647,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"HMGB2","label":"HMGB2","x":2697.012,"y":1339.6629,"size":8.9817,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"HMGCL","label":"HMGCL","x":1632.8095,"y":101.4937,"size":9.0927,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.469<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>BLVRA, CYB5B, CYB5R3, HMGCL, HSD17B10, HSDL2, ILF3, RAB2A, RPS18, SSBP1, TUBA1C, TXNRD1, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=1.85e-04)<br>Valine, leucine and isoleucine degradation (p=1.08e-03)<br>Selenocompound metabolism (p=1.76e-02)<br><br><b>BP:<\/b><br>branched-chain amino acid catabolic process (p=1.01e-04)<br>branched-chain amino acid metabolic process (p=1.42e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=2.95e-05)<br>FAD binding (p=2.92e-04) <br> <b>CC:<\/b><br>nucleoid (p=4.56e-04)<br>mitochondrial nucleoid (p=4.56e-04)<\/div>"},{"id":"HNRNPA0","label":"HNRNPA0","x":2115.7547,"y":2067.8773,"size":9.2011,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"HNRNPH1","label":"HNRNPH1","x":2092.9667,"y":608.79,"size":9.7385,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"HNRNPH3","label":"HNRNPH3","x":734.3634,"y":1207.5979,"size":8.501,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"HNRNPL","label":"HNRNPL","x":733.5193,"y":653.0421,"size":9.1353,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"HNRNPM","label":"HNRNPM","x":2815.2876,"y":1365.6674,"size":11.0296,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"HP","label":"HP","x":870.4635,"y":1595.8997,"size":10.669,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"HSD17B10","label":"HSD17B10","x":1675.9231,"y":185.7531,"size":8.3031,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.469<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>BLVRA, CYB5B, CYB5R3, HMGCL, HSD17B10, HSDL2, ILF3, RAB2A, RPS18, SSBP1, TUBA1C, TXNRD1, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=1.85e-04)<br>Valine, leucine and isoleucine degradation (p=1.08e-03)<br>Selenocompound metabolism (p=1.76e-02)<br><br><b>BP:<\/b><br>branched-chain amino acid catabolic process (p=1.01e-04)<br>branched-chain amino acid metabolic process (p=1.42e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=2.95e-05)<br>FAD binding (p=2.92e-04) <br> <b>CC:<\/b><br>nucleoid (p=4.56e-04)<br>mitochondrial nucleoid (p=4.56e-04)<\/div>"},{"id":"HSD17B12","label":"HSD17B12","x":649.6143,"y":399.5954,"size":11.014,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"HSD17B4","label":"HSD17B4","x":1341.6197,"y":2438.2854,"size":10.2804,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"HSDL2","label":"HSDL2","x":1708.5942,"y":322.5607,"size":20,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.469<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>BLVRA, CYB5B, CYB5R3, HMGCL, HSD17B10, HSDL2, ILF3, RAB2A, RPS18, SSBP1, TUBA1C, TXNRD1, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=1.85e-04)<br>Valine, leucine and isoleucine degradation (p=1.08e-03)<br>Selenocompound metabolism (p=1.76e-02)<br><br><b>BP:<\/b><br>branched-chain amino acid catabolic process (p=1.01e-04)<br>branched-chain amino acid metabolic process (p=1.42e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=2.95e-05)<br>FAD binding (p=2.92e-04) <br> <b>CC:<\/b><br>nucleoid (p=4.56e-04)<br>mitochondrial nucleoid (p=4.56e-04)<\/div>"},{"id":"HSPA12A","label":"HSPA12A","x":1251.2614,"y":200.6565,"size":13.6051,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"HSPA5","label":"HSPA5","x":1409.2837,"y":1840.0312,"size":10.6904,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"HSPB6","label":"HSPB6","x":1283.5971,"y":312.4619,"size":9.9485,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"HSPD1","label":"HSPD1","x":2154.404,"y":2498.0412,"size":8.2947,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"IDH3B","label":"IDH3B","x":2091.8234,"y":193.4611,"size":8.1376,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"ILF3","label":"ILF3","x":1430.4072,"y":556.4622,"size":9.4677,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.469<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>BLVRA, CYB5B, CYB5R3, HMGCL, HSD17B10, HSDL2, ILF3, RAB2A, RPS18, SSBP1, TUBA1C, TXNRD1, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=1.85e-04)<br>Valine, leucine and isoleucine degradation (p=1.08e-03)<br>Selenocompound metabolism (p=1.76e-02)<br><br><b>BP:<\/b><br>branched-chain amino acid catabolic process (p=1.01e-04)<br>branched-chain amino acid metabolic process (p=1.42e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=2.95e-05)<br>FAD binding (p=2.92e-04) <br> <b>CC:<\/b><br>nucleoid (p=4.56e-04)<br>mitochondrial nucleoid (p=4.56e-04)<\/div>"},{"id":"ILK","label":"ILK","x":1499.0236,"y":2046.3206,"size":8.6796,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"IPO5","label":"IPO5","x":1096.3934,"y":1241.881,"size":9.8346,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"ITGA8","label":"ITGA8","x":1432.8778,"y":902.9015,"size":10.5188,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"ITGAV","label":"ITGAV","x":2427.2678,"y":1845.7672,"size":9.4274,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"ITGB1","label":"ITGB1","x":1847.6334,"y":1551.6585,"size":8.8821,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"ITGB3","label":"ITGB3","x":2346.6903,"y":1142.0728,"size":10.669,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.669<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>APEH, APOL1, COMT, HAAO, ITGB3, L3HYPDH, MCAM, NUCB1, PEBP1, PIPOX, PLD3, PRDX5, SLC44A2<\/span><br><br><b>KEGG:<\/b><br> Peroxisome (p=2.58e-03)<br>Tyrosine metabolism (p=3.43e-02)<br>African trypanosomiasis (p=3.43e-02)<br><br><b>BP:<\/b><br>renal filtration (p=1.83e-04)<br>angiogenesis involved in wound healing (p=2.07e-04) <br> <b>MF:<\/b><br>single-stranded DNA exodeoxyribonuclease activity (p=6.95e-03)<br>vascular endothelial growth factor receptor binding (p=9.03e-03) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"ITIH3","label":"ITIH3","x":792.6608,"y":2392.1186,"size":8.3152,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"JAM3","label":"JAM3","x":1082.7622,"y":2261.2705,"size":10.1536,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"KANK2","label":"KANK2","x":1667.1752,"y":1898.5347,"size":8.6873,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"KPNA4","label":"KPNA4","x":761.5684,"y":834.012,"size":9.7223,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"KTN1","label":"KTN1","x":719.1722,"y":931.068,"size":13.005,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"L3HYPDH","label":"L3HYPDH","x":1516.7539,"y":1268.6674,"size":9.5747,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.669<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>APEH, APOL1, COMT, HAAO, ITGB3, L3HYPDH, MCAM, NUCB1, PEBP1, PIPOX, PLD3, PRDX5, SLC44A2<\/span><br><br><b>KEGG:<\/b><br> Peroxisome (p=2.58e-03)<br>Tyrosine metabolism (p=3.43e-02)<br>African trypanosomiasis (p=3.43e-02)<br><br><b>BP:<\/b><br>renal filtration (p=1.83e-04)<br>angiogenesis involved in wound healing (p=2.07e-04) <br> <b>MF:<\/b><br>single-stranded DNA exodeoxyribonuclease activity (p=6.95e-03)<br>vascular endothelial growth factor receptor binding (p=9.03e-03) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"LAMP1","label":"LAMP1","x":794.3161,"y":1731.4835,"size":12.1176,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"LGALS1","label":"LGALS1","x":316.3716,"y":1182.7706,"size":10.0124,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"LHPP","label":"LHPP","x":2626.7067,"y":773.0567,"size":9.0828,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"LRG1","label":"LRG1","x":1138.7094,"y":2543.6673,"size":10.8566,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"LRRC15","label":"LRRC15","x":659.4219,"y":2214.6352,"size":5,"color":"#E78AC3","shape":"triangle","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"LRRFIP1","label":"LRRFIP1","x":569.6745,"y":977.5377,"size":11.5824,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"MAOA","label":"MAOA","x":2549.6811,"y":1899.6301,"size":8.7782,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"MAPK1","label":"MAPK1","x":1616.1845,"y":782.9477,"size":11.054,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"MARCKS","label":"MARCKS","x":1904.0487,"y":847.3277,"size":8.9817,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"MCAM","label":"MCAM","x":2592.148,"y":1074.6653,"size":11.7531,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.669<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>APEH, APOL1, COMT, HAAO, ITGB3, L3HYPDH, MCAM, NUCB1, PEBP1, PIPOX, PLD3, PRDX5, SLC44A2<\/span><br><br><b>KEGG:<\/b><br> Peroxisome (p=2.58e-03)<br>Tyrosine metabolism (p=3.43e-02)<br>African trypanosomiasis (p=3.43e-02)<br><br><b>BP:<\/b><br>renal filtration (p=1.83e-04)<br>angiogenesis involved in wound healing (p=2.07e-04) <br> <b>MF:<\/b><br>single-stranded DNA exodeoxyribonuclease activity (p=6.95e-03)<br>vascular endothelial growth factor receptor binding (p=9.03e-03) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"ME1","label":"ME1","x":1393.2071,"y":1986.3862,"size":8.8821,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"METAP2","label":"METAP2","x":665.2507,"y":1390.949,"size":10.5444,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"MOGS","label":"MOGS","x":3012.9618,"y":1554.9694,"size":17.9511,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"MPP1","label":"MPP1","x":827.7866,"y":2058.7645,"size":9.8346,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"MS4A2","label":"MS4A2","x":2983.0895,"y":1784.1098,"size":5,"color":"#D95F02","shape":"triangle","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"MTHFD1","label":"MTHFD1","x":100,"y":1346.2146,"size":9.0604,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"MYO1C","label":"MYO1C","x":2893.6677,"y":745.4989,"size":8.5271,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.524<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AKAP12, B2M, CLTB, CTNNB1, DLGAP4, H1-2, MYO1C, MYO1D, RAB8B, RILPL1, SORBS2, STXBP3, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=1.34e-03)<br>Motor proteins (p=8.29e-03)<br>Pathogenic Escherichia coli infection (p=8.78e-03)<br><br><b>BP:<\/b><br>establishment of protein localization to membrane (p=3.05e-05)<br>cellular response to type II interferon (p=3.78e-05) <br> <b>MF:<\/b><br>syntaxin-1 binding (p=6.83e-05)<br>microfilament motor activity (p=3.11e-04) <br> <b>CC:<\/b><br>phagocytic vesicle (p=2.37e-08)<br>endocytic vesicle (p=5.05e-08)<\/div>"},{"id":"MYO1D","label":"MYO1D","x":2959.2531,"y":834.3575,"size":10.691,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.524<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AKAP12, B2M, CLTB, CTNNB1, DLGAP4, H1-2, MYO1C, MYO1D, RAB8B, RILPL1, SORBS2, STXBP3, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=1.34e-03)<br>Motor proteins (p=8.29e-03)<br>Pathogenic Escherichia coli infection (p=8.78e-03)<br><br><b>BP:<\/b><br>establishment of protein localization to membrane (p=3.05e-05)<br>cellular response to type II interferon (p=3.78e-05) <br> <b>MF:<\/b><br>syntaxin-1 binding (p=6.83e-05)<br>microfilament motor activity (p=3.11e-04) <br> <b>CC:<\/b><br>phagocytic vesicle (p=2.37e-08)<br>endocytic vesicle (p=5.05e-08)<\/div>"},{"id":"NAGK","label":"NAGK","x":239.0195,"y":1028.2835,"size":8.2257,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"NCL","label":"NCL","x":759.6078,"y":1324.0459,"size":9.5027,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"NID1","label":"NID1","x":2241.2425,"y":2422.8581,"size":9.1854,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"NME1","label":"NME1","x":1767.9602,"y":1822.9915,"size":9.7223,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"NME3","label":"NME3","x":1473.3194,"y":207.8349,"size":14.4541,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"NOTCH3","label":"NOTCH3","x":543.081,"y":1848.5027,"size":9.8917,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"NPM1","label":"NPM1","x":829.4885,"y":936.2828,"size":11.3273,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"NSF","label":"NSF","x":2305.6626,"y":1472.5672,"size":11.3592,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"NUCB1","label":"NUCB1","x":1770.8824,"y":1275.215,"size":11.054,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.669<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>APEH, APOL1, COMT, HAAO, ITGB3, L3HYPDH, MCAM, NUCB1, PEBP1, PIPOX, PLD3, PRDX5, SLC44A2<\/span><br><br><b>KEGG:<\/b><br> Peroxisome (p=2.58e-03)<br>Tyrosine metabolism (p=3.43e-02)<br>African trypanosomiasis (p=3.43e-02)<br><br><b>BP:<\/b><br>renal filtration (p=1.83e-04)<br>angiogenesis involved in wound healing (p=2.07e-04) <br> <b>MF:<\/b><br>single-stranded DNA exodeoxyribonuclease activity (p=6.95e-03)<br>vascular endothelial growth factor receptor binding (p=9.03e-03) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"NUDC","label":"NUDC","x":357.066,"y":948.5544,"size":9.4516,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"NUDT5","label":"NUDT5","x":956.5686,"y":989.4376,"size":9.0828,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"P4HB","label":"P4HB","x":2873.4424,"y":1603.4916,"size":9.2982,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"PA2G4","label":"PA2G4","x":506.8989,"y":683.2158,"size":8.1376,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"PABPC1","label":"PABPC1","x":2016.1387,"y":1051.1988,"size":9.4635,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"PARP1","label":"PARP1","x":360.546,"y":659.4991,"size":8.689,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"PDAP1","label":"PDAP1","x":1550.5194,"y":1624.4488,"size":9.0828,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"PDCD5","label":"PDCD5","x":1953.2784,"y":1933.336,"size":8.3152,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"PDLIM1","label":"PDLIM1","x":1818.5689,"y":433.2127,"size":10.5523,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"PDLIM2","label":"PDLIM2","x":1719.895,"y":1492.9922,"size":9.6955,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"PDLIM4","label":"PDLIM4","x":1896.4261,"y":346.5999,"size":10.4785,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"PEBP1","label":"PEBP1","x":2507.3838,"y":1178.7138,"size":8.4061,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.669<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>APEH, APOL1, COMT, HAAO, ITGB3, L3HYPDH, MCAM, NUCB1, PEBP1, PIPOX, PLD3, PRDX5, SLC44A2<\/span><br><br><b>KEGG:<\/b><br> Peroxisome (p=2.58e-03)<br>Tyrosine metabolism (p=3.43e-02)<br>African trypanosomiasis (p=3.43e-02)<br><br><b>BP:<\/b><br>renal filtration (p=1.83e-04)<br>angiogenesis involved in wound healing (p=2.07e-04) <br> <b>MF:<\/b><br>single-stranded DNA exodeoxyribonuclease activity (p=6.95e-03)<br>vascular endothelial growth factor receptor binding (p=9.03e-03) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"PEF1","label":"PEF1","x":1529.4715,"y":2432.8276,"size":10.4217,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"PFN2","label":"PFN2","x":1922.2124,"y":1639.655,"size":10.1764,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"PGAM1","label":"PGAM1","x":2364.6012,"y":541.838,"size":8.2257,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"PIPOX","label":"PIPOX","x":1418.7946,"y":1314.7782,"size":5,"color":"#8DA0CB","shape":"triangle","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.669<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>APEH, APOL1, COMT, HAAO, ITGB3, L3HYPDH, MCAM, NUCB1, PEBP1, PIPOX, PLD3, PRDX5, SLC44A2<\/span><br><br><b>KEGG:<\/b><br> Peroxisome (p=2.58e-03)<br>Tyrosine metabolism (p=3.43e-02)<br>African trypanosomiasis (p=3.43e-02)<br><br><b>BP:<\/b><br>renal filtration (p=1.83e-04)<br>angiogenesis involved in wound healing (p=2.07e-04) <br> <b>MF:<\/b><br>single-stranded DNA exodeoxyribonuclease activity (p=6.95e-03)<br>vascular endothelial growth factor receptor binding (p=9.03e-03) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"PKLR","label":"PKLR","x":1298.6467,"y":2107.5064,"size":8.2847,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"PLCD1","label":"PLCD1","x":1331.521,"y":2599.0769,"size":9.5951,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"PLD3","label":"PLD3","x":1903.8857,"y":1257.8742,"size":8.9174,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.669<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>APEH, APOL1, COMT, HAAO, ITGB3, L3HYPDH, MCAM, NUCB1, PEBP1, PIPOX, PLD3, PRDX5, SLC44A2<\/span><br><br><b>KEGG:<\/b><br> Peroxisome (p=2.58e-03)<br>Tyrosine metabolism (p=3.43e-02)<br>African trypanosomiasis (p=3.43e-02)<br><br><b>BP:<\/b><br>renal filtration (p=1.83e-04)<br>angiogenesis involved in wound healing (p=2.07e-04) <br> <b>MF:<\/b><br>single-stranded DNA exodeoxyribonuclease activity (p=6.95e-03)<br>vascular endothelial growth factor receptor binding (p=9.03e-03) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"PLEC","label":"PLEC","x":411.4728,"y":1146.933,"size":9.1854,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"PLEKHO2","label":"PLEKHO2","x":1653.8839,"y":2112.9906,"size":8.9817,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"PLIN3","label":"PLIN3","x":1387.5701,"y":2519.9131,"size":9.3825,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"PLP1","label":"PLP1","x":1983.6739,"y":1537.668,"size":8.2257,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"PLP2","label":"PLP2","x":2715.1241,"y":519.0129,"size":8.7771,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"PLPBP","label":"PLPBP","x":234.5811,"y":1275.3371,"size":11.3413,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"PLTP","label":"PLTP","x":1193.3988,"y":2039.8558,"size":10.1816,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"PML","label":"PML","x":1692.3413,"y":2245.6095,"size":10.5259,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"POGLUT3","label":"POGLUT3","x":430.9286,"y":1476.4239,"size":8.2016,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='padding:10px; background:#fff; color:#333; border-radius:8px;'><h4 style='color:#666;'>Cluster 19<\/h4><b>Genes:<\/b> EOGT, POGLUT3<br><i style='color:#999;'>Cluster pequeno para enriquecimiento<\/i><\/div>"},{"id":"POSTN","label":"POSTN","x":528.1008,"y":2162.579,"size":8.5021,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"PPME1","label":"PPME1","x":1457.8044,"y":2307.9502,"size":8.9526,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"PPP1R7","label":"PPP1R7","x":1572.3934,"y":2599.9845,"size":8.4061,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"PPP2CB","label":"PPP2CB","x":548.9477,"y":509.4407,"size":9.784,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"PPP3CA","label":"PPP3CA","x":738.4075,"y":2045.2729,"size":8.4487,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"PRDX5","label":"PRDX5","x":2624.3227,"y":1207.6887,"size":8.2085,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.669<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>APEH, APOL1, COMT, HAAO, ITGB3, L3HYPDH, MCAM, NUCB1, PEBP1, PIPOX, PLD3, PRDX5, SLC44A2<\/span><br><br><b>KEGG:<\/b><br> Peroxisome (p=2.58e-03)<br>Tyrosine metabolism (p=3.43e-02)<br>African trypanosomiasis (p=3.43e-02)<br><br><b>BP:<\/b><br>renal filtration (p=1.83e-04)<br>angiogenesis involved in wound healing (p=2.07e-04) <br> <b>MF:<\/b><br>single-stranded DNA exodeoxyribonuclease activity (p=6.95e-03)<br>vascular endothelial growth factor receptor binding (p=9.03e-03) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"PRPF8","label":"PRPF8","x":854.2638,"y":1083.6238,"size":9.3076,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"PSIP1","label":"PSIP1","x":1201.5798,"y":1275.9808,"size":8.9817,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"PSMA1","label":"PSMA1","x":1247.3571,"y":763.2962,"size":12.0026,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"PSMA2","label":"PSMA2","x":613.6301,"y":583.3329,"size":8.5921,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"PSMA3","label":"PSMA3","x":1910.4295,"y":543.8087,"size":9.1854,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"PSMA4","label":"PSMA4","x":955.2961,"y":678.0557,"size":10.0642,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"PSMA5","label":"PSMA5","x":1851.595,"y":1923.5689,"size":9.0828,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"PSMA6","label":"PSMA6","x":1471.0581,"y":712.0871,"size":10.4217,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"PSMB1","label":"PSMB1","x":1081.1917,"y":622.4569,"size":9.9485,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"PSMB2","label":"PSMB2","x":366.922,"y":1026.8843,"size":11.054,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"PSMB4","label":"PSMB4","x":1592.6785,"y":1119.325,"size":10.1816,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"PSMB5","label":"PSMB5","x":1765.4916,"y":1624.6286,"size":11.4567,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"PSMB7","label":"PSMB7","x":2038.2135,"y":1748.1387,"size":10.1816,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"PSMB8","label":"PSMB8","x":1683.8259,"y":2497.8047,"size":8.8247,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"PSMC4","label":"PSMC4","x":2755.2697,"y":1592.5826,"size":8.6385,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"PSMD13","label":"PSMD13","x":960.3358,"y":1077.0688,"size":9.2834,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"PSME2","label":"PSME2","x":1313.3978,"y":1100.3027,"size":12.3191,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"PTGIS","label":"PTGIS","x":1102.1161,"y":2117.4653,"size":13.177,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"PTPN11","label":"PTPN11","x":1868.3738,"y":1444.8322,"size":8.2257,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"PYGB","label":"PYGB","x":1193.5094,"y":2380.0369,"size":8.9293,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"PYGM","label":"PYGM","x":2223.1739,"y":651.2609,"size":9.5504,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"QSOX1","label":"QSOX1","x":2207.6718,"y":235.9512,"size":9.5078,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"RAB23","label":"RAB23","x":1244.6252,"y":1613.5156,"size":11.3205,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"RAB2A","label":"RAB2A","x":1605.8294,"y":605.0186,"size":9.6051,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.469<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>BLVRA, CYB5B, CYB5R3, HMGCL, HSD17B10, HSDL2, ILF3, RAB2A, RPS18, SSBP1, TUBA1C, TXNRD1, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=1.85e-04)<br>Valine, leucine and isoleucine degradation (p=1.08e-03)<br>Selenocompound metabolism (p=1.76e-02)<br><br><b>BP:<\/b><br>branched-chain amino acid catabolic process (p=1.01e-04)<br>branched-chain amino acid metabolic process (p=1.42e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=2.95e-05)<br>FAD binding (p=2.92e-04) <br> <b>CC:<\/b><br>nucleoid (p=4.56e-04)<br>mitochondrial nucleoid (p=4.56e-04)<\/div>"},{"id":"RAB8B","label":"RAB8B","x":2835.8618,"y":1207.7256,"size":8.901,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.524<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AKAP12, B2M, CLTB, CTNNB1, DLGAP4, H1-2, MYO1C, MYO1D, RAB8B, RILPL1, SORBS2, STXBP3, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=1.34e-03)<br>Motor proteins (p=8.29e-03)<br>Pathogenic Escherichia coli infection (p=8.78e-03)<br><br><b>BP:<\/b><br>establishment of protein localization to membrane (p=3.05e-05)<br>cellular response to type II interferon (p=3.78e-05) <br> <b>MF:<\/b><br>syntaxin-1 binding (p=6.83e-05)<br>microfilament motor activity (p=3.11e-04) <br> <b>CC:<\/b><br>phagocytic vesicle (p=2.37e-08)<br>endocytic vesicle (p=5.05e-08)<\/div>"},{"id":"RAD23B","label":"RAD23B","x":1193.4115,"y":1124.7201,"size":11.8976,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"RANBP1","label":"RANBP1","x":2090.8359,"y":504.957,"size":11.3172,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"RAP1A","label":"RAP1A","x":561.4067,"y":2079.5149,"size":11.4532,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"RARRES2","label":"RARRES2","x":887.5727,"y":2427.2915,"size":9.6566,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"RCN1","label":"RCN1","x":2869.6463,"y":1509.775,"size":9.6052,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"RCN2","label":"RCN2","x":1511.6985,"y":1728.4951,"size":5,"color":"#A6D854","shape":"triangle","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"RECQL","label":"RECQL","x":852.2844,"y":536.5281,"size":8.141,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"RER1","label":"RER1","x":2861.0018,"y":1959.4312,"size":5,"color":"#D95F02","shape":"triangle","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"RHOG","label":"RHOG","x":907.0277,"y":1902.3835,"size":9.7223,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"RILPL1","label":"RILPL1","x":2947.2758,"y":1238.3255,"size":9.346,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.524<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AKAP12, B2M, CLTB, CTNNB1, DLGAP4, H1-2, MYO1C, MYO1D, RAB8B, RILPL1, SORBS2, STXBP3, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=1.34e-03)<br>Motor proteins (p=8.29e-03)<br>Pathogenic Escherichia coli infection (p=8.78e-03)<br><br><b>BP:<\/b><br>establishment of protein localization to membrane (p=3.05e-05)<br>cellular response to type II interferon (p=3.78e-05) <br> <b>MF:<\/b><br>syntaxin-1 binding (p=6.83e-05)<br>microfilament motor activity (p=3.11e-04) <br> <b>CC:<\/b><br>phagocytic vesicle (p=2.37e-08)<br>endocytic vesicle (p=5.05e-08)<\/div>"},{"id":"RNASE3","label":"RNASE3","x":2276.3976,"y":2054.2296,"size":8.8821,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"RNPEP","label":"RNPEP","x":124.1781,"y":1176.1655,"size":16.7178,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"RO60","label":"RO60","x":1573.0056,"y":1011.9798,"size":10.0181,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"RPL12","label":"RPL12","x":466.8134,"y":843.7681,"size":12.4707,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"RPL13","label":"RPL13","x":2001.4366,"y":1841.6812,"size":9.5099,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"RPL23","label":"RPL23","x":2265.6382,"y":1767.4303,"size":8.8076,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"RPL27A","label":"RPL27A","x":1069.3641,"y":725.6246,"size":10.9391,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"RPL31","label":"RPL31","x":1830.4544,"y":1038.8548,"size":8.4984,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"RPL35","label":"RPL35","x":240.6632,"y":1351.5383,"size":12.0805,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"RPN1","label":"RPN1","x":2263.8916,"y":1679.9513,"size":8.7212,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"RPN2","label":"RPN2","x":2996.0743,"y":1642.612,"size":10.495,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"RPS11","label":"RPS11","x":1816.5176,"y":2056.7156,"size":11.054,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"RPS18","label":"RPS18","x":1545.9793,"y":513.066,"size":8.325,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.469<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>BLVRA, CYB5B, CYB5R3, HMGCL, HSD17B10, HSDL2, ILF3, RAB2A, RPS18, SSBP1, TUBA1C, TXNRD1, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=1.85e-04)<br>Valine, leucine and isoleucine degradation (p=1.08e-03)<br>Selenocompound metabolism (p=1.76e-02)<br><br><b>BP:<\/b><br>branched-chain amino acid catabolic process (p=1.01e-04)<br>branched-chain amino acid metabolic process (p=1.42e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=2.95e-05)<br>FAD binding (p=2.92e-04) <br> <b>CC:<\/b><br>nucleoid (p=4.56e-04)<br>mitochondrial nucleoid (p=4.56e-04)<\/div>"},{"id":"RPS23","label":"RPS23","x":1931.6797,"y":2026.6134,"size":8.2309,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"RPS28","label":"RPS28","x":2713.3432,"y":1436.5179,"size":10.9237,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"RPS9","label":"RPS9","x":2275.7753,"y":1896.8319,"size":11.134,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"RRAS2","label":"RRAS2","x":1989.2787,"y":703.3918,"size":8.2257,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"RRBP1","label":"RRBP1","x":903.2472,"y":2199.4014,"size":8.8821,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"S100A11","label":"S100A11","x":2711.0855,"y":604.8671,"size":9.7103,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"S100A6","label":"S100A6","x":255.2999,"y":836.1424,"size":9.8987,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"SAA4","label":"SAA4","x":2407.0748,"y":1353.2172,"size":10.4017,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"SCCPDH","label":"SCCPDH","x":3026.3821,"y":1379.0368,"size":9.7035,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"SCRN2","label":"SCRN2","x":1145.8628,"y":1811.9174,"size":8.6044,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"SEC24C","label":"SEC24C","x":176.7308,"y":1778.1853,"size":8.1642,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"SELENOP","label":"SELENOP","x":2197.2163,"y":970.0554,"size":10.5444,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"SERPINA1","label":"SERPINA1","x":2417.6382,"y":1435.4814,"size":10.5219,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"SERPINA6","label":"SERPINA6","x":987.3474,"y":1500.051,"size":10.3235,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"SERPINC1","label":"SERPINC1","x":2031.9419,"y":2486.1476,"size":10.0745,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"SERPINF2","label":"SERPINF2","x":2568.0249,"y":557.5442,"size":9.6117,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"SERPING1","label":"SERPING1","x":1011.0314,"y":2415.4475,"size":10.4217,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"SERPINH1","label":"SERPINH1","x":234.9934,"y":1713.2654,"size":8.7329,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"SET","label":"SET","x":713.8917,"y":550.0761,"size":12.1698,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"SGCB","label":"SGCB","x":2342.2129,"y":2440.0986,"size":11.7852,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"SGCD","label":"SGCD","x":2771.1252,"y":918.662,"size":8.8429,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"SH3GL1","label":"SH3GL1","x":2428.1622,"y":2347.0941,"size":9.2229,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"SHMT1","label":"SHMT1","x":1401.6821,"y":2174.277,"size":12.1926,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.551<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACSM4, APOA1, CYTL1, DHRS1, FASN, FLAD1, GCLC, GGCT, GYS1, HSD17B4, ITIH3, LRG1, ME1, PEF1, PKLR, PLCD1, PLEKHO2, PLIN3, PLTP, PPME1, PPP1R7, PYGB, RARRES2, SERPING1, SHMT1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=5.01e-05)<br>PPAR signaling pathway (p=2.05e-04)<br>Carbon metabolism (p=7.30e-04)<br><br><b>BP:<\/b><br>vitamin metabolic process (p=1.15e-05)<br>sulfur compound metabolic process (p=4.13e-05) <br> <b>MF:<\/b><br>lyase activity (p=6.04e-06)<br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=1.99e-05) <br> <b>CC:<\/b><br>secretory granule lumen (p=2.44e-06)<br>cytoplasmic vesicle lumen (p=2.67e-06)<\/div>"},{"id":"SLC25A11","label":"SLC25A11","x":760.1786,"y":381.8441,"size":11.8237,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"SLC25A4","label":"SLC25A4","x":1088.7262,"y":1896.7793,"size":8.9805,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"SLC25A6","label":"SLC25A6","x":1908.33,"y":2141.0438,"size":10.9078,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"SLC44A2","label":"SLC44A2","x":2426.2322,"y":1069.4969,"size":8.4061,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.669<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>APEH, APOL1, COMT, HAAO, ITGB3, L3HYPDH, MCAM, NUCB1, PEBP1, PIPOX, PLD3, PRDX5, SLC44A2<\/span><br><br><b>KEGG:<\/b><br> Peroxisome (p=2.58e-03)<br>Tyrosine metabolism (p=3.43e-02)<br>African trypanosomiasis (p=3.43e-02)<br><br><b>BP:<\/b><br>renal filtration (p=1.83e-04)<br>angiogenesis involved in wound healing (p=2.07e-04) <br> <b>MF:<\/b><br>single-stranded DNA exodeoxyribonuclease activity (p=6.95e-03)<br>vascular endothelial growth factor receptor binding (p=9.03e-03) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"SNRPD2","label":"SNRPD2","x":1681.5976,"y":1052.2499,"size":10.2528,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"SNTB2","label":"SNTB2","x":2077.3923,"y":875.0941,"size":11.8743,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"SORBS1","label":"SORBS1","x":682.1955,"y":1828.5855,"size":12.6247,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"SORBS2","label":"SORBS2","x":3096.0357,"y":1262.0396,"size":9.2896,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.524<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AKAP12, B2M, CLTB, CTNNB1, DLGAP4, H1-2, MYO1C, MYO1D, RAB8B, RILPL1, SORBS2, STXBP3, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=1.34e-03)<br>Motor proteins (p=8.29e-03)<br>Pathogenic Escherichia coli infection (p=8.78e-03)<br><br><b>BP:<\/b><br>establishment of protein localization to membrane (p=3.05e-05)<br>cellular response to type II interferon (p=3.78e-05) <br> <b>MF:<\/b><br>syntaxin-1 binding (p=6.83e-05)<br>microfilament motor activity (p=3.11e-04) <br> <b>CC:<\/b><br>phagocytic vesicle (p=2.37e-08)<br>endocytic vesicle (p=5.05e-08)<\/div>"},{"id":"SPCS2","label":"SPCS2","x":2170.8258,"y":1837.6852,"size":17.6369,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.521<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ARF4, COPA, DDX6, GNB2, GNB4, HNRNPA0, HSPA5, NME1, PDAP1, PDCD5, PSMA5, PSMB7, RAB23, RCN2, RPL13, RPL23, RPN1, RPS23, RPS9, SCRN2, SLC25A4, SPCS2<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.12e-04)<br>Parkinson disease (p=6.73e-04)<br>Prion disease (p=7.41e-04)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=3.34e-05)<br>GTP metabolic process (p=3.51e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=4.81e-05)<br>signaling receptor complex adaptor activity (p=1.70e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=7.94e-06)<br>ribosomal subunit (p=4.76e-05)<\/div>"},{"id":"SRC","label":"SRC","x":785.3065,"y":1913.3263,"size":9.6146,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"SSBP1","label":"SSBP1","x":1675.9093,"y":523.9497,"size":8.2719,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.469<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>BLVRA, CYB5B, CYB5R3, HMGCL, HSD17B10, HSDL2, ILF3, RAB2A, RPS18, SSBP1, TUBA1C, TXNRD1, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=1.85e-04)<br>Valine, leucine and isoleucine degradation (p=1.08e-03)<br>Selenocompound metabolism (p=1.76e-02)<br><br><b>BP:<\/b><br>branched-chain amino acid catabolic process (p=1.01e-04)<br>branched-chain amino acid metabolic process (p=1.42e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=2.95e-05)<br>FAD binding (p=2.92e-04) <br> <b>CC:<\/b><br>nucleoid (p=4.56e-04)<br>mitochondrial nucleoid (p=4.56e-04)<\/div>"},{"id":"ST13","label":"ST13","x":1155.3005,"y":157.2721,"size":12.0229,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"STAT3","label":"STAT3","x":1592.5318,"y":2229.5773,"size":8.8503,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"STIP1","label":"STIP1","x":592.0708,"y":1259.803,"size":12.781,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"STXBP3","label":"STXBP3","x":2848.5643,"y":671.4147,"size":8.8336,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.524<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AKAP12, B2M, CLTB, CTNNB1, DLGAP4, H1-2, MYO1C, MYO1D, RAB8B, RILPL1, SORBS2, STXBP3, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=1.34e-03)<br>Motor proteins (p=8.29e-03)<br>Pathogenic Escherichia coli infection (p=8.78e-03)<br><br><b>BP:<\/b><br>establishment of protein localization to membrane (p=3.05e-05)<br>cellular response to type II interferon (p=3.78e-05) <br> <b>MF:<\/b><br>syntaxin-1 binding (p=6.83e-05)<br>microfilament motor activity (p=3.11e-04) <br> <b>CC:<\/b><br>phagocytic vesicle (p=2.37e-08)<br>endocytic vesicle (p=5.05e-08)<\/div>"},{"id":"SUN2","label":"SUN2","x":2179.2497,"y":484.8347,"size":11.5369,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"SURF4","label":"SURF4","x":2752.4559,"y":1935.9046,"size":9.4,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"SVIL","label":"SVIL","x":2149.8547,"y":1364.415,"size":8.8915,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"SYNGR2","label":"SYNGR2","x":2610.1337,"y":2269.682,"size":9.6431,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"TAGLN2","label":"TAGLN2","x":229.4863,"y":1525.0788,"size":8.1376,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"TALDO1","label":"TALDO1","x":1073.218,"y":325.125,"size":8.1376,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"TCOF1","label":"TCOF1","x":2155.7172,"y":2297.8387,"size":9.8346,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"TFG","label":"TFG","x":2452.1868,"y":1668.351,"size":13.1013,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"TMSB4X","label":"TMSB4X","x":816.1379,"y":268.955,"size":10.4016,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AEBP1, ATP5F1D, CHST14, COL6A1, COL6A3, DCXR, DNAJC24, EEF1D, EFEMP2, ENPP1, FILIP1L, FLNC, HSD17B12, HSPA12A, HSPB6, NME3, SLC25A11, ST13, TALDO1, TMSB4X<\/span><br><br><b>KEGG:<\/b><br> Pyrimidine metabolism (p=1.92e-03)<br>Cytoskeleton in muscle cells (p=2.04e-03)<br>Nucleotide metabolism (p=4.08e-03)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=5.85e-09)<br>purine ribonucleoside triphosphate metabolic process (p=4.31e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>collagen binding (p=6.01e-05) <br> <b>CC:<\/b><br>sarcolemma (p=3.80e-04)<br>collagen-containing extracellular matrix (p=8.08e-04)<\/div>"},{"id":"TMX4","label":"TMX4","x":2959.1262,"y":1457.0837,"size":11.7771,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"TNS1","label":"TNS1","x":1669.0132,"y":1801.0253,"size":8.7758,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.574<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ALCAM, BCAP31, CAV1, CD74, CPNE1, ILK, ITGB1, JAM3, KANK2, PDLIM2, PFN2, PLP1, PML, PSMB5, PSMB8, PTGIS, PTPN11, RRBP1, STAT3, TNS1<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=2.71e-04)<br>Proteoglycans in cancer (p=2.99e-04)<br>Leukocyte transendothelial migration (p=8.68e-04)<br><br><b>BP:<\/b><br>ameboidal-type cell migration (p=3.71e-09)<br>fibroblast migration (p=3.30e-07) <br> <b>MF:<\/b><br>nitric-oxide synthase binding (p=5.98e-05)<br>threonine-type peptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>myelin sheath (p=1.37e-05)<br>protein complex involved in cell adhesion (p=2.59e-05)<\/div>"},{"id":"TNXB","label":"TNXB","x":2289.0905,"y":996.5908,"size":9.5027,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"TPI1","label":"TPI1","x":169.6568,"y":1418.9189,"size":9.2896,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"TRIM28","label":"TRIM28","x":1858.1895,"y":2252.5678,"size":9.4773,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"TUBA1C","label":"TUBA1C","x":1948.1717,"y":172.2897,"size":9.2493,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.469<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>BLVRA, CYB5B, CYB5R3, HMGCL, HSD17B10, HSDL2, ILF3, RAB2A, RPS18, SSBP1, TUBA1C, TXNRD1, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=1.85e-04)<br>Valine, leucine and isoleucine degradation (p=1.08e-03)<br>Selenocompound metabolism (p=1.76e-02)<br><br><b>BP:<\/b><br>branched-chain amino acid catabolic process (p=1.01e-04)<br>branched-chain amino acid metabolic process (p=1.42e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=2.95e-05)<br>FAD binding (p=2.92e-04) <br> <b>CC:<\/b><br>nucleoid (p=4.56e-04)<br>mitochondrial nucleoid (p=4.56e-04)<\/div>"},{"id":"TUBA4A","label":"TUBA4A","x":2792.8139,"y":1717.9912,"size":8.8085,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>DDOST, EIF2S3, EPX, ERGIC1, FCGBP, GAA, HMGB2, HNRNPM, MOGS, MS4A2, NSF, P4HB, PSMC4, RCN1, RER1, RPN2, RPS28, SAA4, SCCPDH, SERPINA1, SURF4, TMX4, TUBA4A<\/span><br><br><b>KEGG:<\/b><br> N-Glycan biosynthesis (p=5.22e-05)<br>Protein processing in endoplasmic reticulum (p=6.66e-05)<br>Asthma (p=8.27e-04)<br><br><b>BP:<\/b><br>Golgi vesicle transport (p=1.81e-05)<br>protein N-linked glycosylation (p=7.10e-05) <br> <b>MF:<\/b><br>glucosidase activity (p=1.31e-04)<br>disulfide oxidoreductase activity (p=1.10e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=4.24e-07)<br>azurophil granule membrane (p=4.00e-05)<\/div>"},{"id":"TUBB","label":"TUBB","x":1765.9763,"y":2325.4488,"size":9.0303,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.615<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ALDH16A1, ANXA6, BLVRB, CLU, GSTO1, H1-3, H2AC21, HSPD1, NID1, RPS11, SERPINC1, SGCB, SLC25A6, TCOF1, TRIM28, TUBB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=5.21e-03)<br>Necroptosis (p=1.80e-02)<br>Neutrophil extracellular trap formation (p=2.41e-02)<br><br><b>BP:<\/b><br>apoptotic mitochondrial changes (p=7.75e-05)<br>chaperone-mediated protein complex assembly (p=1.62e-04) <br> <b>MF:<\/b><br>ubiquitin protein ligase binding (p=1.05e-04)<br>ubiquitin-like protein ligase binding (p=1.35e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.25e-04)<br>euchromatin (p=1.15e-03)<\/div>"},{"id":"TUBB2A","label":"TUBB2A","x":188.5467,"y":915.2549,"size":10.4524,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.481<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CNDP2, DDX3X, ECHS1, ETF1, HDGF, KPNA4, KTN1, NAGK, NPM1, NUDC, PA2G4, PARP1, PSMB2, RNPEP, RPL12, S100A6, TUBB2A<\/span><br><br><b>KEGG:<\/b><br> beta-Alanine metabolism (p=7.76e-04)<br>Amyotrophic lateral sclerosis (p=1.24e-02)<br>Histidine metabolism (p=2.95e-02)<br><br><b>BP:<\/b><br>regulation of translation in response to stress (p=2.21e-04)<br>protein localization to nucleus (p=2.67e-04) <br> <b>MF:<\/b><br>ribosomal small subunit binding (p=1.85e-04)<br>ribosome binding (p=1.91e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.84e-04)<br>ribosome (p=1.53e-03)<\/div>"},{"id":"TUBB6","label":"TUBB6","x":2456.103,"y":465.9917,"size":8.6963,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.598<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACOT1, AKT1, BST2, CHMP4B, CLTC, ECH1, FHL1, GALM, HADH, HLA-B, HNRNPH1, MARCKS, PDLIM1, PDLIM4, PGAM1, PYGM, RANBP1, RRAS2, SNTB2, SUN2, TUBB6<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=9.46e-05)<br>Glucagon signaling pathway (p=1.35e-03)<br>Fatty acid elongation (p=1.52e-03)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=3.49e-05)<br>fatty acid beta-oxidation (p=6.36e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=1.26e-04)<br>alpha-actinin binding (p=4.49e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.76e-06)<br>cell-substrate junction (p=4.30e-06)<\/div>"},{"id":"TUBGCP3","label":"TUBGCP3","x":2657.1914,"y":2086.5612,"size":5,"color":"#F781BF","shape":"triangle","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"TXNRD1","label":"TXNRD1","x":1839.6966,"y":111.108,"size":8.7839,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.469<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>BLVRA, CYB5B, CYB5R3, HMGCL, HSD17B10, HSDL2, ILF3, RAB2A, RPS18, SSBP1, TUBA1C, TXNRD1, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=1.85e-04)<br>Valine, leucine and isoleucine degradation (p=1.08e-03)<br>Selenocompound metabolism (p=1.76e-02)<br><br><b>BP:<\/b><br>branched-chain amino acid catabolic process (p=1.01e-04)<br>branched-chain amino acid metabolic process (p=1.42e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=2.95e-05)<br>FAD binding (p=2.92e-04) <br> <b>CC:<\/b><br>nucleoid (p=4.56e-04)<br>mitochondrial nucleoid (p=4.56e-04)<\/div>"},{"id":"UGDH","label":"UGDH","x":1825.0924,"y":200.8344,"size":10.5369,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.469<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>BLVRA, CYB5B, CYB5R3, HMGCL, HSD17B10, HSDL2, ILF3, RAB2A, RPS18, SSBP1, TUBA1C, TXNRD1, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=1.85e-04)<br>Valine, leucine and isoleucine degradation (p=1.08e-03)<br>Selenocompound metabolism (p=1.76e-02)<br><br><b>BP:<\/b><br>branched-chain amino acid catabolic process (p=1.01e-04)<br>branched-chain amino acid metabolic process (p=1.42e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=2.95e-05)<br>FAD binding (p=2.92e-04) <br> <b>CC:<\/b><br>nucleoid (p=4.56e-04)<br>mitochondrial nucleoid (p=4.56e-04)<\/div>"},{"id":"VAMP3","label":"VAMP3","x":2771.8372,"y":1106.5636,"size":11.1195,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.524<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AKAP12, B2M, CLTB, CTNNB1, DLGAP4, H1-2, MYO1C, MYO1D, RAB8B, RILPL1, SORBS2, STXBP3, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=1.34e-03)<br>Motor proteins (p=8.29e-03)<br>Pathogenic Escherichia coli infection (p=8.78e-03)<br><br><b>BP:<\/b><br>establishment of protein localization to membrane (p=3.05e-05)<br>cellular response to type II interferon (p=3.78e-05) <br> <b>MF:<\/b><br>syntaxin-1 binding (p=6.83e-05)<br>microfilament motor activity (p=3.11e-04) <br> <b>CC:<\/b><br>phagocytic vesicle (p=2.37e-08)<br>endocytic vesicle (p=5.05e-08)<\/div>"},{"id":"VAT1L","label":"VAT1L","x":2649.0856,"y":1875.1082,"size":9.0862,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.589<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ALB, ANO6, ANXA3, APOA4, APOC1, AZGP1, DCD, DNM1L, EDNRA, FN3K, GC, H1-0, H1-4, HCLS1, ITGAV, MAOA, RNASE3, SH3GL1, SYNGR2, TFG, TUBGCP3, VAT1L<\/span><br><br><b>KEGG:<\/b><br> Cholesterol metabolism (p=1.85e-03)<br>Efferocytosis (p=1.59e-02)<br>Phenylalanine metabolism (p=1.99e-02)<br><br><b>BP:<\/b><br>phospholipid efflux (p=1.07e-04)<br>lipoprotein metabolic process (p=1.71e-04) <br> <b>MF:<\/b><br>phospholipase inhibitor activity (p=8.71e-05)<br>lipase inhibitor activity (p=1.58e-04) <br> <b>CC:<\/b><br>chylomicron (p=8.23e-05)<br>very-low-density lipoprotein particle (p=2.20e-04)<\/div>"},{"id":"VDAC1","label":"VDAC1","x":1755.08,"y":735.1364,"size":12.2152,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"VDAC3","label":"VDAC3","x":1237.3862,"y":842.8618,"size":8.3595,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"VIM","label":"VIM","x":308.6012,"y":1655.2032,"size":9.3737,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.625<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>ACTG2, ALDH1L1, ANG, ANOS1, APOE, ATP1A2, CD9, DES, DUSP6, MTHFD1, NOTCH3, PLPBP, RPL35, SEC24C, SERPINH1, TAGLN2, TPI1, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>One carbon pool by folate (p=1.43e-03)<br>Thyroid hormone signaling pathway (p=1.33e-02)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=1.17e-04)<br>negative regulation of platelet activation (p=1.31e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (p=1.34e-04)<br>oxidoreductase activity, acting on the CH-NH group of donors (p=3.05e-04) <br> <b>CC:<\/b><br>endocytic vesicle (p=2.59e-04)<br>coated vesicle membrane (p=7.87e-04)<\/div>"},{"id":"VTN","label":"VTN","x":2494.1369,"y":754.2901,"size":10.9613,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"WFS1","label":"WFS1","x":1098.7046,"y":1428.173,"size":8.5662,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.63<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ARF3, ATRN, CD59, CDH13, CFHR3, COL16A1, CPA3, CPE, EHD1, FAM114A1, FBLIM1, FNDC1, GNG12, HEBP1, HP, LAMP1, LRRC15, MPP1, POSTN, PPP3CA, RAP1A, RHOG, SERPINA6, SORBS1, SRC, WFS1<\/span><br><br><b>KEGG:<\/b><br> Adherens junction (p=3.72e-04)<br>Tuberculosis (p=2.61e-03)<br>Chemokine signaling pathway (p=3.08e-03)<br><br><b>BP:<\/b><br>integrin activation (p=4.66e-06)<br>cell-matrix adhesion (p=1.13e-05) <br> <b>MF:<\/b><br>ATPase binding (p=1.89e-04)<br>insulin receptor binding (p=4.29e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.46e-05)<br>cell-substrate junction (p=1.66e-05)<\/div>"},{"id":"WIPF1","label":"WIPF1","x":2196.3766,"y":1196.8709,"size":15.0628,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"},{"id":"XRCC5","label":"XRCC5","x":637.9712,"y":1167.1331,"size":9.0884,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.518<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ATP2A2, CAST, CD47, DNPEP, EIF3B, EIF4B, ERAP1, ERLIN2, GPC4, HNRNPH3, IPO5, LGALS1, LRRFIP1, METAP2, NCL, NUDT5, PLEC, PRPF8, PSIP1, PSMD13, PSME2, RAD23B, STIP1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.60e-03)<br>Non-homologous end-joining (p=2.16e-02)<br>Spinocerebellar ataxia (p=2.35e-02)<br><br><b>BP:<\/b><br>protein-RNA complex assembly (p=8.83e-06)<br>protein-RNA complex organization (p=1.07e-05) <br> <b>MF:<\/b><br>aminopeptidase activity (p=1.80e-05)<br>exopeptidase activity (p=2.96e-04) <br> <b>CC:<\/b><br>proteasome complex (p=6.14e-05)<br>endopeptidase complex (p=2.18e-04)<\/div>"},{"id":"YAP1","label":"YAP1","x":1917.18,"y":1120.3401,"size":11.333,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.536<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, AHNAK, COL6A2, CP, DMD, FBLN5, LHPP, PABPC1, PLP2, PSMB4, RO60, RPL31, S100A11, SELENOP, SERPINF2, SGCD, SNRPD2, TNXB, VTN, YAP1<\/span><br><br><b>KEGG:<\/b><br> ECM-receptor interaction (p=4.82e-04)<br>Cytoskeleton in muscle cells (p=6.37e-04)<br>Hypertrophic cardiomyopathy (p=6.59e-04)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=6.49e-05)<br>negative regulation of fibrinolysis (p=9.20e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.76e-05)<br>structural molecule activity conferring elasticity (p=5.98e-05) <br> <b>CC:<\/b><br>blood microparticle (p=3.57e-07)<br>sarcolemma (p=1.40e-05)<\/div>"},{"id":"YBX3","label":"YBX3","x":925.4447,"y":461.1777,"size":8.4363,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.548<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GUK1, HNRNPL, PPP2CB, PSMA1, PSMA2, PSMA4, PSMA6, PSMB1, RECQL, RPL27A, SET, VDAC3, YBX3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.10e-10)<br>Spinocerebellar ataxia (p=2.10e-09)<br>Parkinson disease (p=9.37e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=9.40e-07)<br>cytoplasmic translation (p=3.00e-04) <br> <b>MF:<\/b><br>pre-mRNA intronic binding (p=1.04e-02)<br>annealing activity (p=1.04e-02) <br> <b>CC:<\/b><br>proteasome core complex (p=1.79e-12)<br>proteasome complex (p=8.64e-10)<\/div>"},{"id":"YWHAB","label":"YWHAB","x":2039.1467,"y":386.9656,"size":9.3057,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.52<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CKB, CTNND1, DDX17, FLII, GNA13, GSN, IDH3B, ITGA8, MAPK1, PSMA3, QSOX1, SVIL, VDAC1, WIPF1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=5.55e-05)<br>Regulation of actin cytoskeleton (p=2.03e-04)<br>Aldosterone-regulated sodium reabsorption (p=1.17e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=4.14e-07)<br>barbed-end actin filament capping (p=1.39e-06) <br> <b>MF:<\/b><br>actin binding (p=3.62e-05)<br>phosphatidylinositol-4,5-bisphosphate binding (p=6.15e-05) <br> <b>CC:<\/b><br>focal adhesion (p=3.09e-08)<br>cell-substrate junction (p=3.63e-08)<\/div>"}],"aristas":[{"from":"AEBP1","to":"EFEMP2","weight":0.419},{"from":"COL6A3","to":"EFEMP2","weight":0.401},{"from":"CP","to":"SELENOP","weight":0.407},{"from":"SELENOP","to":"TNXB","weight":0.436},{"from":"ITGB3","to":"MCAM","weight":0.411},{"from":"ACTC1","to":"MCAM","weight":0.421},{"from":"TAGLN2","to":"VIM","weight":0.407},{"from":"ACTG2","to":"TAGLN2","weight":0.421},{"from":"APOE","to":"NOTCH3","weight":0.403},{"from":"APOE","to":"VIM","weight":0.408},{"from":"COMT","to":"ITGB1","weight":0.41},{"from":"ITGB1","to":"TNS1","weight":0.408},{"from":"TRIM28","to":"TUBB","weight":0.411},{"from":"ANXA6","to":"TUBB","weight":0.402},{"from":"ATP2A2","to":"ERLIN2","weight":0.404},{"from":"ATP2A2","to":"PLEC","weight":0.423},{"from":"RPS11","to":"TRIM28","weight":0.407},{"from":"AZGP1","to":"ITGAV","weight":0.417},{"from":"AZGP1","to":"GSN","weight":0.416},{"from":"COL6A1","to":"FLNC","weight":0.415},{"from":"SLC25A4","to":"SRC","weight":0.407},{"from":"SORBS1","to":"SRC","weight":0.428},{"from":"PGAM1","to":"TUBB6","weight":0.417},{"from":"CLTC","to":"TUBB6","weight":0.425},{"from":"FASN","to":"TUBB","weight":0.404},{"from":"FASN","to":"PYGB","weight":0.402},{"from":"ITGB1","to":"NME1","weight":0.412},{"from":"HSPA5","to":"NME1","weight":0.412},{"from":"ILF3","to":"RPS18","weight":0.446},{"from":"CYB5R3","to":"ILF3","weight":0.405},{"from":"CP","to":"FBLN5","weight":0.432},{"from":"COL6A2","to":"FBLN5","weight":0.446},{"from":"AKAP12","to":"CTNNB1","weight":0.408},{"from":"CTNNB1","to":"MYO1D","weight":0.431},{"from":"ECHS1","to":"S100A6","weight":0.413},{"from":"S100A6","to":"TUBB2A","weight":0.429},{"from":"MYO1C","to":"MYO1D","weight":0.411},{"from":"APOA4","to":"P4HB","weight":0.417},{"from":"P4HB","to":"TUBA4A","weight":0.413},{"from":"HSDL2","to":"UGDH","weight":0.41},{"from":"TUBA1C","to":"UGDH","weight":0.404},{"from":"ACTG2","to":"DES","weight":0.428},{"from":"ARF3","to":"RAP1A","weight":0.426},{"from":"POSTN","to":"RAP1A","weight":0.415},{"from":"ILK","to":"TNS1","weight":0.418},{"from":"FHL1","to":"FLNC","weight":0.405},{"from":"CP","to":"VTN","weight":0.419},{"from":"RPL23","to":"SPCS2","weight":0.405},{"from":"RPL23","to":"RPN1","weight":0.511},{"from":"FHL1","to":"PDLIM1","weight":0.443},{"from":"GSN","to":"SVIL","weight":0.421},{"from":"SERPINH1","to":"VIM","weight":0.417},{"from":"CAV1","to":"ILK","weight":0.404},{"from":"CAV1","to":"PTGIS","weight":0.446},{"from":"ALB","to":"ANXA6","weight":0.416},{"from":"ALB","to":"ANXA3","weight":0.404},{"from":"FBLIM1","to":"SRC","weight":0.527},{"from":"CKB","to":"VDAC1","weight":0.415},{"from":"MAPK1","to":"VDAC1","weight":0.431},{"from":"PGAM1","to":"PYGM","weight":0.424},{"from":"AKT1","to":"FHL1","weight":0.402},{"from":"AKT1","to":"PYGM","weight":0.401},{"from":"LGALS1","to":"PLEC","weight":0.447},{"from":"GNB2","to":"HSPA5","weight":0.429},{"from":"TAGLN2","to":"TPI1","weight":0.407},{"from":"MTHFD1","to":"TPI1","weight":0.477},{"from":"FNDC1","to":"LRRC15","weight":0.401},{"from":"LRRC15","to":"POSTN","weight":0.42},{"from":"ERLIN2","to":"PRPF8","weight":0.423},{"from":"CLU","to":"SERPINC1","weight":0.427},{"from":"GSTO1","to":"SERPINC1","weight":0.404},{"from":"BLVRB","to":"GSTO1","weight":0.407},{"from":"LAMP1","to":"SRC","weight":0.425},{"from":"EHD1","to":"LAMP1","weight":0.411},{"from":"ANXA7","to":"S100A6","weight":0.408},{"from":"P4HB","to":"RPN2","weight":0.514},{"from":"CNDP2","to":"NAGK","weight":0.456},{"from":"CNDP2","to":"RNPEP","weight":0.459},{"from":"NOTCH3","to":"SRC","weight":0.404},{"from":"ATP1A2","to":"NOTCH3","weight":0.403},{"from":"ANXA6","to":"CLU","weight":0.411},{"from":"CLU","to":"NID1","weight":0.466},{"from":"COL6A1","to":"ENPP1","weight":0.529},{"from":"SSBP1","to":"VDAC1","weight":0.404},{"from":"RAB2A","to":"SSBP1","weight":0.422},{"from":"KANK2","to":"TNS1","weight":0.441},{"from":"CKB","to":"GSN","weight":0.413},{"from":"HSPA5","to":"SLC25A4","weight":0.413},{"from":"FASN","to":"PLIN3","weight":0.454},{"from":"PLCD1","to":"PLIN3","weight":0.411},{"from":"RPS18","to":"SSBP1","weight":0.421},{"from":"PABPC1","to":"SELENOP","weight":0.402},{"from":"NME1","to":"RPS11","weight":0.412},{"from":"RPS11","to":"SLC25A6","weight":0.401},{"from":"ARF3","to":"SRC","weight":0.424},{"from":"HSDL2","to":"SSBP1","weight":0.407},{"from":"GNB2","to":"SCRN2","weight":0.418},{"from":"GNB4","to":"SCRN2","weight":0.401},{"from":"HADH","to":"PYGM","weight":0.419},{"from":"ACTC1","to":"DMD","weight":0.401},{"from":"HSD17B10","to":"HSDL2","weight":0.426},{"from":"COPS6","to":"PSMA4","weight":0.405},{"from":"HNRNPL","to":"PSMA4","weight":0.404},{"from":"ACTC1","to":"SGCD","weight":0.504},{"from":"AKAP12","to":"VAMP3","weight":0.405},{"from":"HNRNPH3","to":"PRPF8","weight":0.416},{"from":"HNRNPH3","to":"XRCC5","weight":0.406},{"from":"FLNC","to":"HSPB6","weight":0.417},{"from":"EIF2S3","to":"P4HB","weight":0.408},{"from":"PDLIM1","to":"PDLIM4","weight":0.563},{"from":"FILIP1L","to":"FLNC","weight":0.481},{"from":"DDOST","to":"TUBA4A","weight":0.436},{"from":"PSMA3","to":"VDAC1","weight":0.403},{"from":"DDX17","to":"PSMA3","weight":0.405},{"from":"ALB","to":"ITGAV","weight":0.402},{"from":"ITGAV","to":"MAOA","weight":0.402},{"from":"EPX","to":"MS4A2","weight":0.426},{"from":"EIF2S3","to":"MS4A2","weight":0.408},{"from":"COPA","to":"RPN1","weight":0.412},{"from":"AKT1","to":"HNRNPH1","weight":0.412},{"from":"HNRNPH1","to":"SUN2","weight":0.51},{"from":"DDX3X","to":"HNRNPL","weight":0.403},{"from":"DDX3X","to":"RPL12","weight":0.419},{"from":"AEBP1","to":"COL6A1","weight":0.44},{"from":"ALB","to":"ANO6","weight":0.452},{"from":"HNRNPL","to":"PSMA2","weight":0.415},{"from":"PPP2CB","to":"PSMA2","weight":0.502},{"from":"PSMC4","to":"RPS28","weight":0.417},{"from":"HNRNPM","to":"RPS28","weight":0.417},{"from":"AKT1","to":"RRAS2","weight":0.409},{"from":"COPS6","to":"PSMA1","weight":0.412},{"from":"PSMA1","to":"VDAC3","weight":0.49},{"from":"ITGB1","to":"PDLIM2","weight":0.435},{"from":"CPNE1","to":"PDLIM2","weight":0.415},{"from":"AKT1","to":"SNTB2","weight":0.436},{"from":"NID1","to":"SGCB","weight":0.425},{"from":"PPP3CA","to":"SRC","weight":0.41},{"from":"NME1","to":"RPL13","weight":0.403},{"from":"DDX6","to":"RPL13","weight":0.414},{"from":"FLII","to":"SVIL","weight":0.423},{"from":"APEH","to":"L3HYPDH","weight":0.421},{"from":"L3HYPDH","to":"PIPOX","weight":0.404},{"from":"HAAO","to":"PIPOX","weight":0.407},{"from":"ERGIC1","to":"RER1","weight":0.401},{"from":"DDOST","to":"RER1","weight":0.403},{"from":"FASN","to":"HSD17B4","weight":0.44},{"from":"MCAM","to":"VAMP3","weight":0.408},{"from":"RAB8B","to":"VAMP3","weight":0.443},{"from":"RPL13","to":"SPCS2","weight":0.401},{"from":"RPS9","to":"SPCS2","weight":0.401},{"from":"GALM","to":"PYGM","weight":0.437},{"from":"BLVRA","to":"HSDL2","weight":0.422},{"from":"ATP5F1D","to":"SLC25A11","weight":0.484},{"from":"HSD17B12","to":"SLC25A11","weight":0.473},{"from":"ARF4","to":"RAB23","weight":0.402},{"from":"ARF4","to":"HSPA5","weight":0.408},{"from":"ITGB1","to":"PFN2","weight":0.401},{"from":"NPM1","to":"PRPF8","weight":0.415},{"from":"ERLIN2","to":"LRRFIP1","weight":0.415},{"from":"ATP5F1D","to":"TALDO1","weight":0.408},{"from":"FASN","to":"GYS1","weight":0.402},{"from":"GYS1","to":"PPP1R7","weight":0.508},{"from":"ILK","to":"STAT3","weight":0.417},{"from":"EIF3B","to":"PRPF8","weight":0.415},{"from":"AKT1","to":"ECH1","weight":0.413},{"from":"ACOT1","to":"ECH1","weight":0.411},{"from":"MPP1","to":"SRC","weight":0.429},{"from":"EOGT","to":"POGLUT3","weight":0.545},{"from":"PYGB","to":"SERPING1","weight":0.436},{"from":"RARRES2","to":"SERPING1","weight":0.437},{"from":"NME1","to":"PSMA5","weight":0.411},{"from":"PSMA5","to":"RPS23","weight":0.412},{"from":"P4HB","to":"RCN1","weight":0.492},{"from":"RPL31","to":"SNRPD2","weight":0.404},{"from":"RO60","to":"SNRPD2","weight":0.449},{"from":"AHNAK","to":"DMD","weight":0.416},{"from":"AHNAK","to":"LHPP","weight":0.406},{"from":"PSME2","to":"RAD23B","weight":0.454},{"from":"ERAP1","to":"PSME2","weight":0.472},{"from":"PSMA6","to":"VDAC1","weight":0.41},{"from":"COPS6","to":"PSMA6","weight":0.409},{"from":"AKT1","to":"COMT","weight":0.406},{"from":"P4HB","to":"TMX4","weight":0.419},{"from":"SCCPDH","to":"TMX4","weight":0.469},{"from":"ALB","to":"HCLS1","weight":0.409},{"from":"HCLS1","to":"TUBGCP3","weight":0.407},{"from":"FN3K","to":"TUBGCP3","weight":0.416},{"from":"COPS6","to":"PSMB1","weight":0.412},{"from":"PSMB1","to":"RPL27A","weight":0.423},{"from":"DDX3X","to":"ETF1","weight":0.412},{"from":"ETF1","to":"KPNA4","weight":0.423},{"from":"HP","to":"SERPINA6","weight":0.407},{"from":"SERPINA6","to":"WFS1","weight":0.418},{"from":"DUSP6","to":"NOTCH3","weight":0.406},{"from":"ANOS1","to":"DUSP6","weight":0.401},{"from":"HSPA12A","to":"HSPB6","weight":0.419},{"from":"DNAJC24","to":"HSPA12A","weight":0.433},{"from":"DCXR","to":"DNAJC24","weight":0.408},{"from":"DDX6","to":"HNRNPA0","weight":0.406},{"from":"FCGBP","to":"SERPINA1","weight":0.451},{"from":"NSF","to":"SERPINA1","weight":0.518},{"from":"FASN","to":"PPME1","weight":0.442},{"from":"PSMC4","to":"TUBA4A","weight":0.41},{"from":"APOA1","to":"FASN","weight":0.401},{"from":"APOA1","to":"GGCT","weight":0.426},{"from":"ITGB1","to":"PLP1","weight":0.401},{"from":"ALB","to":"RNASE3","weight":0.435},{"from":"COMT","to":"PLD3","weight":0.41},{"from":"RPL35","to":"TPI1","weight":0.409},{"from":"PLPBP","to":"RPL35","weight":0.594},{"from":"DDOST","to":"SURF4","weight":0.506},{"from":"GNA13","to":"VDAC1","weight":0.412},{"from":"GUK1","to":"PSMB1","weight":0.403},{"from":"GUK1","to":"RECQL","weight":0.666},{"from":"RHOG","to":"SRC","weight":0.46},{"from":"MYO1C","to":"STXBP3","weight":0.57},{"from":"ANXA7","to":"PARP1","weight":0.404},{"from":"ALB","to":"DNM1L","weight":0.416},{"from":"CTNND1","to":"MAPK1","weight":0.41},{"from":"PML","to":"STAT3","weight":0.49},{"from":"SEC24C","to":"SERPINH1","weight":0.43},{"from":"EIF3B","to":"IPO5","weight":0.424},{"from":"FASN","to":"SHMT1","weight":0.421},{"from":"FLAD1","to":"SHMT1","weight":0.405},{"from":"FLAD1","to":"PLEKHO2","weight":0.42},{"from":"PRPF8","to":"PSMD13","weight":0.509},{"from":"AZGP1","to":"DCD","weight":0.421},{"from":"KPNA4","to":"NPM1","weight":0.404},{"from":"ALDOA","to":"YWHAB","weight":0.422},{"from":"ALDOA","to":"IDH3B","weight":0.433},{"from":"DHRS1","to":"FASN","weight":0.412},{"from":"MOGS","to":"P4HB","weight":0.441},{"from":"EIF2S2","to":"PSMA4","weight":0.411},{"from":"FCGBP","to":"RPS28","weight":0.413},{"from":"PSMA3","to":"YWHAB","weight":0.405},{"from":"AHNAK","to":"VTN","weight":0.412},{"from":"HP","to":"LAMP1","weight":0.418},{"from":"APOA4","to":"AZGP1","weight":0.408},{"from":"CTNND1","to":"ITGA8","weight":0.479},{"from":"BCAP31","to":"CAV1","weight":0.415},{"from":"BCAP31","to":"RRBP1","weight":0.419},{"from":"DLGAP4","to":"RILPL1","weight":0.421},{"from":"DLGAP4","to":"SORBS2","weight":0.464},{"from":"COMT","to":"ITGB3","weight":0.403},{"from":"TXNRD1","to":"UGDH","weight":0.429},{"from":"KTN1","to":"NPM1","weight":0.507},{"from":"CDH13","to":"HP","weight":0.429},{"from":"HNRNPH3","to":"STIP1","weight":0.44},{"from":"ITGB3","to":"PEBP1","weight":0.415},{"from":"GC","to":"ITGAV","weight":0.407},{"from":"CLU","to":"HSPD1","weight":0.407},{"from":"HNRNPH3","to":"NCL","weight":0.428},{"from":"CAV1","to":"JAM3","weight":0.42},{"from":"ALCAM","to":"JAM3","weight":0.433},{"from":"HSPB6","to":"TALDO1","weight":0.407},{"from":"NUCB1","to":"PLD3","weight":0.42},{"from":"APEH","to":"NUCB1","weight":0.416},{"from":"ANG","to":"APOE","weight":0.429},{"from":"NUDC","to":"RPL12","weight":0.41},{"from":"NAGK","to":"NUDC","weight":0.41},{"from":"CTNNB1","to":"H1-2","weight":0.42},{"from":"DCD","to":"H1-4","weight":0.414},{"from":"GPC4","to":"NCL","weight":0.428},{"from":"H2AC21","to":"TRIM28","weight":0.444},{"from":"H1-3","to":"H2AC21","weight":0.44},{"from":"ALDOA","to":"QSOX1","weight":0.454},{"from":"ITGB1","to":"PSMB5","weight":0.41},{"from":"CAST","to":"ERAP1","weight":0.622},{"from":"ITGB1","to":"PTPN11","weight":0.431},{"from":"DDX3X","to":"PA2G4","weight":0.414},{"from":"BST2","to":"CHMP4B","weight":0.418},{"from":"BST2","to":"HLA-B","weight":0.471},{"from":"EEF1D","to":"FLNC","weight":0.422},{"from":"ME1","to":"SHMT1","weight":0.464},{"from":"PEBP1","to":"PRDX5","weight":0.423},{"from":"AFM","to":"VTN","weight":0.416},{"from":"AFM","to":"SERPINF2","weight":0.43},{"from":"EIF3B","to":"RAD23B","weight":0.419},{"from":"HSPA12A","to":"ST13","weight":0.439},{"from":"PSMB4","to":"SNRPD2","weight":0.448},{"from":"ITIH3","to":"RARRES2","weight":0.453},{"from":"ECHS1","to":"RPL12","weight":0.417},{"from":"CPA3","to":"POSTN","weight":0.416},{"from":"MAOA","to":"VAT1L","weight":0.48},{"from":"PABPC1","to":"YAP1","weight":0.407},{"from":"ITGB3","to":"SLC44A2","weight":0.412},{"from":"PKLR","to":"SHMT1","weight":0.425},{"from":"PKLR","to":"PLTP","weight":0.409},{"from":"PDCD5","to":"PSMA5","weight":0.451},{"from":"HEBP1","to":"SRC","weight":0.505},{"from":"NUDT5","to":"PRPF8","weight":0.44},{"from":"GAA","to":"MOGS","weight":0.419},{"from":"ALB","to":"H1-0","weight":0.418},{"from":"CD74","to":"STAT3","weight":0.403},{"from":"CD74","to":"PSMB8","weight":0.519},{"from":"APOE","to":"CD9","weight":0.429},{"from":"CHMP4B","to":"CLTC","weight":0.418},{"from":"FAM114A1","to":"POSTN","weight":0.425},{"from":"AEBP1","to":"CHST14","weight":0.411},{"from":"APOA1","to":"LRG1","weight":0.434},{"from":"NUDC","to":"PSMB2","weight":0.402},{"from":"ALB","to":"APOC1","weight":0.457},{"from":"FASN","to":"PEF1","weight":0.447},{"from":"EIF4B","to":"PRPF8","weight":0.416},{"from":"GNG12","to":"SRC","weight":0.508},{"from":"CFHR3","to":"HP","weight":0.409},{"from":"CD59","to":"CFHR3","weight":0.419},{"from":"HMGB2","to":"RPS28","weight":0.53},{"from":"HDGF","to":"PARP1","weight":0.425},{"from":"ACSM4","to":"CYTL1","weight":0.435},{"from":"ACSM4","to":"ME1","weight":0.406},{"from":"CLTB","to":"VAMP3","weight":0.581},{"from":"ATP1B3","to":"VDAC1","weight":0.532},{"from":"ALDH1L1","to":"VIM","weight":0.406},{"from":"AZGP1","to":"TFG","weight":0.414},{"from":"METAP2","to":"NCL","weight":0.416},{"from":"DNPEP","to":"METAP2","weight":0.43},{"from":"AHNAK","to":"S100A11","weight":0.476},{"from":"APOL1","to":"ITGB3","weight":0.42},{"from":"COL16A1","to":"POSTN","weight":0.479},{"from":"IPO5","to":"PSIP1","weight":0.435},{"from":"EDNRA","to":"SYNGR2","weight":0.414},{"from":"ALB","to":"EDNRA","weight":0.403},{"from":"HNRNPL","to":"SET","weight":0.405},{"from":"PSMB7","to":"RPL13","weight":0.404},{"from":"CD47","to":"STIP1","weight":0.47},{"from":"PABPC1","to":"RPL31","weight":0.444},{"from":"PDAP1","to":"RCN2","weight":0.424},{"from":"HSPA5","to":"RCN2","weight":0.406},{"from":"AKT1","to":"MARCKS","weight":0.424},{"from":"ALDH16A1","to":"TRIM28","weight":0.414},{"from":"GUK1","to":"YBX3","weight":0.415},{"from":"PLP2","to":"S100A11","weight":0.545},{"from":"GCLC","to":"ME1","weight":0.46},{"from":"DNM1L","to":"SH3GL1","weight":0.461},{"from":"GSN","to":"WIPF1","weight":0.536},{"from":"B2M","to":"CTNNB1","weight":0.419},{"from":"ATRN","to":"SERPINA6","weight":0.412},{"from":"AIP","to":"NPM1","weight":0.402},{"from":"SAA4","to":"SERPINA1","weight":0.456},{"from":"HNRNPH1","to":"RANBP1","weight":0.409},{"from":"EEF1D","to":"NME3","weight":0.428},{"from":"COL6A3","to":"TMSB4X","weight":0.441},{"from":"RAB8B","to":"RILPL1","weight":0.427},{"from":"HMGCL","to":"HSD17B10","weight":0.429},{"from":"CPE","to":"WFS1","weight":0.448},{"from":"ANXA6","to":"TCOF1","weight":0.596},{"from":"CYB5B","to":"HSDL2","weight":0.414}],"clusters":[{"cluster":12,"color":"#8DA0CB","count":13,"mean_fc":0.669,"rank":1},{"cluster":13,"color":"#E78AC3","count":26,"mean_fc":0.63,"rank":2},{"cluster":4,"color":"#984EA3","count":18,"mean_fc":0.625,"rank":3},{"cluster":10,"color":"#66C2A5","count":16,"mean_fc":0.615,"rank":4},{"cluster":5,"color":"#FF7F00","count":20,"mean_fc":0.598,"rank":5},{"cluster":1,"color":"#E41A1C","count":21,"mean_fc":0.598,"rank":6},{"cluster":18,"color":"#D95F02","count":23,"mean_fc":0.589,"rank":7},{"cluster":8,"color":"#F781BF","count":22,"mean_fc":0.589,"rank":8},{"cluster":9,"color":"#999999","count":20,"mean_fc":0.574,"rank":9},{"cluster":2,"color":"#377EB8","count":25,"mean_fc":0.551,"rank":10},{"cluster":17,"color":"#1B9E77","count":15,"mean_fc":0.548,"rank":11},{"cluster":3,"color":"#4DAF4A","count":21,"mean_fc":0.536,"rank":12},{"cluster":7,"color":"#A65628","count":13,"mean_fc":0.524,"rank":13},{"cluster":14,"color":"#A6D854","count":22,"mean_fc":0.521,"rank":14},{"cluster":11,"color":"#FC8D62","count":17,"mean_fc":0.52,"rank":15},{"cluster":15,"color":"#FFD92F","count":24,"mean_fc":0.518,"rank":16},{"cluster":6,"color":"#FFFF33","count":19,"mean_fc":0.481,"rank":17},{"cluster":19,"color":"#7570B3","count":2,"mean_fc":0.476,"rank":18},{"cluster":16,"color":"#B3B3B3","count":13,"mean_fc":0.469,"rank":19}],"stats":{"nodos":350,"aristas":348,"clusters":19}},"P001":{"nodos":[{"id":"ACOT1","label":"ACOT1","x":655.7547,"y":1145.7992,"size":10.2947,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.773<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT1, ALDH16A1, ANXA7, ATP5F1D, DLGAP4, ECH1, ECHS1, HSD17B12, HSD17B4, S100A6, SHMT1, SLC25A11<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of unsaturated fatty acids (p=1.67e-06)<br>Fatty acid elongation (p=1.87e-06)<br>Fatty acid metabolism (p=1.65e-05)<br><br><b>BP:<\/b><br>fatty acid metabolic process (p=2.07e-06)<br>organic acid catabolic process (p=8.22e-06) <br> <b>MF:<\/b><br>enoyl-CoA hydratase activity (p=2.50e-05)<br>intramolecular oxidoreductase activity, transposing C=C bonds (p=3.97e-05) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"ACTG2","label":"ACTG2","x":2920.0676,"y":1507.8399,"size":12.6247,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"AEBP1","label":"AEBP1","x":2047.1806,"y":2458.9358,"size":5,"color":"#4DAF4A","shape":"triangle","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"AHNAK","label":"AHNAK","x":2072.5147,"y":2346.9907,"size":12.8262,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"AKAP12","label":"AKAP12","x":2240.352,"y":100,"size":10.0642,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.754<\/b><\/p><b>Genes (7):<\/b><br><span style='font-size:11px;'>AKAP12, APOL1, ITGB3, MCAM, PFN2, RAP1A, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=1.04e-04)<br>Platelet activation (p=1.68e-03)<br>Phagosome (p=2.66e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter transport (p=5.50e-06)<br>positive regulation of fibroblast migration (p=1.24e-05) <br> <b>MF:<\/b><br>adenylate cyclase binding (p=4.50e-03)<br>vascular endothelial growth factor receptor binding (p=4.87e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.16e-04)<br>cell-substrate junction (p=3.39e-04)<\/div>"},{"id":"ALDH16A1","label":"ALDH16A1","x":552.687,"y":835.1574,"size":16.9798,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.773<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT1, ALDH16A1, ANXA7, ATP5F1D, DLGAP4, ECH1, ECHS1, HSD17B12, HSD17B4, S100A6, SHMT1, SLC25A11<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of unsaturated fatty acids (p=1.67e-06)<br>Fatty acid elongation (p=1.87e-06)<br>Fatty acid metabolism (p=1.65e-05)<br><br><b>BP:<\/b><br>fatty acid metabolic process (p=2.07e-06)<br>organic acid catabolic process (p=8.22e-06) <br> <b>MF:<\/b><br>enoyl-CoA hydratase activity (p=2.50e-05)<br>intramolecular oxidoreductase activity, transposing C=C bonds (p=3.97e-05) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"ALDOA","label":"ALDOA","x":1931.6763,"y":1474.9884,"size":11.1863,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.482<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CYB5R3, GNA13, GYS1, KTN1, NPM1, SUN2, TMEM214, VDAC1<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=1.71e-04)<br>Diabetic cardiomyopathy (p=8.95e-03)<br>Cytoskeleton in muscle cells (p=1.15e-02)<br><br><b>BP:<\/b><br>pyruvate metabolic process (p=1.97e-03)<br>regulation of cell shape (p=2.35e-03) <br> <b>MF:<\/b><br>monosaccharide binding (p=5.50e-04)<br>Tat protein binding (p=4.82e-03) <br> <b>CC:<\/b><br>melanosome (p=1.35e-03)<br>pigment granule (p=1.35e-03)<\/div>"},{"id":"ANXA7","label":"ANXA7","x":455.589,"y":1264.2402,"size":11.1459,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.773<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT1, ALDH16A1, ANXA7, ATP5F1D, DLGAP4, ECH1, ECHS1, HSD17B12, HSD17B4, S100A6, SHMT1, SLC25A11<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of unsaturated fatty acids (p=1.67e-06)<br>Fatty acid elongation (p=1.87e-06)<br>Fatty acid metabolism (p=1.65e-05)<br><br><b>BP:<\/b><br>fatty acid metabolic process (p=2.07e-06)<br>organic acid catabolic process (p=8.22e-06) <br> <b>MF:<\/b><br>enoyl-CoA hydratase activity (p=2.50e-05)<br>intramolecular oxidoreductase activity, transposing C=C bonds (p=3.97e-05) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"APEH","label":"APEH","x":405.5499,"y":2017.8921,"size":12.2391,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"APOA4","label":"APOA4","x":1947.764,"y":584.9896,"size":18.5557,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>APOA4, AZGP1, CLU, DCD, LRG1, NSF, PEF1, PLTP, SAA4, SERPINA1, SERPINC1, TFG<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.57e-05)<br>Cholesterol metabolism (p=5.99e-04)<br>Vitamin digestion and absorption (p=1.89e-02)<br><br><b>BP:<\/b><br>cholesterol transport (p=5.75e-05)<br>reverse cholesterol transport (p=7.05e-05) <br> <b>MF:<\/b><br>cholesterol transfer activity (p=1.13e-04)<br>phosphatidylcholine binding (p=1.64e-04) <br> <b>CC:<\/b><br>high-density lipoprotein particle (p=1.33e-09)<br>plasma lipoprotein particle (p=4.97e-09)<\/div>"},{"id":"APOE","label":"APOE","x":2682.3426,"y":1547.2282,"size":12.7903,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"APOL1","label":"APOL1","x":2075.9503,"y":526.158,"size":18.7416,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.754<\/b><\/p><b>Genes (7):<\/b><br><span style='font-size:11px;'>AKAP12, APOL1, ITGB3, MCAM, PFN2, RAP1A, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=1.04e-04)<br>Platelet activation (p=1.68e-03)<br>Phagosome (p=2.66e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter transport (p=5.50e-06)<br>positive regulation of fibroblast migration (p=1.24e-05) <br> <b>MF:<\/b><br>adenylate cyclase binding (p=4.50e-03)<br>vascular endothelial growth factor receptor binding (p=4.87e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.16e-04)<br>cell-substrate junction (p=3.39e-04)<\/div>"},{"id":"ARF4","label":"ARF4","x":155.2837,"y":836.1913,"size":5,"color":"#F781BF","shape":"triangle","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.538<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ARF4, BLVRA, DDOST, GNB2, GNB4, HSDL2, HSPA5, MOGS, PSMB2, RAB23, TUBB2A, UGDH<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=6.47e-04)<br>N-Glycan biosynthesis (p=1.47e-03)<br>Parkinson disease (p=2.33e-03)<br><br><b>BP:<\/b><br>substantia nigra development (p=3.80e-04)<br>neural nucleus development (p=8.55e-04) <br> <b>MF:<\/b><br>GTPase activity (p=2.92e-05)<br>signaling receptor complex adaptor activity (p=4.13e-04) <br> <b>CC:<\/b><br>heterotrimeric G-protein complex (p=1.97e-04)<br>GTPase complex (p=2.70e-04)<\/div>"},{"id":"ATP1A2","label":"ATP1A2","x":2585.7108,"y":1526.2289,"size":11.6069,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"ATP1B3","label":"ATP1B3","x":1884.8003,"y":1551.2362,"size":10.2856,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.482<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CYB5R3, GNA13, GYS1, KTN1, NPM1, SUN2, TMEM214, VDAC1<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=1.71e-04)<br>Diabetic cardiomyopathy (p=8.95e-03)<br>Cytoskeleton in muscle cells (p=1.15e-02)<br><br><b>BP:<\/b><br>pyruvate metabolic process (p=1.97e-03)<br>regulation of cell shape (p=2.35e-03) <br> <b>MF:<\/b><br>monosaccharide binding (p=5.50e-04)<br>Tat protein binding (p=4.82e-03) <br> <b>CC:<\/b><br>melanosome (p=1.35e-03)<br>pigment granule (p=1.35e-03)<\/div>"},{"id":"ATP5F1D","label":"ATP5F1D","x":617.6445,"y":1259.0849,"size":17.4548,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.773<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT1, ALDH16A1, ANXA7, ATP5F1D, DLGAP4, ECH1, ECHS1, HSD17B12, HSD17B4, S100A6, SHMT1, SLC25A11<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of unsaturated fatty acids (p=1.67e-06)<br>Fatty acid elongation (p=1.87e-06)<br>Fatty acid metabolism (p=1.65e-05)<br><br><b>BP:<\/b><br>fatty acid metabolic process (p=2.07e-06)<br>organic acid catabolic process (p=8.22e-06) <br> <b>MF:<\/b><br>enoyl-CoA hydratase activity (p=2.50e-05)<br>intramolecular oxidoreductase activity, transposing C=C bonds (p=3.97e-05) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"ATRN","label":"ATRN","x":1908.9718,"y":2193.8222,"size":10.3007,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"AZGP1","label":"AZGP1","x":2000.2591,"y":673.963,"size":10.2377,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>APOA4, AZGP1, CLU, DCD, LRG1, NSF, PEF1, PLTP, SAA4, SERPINA1, SERPINC1, TFG<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.57e-05)<br>Cholesterol metabolism (p=5.99e-04)<br>Vitamin digestion and absorption (p=1.89e-02)<br><br><b>BP:<\/b><br>cholesterol transport (p=5.75e-05)<br>reverse cholesterol transport (p=7.05e-05) <br> <b>MF:<\/b><br>cholesterol transfer activity (p=1.13e-04)<br>phosphatidylcholine binding (p=1.64e-04) <br> <b>CC:<\/b><br>high-density lipoprotein particle (p=1.33e-09)<br>plasma lipoprotein particle (p=4.97e-09)<\/div>"},{"id":"BCAP31","label":"BCAP31","x":2089.988,"y":1941.9264,"size":11.1231,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.562<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>BCAP31, CAV1, ENPP1, FHL1, GALM, JAM3, LAMP1, MFSD2A, PDLIM1, PDLIM4, PTGIS, SOST<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.04e-03)<br>Virion - Lassa virus and SFTS virus (p=1.94e-02)<br>Pantothenate and CoA biosynthesis (p=2.39e-02)<br><br><b>BP:<\/b><br>negative regulation of nitric oxide biosynthetic process (p=3.90e-05)<br>negative regulation of nitric oxide metabolic process (p=3.90e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=3.97e-05)<br>alpha-actinin binding (p=1.42e-04) <br> <b>CC:<\/b><br>filamentous actin (p=6.09e-07)<br>actin filament (p=4.10e-05)<\/div>"},{"id":"BLVRA","label":"BLVRA","x":186.7553,"y":1024.6962,"size":10.7954,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.538<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ARF4, BLVRA, DDOST, GNB2, GNB4, HSDL2, HSPA5, MOGS, PSMB2, RAB23, TUBB2A, UGDH<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=6.47e-04)<br>N-Glycan biosynthesis (p=1.47e-03)<br>Parkinson disease (p=2.33e-03)<br><br><b>BP:<\/b><br>substantia nigra development (p=3.80e-04)<br>neural nucleus development (p=8.55e-04) <br> <b>MF:<\/b><br>GTPase activity (p=2.92e-05)<br>signaling receptor complex adaptor activity (p=4.13e-04) <br> <b>CC:<\/b><br>heterotrimeric G-protein complex (p=1.97e-04)<br>GTPase complex (p=2.70e-04)<\/div>"},{"id":"BST2","label":"BST2","x":2885.5647,"y":1594.7481,"size":15.5481,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"CAST","label":"CAST","x":944.2774,"y":2212.399,"size":10.0642,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.64<\/b><\/p><b>Genes (7):<\/b><br><span style='font-size:11px;'>CAST, EIF3B, ERAP1, IPO5, PSME2, RAD23B, STIP1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.38e-02)<br>Nucleotide excision repair (p=3.25e-02)<br>Antigen processing and presentation (p=4.22e-02)<br><br><b>BP:<\/b><br>cellular response to interleukin-7 (p=2.25e-05)<br>response to interleukin-7 (p=2.49e-05) <br> <b>MF:<\/b><br>endopeptidase regulator activity (p=1.97e-03)<br>peptidase regulator activity (p=2.95e-03) <br> <b>CC:<\/b><br>proteasome complex (p=2.12e-04)<br>endopeptidase complex (p=4.97e-04)<\/div>"},{"id":"CAV1","label":"CAV1","x":2205.1769,"y":2052.9673,"size":10.3137,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.562<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>BCAP31, CAV1, ENPP1, FHL1, GALM, JAM3, LAMP1, MFSD2A, PDLIM1, PDLIM4, PTGIS, SOST<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.04e-03)<br>Virion - Lassa virus and SFTS virus (p=1.94e-02)<br>Pantothenate and CoA biosynthesis (p=2.39e-02)<br><br><b>BP:<\/b><br>negative regulation of nitric oxide biosynthetic process (p=3.90e-05)<br>negative regulation of nitric oxide metabolic process (p=3.90e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=3.97e-05)<br>alpha-actinin binding (p=1.42e-04) <br> <b>CC:<\/b><br>filamentous actin (p=6.09e-07)<br>actin filament (p=4.10e-05)<\/div>"},{"id":"CFHR3","label":"CFHR3","x":1941.7317,"y":2271.3244,"size":10.5444,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"CHMP4B","label":"CHMP4B","x":2971.14,"y":1622.3254,"size":10.4217,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"CHST14","label":"CHST14","x":2060.9711,"y":2539.7641,"size":10.0642,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"CKB","label":"CKB","x":1946.177,"y":1242.3351,"size":12.3191,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.728<\/b><\/p><b>Genes (6):<\/b><br><span style='font-size:11px;'>CKB, GSN, MPP1, MYH9, MYO1D, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=9.14e-05)<br>Motor proteins (p=4.05e-03)<br>Regulation of actin cytoskeleton (p=5.59e-03)<br><br><b>BP:<\/b><br>actin filament-based movement (p=4.24e-08)<br>establishment of T cell polarity (p=8.89e-06) <br> <b>MF:<\/b><br>actin binding (p=4.55e-06)<br>actin filament binding (p=2.71e-05) <br> <b>CC:<\/b><br>cell cortex (p=1.03e-06)<br>cortical cytoskeleton (p=3.17e-06)<\/div>"},{"id":"CLU","label":"CLU","x":1870.573,"y":451.6902,"size":11.2037,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>APOA4, AZGP1, CLU, DCD, LRG1, NSF, PEF1, PLTP, SAA4, SERPINA1, SERPINC1, TFG<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.57e-05)<br>Cholesterol metabolism (p=5.99e-04)<br>Vitamin digestion and absorption (p=1.89e-02)<br><br><b>BP:<\/b><br>cholesterol transport (p=5.75e-05)<br>reverse cholesterol transport (p=7.05e-05) <br> <b>MF:<\/b><br>cholesterol transfer activity (p=1.13e-04)<br>phosphatidylcholine binding (p=1.64e-04) <br> <b>CC:<\/b><br>high-density lipoprotein particle (p=1.33e-09)<br>plasma lipoprotein particle (p=4.97e-09)<\/div>"},{"id":"CNDP2","label":"CNDP2","x":1935.7529,"y":2401.9131,"size":10.2008,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"COL6A2","label":"COL6A2","x":1883.4687,"y":2425.0681,"size":10.4217,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"COPS6","label":"COPS6","x":1492.0441,"y":1687.2854,"size":13.023,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.578<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>COPS6, FBXL7, GUK1, PPP2CB, PSMA1, PSMA4, PSMA6, PSMB1, PSMB5, PSMB7, RPL27A<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=7.35e-13)<br>Spinocerebellar ataxia (p=8.51e-10)<br>Parkinson disease (p=3.84e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.11e-11)<br>GDP-mannose metabolic process (p=5.84e-03) <br> <b>MF:<\/b><br>threonine-type peptidase activity (p=5.39e-05)<br>endopeptidase activity (p=1.48e-03) <br> <b>CC:<\/b><br>proteasome core complex (p=2.08e-16)<br>proteasome complex (p=3.99e-13)<\/div>"},{"id":"CPE","label":"CPE","x":1927.2418,"y":2599.9943,"size":10.2924,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"CTNND1","label":"CTNND1","x":2257.4978,"y":1518.929,"size":10.7314,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"CYB5R3","label":"CYB5R3","x":1955.6151,"y":1562.3315,"size":10.4576,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.482<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CYB5R3, GNA13, GYS1, KTN1, NPM1, SUN2, TMEM214, VDAC1<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=1.71e-04)<br>Diabetic cardiomyopathy (p=8.95e-03)<br>Cytoskeleton in muscle cells (p=1.15e-02)<br><br><b>BP:<\/b><br>pyruvate metabolic process (p=1.97e-03)<br>regulation of cell shape (p=2.35e-03) <br> <b>MF:<\/b><br>monosaccharide binding (p=5.50e-04)<br>Tat protein binding (p=4.82e-03) <br> <b>CC:<\/b><br>melanosome (p=1.35e-03)<br>pigment granule (p=1.35e-03)<\/div>"},{"id":"DCD","label":"DCD","x":2037.903,"y":635.4568,"size":16.5126,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>APOA4, AZGP1, CLU, DCD, LRG1, NSF, PEF1, PLTP, SAA4, SERPINA1, SERPINC1, TFG<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.57e-05)<br>Cholesterol metabolism (p=5.99e-04)<br>Vitamin digestion and absorption (p=1.89e-02)<br><br><b>BP:<\/b><br>cholesterol transport (p=5.75e-05)<br>reverse cholesterol transport (p=7.05e-05) <br> <b>MF:<\/b><br>cholesterol transfer activity (p=1.13e-04)<br>phosphatidylcholine binding (p=1.64e-04) <br> <b>CC:<\/b><br>high-density lipoprotein particle (p=1.33e-09)<br>plasma lipoprotein particle (p=4.97e-09)<\/div>"},{"id":"DDOST","label":"DDOST","x":236.7537,"y":842.3738,"size":10.0804,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.538<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ARF4, BLVRA, DDOST, GNB2, GNB4, HSDL2, HSPA5, MOGS, PSMB2, RAB23, TUBB2A, UGDH<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=6.47e-04)<br>N-Glycan biosynthesis (p=1.47e-03)<br>Parkinson disease (p=2.33e-03)<br><br><b>BP:<\/b><br>substantia nigra development (p=3.80e-04)<br>neural nucleus development (p=8.55e-04) <br> <b>MF:<\/b><br>GTPase activity (p=2.92e-05)<br>signaling receptor complex adaptor activity (p=4.13e-04) <br> <b>CC:<\/b><br>heterotrimeric G-protein complex (p=1.97e-04)<br>GTPase complex (p=2.70e-04)<\/div>"},{"id":"DDX17","label":"DDX17","x":2726.0028,"y":1572.7216,"size":10.1218,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"DES","label":"DES","x":2974.2365,"y":1486.7809,"size":10.5444,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"DLGAP4","label":"DLGAP4","x":541.6608,"y":774.7939,"size":12.5249,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.773<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT1, ALDH16A1, ANXA7, ATP5F1D, DLGAP4, ECH1, ECHS1, HSD17B12, HSD17B4, S100A6, SHMT1, SLC25A11<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of unsaturated fatty acids (p=1.67e-06)<br>Fatty acid elongation (p=1.87e-06)<br>Fatty acid metabolism (p=1.65e-05)<br><br><b>BP:<\/b><br>fatty acid metabolic process (p=2.07e-06)<br>organic acid catabolic process (p=8.22e-06) <br> <b>MF:<\/b><br>enoyl-CoA hydratase activity (p=2.50e-05)<br>intramolecular oxidoreductase activity, transposing C=C bonds (p=3.97e-05) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"ECH1","label":"ECH1","x":641.8689,"y":1199.9186,"size":5,"color":"#E41A1C","shape":"triangle","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.773<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT1, ALDH16A1, ANXA7, ATP5F1D, DLGAP4, ECH1, ECHS1, HSD17B12, HSD17B4, S100A6, SHMT1, SLC25A11<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of unsaturated fatty acids (p=1.67e-06)<br>Fatty acid elongation (p=1.87e-06)<br>Fatty acid metabolism (p=1.65e-05)<br><br><b>BP:<\/b><br>fatty acid metabolic process (p=2.07e-06)<br>organic acid catabolic process (p=8.22e-06) <br> <b>MF:<\/b><br>enoyl-CoA hydratase activity (p=2.50e-05)<br>intramolecular oxidoreductase activity, transposing C=C bonds (p=3.97e-05) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"ECHS1","label":"ECHS1","x":615.8473,"y":1404.4619,"size":14.1262,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.773<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT1, ALDH16A1, ANXA7, ATP5F1D, DLGAP4, ECH1, ECHS1, HSD17B12, HSD17B4, S100A6, SHMT1, SLC25A11<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of unsaturated fatty acids (p=1.67e-06)<br>Fatty acid elongation (p=1.87e-06)<br>Fatty acid metabolism (p=1.65e-05)<br><br><b>BP:<\/b><br>fatty acid metabolic process (p=2.07e-06)<br>organic acid catabolic process (p=8.22e-06) <br> <b>MF:<\/b><br>enoyl-CoA hydratase activity (p=2.50e-05)<br>intramolecular oxidoreductase activity, transposing C=C bonds (p=3.97e-05) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"EFEMP2","label":"EFEMP2","x":2031.4035,"y":2352.1687,"size":11.054,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"EIF2S3","label":"EIF2S3","x":283.9772,"y":1715.5145,"size":11.054,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"EIF3B","label":"EIF3B","x":936.2434,"y":2013.3845,"size":10.9741,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.64<\/b><\/p><b>Genes (7):<\/b><br><span style='font-size:11px;'>CAST, EIF3B, ERAP1, IPO5, PSME2, RAD23B, STIP1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.38e-02)<br>Nucleotide excision repair (p=3.25e-02)<br>Antigen processing and presentation (p=4.22e-02)<br><br><b>BP:<\/b><br>cellular response to interleukin-7 (p=2.25e-05)<br>response to interleukin-7 (p=2.49e-05) <br> <b>MF:<\/b><br>endopeptidase regulator activity (p=1.97e-03)<br>peptidase regulator activity (p=2.95e-03) <br> <b>CC:<\/b><br>proteasome complex (p=2.12e-04)<br>endopeptidase complex (p=4.97e-04)<\/div>"},{"id":"ENPP1","label":"ENPP1","x":2326.9027,"y":2133.3798,"size":10.3028,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.562<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>BCAP31, CAV1, ENPP1, FHL1, GALM, JAM3, LAMP1, MFSD2A, PDLIM1, PDLIM4, PTGIS, SOST<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.04e-03)<br>Virion - Lassa virus and SFTS virus (p=1.94e-02)<br>Pantothenate and CoA biosynthesis (p=2.39e-02)<br><br><b>BP:<\/b><br>negative regulation of nitric oxide biosynthetic process (p=3.90e-05)<br>negative regulation of nitric oxide metabolic process (p=3.90e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=3.97e-05)<br>alpha-actinin binding (p=1.42e-04) <br> <b>CC:<\/b><br>filamentous actin (p=6.09e-07)<br>actin filament (p=4.10e-05)<\/div>"},{"id":"ERAP1","label":"ERAP1","x":961.0842,"y":2149.3233,"size":12.5526,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.64<\/b><\/p><b>Genes (7):<\/b><br><span style='font-size:11px;'>CAST, EIF3B, ERAP1, IPO5, PSME2, RAD23B, STIP1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.38e-02)<br>Nucleotide excision repair (p=3.25e-02)<br>Antigen processing and presentation (p=4.22e-02)<br><br><b>BP:<\/b><br>cellular response to interleukin-7 (p=2.25e-05)<br>response to interleukin-7 (p=2.49e-05) <br> <b>MF:<\/b><br>endopeptidase regulator activity (p=1.97e-03)<br>peptidase regulator activity (p=2.95e-03) <br> <b>CC:<\/b><br>proteasome complex (p=2.12e-04)<br>endopeptidase complex (p=4.97e-04)<\/div>"},{"id":"FBLN5","label":"FBLN5","x":1909.4758,"y":2353.8085,"size":10.6526,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"FBXL7","label":"FBXL7","x":1281.9105,"y":1808.3859,"size":5,"color":"#8DA0CB","shape":"triangle","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.578<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>COPS6, FBXL7, GUK1, PPP2CB, PSMA1, PSMA4, PSMA6, PSMB1, PSMB5, PSMB7, RPL27A<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=7.35e-13)<br>Spinocerebellar ataxia (p=8.51e-10)<br>Parkinson disease (p=3.84e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.11e-11)<br>GDP-mannose metabolic process (p=5.84e-03) <br> <b>MF:<\/b><br>threonine-type peptidase activity (p=5.39e-05)<br>endopeptidase activity (p=1.48e-03) <br> <b>CC:<\/b><br>proteasome core complex (p=2.08e-16)<br>proteasome complex (p=3.99e-13)<\/div>"},{"id":"FHL1","label":"FHL1","x":2360.9901,"y":2306.4627,"size":10.4199,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.562<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>BCAP31, CAV1, ENPP1, FHL1, GALM, JAM3, LAMP1, MFSD2A, PDLIM1, PDLIM4, PTGIS, SOST<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.04e-03)<br>Virion - Lassa virus and SFTS virus (p=1.94e-02)<br>Pantothenate and CoA biosynthesis (p=2.39e-02)<br><br><b>BP:<\/b><br>negative regulation of nitric oxide biosynthetic process (p=3.90e-05)<br>negative regulation of nitric oxide metabolic process (p=3.90e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=3.97e-05)<br>alpha-actinin binding (p=1.42e-04) <br> <b>CC:<\/b><br>filamentous actin (p=6.09e-07)<br>actin filament (p=4.10e-05)<\/div>"},{"id":"FN3K","label":"FN3K","x":2223.6562,"y":1276.5553,"size":12.3973,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.653<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>FN3K, H2AC21, HCLS1, HSPA12A, HSPB6, MAPK1, PML, ST13, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Acute myeloid leukemia (p=2.96e-04)<br>Influenza A (p=1.91e-03)<br>Alcoholism (p=2.32e-03)<br><br><b>BP:<\/b><br>mammary gland epithelium development (p=3.66e-04)<br>positive regulation of telomere maintenance (p=4.33e-04) <br> <b>MF:<\/b><br>protein-folding chaperone binding (p=1.79e-03)<br>RNA polymerase II CTD heptapeptide repeat kinase activity (p=4.82e-03) <br> <b>CC:<\/b><br>gamma-tubulin complex (p=8.12e-03)<br>pseudopodium (p=8.12e-03)<\/div>"},{"id":"GALM","label":"GALM","x":2331.7401,"y":2047.8675,"size":11.4567,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.562<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>BCAP31, CAV1, ENPP1, FHL1, GALM, JAM3, LAMP1, MFSD2A, PDLIM1, PDLIM4, PTGIS, SOST<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.04e-03)<br>Virion - Lassa virus and SFTS virus (p=1.94e-02)<br>Pantothenate and CoA biosynthesis (p=2.39e-02)<br><br><b>BP:<\/b><br>negative regulation of nitric oxide biosynthetic process (p=3.90e-05)<br>negative regulation of nitric oxide metabolic process (p=3.90e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=3.97e-05)<br>alpha-actinin binding (p=1.42e-04) <br> <b>CC:<\/b><br>filamentous actin (p=6.09e-07)<br>actin filament (p=4.10e-05)<\/div>"},{"id":"GMPPB","label":"GMPPB","x":1049.1505,"y":1731.4393,"size":5,"color":"#A6D854","shape":"triangle","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>GMPPB, LRRFIP1, MAGT1, PSMB4, RO60, RPN2, RPS9, SET, SGCB, SNRPD2, SNTB2, SPCS2, SRPK2, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Various types of N-glycan biosynthesis (p=1.11e-03)<br>N-Glycan biosynthesis (p=1.79e-03)<br>Viral myocarditis (p=2.78e-03)<br><br><b>BP:<\/b><br>protein glycosylation (p=4.20e-04)<br>macromolecule glycosylation (p=4.20e-04) <br> <b>MF:<\/b><br>magnesium ion transmembrane transporter activity (p=1.49e-02)<br>14-3-3 protein binding (p=2.45e-02) <br> <b>CC:<\/b><br>oligosaccharyltransferase complex (p=4.17e-05)<br>dystrophin-associated glycoprotein complex (p=7.00e-05)<\/div>"},{"id":"GNA13","label":"GNA13","x":1914.7196,"y":1597.7889,"size":10.2492,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.482<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CYB5R3, GNA13, GYS1, KTN1, NPM1, SUN2, TMEM214, VDAC1<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=1.71e-04)<br>Diabetic cardiomyopathy (p=8.95e-03)<br>Cytoskeleton in muscle cells (p=1.15e-02)<br><br><b>BP:<\/b><br>pyruvate metabolic process (p=1.97e-03)<br>regulation of cell shape (p=2.35e-03) <br> <b>MF:<\/b><br>monosaccharide binding (p=5.50e-04)<br>Tat protein binding (p=4.82e-03) <br> <b>CC:<\/b><br>melanosome (p=1.35e-03)<br>pigment granule (p=1.35e-03)<\/div>"},{"id":"GNB2","label":"GNB2","x":202.3241,"y":791.5256,"size":12.1666,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.538<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ARF4, BLVRA, DDOST, GNB2, GNB4, HSDL2, HSPA5, MOGS, PSMB2, RAB23, TUBB2A, UGDH<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=6.47e-04)<br>N-Glycan biosynthesis (p=1.47e-03)<br>Parkinson disease (p=2.33e-03)<br><br><b>BP:<\/b><br>substantia nigra development (p=3.80e-04)<br>neural nucleus development (p=8.55e-04) <br> <b>MF:<\/b><br>GTPase activity (p=2.92e-05)<br>signaling receptor complex adaptor activity (p=4.13e-04) <br> <b>CC:<\/b><br>heterotrimeric G-protein complex (p=1.97e-04)<br>GTPase complex (p=2.70e-04)<\/div>"},{"id":"GNB4","label":"GNB4","x":179.7292,"y":737.3404,"size":9.9814,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.538<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ARF4, BLVRA, DDOST, GNB2, GNB4, HSDL2, HSPA5, MOGS, PSMB2, RAB23, TUBB2A, UGDH<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=6.47e-04)<br>N-Glycan biosynthesis (p=1.47e-03)<br>Parkinson disease (p=2.33e-03)<br><br><b>BP:<\/b><br>substantia nigra development (p=3.80e-04)<br>neural nucleus development (p=8.55e-04) <br> <b>MF:<\/b><br>GTPase activity (p=2.92e-05)<br>signaling receptor complex adaptor activity (p=4.13e-04) <br> <b>CC:<\/b><br>heterotrimeric G-protein complex (p=1.97e-04)<br>GTPase complex (p=2.70e-04)<\/div>"},{"id":"GSN","label":"GSN","x":1977.0697,"y":948.6896,"size":10.732,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.728<\/b><\/p><b>Genes (6):<\/b><br><span style='font-size:11px;'>CKB, GSN, MPP1, MYH9, MYO1D, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=9.14e-05)<br>Motor proteins (p=4.05e-03)<br>Regulation of actin cytoskeleton (p=5.59e-03)<br><br><b>BP:<\/b><br>actin filament-based movement (p=4.24e-08)<br>establishment of T cell polarity (p=8.89e-06) <br> <b>MF:<\/b><br>actin binding (p=4.55e-06)<br>actin filament binding (p=2.71e-05) <br> <b>CC:<\/b><br>cell cortex (p=1.03e-06)<br>cortical cytoskeleton (p=3.17e-06)<\/div>"},{"id":"GUK1","label":"GUK1","x":1509.9739,"y":1834.7479,"size":11.0402,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.578<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>COPS6, FBXL7, GUK1, PPP2CB, PSMA1, PSMA4, PSMA6, PSMB1, PSMB5, PSMB7, RPL27A<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=7.35e-13)<br>Spinocerebellar ataxia (p=8.51e-10)<br>Parkinson disease (p=3.84e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.11e-11)<br>GDP-mannose metabolic process (p=5.84e-03) <br> <b>MF:<\/b><br>threonine-type peptidase activity (p=5.39e-05)<br>endopeptidase activity (p=1.48e-03) <br> <b>CC:<\/b><br>proteasome core complex (p=2.08e-16)<br>proteasome complex (p=3.99e-13)<\/div>"},{"id":"GYS1","label":"GYS1","x":1943.7927,"y":1426.5964,"size":10.1305,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.482<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CYB5R3, GNA13, GYS1, KTN1, NPM1, SUN2, TMEM214, VDAC1<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=1.71e-04)<br>Diabetic cardiomyopathy (p=8.95e-03)<br>Cytoskeleton in muscle cells (p=1.15e-02)<br><br><b>BP:<\/b><br>pyruvate metabolic process (p=1.97e-03)<br>regulation of cell shape (p=2.35e-03) <br> <b>MF:<\/b><br>monosaccharide binding (p=5.50e-04)<br>Tat protein binding (p=4.82e-03) <br> <b>CC:<\/b><br>melanosome (p=1.35e-03)<br>pigment granule (p=1.35e-03)<\/div>"},{"id":"H2AC21","label":"H2AC21","x":2171.1192,"y":1560.3305,"size":9.8346,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.653<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>FN3K, H2AC21, HCLS1, HSPA12A, HSPB6, MAPK1, PML, ST13, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Acute myeloid leukemia (p=2.96e-04)<br>Influenza A (p=1.91e-03)<br>Alcoholism (p=2.32e-03)<br><br><b>BP:<\/b><br>mammary gland epithelium development (p=3.66e-04)<br>positive regulation of telomere maintenance (p=4.33e-04) <br> <b>MF:<\/b><br>protein-folding chaperone binding (p=1.79e-03)<br>RNA polymerase II CTD heptapeptide repeat kinase activity (p=4.82e-03) <br> <b>CC:<\/b><br>gamma-tubulin complex (p=8.12e-03)<br>pseudopodium (p=8.12e-03)<\/div>"},{"id":"HAAO","label":"HAAO","x":3099.9956,"y":1654.125,"size":14.1584,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"HCLS1","label":"HCLS1","x":2170.3749,"y":1413.5427,"size":10.0642,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.653<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>FN3K, H2AC21, HCLS1, HSPA12A, HSPB6, MAPK1, PML, ST13, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Acute myeloid leukemia (p=2.96e-04)<br>Influenza A (p=1.91e-03)<br>Alcoholism (p=2.32e-03)<br><br><b>BP:<\/b><br>mammary gland epithelium development (p=3.66e-04)<br>positive regulation of telomere maintenance (p=4.33e-04) <br> <b>MF:<\/b><br>protein-folding chaperone binding (p=1.79e-03)<br>RNA polymerase II CTD heptapeptide repeat kinase activity (p=4.82e-03) <br> <b>CC:<\/b><br>gamma-tubulin complex (p=8.12e-03)<br>pseudopodium (p=8.12e-03)<\/div>"},{"id":"HLA-B","label":"HLA-B","x":2797.2493,"y":1558.4981,"size":12.6647,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"HNRNPM","label":"HNRNPM","x":558.8575,"y":1704.4873,"size":11.0296,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"HP","label":"HP","x":1972.1178,"y":2089.9483,"size":10.669,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"HSD17B12","label":"HSD17B12","x":575.8175,"y":1017.1877,"size":11.014,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.773<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT1, ALDH16A1, ANXA7, ATP5F1D, DLGAP4, ECH1, ECHS1, HSD17B12, HSD17B4, S100A6, SHMT1, SLC25A11<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of unsaturated fatty acids (p=1.67e-06)<br>Fatty acid elongation (p=1.87e-06)<br>Fatty acid metabolism (p=1.65e-05)<br><br><b>BP:<\/b><br>fatty acid metabolic process (p=2.07e-06)<br>organic acid catabolic process (p=8.22e-06) <br> <b>MF:<\/b><br>enoyl-CoA hydratase activity (p=2.50e-05)<br>intramolecular oxidoreductase activity, transposing C=C bonds (p=3.97e-05) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"HSD17B4","label":"HSD17B4","x":565.625,"y":919.0942,"size":10.2804,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.773<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT1, ALDH16A1, ANXA7, ATP5F1D, DLGAP4, ECH1, ECHS1, HSD17B12, HSD17B4, S100A6, SHMT1, SLC25A11<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of unsaturated fatty acids (p=1.67e-06)<br>Fatty acid elongation (p=1.87e-06)<br>Fatty acid metabolism (p=1.65e-05)<br><br><b>BP:<\/b><br>fatty acid metabolic process (p=2.07e-06)<br>organic acid catabolic process (p=8.22e-06) <br> <b>MF:<\/b><br>enoyl-CoA hydratase activity (p=2.50e-05)<br>intramolecular oxidoreductase activity, transposing C=C bonds (p=3.97e-05) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"HSDL2","label":"HSDL2","x":240.8885,"y":1021.5973,"size":20,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.538<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ARF4, BLVRA, DDOST, GNB2, GNB4, HSDL2, HSPA5, MOGS, PSMB2, RAB23, TUBB2A, UGDH<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=6.47e-04)<br>N-Glycan biosynthesis (p=1.47e-03)<br>Parkinson disease (p=2.33e-03)<br><br><b>BP:<\/b><br>substantia nigra development (p=3.80e-04)<br>neural nucleus development (p=8.55e-04) <br> <b>MF:<\/b><br>GTPase activity (p=2.92e-05)<br>signaling receptor complex adaptor activity (p=4.13e-04) <br> <b>CC:<\/b><br>heterotrimeric G-protein complex (p=1.97e-04)<br>GTPase complex (p=2.70e-04)<\/div>"},{"id":"HSPA12A","label":"HSPA12A","x":2302.0645,"y":1315.4663,"size":13.6051,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.653<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>FN3K, H2AC21, HCLS1, HSPA12A, HSPB6, MAPK1, PML, ST13, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Acute myeloid leukemia (p=2.96e-04)<br>Influenza A (p=1.91e-03)<br>Alcoholism (p=2.32e-03)<br><br><b>BP:<\/b><br>mammary gland epithelium development (p=3.66e-04)<br>positive regulation of telomere maintenance (p=4.33e-04) <br> <b>MF:<\/b><br>protein-folding chaperone binding (p=1.79e-03)<br>RNA polymerase II CTD heptapeptide repeat kinase activity (p=4.82e-03) <br> <b>CC:<\/b><br>gamma-tubulin complex (p=8.12e-03)<br>pseudopodium (p=8.12e-03)<\/div>"},{"id":"HSPA5","label":"HSPA5","x":231.7722,"y":890.7293,"size":10.6904,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.538<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ARF4, BLVRA, DDOST, GNB2, GNB4, HSDL2, HSPA5, MOGS, PSMB2, RAB23, TUBB2A, UGDH<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=6.47e-04)<br>N-Glycan biosynthesis (p=1.47e-03)<br>Parkinson disease (p=2.33e-03)<br><br><b>BP:<\/b><br>substantia nigra development (p=3.80e-04)<br>neural nucleus development (p=8.55e-04) <br> <b>MF:<\/b><br>GTPase activity (p=2.92e-05)<br>signaling receptor complex adaptor activity (p=4.13e-04) <br> <b>CC:<\/b><br>heterotrimeric G-protein complex (p=1.97e-04)<br>GTPase complex (p=2.70e-04)<\/div>"},{"id":"HSPB6","label":"HSPB6","x":2240.7385,"y":1363.006,"size":9.9485,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.653<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>FN3K, H2AC21, HCLS1, HSPA12A, HSPB6, MAPK1, PML, ST13, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Acute myeloid leukemia (p=2.96e-04)<br>Influenza A (p=1.91e-03)<br>Alcoholism (p=2.32e-03)<br><br><b>BP:<\/b><br>mammary gland epithelium development (p=3.66e-04)<br>positive regulation of telomere maintenance (p=4.33e-04) <br> <b>MF:<\/b><br>protein-folding chaperone binding (p=1.79e-03)<br>RNA polymerase II CTD heptapeptide repeat kinase activity (p=4.82e-03) <br> <b>CC:<\/b><br>gamma-tubulin complex (p=8.12e-03)<br>pseudopodium (p=8.12e-03)<\/div>"},{"id":"IPO5","label":"IPO5","x":903.7253,"y":2077.9885,"size":9.8346,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.64<\/b><\/p><b>Genes (7):<\/b><br><span style='font-size:11px;'>CAST, EIF3B, ERAP1, IPO5, PSME2, RAD23B, STIP1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.38e-02)<br>Nucleotide excision repair (p=3.25e-02)<br>Antigen processing and presentation (p=4.22e-02)<br><br><b>BP:<\/b><br>cellular response to interleukin-7 (p=2.25e-05)<br>response to interleukin-7 (p=2.49e-05) <br> <b>MF:<\/b><br>endopeptidase regulator activity (p=1.97e-03)<br>peptidase regulator activity (p=2.95e-03) <br> <b>CC:<\/b><br>proteasome complex (p=2.12e-04)<br>endopeptidase complex (p=4.97e-04)<\/div>"},{"id":"ITGA8","label":"ITGA8","x":2299.0548,"y":1528.7742,"size":10.5188,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"ITGB3","label":"ITGB3","x":2146.1786,"y":383.8693,"size":10.669,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.754<\/b><\/p><b>Genes (7):<\/b><br><span style='font-size:11px;'>AKAP12, APOL1, ITGB3, MCAM, PFN2, RAP1A, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=1.04e-04)<br>Platelet activation (p=1.68e-03)<br>Phagosome (p=2.66e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter transport (p=5.50e-06)<br>positive regulation of fibroblast migration (p=1.24e-05) <br> <b>MF:<\/b><br>adenylate cyclase binding (p=4.50e-03)<br>vascular endothelial growth factor receptor binding (p=4.87e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.16e-04)<br>cell-substrate junction (p=3.39e-04)<\/div>"},{"id":"JAM3","label":"JAM3","x":2271.0199,"y":2160.1536,"size":10.1536,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.562<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>BCAP31, CAV1, ENPP1, FHL1, GALM, JAM3, LAMP1, MFSD2A, PDLIM1, PDLIM4, PTGIS, SOST<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.04e-03)<br>Virion - Lassa virus and SFTS virus (p=1.94e-02)<br>Pantothenate and CoA biosynthesis (p=2.39e-02)<br><br><b>BP:<\/b><br>negative regulation of nitric oxide biosynthetic process (p=3.90e-05)<br>negative regulation of nitric oxide metabolic process (p=3.90e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=3.97e-05)<br>alpha-actinin binding (p=1.42e-04) <br> <b>CC:<\/b><br>filamentous actin (p=6.09e-07)<br>actin filament (p=4.10e-05)<\/div>"},{"id":"KTN1","label":"KTN1","x":1832.7417,"y":1358.6776,"size":13.005,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.482<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CYB5R3, GNA13, GYS1, KTN1, NPM1, SUN2, TMEM214, VDAC1<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=1.71e-04)<br>Diabetic cardiomyopathy (p=8.95e-03)<br>Cytoskeleton in muscle cells (p=1.15e-02)<br><br><b>BP:<\/b><br>pyruvate metabolic process (p=1.97e-03)<br>regulation of cell shape (p=2.35e-03) <br> <b>MF:<\/b><br>monosaccharide binding (p=5.50e-04)<br>Tat protein binding (p=4.82e-03) <br> <b>CC:<\/b><br>melanosome (p=1.35e-03)<br>pigment granule (p=1.35e-03)<\/div>"},{"id":"LAMP1","label":"LAMP1","x":1977.9293,"y":1831.4128,"size":12.1176,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.562<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>BCAP31, CAV1, ENPP1, FHL1, GALM, JAM3, LAMP1, MFSD2A, PDLIM1, PDLIM4, PTGIS, SOST<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.04e-03)<br>Virion - Lassa virus and SFTS virus (p=1.94e-02)<br>Pantothenate and CoA biosynthesis (p=2.39e-02)<br><br><b>BP:<\/b><br>negative regulation of nitric oxide biosynthetic process (p=3.90e-05)<br>negative regulation of nitric oxide metabolic process (p=3.90e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=3.97e-05)<br>alpha-actinin binding (p=1.42e-04) <br> <b>CC:<\/b><br>filamentous actin (p=6.09e-07)<br>actin filament (p=4.10e-05)<\/div>"},{"id":"LGALS1","label":"LGALS1","x":398.3789,"y":1679.6692,"size":10.0124,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"LRG1","label":"LRG1","x":2000.2357,"y":619.8647,"size":10.8566,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>APOA4, AZGP1, CLU, DCD, LRG1, NSF, PEF1, PLTP, SAA4, SERPINA1, SERPINC1, TFG<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.57e-05)<br>Cholesterol metabolism (p=5.99e-04)<br>Vitamin digestion and absorption (p=1.89e-02)<br><br><b>BP:<\/b><br>cholesterol transport (p=5.75e-05)<br>reverse cholesterol transport (p=7.05e-05) <br> <b>MF:<\/b><br>cholesterol transfer activity (p=1.13e-04)<br>phosphatidylcholine binding (p=1.64e-04) <br> <b>CC:<\/b><br>high-density lipoprotein particle (p=1.33e-09)<br>plasma lipoprotein particle (p=4.97e-09)<\/div>"},{"id":"LRRFIP1","label":"LRRFIP1","x":775.9369,"y":1754.5862,"size":11.5824,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>GMPPB, LRRFIP1, MAGT1, PSMB4, RO60, RPN2, RPS9, SET, SGCB, SNRPD2, SNTB2, SPCS2, SRPK2, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Various types of N-glycan biosynthesis (p=1.11e-03)<br>N-Glycan biosynthesis (p=1.79e-03)<br>Viral myocarditis (p=2.78e-03)<br><br><b>BP:<\/b><br>protein glycosylation (p=4.20e-04)<br>macromolecule glycosylation (p=4.20e-04) <br> <b>MF:<\/b><br>magnesium ion transmembrane transporter activity (p=1.49e-02)<br>14-3-3 protein binding (p=2.45e-02) <br> <b>CC:<\/b><br>oligosaccharyltransferase complex (p=4.17e-05)<br>dystrophin-associated glycoprotein complex (p=7.00e-05)<\/div>"},{"id":"MAGT1","label":"MAGT1","x":819.0395,"y":1730.4569,"size":5,"color":"#A6D854","shape":"triangle","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>GMPPB, LRRFIP1, MAGT1, PSMB4, RO60, RPN2, RPS9, SET, SGCB, SNRPD2, SNTB2, SPCS2, SRPK2, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Various types of N-glycan biosynthesis (p=1.11e-03)<br>N-Glycan biosynthesis (p=1.79e-03)<br>Viral myocarditis (p=2.78e-03)<br><br><b>BP:<\/b><br>protein glycosylation (p=4.20e-04)<br>macromolecule glycosylation (p=4.20e-04) <br> <b>MF:<\/b><br>magnesium ion transmembrane transporter activity (p=1.49e-02)<br>14-3-3 protein binding (p=2.45e-02) <br> <b>CC:<\/b><br>oligosaccharyltransferase complex (p=4.17e-05)<br>dystrophin-associated glycoprotein complex (p=7.00e-05)<\/div>"},{"id":"MAPK1","label":"MAPK1","x":2100.2739,"y":1505.8825,"size":11.054,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.653<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>FN3K, H2AC21, HCLS1, HSPA12A, HSPB6, MAPK1, PML, ST13, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Acute myeloid leukemia (p=2.96e-04)<br>Influenza A (p=1.91e-03)<br>Alcoholism (p=2.32e-03)<br><br><b>BP:<\/b><br>mammary gland epithelium development (p=3.66e-04)<br>positive regulation of telomere maintenance (p=4.33e-04) <br> <b>MF:<\/b><br>protein-folding chaperone binding (p=1.79e-03)<br>RNA polymerase II CTD heptapeptide repeat kinase activity (p=4.82e-03) <br> <b>CC:<\/b><br>gamma-tubulin complex (p=8.12e-03)<br>pseudopodium (p=8.12e-03)<\/div>"},{"id":"MCAM","label":"MCAM","x":2182.6181,"y":265.5753,"size":11.7531,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.754<\/b><\/p><b>Genes (7):<\/b><br><span style='font-size:11px;'>AKAP12, APOL1, ITGB3, MCAM, PFN2, RAP1A, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=1.04e-04)<br>Platelet activation (p=1.68e-03)<br>Phagosome (p=2.66e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter transport (p=5.50e-06)<br>positive regulation of fibroblast migration (p=1.24e-05) <br> <b>MF:<\/b><br>adenylate cyclase binding (p=4.50e-03)<br>vascular endothelial growth factor receptor binding (p=4.87e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.16e-04)<br>cell-substrate junction (p=3.39e-04)<\/div>"},{"id":"METAP2","label":"METAP2","x":335.0937,"y":1719.9784,"size":10.5444,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"MFSD2A","label":"MFSD2A","x":2274.6906,"y":2045.1928,"size":5,"color":"#999999","shape":"triangle","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.562<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>BCAP31, CAV1, ENPP1, FHL1, GALM, JAM3, LAMP1, MFSD2A, PDLIM1, PDLIM4, PTGIS, SOST<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.04e-03)<br>Virion - Lassa virus and SFTS virus (p=1.94e-02)<br>Pantothenate and CoA biosynthesis (p=2.39e-02)<br><br><b>BP:<\/b><br>negative regulation of nitric oxide biosynthetic process (p=3.90e-05)<br>negative regulation of nitric oxide metabolic process (p=3.90e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=3.97e-05)<br>alpha-actinin binding (p=1.42e-04) <br> <b>CC:<\/b><br>filamentous actin (p=6.09e-07)<br>actin filament (p=4.10e-05)<\/div>"},{"id":"MOGS","label":"MOGS","x":203.4554,"y":857.9055,"size":17.9511,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.538<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ARF4, BLVRA, DDOST, GNB2, GNB4, HSDL2, HSPA5, MOGS, PSMB2, RAB23, TUBB2A, UGDH<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=6.47e-04)<br>N-Glycan biosynthesis (p=1.47e-03)<br>Parkinson disease (p=2.33e-03)<br><br><b>BP:<\/b><br>substantia nigra development (p=3.80e-04)<br>neural nucleus development (p=8.55e-04) <br> <b>MF:<\/b><br>GTPase activity (p=2.92e-05)<br>signaling receptor complex adaptor activity (p=4.13e-04) <br> <b>CC:<\/b><br>heterotrimeric G-protein complex (p=1.97e-04)<br>GTPase complex (p=2.70e-04)<\/div>"},{"id":"MPP1","label":"MPP1","x":1963.9946,"y":911.0699,"size":9.8346,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.728<\/b><\/p><b>Genes (6):<\/b><br><span style='font-size:11px;'>CKB, GSN, MPP1, MYH9, MYO1D, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=9.14e-05)<br>Motor proteins (p=4.05e-03)<br>Regulation of actin cytoskeleton (p=5.59e-03)<br><br><b>BP:<\/b><br>actin filament-based movement (p=4.24e-08)<br>establishment of T cell polarity (p=8.89e-06) <br> <b>MF:<\/b><br>actin binding (p=4.55e-06)<br>actin filament binding (p=2.71e-05) <br> <b>CC:<\/b><br>cell cortex (p=1.03e-06)<br>cortical cytoskeleton (p=3.17e-06)<\/div>"},{"id":"MYH9","label":"MYH9","x":2070.4925,"y":830.7097,"size":5,"color":"#FC8D62","shape":"triangle","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.728<\/b><\/p><b>Genes (6):<\/b><br><span style='font-size:11px;'>CKB, GSN, MPP1, MYH9, MYO1D, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=9.14e-05)<br>Motor proteins (p=4.05e-03)<br>Regulation of actin cytoskeleton (p=5.59e-03)<br><br><b>BP:<\/b><br>actin filament-based movement (p=4.24e-08)<br>establishment of T cell polarity (p=8.89e-06) <br> <b>MF:<\/b><br>actin binding (p=4.55e-06)<br>actin filament binding (p=2.71e-05) <br> <b>CC:<\/b><br>cell cortex (p=1.03e-06)<br>cortical cytoskeleton (p=3.17e-06)<\/div>"},{"id":"MYO1D","label":"MYO1D","x":2111.2242,"y":790.0594,"size":10.691,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.728<\/b><\/p><b>Genes (6):<\/b><br><span style='font-size:11px;'>CKB, GSN, MPP1, MYH9, MYO1D, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=9.14e-05)<br>Motor proteins (p=4.05e-03)<br>Regulation of actin cytoskeleton (p=5.59e-03)<br><br><b>BP:<\/b><br>actin filament-based movement (p=4.24e-08)<br>establishment of T cell polarity (p=8.89e-06) <br> <b>MF:<\/b><br>actin binding (p=4.55e-06)<br>actin filament binding (p=2.71e-05) <br> <b>CC:<\/b><br>cell cortex (p=1.03e-06)<br>cortical cytoskeleton (p=3.17e-06)<\/div>"},{"id":"NME3","label":"NME3","x":395.4486,"y":1732.0992,"size":14.4541,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"NOTCH3","label":"NOTCH3","x":2542.1997,"y":1535.7505,"size":9.8917,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"NPM1","label":"NPM1","x":1871.1596,"y":1443.3867,"size":11.3273,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.482<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CYB5R3, GNA13, GYS1, KTN1, NPM1, SUN2, TMEM214, VDAC1<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=1.71e-04)<br>Diabetic cardiomyopathy (p=8.95e-03)<br>Cytoskeleton in muscle cells (p=1.15e-02)<br><br><b>BP:<\/b><br>pyruvate metabolic process (p=1.97e-03)<br>regulation of cell shape (p=2.35e-03) <br> <b>MF:<\/b><br>monosaccharide binding (p=5.50e-04)<br>Tat protein binding (p=4.82e-03) <br> <b>CC:<\/b><br>melanosome (p=1.35e-03)<br>pigment granule (p=1.35e-03)<\/div>"},{"id":"NSF","label":"NSF","x":1982.8093,"y":296.594,"size":11.3592,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>APOA4, AZGP1, CLU, DCD, LRG1, NSF, PEF1, PLTP, SAA4, SERPINA1, SERPINC1, TFG<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.57e-05)<br>Cholesterol metabolism (p=5.99e-04)<br>Vitamin digestion and absorption (p=1.89e-02)<br><br><b>BP:<\/b><br>cholesterol transport (p=5.75e-05)<br>reverse cholesterol transport (p=7.05e-05) <br> <b>MF:<\/b><br>cholesterol transfer activity (p=1.13e-04)<br>phosphatidylcholine binding (p=1.64e-04) <br> <b>CC:<\/b><br>high-density lipoprotein particle (p=1.33e-09)<br>plasma lipoprotein particle (p=4.97e-09)<\/div>"},{"id":"NUCB1","label":"NUCB1","x":368.9754,"y":2081.1358,"size":11.054,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"PACSIN3","label":"PACSIN3","x":3045.3182,"y":1641.6676,"size":5,"color":"#377EB8","shape":"triangle","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"PDLIM1","label":"PDLIM1","x":2326.6544,"y":2239.0158,"size":10.5523,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.562<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>BCAP31, CAV1, ENPP1, FHL1, GALM, JAM3, LAMP1, MFSD2A, PDLIM1, PDLIM4, PTGIS, SOST<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.04e-03)<br>Virion - Lassa virus and SFTS virus (p=1.94e-02)<br>Pantothenate and CoA biosynthesis (p=2.39e-02)<br><br><b>BP:<\/b><br>negative regulation of nitric oxide biosynthetic process (p=3.90e-05)<br>negative regulation of nitric oxide metabolic process (p=3.90e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=3.97e-05)<br>alpha-actinin binding (p=1.42e-04) <br> <b>CC:<\/b><br>filamentous actin (p=6.09e-07)<br>actin filament (p=4.10e-05)<\/div>"},{"id":"PDLIM4","label":"PDLIM4","x":2367.2789,"y":2268.1784,"size":10.4785,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.562<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>BCAP31, CAV1, ENPP1, FHL1, GALM, JAM3, LAMP1, MFSD2A, PDLIM1, PDLIM4, PTGIS, SOST<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.04e-03)<br>Virion - Lassa virus and SFTS virus (p=1.94e-02)<br>Pantothenate and CoA biosynthesis (p=2.39e-02)<br><br><b>BP:<\/b><br>negative regulation of nitric oxide biosynthetic process (p=3.90e-05)<br>negative regulation of nitric oxide metabolic process (p=3.90e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=3.97e-05)<br>alpha-actinin binding (p=1.42e-04) <br> <b>CC:<\/b><br>filamentous actin (p=6.09e-07)<br>actin filament (p=4.10e-05)<\/div>"},{"id":"PEF1","label":"PEF1","x":1958.902,"y":408.6535,"size":10.4217,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>APOA4, AZGP1, CLU, DCD, LRG1, NSF, PEF1, PLTP, SAA4, SERPINA1, SERPINC1, TFG<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.57e-05)<br>Cholesterol metabolism (p=5.99e-04)<br>Vitamin digestion and absorption (p=1.89e-02)<br><br><b>BP:<\/b><br>cholesterol transport (p=5.75e-05)<br>reverse cholesterol transport (p=7.05e-05) <br> <b>MF:<\/b><br>cholesterol transfer activity (p=1.13e-04)<br>phosphatidylcholine binding (p=1.64e-04) <br> <b>CC:<\/b><br>high-density lipoprotein particle (p=1.33e-09)<br>plasma lipoprotein particle (p=4.97e-09)<\/div>"},{"id":"PFN2","label":"PFN2","x":2238.6813,"y":278.8301,"size":10.1764,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.754<\/b><\/p><b>Genes (7):<\/b><br><span style='font-size:11px;'>AKAP12, APOL1, ITGB3, MCAM, PFN2, RAP1A, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=1.04e-04)<br>Platelet activation (p=1.68e-03)<br>Phagosome (p=2.66e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter transport (p=5.50e-06)<br>positive regulation of fibroblast migration (p=1.24e-05) <br> <b>MF:<\/b><br>adenylate cyclase binding (p=4.50e-03)<br>vascular endothelial growth factor receptor binding (p=4.87e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.16e-04)<br>cell-substrate junction (p=3.39e-04)<\/div>"},{"id":"PLPBP","label":"PLPBP","x":314.7168,"y":1970.9838,"size":11.3413,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"PLTP","label":"PLTP","x":1936.171,"y":338.2932,"size":10.1816,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>APOA4, AZGP1, CLU, DCD, LRG1, NSF, PEF1, PLTP, SAA4, SERPINA1, SERPINC1, TFG<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.57e-05)<br>Cholesterol metabolism (p=5.99e-04)<br>Vitamin digestion and absorption (p=1.89e-02)<br><br><b>BP:<\/b><br>cholesterol transport (p=5.75e-05)<br>reverse cholesterol transport (p=7.05e-05) <br> <b>MF:<\/b><br>cholesterol transfer activity (p=1.13e-04)<br>phosphatidylcholine binding (p=1.64e-04) <br> <b>CC:<\/b><br>high-density lipoprotein particle (p=1.33e-09)<br>plasma lipoprotein particle (p=4.97e-09)<\/div>"},{"id":"PML","label":"PML","x":2138.8343,"y":1533.1001,"size":10.5259,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.653<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>FN3K, H2AC21, HCLS1, HSPA12A, HSPB6, MAPK1, PML, ST13, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Acute myeloid leukemia (p=2.96e-04)<br>Influenza A (p=1.91e-03)<br>Alcoholism (p=2.32e-03)<br><br><b>BP:<\/b><br>mammary gland epithelium development (p=3.66e-04)<br>positive regulation of telomere maintenance (p=4.33e-04) <br> <b>MF:<\/b><br>protein-folding chaperone binding (p=1.79e-03)<br>RNA polymerase II CTD heptapeptide repeat kinase activity (p=4.82e-03) <br> <b>CC:<\/b><br>gamma-tubulin complex (p=8.12e-03)<br>pseudopodium (p=8.12e-03)<\/div>"},{"id":"PPP2CB","label":"PPP2CB","x":1284.3256,"y":1862.3426,"size":9.784,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.578<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>COPS6, FBXL7, GUK1, PPP2CB, PSMA1, PSMA4, PSMA6, PSMB1, PSMB5, PSMB7, RPL27A<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=7.35e-13)<br>Spinocerebellar ataxia (p=8.51e-10)<br>Parkinson disease (p=3.84e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.11e-11)<br>GDP-mannose metabolic process (p=5.84e-03) <br> <b>MF:<\/b><br>threonine-type peptidase activity (p=5.39e-05)<br>endopeptidase activity (p=1.48e-03) <br> <b>CC:<\/b><br>proteasome core complex (p=2.08e-16)<br>proteasome complex (p=3.99e-13)<\/div>"},{"id":"PSMA1","label":"PSMA1","x":1280.1547,"y":1747.3787,"size":12.0026,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.578<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>COPS6, FBXL7, GUK1, PPP2CB, PSMA1, PSMA4, PSMA6, PSMB1, PSMB5, PSMB7, RPL27A<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=7.35e-13)<br>Spinocerebellar ataxia (p=8.51e-10)<br>Parkinson disease (p=3.84e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.11e-11)<br>GDP-mannose metabolic process (p=5.84e-03) <br> <b>MF:<\/b><br>threonine-type peptidase activity (p=5.39e-05)<br>endopeptidase activity (p=1.48e-03) <br> <b>CC:<\/b><br>proteasome core complex (p=2.08e-16)<br>proteasome complex (p=3.99e-13)<\/div>"},{"id":"PSMA4","label":"PSMA4","x":1450.7248,"y":1673.069,"size":10.0642,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.578<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>COPS6, FBXL7, GUK1, PPP2CB, PSMA1, PSMA4, PSMA6, PSMB1, PSMB5, PSMB7, RPL27A<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=7.35e-13)<br>Spinocerebellar ataxia (p=8.51e-10)<br>Parkinson disease (p=3.84e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.11e-11)<br>GDP-mannose metabolic process (p=5.84e-03) <br> <b>MF:<\/b><br>threonine-type peptidase activity (p=5.39e-05)<br>endopeptidase activity (p=1.48e-03) <br> <b>CC:<\/b><br>proteasome core complex (p=2.08e-16)<br>proteasome complex (p=3.99e-13)<\/div>"},{"id":"PSMA6","label":"PSMA6","x":1705.869,"y":1614.2583,"size":10.4217,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.578<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>COPS6, FBXL7, GUK1, PPP2CB, PSMA1, PSMA4, PSMA6, PSMB1, PSMB5, PSMB7, RPL27A<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=7.35e-13)<br>Spinocerebellar ataxia (p=8.51e-10)<br>Parkinson disease (p=3.84e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.11e-11)<br>GDP-mannose metabolic process (p=5.84e-03) <br> <b>MF:<\/b><br>threonine-type peptidase activity (p=5.39e-05)<br>endopeptidase activity (p=1.48e-03) <br> <b>CC:<\/b><br>proteasome core complex (p=2.08e-16)<br>proteasome complex (p=3.99e-13)<\/div>"},{"id":"PSMB1","label":"PSMB1","x":1491.2547,"y":1777.4143,"size":9.9485,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.578<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>COPS6, FBXL7, GUK1, PPP2CB, PSMA1, PSMA4, PSMA6, PSMB1, PSMB5, PSMB7, RPL27A<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=7.35e-13)<br>Spinocerebellar ataxia (p=8.51e-10)<br>Parkinson disease (p=3.84e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.11e-11)<br>GDP-mannose metabolic process (p=5.84e-03) <br> <b>MF:<\/b><br>threonine-type peptidase activity (p=5.39e-05)<br>endopeptidase activity (p=1.48e-03) <br> <b>CC:<\/b><br>proteasome core complex (p=2.08e-16)<br>proteasome complex (p=3.99e-13)<\/div>"},{"id":"PSMB2","label":"PSMB2","x":179.537,"y":890.356,"size":11.054,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.538<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ARF4, BLVRA, DDOST, GNB2, GNB4, HSDL2, HSPA5, MOGS, PSMB2, RAB23, TUBB2A, UGDH<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=6.47e-04)<br>N-Glycan biosynthesis (p=1.47e-03)<br>Parkinson disease (p=2.33e-03)<br><br><b>BP:<\/b><br>substantia nigra development (p=3.80e-04)<br>neural nucleus development (p=8.55e-04) <br> <b>MF:<\/b><br>GTPase activity (p=2.92e-05)<br>signaling receptor complex adaptor activity (p=4.13e-04) <br> <b>CC:<\/b><br>heterotrimeric G-protein complex (p=1.97e-04)<br>GTPase complex (p=2.70e-04)<\/div>"},{"id":"PSMB4","label":"PSMB4","x":1133.0431,"y":1962.4703,"size":10.1816,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>GMPPB, LRRFIP1, MAGT1, PSMB4, RO60, RPN2, RPS9, SET, SGCB, SNRPD2, SNTB2, SPCS2, SRPK2, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Various types of N-glycan biosynthesis (p=1.11e-03)<br>N-Glycan biosynthesis (p=1.79e-03)<br>Viral myocarditis (p=2.78e-03)<br><br><b>BP:<\/b><br>protein glycosylation (p=4.20e-04)<br>macromolecule glycosylation (p=4.20e-04) <br> <b>MF:<\/b><br>magnesium ion transmembrane transporter activity (p=1.49e-02)<br>14-3-3 protein binding (p=2.45e-02) <br> <b>CC:<\/b><br>oligosaccharyltransferase complex (p=4.17e-05)<br>dystrophin-associated glycoprotein complex (p=7.00e-05)<\/div>"},{"id":"PSMB5","label":"PSMB5","x":1483.0048,"y":1639.3571,"size":11.4567,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.578<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>COPS6, FBXL7, GUK1, PPP2CB, PSMA1, PSMA4, PSMA6, PSMB1, PSMB5, PSMB7, RPL27A<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=7.35e-13)<br>Spinocerebellar ataxia (p=8.51e-10)<br>Parkinson disease (p=3.84e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.11e-11)<br>GDP-mannose metabolic process (p=5.84e-03) <br> <b>MF:<\/b><br>threonine-type peptidase activity (p=5.39e-05)<br>endopeptidase activity (p=1.48e-03) <br> <b>CC:<\/b><br>proteasome core complex (p=2.08e-16)<br>proteasome complex (p=3.99e-13)<\/div>"},{"id":"PSMB7","label":"PSMB7","x":1524.9875,"y":1674.078,"size":10.1816,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.578<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>COPS6, FBXL7, GUK1, PPP2CB, PSMA1, PSMA4, PSMA6, PSMB1, PSMB5, PSMB7, RPL27A<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=7.35e-13)<br>Spinocerebellar ataxia (p=8.51e-10)<br>Parkinson disease (p=3.84e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.11e-11)<br>GDP-mannose metabolic process (p=5.84e-03) <br> <b>MF:<\/b><br>threonine-type peptidase activity (p=5.39e-05)<br>endopeptidase activity (p=1.48e-03) <br> <b>CC:<\/b><br>proteasome core complex (p=2.08e-16)<br>proteasome complex (p=3.99e-13)<\/div>"},{"id":"PSME2","label":"PSME2","x":982.4827,"y":2051.8142,"size":12.3191,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.64<\/b><\/p><b>Genes (7):<\/b><br><span style='font-size:11px;'>CAST, EIF3B, ERAP1, IPO5, PSME2, RAD23B, STIP1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.38e-02)<br>Nucleotide excision repair (p=3.25e-02)<br>Antigen processing and presentation (p=4.22e-02)<br><br><b>BP:<\/b><br>cellular response to interleukin-7 (p=2.25e-05)<br>response to interleukin-7 (p=2.49e-05) <br> <b>MF:<\/b><br>endopeptidase regulator activity (p=1.97e-03)<br>peptidase regulator activity (p=2.95e-03) <br> <b>CC:<\/b><br>proteasome complex (p=2.12e-04)<br>endopeptidase complex (p=4.97e-04)<\/div>"},{"id":"PTGIS","label":"PTGIS","x":2215.1813,"y":2103.2397,"size":13.177,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.562<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>BCAP31, CAV1, ENPP1, FHL1, GALM, JAM3, LAMP1, MFSD2A, PDLIM1, PDLIM4, PTGIS, SOST<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.04e-03)<br>Virion - Lassa virus and SFTS virus (p=1.94e-02)<br>Pantothenate and CoA biosynthesis (p=2.39e-02)<br><br><b>BP:<\/b><br>negative regulation of nitric oxide biosynthetic process (p=3.90e-05)<br>negative regulation of nitric oxide metabolic process (p=3.90e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=3.97e-05)<br>alpha-actinin binding (p=1.42e-04) <br> <b>CC:<\/b><br>filamentous actin (p=6.09e-07)<br>actin filament (p=4.10e-05)<\/div>"},{"id":"RAB23","label":"RAB23","x":100,"y":795.5747,"size":11.3205,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.538<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ARF4, BLVRA, DDOST, GNB2, GNB4, HSDL2, HSPA5, MOGS, PSMB2, RAB23, TUBB2A, UGDH<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=6.47e-04)<br>N-Glycan biosynthesis (p=1.47e-03)<br>Parkinson disease (p=2.33e-03)<br><br><b>BP:<\/b><br>substantia nigra development (p=3.80e-04)<br>neural nucleus development (p=8.55e-04) <br> <b>MF:<\/b><br>GTPase activity (p=2.92e-05)<br>signaling receptor complex adaptor activity (p=4.13e-04) <br> <b>CC:<\/b><br>heterotrimeric G-protein complex (p=1.97e-04)<br>GTPase complex (p=2.70e-04)<\/div>"},{"id":"RAD23B","label":"RAD23B","x":1004.5859,"y":1937.0378,"size":11.8976,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.64<\/b><\/p><b>Genes (7):<\/b><br><span style='font-size:11px;'>CAST, EIF3B, ERAP1, IPO5, PSME2, RAD23B, STIP1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.38e-02)<br>Nucleotide excision repair (p=3.25e-02)<br>Antigen processing and presentation (p=4.22e-02)<br><br><b>BP:<\/b><br>cellular response to interleukin-7 (p=2.25e-05)<br>response to interleukin-7 (p=2.49e-05) <br> <b>MF:<\/b><br>endopeptidase regulator activity (p=1.97e-03)<br>peptidase regulator activity (p=2.95e-03) <br> <b>CC:<\/b><br>proteasome complex (p=2.12e-04)<br>endopeptidase complex (p=4.97e-04)<\/div>"},{"id":"RANBP1","label":"RANBP1","x":415.2757,"y":1886.11,"size":11.3172,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"RAP1A","label":"RAP1A","x":2198.1576,"y":324.8515,"size":11.4532,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.754<\/b><\/p><b>Genes (7):<\/b><br><span style='font-size:11px;'>AKAP12, APOL1, ITGB3, MCAM, PFN2, RAP1A, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=1.04e-04)<br>Platelet activation (p=1.68e-03)<br>Phagosome (p=2.66e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter transport (p=5.50e-06)<br>positive regulation of fibroblast migration (p=1.24e-05) <br> <b>MF:<\/b><br>adenylate cyclase binding (p=4.50e-03)<br>vascular endothelial growth factor receptor binding (p=4.87e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.16e-04)<br>cell-substrate junction (p=3.39e-04)<\/div>"},{"id":"RNPEP","label":"RNPEP","x":1929.7677,"y":2516.9173,"size":16.7178,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"RO60","label":"RO60","x":1068.8693,"y":1972.174,"size":10.0181,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>GMPPB, LRRFIP1, MAGT1, PSMB4, RO60, RPN2, RPS9, SET, SGCB, SNRPD2, SNTB2, SPCS2, SRPK2, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Various types of N-glycan biosynthesis (p=1.11e-03)<br>N-Glycan biosynthesis (p=1.79e-03)<br>Viral myocarditis (p=2.78e-03)<br><br><b>BP:<\/b><br>protein glycosylation (p=4.20e-04)<br>macromolecule glycosylation (p=4.20e-04) <br> <b>MF:<\/b><br>magnesium ion transmembrane transporter activity (p=1.49e-02)<br>14-3-3 protein binding (p=2.45e-02) <br> <b>CC:<\/b><br>oligosaccharyltransferase complex (p=4.17e-05)<br>dystrophin-associated glycoprotein complex (p=7.00e-05)<\/div>"},{"id":"RPL12","label":"RPL12","x":699.5994,"y":1606.7425,"size":12.4707,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"RPL27A","label":"RPL27A","x":1472.6373,"y":1832.8725,"size":10.9391,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.578<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>COPS6, FBXL7, GUK1, PPP2CB, PSMA1, PSMA4, PSMA6, PSMB1, PSMB5, PSMB7, RPL27A<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=7.35e-13)<br>Spinocerebellar ataxia (p=8.51e-10)<br>Parkinson disease (p=3.84e-08)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.11e-11)<br>GDP-mannose metabolic process (p=5.84e-03) <br> <b>MF:<\/b><br>threonine-type peptidase activity (p=5.39e-05)<br>endopeptidase activity (p=1.48e-03) <br> <b>CC:<\/b><br>proteasome core complex (p=2.08e-16)<br>proteasome complex (p=3.99e-13)<\/div>"},{"id":"RPL35","label":"RPL35","x":353.8487,"y":1937.2559,"size":12.0805,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"RPN2","label":"RPN2","x":854.5563,"y":1668.9911,"size":10.495,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>GMPPB, LRRFIP1, MAGT1, PSMB4, RO60, RPN2, RPS9, SET, SGCB, SNRPD2, SNTB2, SPCS2, SRPK2, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Various types of N-glycan biosynthesis (p=1.11e-03)<br>N-Glycan biosynthesis (p=1.79e-03)<br>Viral myocarditis (p=2.78e-03)<br><br><b>BP:<\/b><br>protein glycosylation (p=4.20e-04)<br>macromolecule glycosylation (p=4.20e-04) <br> <b>MF:<\/b><br>magnesium ion transmembrane transporter activity (p=1.49e-02)<br>14-3-3 protein binding (p=2.45e-02) <br> <b>CC:<\/b><br>oligosaccharyltransferase complex (p=4.17e-05)<br>dystrophin-associated glycoprotein complex (p=7.00e-05)<\/div>"},{"id":"RPS11","label":"RPS11","x":485.413,"y":1827.38,"size":11.054,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"RPS28","label":"RPS28","x":437.9529,"y":1709.0788,"size":10.9237,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"RPS9","label":"RPS9","x":1071.0382,"y":1798.4946,"size":11.134,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>GMPPB, LRRFIP1, MAGT1, PSMB4, RO60, RPN2, RPS9, SET, SGCB, SNRPD2, SNTB2, SPCS2, SRPK2, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Various types of N-glycan biosynthesis (p=1.11e-03)<br>N-Glycan biosynthesis (p=1.79e-03)<br>Viral myocarditis (p=2.78e-03)<br><br><b>BP:<\/b><br>protein glycosylation (p=4.20e-04)<br>macromolecule glycosylation (p=4.20e-04) <br> <b>MF:<\/b><br>magnesium ion transmembrane transporter activity (p=1.49e-02)<br>14-3-3 protein binding (p=2.45e-02) <br> <b>CC:<\/b><br>oligosaccharyltransferase complex (p=4.17e-05)<br>dystrophin-associated glycoprotein complex (p=7.00e-05)<\/div>"},{"id":"S100A6","label":"S100A6","x":504.3497,"y":1273.654,"size":9.8987,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.773<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT1, ALDH16A1, ANXA7, ATP5F1D, DLGAP4, ECH1, ECHS1, HSD17B12, HSD17B4, S100A6, SHMT1, SLC25A11<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of unsaturated fatty acids (p=1.67e-06)<br>Fatty acid elongation (p=1.87e-06)<br>Fatty acid metabolism (p=1.65e-05)<br><br><b>BP:<\/b><br>fatty acid metabolic process (p=2.07e-06)<br>organic acid catabolic process (p=8.22e-06) <br> <b>MF:<\/b><br>enoyl-CoA hydratase activity (p=2.50e-05)<br>intramolecular oxidoreductase activity, transposing C=C bonds (p=3.97e-05) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"SAA4","label":"SAA4","x":2012.0149,"y":296.0506,"size":10.4017,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>APOA4, AZGP1, CLU, DCD, LRG1, NSF, PEF1, PLTP, SAA4, SERPINA1, SERPINC1, TFG<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.57e-05)<br>Cholesterol metabolism (p=5.99e-04)<br>Vitamin digestion and absorption (p=1.89e-02)<br><br><b>BP:<\/b><br>cholesterol transport (p=5.75e-05)<br>reverse cholesterol transport (p=7.05e-05) <br> <b>MF:<\/b><br>cholesterol transfer activity (p=1.13e-04)<br>phosphatidylcholine binding (p=1.64e-04) <br> <b>CC:<\/b><br>high-density lipoprotein particle (p=1.33e-09)<br>plasma lipoprotein particle (p=4.97e-09)<\/div>"},{"id":"SELENOP","label":"SELENOP","x":2721.4124,"y":1517.6363,"size":10.5444,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"SERPINA1","label":"SERPINA1","x":1992.0973,"y":371.105,"size":10.5219,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>APOA4, AZGP1, CLU, DCD, LRG1, NSF, PEF1, PLTP, SAA4, SERPINA1, SERPINC1, TFG<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.57e-05)<br>Cholesterol metabolism (p=5.99e-04)<br>Vitamin digestion and absorption (p=1.89e-02)<br><br><b>BP:<\/b><br>cholesterol transport (p=5.75e-05)<br>reverse cholesterol transport (p=7.05e-05) <br> <b>MF:<\/b><br>cholesterol transfer activity (p=1.13e-04)<br>phosphatidylcholine binding (p=1.64e-04) <br> <b>CC:<\/b><br>high-density lipoprotein particle (p=1.33e-09)<br>plasma lipoprotein particle (p=4.97e-09)<\/div>"},{"id":"SERPINA6","label":"SERPINA6","x":1938.8329,"y":2148.6812,"size":10.3235,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"SERPINC1","label":"SERPINC1","x":1903.3563,"y":510.3737,"size":10.0745,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>APOA4, AZGP1, CLU, DCD, LRG1, NSF, PEF1, PLTP, SAA4, SERPINA1, SERPINC1, TFG<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.57e-05)<br>Cholesterol metabolism (p=5.99e-04)<br>Vitamin digestion and absorption (p=1.89e-02)<br><br><b>BP:<\/b><br>cholesterol transport (p=5.75e-05)<br>reverse cholesterol transport (p=7.05e-05) <br> <b>MF:<\/b><br>cholesterol transfer activity (p=1.13e-04)<br>phosphatidylcholine binding (p=1.64e-04) <br> <b>CC:<\/b><br>high-density lipoprotein particle (p=1.33e-09)<br>plasma lipoprotein particle (p=4.97e-09)<\/div>"},{"id":"SERPING1","label":"SERPING1","x":2114.4569,"y":2431.2788,"size":10.4217,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"SET","label":"SET","x":1102.1073,"y":1985.4369,"size":12.1698,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>GMPPB, LRRFIP1, MAGT1, PSMB4, RO60, RPN2, RPS9, SET, SGCB, SNRPD2, SNTB2, SPCS2, SRPK2, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Various types of N-glycan biosynthesis (p=1.11e-03)<br>N-Glycan biosynthesis (p=1.79e-03)<br>Viral myocarditis (p=2.78e-03)<br><br><b>BP:<\/b><br>protein glycosylation (p=4.20e-04)<br>macromolecule glycosylation (p=4.20e-04) <br> <b>MF:<\/b><br>magnesium ion transmembrane transporter activity (p=1.49e-02)<br>14-3-3 protein binding (p=2.45e-02) <br> <b>CC:<\/b><br>oligosaccharyltransferase complex (p=4.17e-05)<br>dystrophin-associated glycoprotein complex (p=7.00e-05)<\/div>"},{"id":"SGCB","label":"SGCB","x":1030.4519,"y":1669.836,"size":11.7852,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>GMPPB, LRRFIP1, MAGT1, PSMB4, RO60, RPN2, RPS9, SET, SGCB, SNRPD2, SNTB2, SPCS2, SRPK2, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Various types of N-glycan biosynthesis (p=1.11e-03)<br>N-Glycan biosynthesis (p=1.79e-03)<br>Viral myocarditis (p=2.78e-03)<br><br><b>BP:<\/b><br>protein glycosylation (p=4.20e-04)<br>macromolecule glycosylation (p=4.20e-04) <br> <b>MF:<\/b><br>magnesium ion transmembrane transporter activity (p=1.49e-02)<br>14-3-3 protein binding (p=2.45e-02) <br> <b>CC:<\/b><br>oligosaccharyltransferase complex (p=4.17e-05)<br>dystrophin-associated glycoprotein complex (p=7.00e-05)<\/div>"},{"id":"SHMT1","label":"SHMT1","x":548.6225,"y":974.9614,"size":12.1926,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.773<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT1, ALDH16A1, ANXA7, ATP5F1D, DLGAP4, ECH1, ECHS1, HSD17B12, HSD17B4, S100A6, SHMT1, SLC25A11<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of unsaturated fatty acids (p=1.67e-06)<br>Fatty acid elongation (p=1.87e-06)<br>Fatty acid metabolism (p=1.65e-05)<br><br><b>BP:<\/b><br>fatty acid metabolic process (p=2.07e-06)<br>organic acid catabolic process (p=8.22e-06) <br> <b>MF:<\/b><br>enoyl-CoA hydratase activity (p=2.50e-05)<br>intramolecular oxidoreductase activity, transposing C=C bonds (p=3.97e-05) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"SLC25A11","label":"SLC25A11","x":595.8663,"y":1135.6698,"size":11.8237,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.773<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT1, ALDH16A1, ANXA7, ATP5F1D, DLGAP4, ECH1, ECHS1, HSD17B12, HSD17B4, S100A6, SHMT1, SLC25A11<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of unsaturated fatty acids (p=1.67e-06)<br>Fatty acid elongation (p=1.87e-06)<br>Fatty acid metabolism (p=1.65e-05)<br><br><b>BP:<\/b><br>fatty acid metabolic process (p=2.07e-06)<br>organic acid catabolic process (p=8.22e-06) <br> <b>MF:<\/b><br>enoyl-CoA hydratase activity (p=2.50e-05)<br>intramolecular oxidoreductase activity, transposing C=C bonds (p=3.97e-05) <br> <b>CC:<\/b><br>peroxisomal matrix (p=4.36e-04)<br>microbody lumen (p=4.36e-04)<\/div>"},{"id":"SLC25A6","label":"SLC25A6","x":445.3022,"y":1934.3743,"size":10.9078,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"SNRPD2","label":"SNRPD2","x":1098.9209,"y":1930.4248,"size":10.2528,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>GMPPB, LRRFIP1, MAGT1, PSMB4, RO60, RPN2, RPS9, SET, SGCB, SNRPD2, SNTB2, SPCS2, SRPK2, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Various types of N-glycan biosynthesis (p=1.11e-03)<br>N-Glycan biosynthesis (p=1.79e-03)<br>Viral myocarditis (p=2.78e-03)<br><br><b>BP:<\/b><br>protein glycosylation (p=4.20e-04)<br>macromolecule glycosylation (p=4.20e-04) <br> <b>MF:<\/b><br>magnesium ion transmembrane transporter activity (p=1.49e-02)<br>14-3-3 protein binding (p=2.45e-02) <br> <b>CC:<\/b><br>oligosaccharyltransferase complex (p=4.17e-05)<br>dystrophin-associated glycoprotein complex (p=7.00e-05)<\/div>"},{"id":"SNTB2","label":"SNTB2","x":1016.995,"y":1627.8764,"size":11.8743,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>GMPPB, LRRFIP1, MAGT1, PSMB4, RO60, RPN2, RPS9, SET, SGCB, SNRPD2, SNTB2, SPCS2, SRPK2, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Various types of N-glycan biosynthesis (p=1.11e-03)<br>N-Glycan biosynthesis (p=1.79e-03)<br>Viral myocarditis (p=2.78e-03)<br><br><b>BP:<\/b><br>protein glycosylation (p=4.20e-04)<br>macromolecule glycosylation (p=4.20e-04) <br> <b>MF:<\/b><br>magnesium ion transmembrane transporter activity (p=1.49e-02)<br>14-3-3 protein binding (p=2.45e-02) <br> <b>CC:<\/b><br>oligosaccharyltransferase complex (p=4.17e-05)<br>dystrophin-associated glycoprotein complex (p=7.00e-05)<\/div>"},{"id":"SORBS1","label":"SORBS1","x":2858.5891,"y":1533.1542,"size":12.6247,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"},{"id":"SOST","label":"SOST","x":2271.958,"y":2099.4286,"size":5,"color":"#999999","shape":"triangle","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.562<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>BCAP31, CAV1, ENPP1, FHL1, GALM, JAM3, LAMP1, MFSD2A, PDLIM1, PDLIM4, PTGIS, SOST<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.04e-03)<br>Virion - Lassa virus and SFTS virus (p=1.94e-02)<br>Pantothenate and CoA biosynthesis (p=2.39e-02)<br><br><b>BP:<\/b><br>negative regulation of nitric oxide biosynthetic process (p=3.90e-05)<br>negative regulation of nitric oxide metabolic process (p=3.90e-05) <br> <b>MF:<\/b><br>muscle alpha-actinin binding (p=3.97e-05)<br>alpha-actinin binding (p=1.42e-04) <br> <b>CC:<\/b><br>filamentous actin (p=6.09e-07)<br>actin filament (p=4.10e-05)<\/div>"},{"id":"SPCS2","label":"SPCS2","x":875.4316,"y":1702.1956,"size":17.6369,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>GMPPB, LRRFIP1, MAGT1, PSMB4, RO60, RPN2, RPS9, SET, SGCB, SNRPD2, SNTB2, SPCS2, SRPK2, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Various types of N-glycan biosynthesis (p=1.11e-03)<br>N-Glycan biosynthesis (p=1.79e-03)<br>Viral myocarditis (p=2.78e-03)<br><br><b>BP:<\/b><br>protein glycosylation (p=4.20e-04)<br>macromolecule glycosylation (p=4.20e-04) <br> <b>MF:<\/b><br>magnesium ion transmembrane transporter activity (p=1.49e-02)<br>14-3-3 protein binding (p=2.45e-02) <br> <b>CC:<\/b><br>oligosaccharyltransferase complex (p=4.17e-05)<br>dystrophin-associated glycoprotein complex (p=7.00e-05)<\/div>"},{"id":"SRPK2","label":"SRPK2","x":1114.316,"y":2037.8808,"size":5,"color":"#A6D854","shape":"triangle","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>GMPPB, LRRFIP1, MAGT1, PSMB4, RO60, RPN2, RPS9, SET, SGCB, SNRPD2, SNTB2, SPCS2, SRPK2, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Various types of N-glycan biosynthesis (p=1.11e-03)<br>N-Glycan biosynthesis (p=1.79e-03)<br>Viral myocarditis (p=2.78e-03)<br><br><b>BP:<\/b><br>protein glycosylation (p=4.20e-04)<br>macromolecule glycosylation (p=4.20e-04) <br> <b>MF:<\/b><br>magnesium ion transmembrane transporter activity (p=1.49e-02)<br>14-3-3 protein binding (p=2.45e-02) <br> <b>CC:<\/b><br>oligosaccharyltransferase complex (p=4.17e-05)<br>dystrophin-associated glycoprotein complex (p=7.00e-05)<\/div>"},{"id":"ST13","label":"ST13","x":2346.9043,"y":1279.5352,"size":12.0229,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.653<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>FN3K, H2AC21, HCLS1, HSPA12A, HSPB6, MAPK1, PML, ST13, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Acute myeloid leukemia (p=2.96e-04)<br>Influenza A (p=1.91e-03)<br>Alcoholism (p=2.32e-03)<br><br><b>BP:<\/b><br>mammary gland epithelium development (p=3.66e-04)<br>positive regulation of telomere maintenance (p=4.33e-04) <br> <b>MF:<\/b><br>protein-folding chaperone binding (p=1.79e-03)<br>RNA polymerase II CTD heptapeptide repeat kinase activity (p=4.82e-03) <br> <b>CC:<\/b><br>gamma-tubulin complex (p=8.12e-03)<br>pseudopodium (p=8.12e-03)<\/div>"},{"id":"STIP1","label":"STIP1","x":886.4891,"y":2044.1586,"size":12.781,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.64<\/b><\/p><b>Genes (7):<\/b><br><span style='font-size:11px;'>CAST, EIF3B, ERAP1, IPO5, PSME2, RAD23B, STIP1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.38e-02)<br>Nucleotide excision repair (p=3.25e-02)<br>Antigen processing and presentation (p=4.22e-02)<br><br><b>BP:<\/b><br>cellular response to interleukin-7 (p=2.25e-05)<br>response to interleukin-7 (p=2.49e-05) <br> <b>MF:<\/b><br>endopeptidase regulator activity (p=1.97e-03)<br>peptidase regulator activity (p=2.95e-03) <br> <b>CC:<\/b><br>proteasome complex (p=2.12e-04)<br>endopeptidase complex (p=4.97e-04)<\/div>"},{"id":"SUN2","label":"SUN2","x":1775.0456,"y":1218.2692,"size":11.5369,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.482<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CYB5R3, GNA13, GYS1, KTN1, NPM1, SUN2, TMEM214, VDAC1<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=1.71e-04)<br>Diabetic cardiomyopathy (p=8.95e-03)<br>Cytoskeleton in muscle cells (p=1.15e-02)<br><br><b>BP:<\/b><br>pyruvate metabolic process (p=1.97e-03)<br>regulation of cell shape (p=2.35e-03) <br> <b>MF:<\/b><br>monosaccharide binding (p=5.50e-04)<br>Tat protein binding (p=4.82e-03) <br> <b>CC:<\/b><br>melanosome (p=1.35e-03)<br>pigment granule (p=1.35e-03)<\/div>"},{"id":"TCOF1","label":"TCOF1","x":1119.5365,"y":2115.9784,"size":9.8346,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>GMPPB, LRRFIP1, MAGT1, PSMB4, RO60, RPN2, RPS9, SET, SGCB, SNRPD2, SNTB2, SPCS2, SRPK2, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Various types of N-glycan biosynthesis (p=1.11e-03)<br>N-Glycan biosynthesis (p=1.79e-03)<br>Viral myocarditis (p=2.78e-03)<br><br><b>BP:<\/b><br>protein glycosylation (p=4.20e-04)<br>macromolecule glycosylation (p=4.20e-04) <br> <b>MF:<\/b><br>magnesium ion transmembrane transporter activity (p=1.49e-02)<br>14-3-3 protein binding (p=2.45e-02) <br> <b>CC:<\/b><br>oligosaccharyltransferase complex (p=4.17e-05)<br>dystrophin-associated glycoprotein complex (p=7.00e-05)<\/div>"},{"id":"TFG","label":"TFG","x":1985.0829,"y":494.529,"size":13.1013,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>APOA4, AZGP1, CLU, DCD, LRG1, NSF, PEF1, PLTP, SAA4, SERPINA1, SERPINC1, TFG<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.57e-05)<br>Cholesterol metabolism (p=5.99e-04)<br>Vitamin digestion and absorption (p=1.89e-02)<br><br><b>BP:<\/b><br>cholesterol transport (p=5.75e-05)<br>reverse cholesterol transport (p=7.05e-05) <br> <b>MF:<\/b><br>cholesterol transfer activity (p=1.13e-04)<br>phosphatidylcholine binding (p=1.64e-04) <br> <b>CC:<\/b><br>high-density lipoprotein particle (p=1.33e-09)<br>plasma lipoprotein particle (p=4.97e-09)<\/div>"},{"id":"TMEM214","label":"TMEM214","x":1799.3296,"y":1278.4948,"size":5,"color":"#FF7F00","shape":"triangle","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.482<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CYB5R3, GNA13, GYS1, KTN1, NPM1, SUN2, TMEM214, VDAC1<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=1.71e-04)<br>Diabetic cardiomyopathy (p=8.95e-03)<br>Cytoskeleton in muscle cells (p=1.15e-02)<br><br><b>BP:<\/b><br>pyruvate metabolic process (p=1.97e-03)<br>regulation of cell shape (p=2.35e-03) <br> <b>MF:<\/b><br>monosaccharide binding (p=5.50e-04)<br>Tat protein binding (p=4.82e-03) <br> <b>CC:<\/b><br>melanosome (p=1.35e-03)<br>pigment granule (p=1.35e-03)<\/div>"},{"id":"TMSB4X","label":"TMSB4X","x":2143.6248,"y":2492.77,"size":10.4016,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"TMX4","label":"TMX4","x":193.1404,"y":1750.2778,"size":11.7771,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"TUBB2A","label":"TUBB2A","x":404.6545,"y":1143.4348,"size":10.4524,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.538<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ARF4, BLVRA, DDOST, GNB2, GNB4, HSDL2, HSPA5, MOGS, PSMB2, RAB23, TUBB2A, UGDH<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=6.47e-04)<br>N-Glycan biosynthesis (p=1.47e-03)<br>Parkinson disease (p=2.33e-03)<br><br><b>BP:<\/b><br>substantia nigra development (p=3.80e-04)<br>neural nucleus development (p=8.55e-04) <br> <b>MF:<\/b><br>GTPase activity (p=2.92e-05)<br>signaling receptor complex adaptor activity (p=4.13e-04) <br> <b>CC:<\/b><br>heterotrimeric G-protein complex (p=1.97e-04)<br>GTPase complex (p=2.70e-04)<\/div>"},{"id":"TUBGCP3","label":"TUBGCP3","x":2197.6833,"y":1335.7828,"size":5,"color":"#E78AC3","shape":"triangle","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.653<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>FN3K, H2AC21, HCLS1, HSPA12A, HSPB6, MAPK1, PML, ST13, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Acute myeloid leukemia (p=2.96e-04)<br>Influenza A (p=1.91e-03)<br>Alcoholism (p=2.32e-03)<br><br><b>BP:<\/b><br>mammary gland epithelium development (p=3.66e-04)<br>positive regulation of telomere maintenance (p=4.33e-04) <br> <b>MF:<\/b><br>protein-folding chaperone binding (p=1.79e-03)<br>RNA polymerase II CTD heptapeptide repeat kinase activity (p=4.82e-03) <br> <b>CC:<\/b><br>gamma-tubulin complex (p=8.12e-03)<br>pseudopodium (p=8.12e-03)<\/div>"},{"id":"TXNL1","label":"TXNL1","x":252.4273,"y":1738.1867,"size":5,"color":"#FFFF33","shape":"triangle","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.541<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APEH, EIF2S3, HNRNPM, LGALS1, METAP2, NME3, NUCB1, PLPBP, RANBP1, RPL12, RPL35, RPS11, RPS28, SLC25A6, TMX4, TXNL1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.42e-05)<br>Human T-cell leukemia virus 1 infection (p=1.39e-02)<br>Pyrimidine metabolism (p=4.75e-02)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.04e-07)<br>ribonucleoprotein complex biogenesis (p=3.82e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=1.25e-05)<br>disulfide oxidoreductase activity (p=5.29e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=2.03e-06)<br>ribosomal subunit (p=1.24e-05)<\/div>"},{"id":"UGDH","label":"UGDH","x":309.154,"y":1020.5156,"size":10.5369,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.538<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ARF4, BLVRA, DDOST, GNB2, GNB4, HSDL2, HSPA5, MOGS, PSMB2, RAB23, TUBB2A, UGDH<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=6.47e-04)<br>N-Glycan biosynthesis (p=1.47e-03)<br>Parkinson disease (p=2.33e-03)<br><br><b>BP:<\/b><br>substantia nigra development (p=3.80e-04)<br>neural nucleus development (p=8.55e-04) <br> <b>MF:<\/b><br>GTPase activity (p=2.92e-05)<br>signaling receptor complex adaptor activity (p=4.13e-04) <br> <b>CC:<\/b><br>heterotrimeric G-protein complex (p=1.97e-04)<br>GTPase complex (p=2.70e-04)<\/div>"},{"id":"VAMP3","label":"VAMP3","x":2216.0743,"y":169.0627,"size":11.1195,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.754<\/b><\/p><b>Genes (7):<\/b><br><span style='font-size:11px;'>AKAP12, APOL1, ITGB3, MCAM, PFN2, RAP1A, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=1.04e-04)<br>Platelet activation (p=1.68e-03)<br>Phagosome (p=2.66e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter transport (p=5.50e-06)<br>positive regulation of fibroblast migration (p=1.24e-05) <br> <b>MF:<\/b><br>adenylate cyclase binding (p=4.50e-03)<br>vascular endothelial growth factor receptor binding (p=4.87e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.16e-04)<br>cell-substrate junction (p=3.39e-04)<\/div>"},{"id":"VDAC1","label":"VDAC1","x":1920.7312,"y":1541.2907,"size":12.2152,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.482<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>ALDOA, ATP1B3, CYB5R3, GNA13, GYS1, KTN1, NPM1, SUN2, TMEM214, VDAC1<\/span><br><br><b>KEGG:<\/b><br> cGMP-PKG signaling pathway (p=1.71e-04)<br>Diabetic cardiomyopathy (p=8.95e-03)<br>Cytoskeleton in muscle cells (p=1.15e-02)<br><br><b>BP:<\/b><br>pyruvate metabolic process (p=1.97e-03)<br>regulation of cell shape (p=2.35e-03) <br> <b>MF:<\/b><br>monosaccharide binding (p=5.50e-04)<br>Tat protein binding (p=4.82e-03) <br> <b>CC:<\/b><br>melanosome (p=1.35e-03)<br>pigment granule (p=1.35e-03)<\/div>"},{"id":"VTN","label":"VTN","x":2019.2021,"y":2247.4016,"size":10.9613,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.683<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AEBP1, AHNAK, ATRN, CFHR3, CHST14, CNDP2, COL6A2, CPE, EFEMP2, FBLN5, HP, RNPEP, SERPINA6, SERPING1, TMSB4X, VTN<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=6.08e-05)<br>ECM-receptor interaction (p=2.96e-03)<br>Integrin signaling (p=8.62e-03)<br><br><b>BP:<\/b><br>elastic fiber assembly (p=3.72e-05)<br>extracellular matrix organization (p=1.59e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.26e-07)<br>metalloexopeptidase activity (p=2.30e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.77e-07)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"WIPF1","label":"WIPF1","x":2021.751,"y":886.8936,"size":15.0628,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.728<\/b><\/p><b>Genes (6):<\/b><br><span style='font-size:11px;'>CKB, GSN, MPP1, MYH9, MYO1D, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=9.14e-05)<br>Motor proteins (p=4.05e-03)<br>Regulation of actin cytoskeleton (p=5.59e-03)<br><br><b>BP:<\/b><br>actin filament-based movement (p=4.24e-08)<br>establishment of T cell polarity (p=8.89e-06) <br> <b>MF:<\/b><br>actin binding (p=4.55e-06)<br>actin filament binding (p=2.71e-05) <br> <b>CC:<\/b><br>cell cortex (p=1.03e-06)<br>cortical cytoskeleton (p=3.17e-06)<\/div>"},{"id":"YAP1","label":"YAP1","x":2399.6484,"y":1527.4647,"size":11.333,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.744<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ACTG2, APOE, ATP1A2, BST2, CHMP4B, CTNND1, DDX17, DES, HAAO, HLA-B, ITGA8, NOTCH3, PACSIN3, SELENOP, SORBS1, YAP1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.07e-04)<br>Viral life cycle - HIV-1 (p=4.25e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=5.85e-03)<br><br><b>BP:<\/b><br>locomotory exploration behavior (p=9.16e-05)<br>positive regulation of membrane protein ectodomain proteolysis (p=9.16e-05) <br> <b>MF:<\/b><br>cadherin binding (p=2.69e-03)<br>protein-folding chaperone binding (p=5.76e-03) <br> <b>CC:<\/b><br>multivesicular body (p=1.99e-05)<br>apical junction complex (p=2.42e-04)<\/div>"}],"aristas":[{"from":"CKB","to":"VDAC1","weight":0.415},{"from":"CKB","to":"GSN","weight":0.413},{"from":"ACTG2","to":"SORBS1","weight":0.546},{"from":"TUBB2A","to":"UGDH","weight":0.46},{"from":"HSPA5","to":"UGDH","weight":0.454},{"from":"MAPK1","to":"VDAC1","weight":0.431},{"from":"CYB5R3","to":"VDAC1","weight":0.497},{"from":"GSN","to":"WIPF1","weight":0.536},{"from":"MYH9","to":"WIPF1","weight":0.407},{"from":"MYH9","to":"MYO1D","weight":0.408},{"from":"ECHS1","to":"S100A6","weight":0.413},{"from":"S100A6","to":"TUBB2A","weight":0.429},{"from":"CFHR3","to":"FBLN5","weight":0.526},{"from":"COL6A2","to":"FBLN5","weight":0.446},{"from":"ACTG2","to":"DES","weight":0.428},{"from":"JAM3","to":"PDLIM1","weight":0.547},{"from":"FHL1","to":"PDLIM1","weight":0.443},{"from":"CFHR3","to":"HP","weight":0.409},{"from":"CAV1","to":"JAM3","weight":0.42},{"from":"BCAP31","to":"CAV1","weight":0.415},{"from":"CAV1","to":"PTGIS","weight":0.446},{"from":"CTNND1","to":"YAP1","weight":0.452},{"from":"CTNND1","to":"MAPK1","weight":0.41},{"from":"HNRNPM","to":"RPS28","weight":0.417},{"from":"LGALS1","to":"RPS28","weight":0.454},{"from":"GNB2","to":"HSPA5","weight":0.429},{"from":"ANXA7","to":"S100A6","weight":0.408},{"from":"RPS9","to":"SPCS2","weight":0.401},{"from":"RPN2","to":"SPCS2","weight":0.637},{"from":"CFHR3","to":"CNDP2","weight":0.489},{"from":"CNDP2","to":"RNPEP","weight":0.459},{"from":"APOE","to":"NOTCH3","weight":0.403},{"from":"ATP1A2","to":"NOTCH3","weight":0.403},{"from":"CAV1","to":"SOST","weight":0.401},{"from":"ENPP1","to":"SOST","weight":0.403},{"from":"HNRNPM","to":"RPS11","weight":0.444},{"from":"RPS11","to":"SLC25A6","weight":0.401},{"from":"GNB2","to":"GNB4","weight":0.732},{"from":"HCLS1","to":"MAPK1","weight":0.448},{"from":"HCLS1","to":"HSPB6","weight":0.419},{"from":"METAP2","to":"RPS28","weight":0.439},{"from":"EIF2S3","to":"METAP2","weight":0.449},{"from":"PDLIM1","to":"PDLIM4","weight":0.563},{"from":"DDOST","to":"HSPA5","weight":0.721},{"from":"APOE","to":"HLA-B","weight":0.499},{"from":"APOE","to":"DDX17","weight":0.432},{"from":"APOL1","to":"ITGB3","weight":0.42},{"from":"ITGB3","to":"RAP1A","weight":0.518},{"from":"KTN1","to":"NPM1","weight":0.507},{"from":"KTN1","to":"TMEM214","weight":0.412},{"from":"SUN2","to":"TMEM214","weight":0.424},{"from":"RPL12","to":"SPCS2","weight":0.45},{"from":"HP","to":"VTN","weight":0.453},{"from":"EFEMP2","to":"VTN","weight":0.566},{"from":"COPS6","to":"PSMA1","weight":0.412},{"from":"FBXL7","to":"PSMA1","weight":0.401},{"from":"FBXL7","to":"PPP2CB","weight":0.413},{"from":"HNRNPM","to":"RPL12","weight":0.435},{"from":"GMPPB","to":"SGCB","weight":0.432},{"from":"SGCB","to":"SNTB2","weight":0.688},{"from":"PSMA1","to":"RPS9","weight":0.424},{"from":"GMPPB","to":"RPS9","weight":0.401},{"from":"BST2","to":"CHMP4B","weight":0.418},{"from":"CHMP4B","to":"PACSIN3","weight":0.404},{"from":"HAAO","to":"PACSIN3","weight":0.422},{"from":"HSD17B12","to":"SLC25A11","weight":0.473},{"from":"HSD17B12","to":"HSD17B4","weight":0.512},{"from":"CAV1","to":"MFSD2A","weight":0.406},{"from":"GALM","to":"MFSD2A","weight":0.403},{"from":"HSDL2","to":"UGDH","weight":0.41},{"from":"BLVRA","to":"HSDL2","weight":0.422},{"from":"ATP5F1D","to":"SLC25A11","weight":0.484},{"from":"ARF4","to":"RAB23","weight":0.402},{"from":"ARF4","to":"HSPA5","weight":0.408},{"from":"PFN2","to":"RAP1A","weight":0.515},{"from":"MAGT1","to":"SPCS2","weight":0.404},{"from":"LRRFIP1","to":"MAGT1","weight":0.406},{"from":"ATP5F1D","to":"ECHS1","weight":0.422},{"from":"RAD23B","to":"RPS9","weight":0.452},{"from":"EIF3B","to":"RAD23B","weight":0.419},{"from":"ATP5F1D","to":"ECH1","weight":0.416},{"from":"ACOT1","to":"ECH1","weight":0.411},{"from":"GSN","to":"MPP1","weight":0.824},{"from":"RPS9","to":"SNRPD2","weight":0.457},{"from":"RO60","to":"SNRPD2","weight":0.449},{"from":"PSME2","to":"RAD23B","weight":0.454},{"from":"ERAP1","to":"PSME2","weight":0.472},{"from":"PSMA6","to":"VDAC1","weight":0.41},{"from":"COPS6","to":"PSMA6","weight":0.409},{"from":"HCLS1","to":"TUBGCP3","weight":0.407},{"from":"FN3K","to":"TUBGCP3","weight":0.416},{"from":"COPS6","to":"PSMB1","weight":0.412},{"from":"PSMB1","to":"RPL27A","weight":0.423},{"from":"SERPINA1","to":"TFG","weight":0.499},{"from":"NSF","to":"SERPINA1","weight":0.518},{"from":"HSPA12A","to":"HSPB6","weight":0.419},{"from":"RANBP1","to":"RPL35","weight":0.448},{"from":"PLPBP","to":"RPL35","weight":0.594},{"from":"GNA13","to":"VDAC1","weight":0.412},{"from":"ALDOA","to":"VDAC1","weight":0.423},{"from":"ALDOA","to":"GYS1","weight":0.534},{"from":"NOTCH3","to":"YAP1","weight":0.431},{"from":"MAPK1","to":"PML","weight":0.583},{"from":"METAP2","to":"TXNL1","weight":0.404},{"from":"TMX4","to":"TXNL1","weight":0.406},{"from":"EIF3B","to":"IPO5","weight":0.424},{"from":"AZGP1","to":"GSN","weight":0.416},{"from":"AZGP1","to":"DCD","weight":0.421},{"from":"HSPA5","to":"MOGS","weight":0.694},{"from":"AHNAK","to":"VTN","weight":0.412},{"from":"AZGP1","to":"TFG","weight":0.414},{"from":"LAMP1","to":"VDAC1","weight":0.429},{"from":"HP","to":"LAMP1","weight":0.418},{"from":"APOA4","to":"AZGP1","weight":0.408},{"from":"CTNND1","to":"ITGA8","weight":0.479},{"from":"APOA4","to":"SERPINC1","weight":0.431},{"from":"CLU","to":"SERPINC1","weight":0.427},{"from":"HLA-B","to":"SORBS1","weight":0.702},{"from":"ITGB3","to":"MCAM","weight":0.411},{"from":"NPM1","to":"VDAC1","weight":0.432},{"from":"EIF3B","to":"STIP1","weight":0.444},{"from":"AHNAK","to":"SERPING1","weight":0.447},{"from":"APEH","to":"SLC25A6","weight":0.459},{"from":"MCAM","to":"VAMP3","weight":0.408},{"from":"AKAP12","to":"VAMP3","weight":0.405},{"from":"COPS6","to":"PSMB5","weight":0.576},{"from":"CAST","to":"ERAP1","weight":0.622},{"from":"APOL1","to":"AZGP1","weight":0.436},{"from":"BCAP31","to":"LAMP1","weight":0.441},{"from":"HSPA12A","to":"ST13","weight":0.439},{"from":"PSMB4","to":"SNRPD2","weight":0.448},{"from":"HP","to":"SERPINA6","weight":0.407},{"from":"ECHS1","to":"RPL12","weight":0.417},{"from":"COPS6","to":"PSMA4","weight":0.405},{"from":"PEF1","to":"TFG","weight":0.53},{"from":"PEF1","to":"PLTP","weight":0.467},{"from":"BST2","to":"HLA-B","weight":0.471},{"from":"AEBP1","to":"CHST14","weight":0.411},{"from":"AEBP1","to":"EFEMP2","weight":0.419},{"from":"AZGP1","to":"LRG1","weight":0.45},{"from":"HSPA5","to":"PSMB2","weight":0.497},{"from":"ATP1B3","to":"VDAC1","weight":0.532},{"from":"APEH","to":"NUCB1","weight":0.416},{"from":"SET","to":"SNRPD2","weight":0.506},{"from":"COPS6","to":"PSMB7","weight":0.447},{"from":"ALDH16A1","to":"HSD17B4","weight":0.492},{"from":"RANBP1","to":"RPS11","weight":0.446},{"from":"ATRN","to":"SERPINA6","weight":0.412},{"from":"SAA4","to":"SERPINA1","weight":0.456},{"from":"APOE","to":"SELENOP","weight":0.478},{"from":"H2AC21","to":"PML","weight":0.526},{"from":"NME3","to":"RPS28","weight":0.464},{"from":"GUK1","to":"PSMB1","weight":0.403},{"from":"SERPING1","to":"TMSB4X","weight":0.496},{"from":"CPE","to":"RNPEP","weight":0.474},{"from":"SRPK2","to":"TCOF1","weight":0.411},{"from":"SNRPD2","to":"SRPK2","weight":0.411},{"from":"ALDH16A1","to":"DLGAP4","weight":0.554},{"from":"HSD17B12","to":"SHMT1","weight":0.526}],"clusters":[{"cluster":1,"color":"#E41A1C","count":12,"mean_fc":0.773,"rank":1},{"cluster":4,"color":"#984EA3","count":7,"mean_fc":0.754,"rank":2},{"cluster":2,"color":"#377EB8","count":16,"mean_fc":0.744,"rank":3},{"cluster":11,"color":"#FC8D62","count":6,"mean_fc":0.728,"rank":4},{"cluster":3,"color":"#4DAF4A","count":16,"mean_fc":0.683,"rank":5},{"cluster":14,"color":"#A6D854","count":14,"mean_fc":0.673,"rank":6},{"cluster":7,"color":"#A65628","count":12,"mean_fc":0.672,"rank":7},{"cluster":13,"color":"#E78AC3","count":9,"mean_fc":0.653,"rank":8},{"cluster":10,"color":"#66C2A5","count":7,"mean_fc":0.64,"rank":9},{"cluster":12,"color":"#8DA0CB","count":11,"mean_fc":0.578,"rank":10},{"cluster":9,"color":"#999999","count":12,"mean_fc":0.562,"rank":11},{"cluster":6,"color":"#FFFF33","count":16,"mean_fc":0.541,"rank":12},{"cluster":8,"color":"#F781BF","count":12,"mean_fc":0.538,"rank":13},{"cluster":5,"color":"#FF7F00","count":10,"mean_fc":0.482,"rank":14}],"stats":{"nodos":160,"aristas":159,"clusters":14}}},"RAIZ":{"P005":{"nodos":[{"id":"A1BG","label":"A1BG","x":855.9408,"y":1176.1517,"size":8.8168,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"A2M","label":"A2M","x":1277.5824,"y":2572.7813,"size":8.4603,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"ABI3BP","label":"ABI3BP","x":1080.5237,"y":307.5604,"size":8.9026,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"ACAT1","label":"ACAT1","x":1907.258,"y":1938.2643,"size":8.8168,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"ACLY","label":"ACLY","x":1501.334,"y":936.9463,"size":8.6674,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"ACOT9","label":"ACOT9","x":1535.4297,"y":2166.9412,"size":10.5651,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"ACSM4","label":"ACSM4","x":656.9178,"y":952.8636,"size":5,"color":"#A65628","shape":"triangle","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"ACTB","label":"ACTB","x":1576.2077,"y":2116.1493,"size":10.1971,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"ACTC1","label":"ACTC1","x":669.8117,"y":319.5669,"size":9.6845,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"ACTG2","label":"ACTG2","x":1169.7711,"y":249.5272,"size":20,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"ACTN1","label":"ACTN1","x":1424.1097,"y":1182.0611,"size":10.5806,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"ACTN2","label":"ACTN2","x":1640.4594,"y":1375.335,"size":8.8168,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"ADAMTS4","label":"ADAMTS4","x":1349.0384,"y":2490.4856,"size":5,"color":"#377EB8","shape":"triangle","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"ADAMTSL3","label":"ADAMTSL3","x":1222.9713,"y":2595.8408,"size":9.3375,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"ADD3","label":"ADD3","x":1594.4583,"y":1512.875,"size":11.3124,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"AEBP1","label":"AEBP1","x":1399.6976,"y":2046.4502,"size":8.9076,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"AFM","label":"AFM","x":755.18,"y":310.4403,"size":13.0767,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"AGL","label":"AGL","x":1240.7315,"y":1695.8286,"size":10.5651,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"AGRN","label":"AGRN","x":669.9267,"y":1237.3684,"size":11.6568,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"AHCYL1","label":"AHCYL1","x":829.1278,"y":976.0943,"size":8.3998,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"AHNAK","label":"AHNAK","x":1612.2991,"y":791.3191,"size":9.0696,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"AHSG","label":"AHSG","x":1258.655,"y":2542.7729,"size":10.7699,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"AIP","label":"AIP","x":1814.918,"y":2379.6073,"size":8.0699,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"AKAP12","label":"AKAP12","x":1480.7621,"y":1211.1143,"size":10.9807,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"AKR1A1","label":"AKR1A1","x":1146.1149,"y":1730.6652,"size":8.7489,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"AKR7A2","label":"AKR7A2","x":1170.0257,"y":298.9787,"size":11.1989,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"AKT1","label":"AKT1","x":1807.6513,"y":801.2841,"size":14.1235,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"ALB","label":"ALB","x":949.4646,"y":291.7041,"size":11.251,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"ALCAM","label":"ALCAM","x":1267.0262,"y":478.9436,"size":10.6116,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"ALDH16A1","label":"ALDH16A1","x":231.2125,"y":1307.911,"size":11.8971,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"ALDH1L1","label":"ALDH1L1","x":1656.0352,"y":1839.0505,"size":7.843,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"ALDH2","label":"ALDH2","x":1965.4007,"y":1963.5288,"size":8.9881,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"ALDH4A1","label":"ALDH4A1","x":651.3683,"y":939.0825,"size":9.9873,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"ALDH9A1","label":"ALDH9A1","x":1211.3304,"y":1696.3794,"size":9.0502,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"ALDOA","label":"ALDOA","x":522.9828,"y":903.9074,"size":8.9595,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"AMPD2","label":"AMPD2","x":1517.1302,"y":931.605,"size":11.3026,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"ANG","label":"ANG","x":1648.6673,"y":1678.9453,"size":8.0489,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"ANK3","label":"ANK3","x":634.7362,"y":1241.5081,"size":11.6568,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"ANO1","label":"ANO1","x":980.8978,"y":377.432,"size":11.106,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"ANO6","label":"ANO6","x":930.7576,"y":290.4056,"size":10.9807,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"ANOS1","label":"ANOS1","x":752.9514,"y":324.068,"size":10.8603,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"ANXA11","label":"ANXA11","x":2548.6022,"y":862.97,"size":11.9758,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"ANXA13","label":"ANXA13","x":1694.1551,"y":1389.4068,"size":9.8055,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"ANXA3","label":"ANXA3","x":920.64,"y":271.8651,"size":8.5923,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"ANXA6","label":"ANXA6","x":1148.9913,"y":1644.129,"size":10.5696,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"ANXA7","label":"ANXA7","x":1617.5866,"y":1168.443,"size":14.643,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"AP2B1","label":"AP2B1","x":503.4739,"y":889.0664,"size":8.33,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"APEH","label":"APEH","x":2521.592,"y":827.3562,"size":9.36,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"APOA2","label":"APOA2","x":832.4893,"y":1177.9762,"size":7.9772,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"APOA4","label":"APOA4","x":1226.8999,"y":2549.9211,"size":8.7329,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"APOE","label":"APOE","x":1633.1777,"y":1672.7068,"size":9.8858,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"APOL1","label":"APOL1","x":1223.8093,"y":2541.2784,"size":12.676,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"APRT","label":"APRT","x":2599.379,"y":769.2988,"size":7.7612,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"ARCN1","label":"ARCN1","x":1496.2787,"y":1482.4691,"size":8.8168,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"ARF3","label":"ARF3","x":2095.7277,"y":682.1127,"size":9.3784,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"ARPC4","label":"ARPC4","x":979.231,"y":361.5247,"size":8.2874,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"ARPC5","label":"ARPC5","x":1357.7497,"y":1019.2019,"size":7.9772,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"ASAH1","label":"ASAH1","x":983.9285,"y":1137.2864,"size":9.2527,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"ATL3","label":"ATL3","x":2296.6825,"y":1280.2466,"size":10.5899,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"ATP1A1","label":"ATP1A1","x":1644.2149,"y":1454.5103,"size":9.0978,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"ATP1A2","label":"ATP1A2","x":2054.2603,"y":1852.6154,"size":17.012,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"ATP1B3","label":"ATP1B3","x":1782.1361,"y":2393.7711,"size":9.3573,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"ATP2A2","label":"ATP2A2","x":1545.6986,"y":2105.6979,"size":10.119,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"ATP5F1D","label":"ATP5F1D","x":1266.8402,"y":1720.9527,"size":14.5785,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"AZGP1","label":"AZGP1","x":1241.9328,"y":2527.311,"size":11.8837,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"BASP1","label":"BASP1","x":1584.2892,"y":1524.073,"size":11.5737,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"BCAP31","label":"BCAP31","x":2283.346,"y":1283.4364,"size":11.5842,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"BGN","label":"BGN","x":1251.1225,"y":1352.2658,"size":11.8971,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"BLVRA","label":"BLVRA","x":644.355,"y":897.6577,"size":8.2422,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"BLVRB","label":"BLVRB","x":1495.8554,"y":691.8022,"size":7.8837,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"BST1","label":"BST1","x":1265.307,"y":440.0854,"size":8.4636,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"BST2","label":"BST2","x":1248.2366,"y":1836.4774,"size":12.6571,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"BUB3","label":"BUB3","x":2057.9103,"y":1453.3863,"size":11.8971,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"C1orf198","label":"C1orf198","x":1497.427,"y":668.4385,"size":8.5218,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"C4BPA","label":"C4BPA","x":1250.6468,"y":2568.8774,"size":8.4692,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"CA1","label":"CA1","x":1561.0401,"y":2125.9288,"size":7.9028,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"CACYBP","label":"CACYBP","x":164.5688,"y":1356.3806,"size":8.7268,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"CALD1","label":"CALD1","x":2006.1972,"y":1841.8035,"size":8.1367,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"CAP2","label":"CAP2","x":931.9189,"y":206.3824,"size":8.4049,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"CAPNS1","label":"CAPNS1","x":1578.299,"y":2099.2624,"size":7.8712,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"CAST","label":"CAST","x":2125.886,"y":1278.6885,"size":10.4715,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"CAVIN1","label":"CAVIN1","x":1424.1809,"y":2036.6487,"size":9.2907,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"CBR1","label":"CBR1","x":1189.1664,"y":1716.4903,"size":7.7634,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"CCT2","label":"CCT2","x":1839.5055,"y":1315.5469,"size":9.2907,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"CCT3","label":"CCT3","x":874.1376,"y":1767.9381,"size":8.2822,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"CCT7","label":"CCT7","x":2041.5772,"y":749.6717,"size":9.4575,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"CCT8","label":"CCT8","x":1609.5335,"y":1419.4013,"size":11.6568,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"CD14","label":"CD14","x":973.3181,"y":979.3451,"size":11.8971,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"CD163","label":"CD163","x":1366.2095,"y":1063.6547,"size":8.3802,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"CD55","label":"CD55","x":2184.1874,"y":1300.8619,"size":8.1277,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"CD59","label":"CD59","x":1707.0961,"y":900.9924,"size":12.1477,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"CD74","label":"CD74","x":1432.2473,"y":1346.4115,"size":12.676,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"CD81","label":"CD81","x":1385.5078,"y":1067.5119,"size":10.0581,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"CDH1","label":"CDH1","x":1121.0619,"y":1106.6207,"size":8.3294,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"CDH13","label":"CDH13","x":1688.5386,"y":887.4624,"size":9.8369,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"CFHR1","label":"CFHR1","x":1270.1098,"y":2516.2005,"size":9.6291,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"CKB","label":"CKB","x":1324.0791,"y":2434.0112,"size":12.1477,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"CLIC1","label":"CLIC1","x":1906.4001,"y":1949.4502,"size":7.7987,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"CLTA","label":"CLTA","x":2003.9061,"y":1813.1114,"size":11.2852,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"CLTB","label":"CLTB","x":1449.5103,"y":1180.2811,"size":11.0331,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"CLTC","label":"CLTC","x":2065.2773,"y":1443.9137,"size":11.5965,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"CMAS","label":"CMAS","x":722.4026,"y":272.7176,"size":14.6205,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"CNN1","label":"CNN1","x":1607.0995,"y":1980.8888,"size":7.9623,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"CNP","label":"CNP","x":945.5613,"y":270.8583,"size":9.7529,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"COL12A1","label":"COL12A1","x":1298.4337,"y":1338.1351,"size":11.9192,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"COL18A1","label":"COL18A1","x":2965.7497,"y":892.3444,"size":8.2999,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"COL4A1","label":"COL4A1","x":1737.298,"y":964.8031,"size":7.9772,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"COL4A2","label":"COL4A2","x":1599.6883,"y":1574.5671,"size":8.3802,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"COL6A1","label":"COL6A1","x":888.1123,"y":1172.7308,"size":9.4575,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"COL6A2","label":"COL6A2","x":838.1916,"y":347.8954,"size":8.2611,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"COL6A3","label":"COL6A3","x":1946.5911,"y":1827.3503,"size":8.2339,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"COMP","label":"COMP","x":320.7672,"y":1350.169,"size":11.6568,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"COMT","label":"COMT","x":1839.9977,"y":806.932,"size":8.3597,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"COPS2","label":"COPS2","x":1585.7882,"y":2134.3284,"size":9.0015,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"COPS4","label":"COPS4","x":2065.3686,"y":1401.5029,"size":8.1647,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"COPS6","label":"COPS6","x":2075.4192,"y":1383.5319,"size":16.9158,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"CORO1B","label":"CORO1B","x":1621.8342,"y":2145.8047,"size":8.1764,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"COTL1","label":"COTL1","x":1146.733,"y":1627.8952,"size":8.9288,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"COX4I1","label":"COX4I1","x":1197.5723,"y":1587.8867,"size":9.9873,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"CP","label":"CP","x":1868.8208,"y":1248.438,"size":8.7384,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"CPNE1","label":"CPNE1","x":1651.0536,"y":2174.7679,"size":9.3456,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"CPNE3","label":"CPNE3","x":1683.9706,"y":868.1269,"size":13.2493,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"CRYL1","label":"CRYL1","x":1764.0385,"y":2376.3149,"size":8.9372,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"CS","label":"CS","x":257.9046,"y":1306.8791,"size":8.108,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"CSRP2","label":"CSRP2","x":2786.6456,"y":831.2451,"size":9.3418,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"CTNNB1","label":"CTNNB1","x":1409.748,"y":1071.3801,"size":11.1161,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"CTNND1","label":"CTNND1","x":1499.1533,"y":2199.6119,"size":17.5177,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"CTPS1","label":"CTPS1","x":911.5902,"y":1750.6399,"size":8.7595,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"CTSB","label":"CTSB","x":999.612,"y":1138.8806,"size":9.3318,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"CTTN","label":"CTTN","x":998.8338,"y":376.4495,"size":11.8971,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"CYB5B","label":"CYB5B","x":1443.967,"y":777.7699,"size":9.8055,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"CYB5R3","label":"CYB5R3","x":1638.6443,"y":1471.0839,"size":15.4563,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"CYTL1","label":"CYTL1","x":629.8487,"y":950.8848,"size":9.7642,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"DCD","label":"DCD","x":1865.2271,"y":2431.6302,"size":12.621,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"DCXR","label":"DCXR","x":1775.6687,"y":2401.6988,"size":10.5463,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"DDI2","label":"DDI2","x":1085.272,"y":427.6346,"size":8.2422,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"DDOST","label":"DDOST","x":702.8478,"y":962.5085,"size":14.8444,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"DDX1","label":"DDX1","x":1275.6085,"y":1818.8459,"size":7.9208,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"DDX17","label":"DDX17","x":1435.6276,"y":845.5175,"size":9.6428,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"DDX3X","label":"DDX3X","x":1882.5128,"y":1380.8644,"size":11.857,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"DENR","label":"DENR","x":1396.6907,"y":778.4412,"size":8.5422,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"DES","label":"DES","x":837.4571,"y":152.1882,"size":13.4832,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"DHRS7","label":"DHRS7","x":1764.9586,"y":2399.3635,"size":8.4917,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"DHX9","label":"DHX9","x":998.881,"y":1715.8361,"size":9.6693,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"DLGAP4","label":"DLGAP4","x":1590.7523,"y":2209.4036,"size":13.108,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"DMD","label":"DMD","x":719.8452,"y":322.9798,"size":11.2374,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"DNAJB4","label":"DNAJB4","x":1310.739,"y":2419.5169,"size":8.0822,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"DNM1L","label":"DNM1L","x":695.9783,"y":929.3488,"size":11.8375,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"DNM2","label":"DNM2","x":999.7766,"y":998.9042,"size":7.9772,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"DNPEP","label":"DNPEP","x":1371.3789,"y":1553.2084,"size":8.6525,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"DPP7","label":"DPP7","x":2542.6491,"y":817.7922,"size":8.6011,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"DPT","label":"DPT","x":1313.2401,"y":419.9981,"size":9.2907,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"DSP","label":"DSP","x":641.6933,"y":309.6373,"size":12.9541,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"DYNLL1","label":"DYNLL1","x":900.7285,"y":164.0718,"size":8.164,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"ECH1","label":"ECH1","x":1387.1066,"y":1544.8592,"size":8.4235,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"EDNRA","label":"EDNRA","x":953.7089,"y":258.6294,"size":5,"color":"#FFD92F","shape":"triangle","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"EEF1D","label":"EEF1D","x":1926.2663,"y":1407.6642,"size":9.6291,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"EEF1G","label":"EEF1G","x":300.917,"y":1313.8876,"size":9.729,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"EFEMP1","label":"EFEMP1","x":808.0465,"y":332.12,"size":8.6343,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"EFEMP2","label":"EFEMP2","x":1995.6611,"y":1824.6951,"size":11.1817,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"EFTUD2","label":"EFTUD2","x":928.8347,"y":997.1475,"size":9.9104,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"EHD1","label":"EHD1","x":1739.8282,"y":862.0918,"size":16.8642,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"EHD3","label":"EHD3","x":1204.1613,"y":1050.5229,"size":9.4071,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"EHD4","label":"EHD4","x":1217.9556,"y":1059.6542,"size":7.9386,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"EIF2S1","label":"EIF2S1","x":2605.962,"y":856.562,"size":9.96,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"EIF2S2","label":"EIF2S2","x":2060.8441,"y":1386.8445,"size":9.2907,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"EIF2S3","label":"EIF2S3","x":334.3587,"y":1314.4488,"size":10.4665,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"EIF3B","label":"EIF3B","x":1855.6297,"y":2394.914,"size":10.5651,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"EIF4B","label":"EIF4B","x":1595.9042,"y":2123.5787,"size":7.85,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"EIF4H","label":"EIF4H","x":2718.1697,"y":848.3919,"size":9.8626,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"ELAVL1","label":"ELAVL1","x":1927.7397,"y":1366.7843,"size":10.0652,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"ELOC","label":"ELOC","x":1972.6453,"y":2018.308,"size":8.6025,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"EML1","label":"EML1","x":1164.7729,"y":1639.0299,"size":8.6674,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"ENPP1","label":"ENPP1","x":1889.9127,"y":1920.2229,"size":10.7182,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"ENSA","label":"ENSA","x":1488.8959,"y":2380.6537,"size":8.8168,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"ENTPD1","label":"ENTPD1","x":939.6296,"y":1150.7055,"size":9.5736,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"EOGT","label":"EOGT","x":1213.8581,"y":1736.4692,"size":16.7273,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"EPX","label":"EPX","x":956.4758,"y":1113.1114,"size":9.2907,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"ERAP1","label":"ERAP1","x":1951.008,"y":2005.4602,"size":8.0953,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"ERGIC1","label":"ERGIC1","x":1427.9398,"y":1508.2584,"size":11.7166,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"ERLIN2","label":"ERLIN2","x":1523.3697,"y":2101.561,"size":12.8351,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"ESYT1","label":"ESYT1","x":1597.9761,"y":1537.4503,"size":12.8731,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"ESYT2","label":"ESYT2","x":2323.8881,"y":1278.0259,"size":16.6216,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"ETF1","label":"ETF1","x":1907.2963,"y":1372.0525,"size":11.9722,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"F10","label":"F10","x":1758.0629,"y":957.4674,"size":11.1989,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"FAM114A1","label":"FAM114A1","x":1491.7525,"y":2125.0029,"size":9.5008,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"FARSB","label":"FARSB","x":1273.7885,"y":1770.2735,"size":9.8403,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"FBLN5","label":"FBLN5","x":1291.7498,"y":471.5799,"size":12.2792,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"FCER1G","label":"FCER1G","x":975.7436,"y":1123.7135,"size":5,"color":"#E41A1C","shape":"triangle","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"FCGBP","label":"FCGBP","x":1421.5201,"y":1335.3214,"size":9.1283,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"FCN1","label":"FCN1","x":928.1203,"y":1139.173,"size":5,"color":"#E41A1C","shape":"triangle","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"FERMT2","label":"FERMT2","x":1355.6587,"y":2439.8188,"size":10.7699,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"FGL2","label":"FGL2","x":1411.391,"y":1354.4548,"size":11.7354,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"FHL1","label":"FHL1","x":1841.7496,"y":771.0819,"size":9.235,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"FILIP1L","label":"FILIP1L","x":1884.0319,"y":724.6366,"size":8.7839,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"FLII","label":"FLII","x":1676.5021,"y":2169.2414,"size":8.258,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"FLNC","label":"FLNC","x":1868.0055,"y":743.8262,"size":9.872,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"FLOT1","label":"FLOT1","x":639.4586,"y":319.0721,"size":9.9873,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"FLOT2","label":"FLOT2","x":1976.7285,"y":1346.5947,"size":7.8256,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"FMOD","label":"FMOD","x":1708.559,"y":974.3819,"size":8.7109,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"FN1","label":"FN1","x":776.0543,"y":322.5162,"size":10.8082,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"FN3K","label":"FN3K","x":3099.9982,"y":895.0003,"size":15.0122,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"FNDC1","label":"FNDC1","x":296.7423,"y":1359.992,"size":8.5218,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"FTO","label":"FTO","x":1237.5961,"y":2573.5874,"size":5,"color":"#377EB8","shape":"triangle","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"FUS","label":"FUS","x":2526.5131,"y":858.4394,"size":7.9396,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"G6PD","label":"G6PD","x":210.8312,"y":1374.5118,"size":10.1741,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"GAA","label":"GAA","x":300.2419,"y":1333.2373,"size":8.2422,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"GALM","label":"GALM","x":1174.935,"y":1713.688,"size":10.5577,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"GALNT2","label":"GALNT2","x":892.2296,"y":145.2468,"size":9.5477,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"GC","label":"GC","x":1690.3489,"y":830.0102,"size":13.7822,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"GFAP","label":"GFAP","x":1954.0705,"y":1954.3034,"size":7.7598,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"GLG1","label":"GLG1","x":1842.4855,"y":1364.636,"size":11.7046,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"GMPR2","label":"GMPR2","x":962.8291,"y":1727.3165,"size":12.9567,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"GNA13","label":"GNA13","x":1474.7669,"y":863.7423,"size":13.9168,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"GNAS","label":"GNAS","x":2742.4064,"y":839.2757,"size":9.2907,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"GNB2","label":"GNB2","x":1643.3074,"y":2103.7941,"size":17.8987,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"GNB4","label":"GNB4","x":1356.8206,"y":1342.007,"size":13.4183,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"GNG12","label":"GNG12","x":1998.3964,"y":1338.0218,"size":9.8071,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"GNPDA2","label":"GNPDA2","x":1871.6554,"y":1917.4484,"size":8.0042,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"GPD1L","label":"GPD1L","x":526.0207,"y":921.3503,"size":8.4076,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"GRB2","label":"GRB2","x":852.3064,"y":172.0206,"size":18.0661,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"GSN","label":"GSN","x":1281.8158,"y":2499.0896,"size":12.1477,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"GSR","label":"GSR","x":2528.4896,"y":810.6165,"size":7.85,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"GSS","label":"GSS","x":1126.0599,"y":1743.4825,"size":10.2075,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"GSTO1","label":"GSTO1","x":1493.7037,"y":724.9597,"size":9.0282,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"GYS1","label":"GYS1","x":183.8886,"y":1380.4509,"size":17.7076,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"H1-0","label":"H1-0","x":935.5292,"y":277.5498,"size":9.4575,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"H1-2","label":"H1-2","x":1414.6451,"y":1058.068,"size":8.0528,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"H1-3","label":"H1-3","x":1033.5626,"y":1674.6571,"size":7.98,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"H1-4","label":"H1-4","x":1847.05,"y":2415.436,"size":7.846,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"H2AC21","label":"H2AC21","x":1058.5722,"y":1671.9737,"size":8.8653,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"H2AZ2","label":"H2AZ2","x":1824.1001,"y":2394.5595,"size":8.0686,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"HAAO","label":"HAAO","x":1354.895,"y":2067.1507,"size":15.5302,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"HADH","label":"HADH","x":1867.3612,"y":779.0595,"size":8.7635,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"HADHA","label":"HADHA","x":1540.6573,"y":2147.2442,"size":10.1609,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"HADHB","label":"HADHB","x":730.3083,"y":954.9304,"size":9.9967,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"HBE1","label":"HBE1","x":190.3897,"y":1390.0756,"size":7.9588,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"HBG2","label":"HBG2","x":1640.7014,"y":1486.1342,"size":9.2907,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"HCLS1","label":"HCLS1","x":907.0022,"y":241.9964,"size":8.1209,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"HDGF","label":"HDGF","x":564.1274,"y":1267.9657,"size":11.6568,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"HDGFL3","label":"HDGFL3","x":2240.5561,"y":505.1967,"size":11.8971,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"HEBP1","label":"HEBP1","x":1121.3497,"y":1623.7373,"size":7.8131,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"HEBP2","label":"HEBP2","x":1524.6858,"y":2269.7188,"size":10.8393,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"HEXB","label":"HEXB","x":1724.1555,"y":852.4474,"size":8.8399,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"HIBADH","label":"HIBADH","x":651.9748,"y":264.4092,"size":8.1562,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"HK1","label":"HK1","x":1493.9772,"y":924.2562,"size":8.1744,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"HLA-B","label":"HLA-B","x":1227.4805,"y":1850.4217,"size":8.7196,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"HLA-DRA","label":"HLA-DRA","x":1979.8385,"y":1818.3846,"size":8.2422,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"HLA-DRB1","label":"HLA-DRB1","x":1360.0581,"y":2416.3933,"size":9.8055,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"HLA-DRB5","label":"HLA-DRB5","x":825.5881,"y":129.0965,"size":8.3802,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"HNRNPA0","label":"HNRNPA0","x":1892.8534,"y":1393.5966,"size":8.0218,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"HNRNPA2B1","label":"HNRNPA2B1","x":1990.2521,"y":799.1222,"size":8.3652,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"HNRNPC","label":"HNRNPC","x":2242.1161,"y":781.6599,"size":8.2576,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"HNRNPH1","label":"HNRNPH1","x":1817.6454,"y":767.1517,"size":13.9174,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"HNRNPH3","label":"HNRNPH3","x":2095.9001,"y":721.8913,"size":10.0491,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"HNRNPL","label":"HNRNPL","x":1969.1293,"y":1393.6072,"size":9.1346,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"HNRNPM","label":"HNRNPM","x":1886.1165,"y":1283.9379,"size":12.1746,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"HNRNPR","label":"HNRNPR","x":1403.9335,"y":1174.6424,"size":9.3231,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"HNRNPU","label":"HNRNPU","x":2041.6633,"y":1437.2196,"size":8.8168,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"HP","label":"HP","x":1692.7673,"y":912.5634,"size":10.7699,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"HPX","label":"HPX","x":1633.0612,"y":1687.8357,"size":9.1283,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"HSD17B10","label":"HSD17B10","x":2062.1264,"y":2005.3954,"size":9.8987,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"HSD17B12","label":"HSD17B12","x":614.747,"y":252.4472,"size":9.7325,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"HSD17B4","label":"HSD17B4","x":2045.4117,"y":2004.0971,"size":17.828,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"HSDL2","label":"HSDL2","x":1442.2139,"y":800.8744,"size":13.651,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"HSPA12A","label":"HSPA12A","x":1696.6045,"y":2121.6843,"size":10.7699,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"HSPA5","label":"HSPA5","x":1158.3918,"y":315.0787,"size":10.1741,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"HSPB1","label":"HSPB1","x":1338.7149,"y":2395.6562,"size":7.9787,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"HSPD1","label":"HSPD1","x":2477.5134,"y":840.2293,"size":10.7021,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"HSPH1","label":"HSPH1","x":128.2904,"y":1359.3106,"size":7.8724,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"IDH3B","label":"IDH3B","x":1516.9081,"y":2160.2574,"size":9.4575,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"IGFBP6","label":"IGFBP6","x":1139.9647,"y":271.9871,"size":10.3928,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"IGLL5","label":"IGLL5","x":1655.3726,"y":1484.4854,"size":9.2907,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"ILK","label":"ILK","x":1539.5625,"y":1997.2272,"size":10.0714,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"IPO7","label":"IPO7","x":1692.5044,"y":2385.8403,"size":7.8242,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"IRGQ","label":"IRGQ","x":1662.4694,"y":2193.7004,"size":12.4732,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"ISLR","label":"ISLR","x":1226.483,"y":1353.2394,"size":10.5651,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"IST1","label":"IST1","x":2124.239,"y":1307.769,"size":9.1951,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"ISYNA1","label":"ISYNA1","x":2619.0687,"y":763.2922,"size":8.0319,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"ITGA1","label":"ITGA1","x":1735.1935,"y":852.564,"size":8.4715,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"ITGA6","label":"ITGA6","x":1702.4523,"y":1831.7605,"size":9.0038,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"ITGA8","label":"ITGA8","x":1479.2875,"y":2216.327,"size":8.6936,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"ITGB1","label":"ITGB1","x":1129.675,"y":447.0909,"size":8.7667,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"ITGB2","label":"ITGB2","x":1922.5808,"y":1249.5412,"size":9.1839,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"ITIH2","label":"ITIH2","x":1692.0088,"y":990.7941,"size":8.4612,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"IVD","label":"IVD","x":2023.1605,"y":1987.6186,"size":11.7409,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"KANK2","label":"KANK2","x":1129.3881,"y":406.8641,"size":9.6291,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"KARS1","label":"KARS1","x":2319.2821,"y":828.4917,"size":7.7721,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"KTN1","label":"KTN1","x":1599.2013,"y":1558.7323,"size":8.7266,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"L3HYPDH","label":"L3HYPDH","x":2557.1813,"y":816.4042,"size":9.8469,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"LAMA2","label":"LAMA2","x":1309.1169,"y":442.0246,"size":14.1969,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"LAMA4","label":"LAMA4","x":1285.2238,"y":1350.0657,"size":10.831,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"LAMA5","label":"LAMA5","x":3022.4478,"y":895.191,"size":8.9946,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"LAMC1","label":"LAMC1","x":847.2646,"y":1780.3225,"size":8.7187,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"LAMP1","label":"LAMP1","x":1718.2159,"y":873.8171,"size":11.1861,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"LDB3","label":"LDB3","x":1591.9526,"y":1992.2142,"size":10.7098,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"LGALS1","label":"LGALS1","x":1571.3348,"y":1981.6767,"size":10.9853,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"LHPP","label":"LHPP","x":1613.1123,"y":768.5737,"size":15.3059,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"LIMS1","label":"LIMS1","x":739.0922,"y":289.7298,"size":8.769,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"LIMS2","label":"LIMS2","x":712.6014,"y":262.8836,"size":10.1741,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"LIX1","label":"LIX1","x":2094.8127,"y":1861.8938,"size":5,"color":"#1B9E77","shape":"triangle","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"LMAN2","label":"LMAN2","x":1444.5,"y":1502.462,"size":9.6458,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"LNPEP","label":"LNPEP","x":2107.1482,"y":1293.5945,"size":8.3813,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"LRG1","label":"LRG1","x":305.1901,"y":1367.4636,"size":9.6291,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"LRRC17","label":"LRRC17","x":1485.0226,"y":2130.7586,"size":8.3802,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"LRRC59","label":"LRRC59","x":457.9578,"y":1296.7401,"size":11.4144,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"LRRFIP1","label":"LRRFIP1","x":1713.9882,"y":2339.9036,"size":16.8488,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"LSS","label":"LSS","x":1508.3992,"y":920.5378,"size":13.7571,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"LTBP2","label":"LTBP2","x":1859.0354,"y":1825.2463,"size":9.704,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"LXN","label":"LXN","x":2124.8091,"y":1869.2815,"size":8.2722,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"M6PR","label":"M6PR","x":1136.2468,"y":1045.3473,"size":10.5214,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"MAGT1","label":"MAGT1","x":1702.0895,"y":2317.6448,"size":8.4283,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"MAMDC2","label":"MAMDC2","x":1091.7196,"y":321.4552,"size":12.818,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"MAN2C1","label":"MAN2C1","x":1226.4105,"y":1718.7789,"size":8.3319,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"MAOA","label":"MAOA","x":959.6786,"y":274.5677,"size":8.7599,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"MAPK1","label":"MAPK1","x":1430.5611,"y":2283.6507,"size":12.1477,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"MARCKS","label":"MARCKS","x":1819.7793,"y":790.4305,"size":11.8971,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"MASP2","label":"MASP2","x":1273.0603,"y":2599.9984,"size":11.0021,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"MATN2","label":"MATN2","x":1395.5264,"y":1361.4035,"size":7.7889,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"MBP","label":"MBP","x":1519.4988,"y":2001.1419,"size":9.1283,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"ME1","label":"ME1","x":140.2954,"y":1399.4914,"size":9.1283,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"ME2","label":"ME2","x":691.7961,"y":952.7747,"size":8.5218,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"MFAP4","label":"MFAP4","x":816.6447,"y":352.0443,"size":9.8812,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"MGST3","label":"MGST3","x":794.5831,"y":314.0983,"size":7.9198,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"MMP2","label":"MMP2","x":1368.0962,"y":2368.0139,"size":9.4335,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"MOGS","label":"MOGS","x":323.2925,"y":1329.2333,"size":11.1989,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"MPST","label":"MPST","x":1726.3434,"y":2487.3359,"size":8.2422,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"MRC1","label":"MRC1","x":959.0937,"y":1142.6558,"size":8.9004,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"MTERF2","label":"MTERF2","x":2234.4062,"y":525.545,"size":5,"color":"#E64545","shape":"triangle","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"MTHFD1","label":"MTHFD1","x":2578.2141,"y":783.8253,"size":10.6772,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"MVP","label":"MVP","x":1866.2039,"y":1956.0762,"size":11.2093,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"MYADM","label":"MYADM","x":1659.1605,"y":1069.4148,"size":7.9226,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"MYO1C","label":"MYO1C","x":1371.2416,"y":1030.6284,"size":8.4117,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"MYO1D","label":"MYO1D","x":1390.1824,"y":1048.9138,"size":8.995,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"NADK2","label":"NADK2","x":1608.1511,"y":1226.7384,"size":9.0368,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"NAE1","label":"NAE1","x":1715.7579,"y":2446.5958,"size":9.4097,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"NAGK","label":"NAGK","x":2185.5671,"y":809.95,"size":9.1283,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"NAP1L4","label":"NAP1L4","x":278.1602,"y":1307.812,"size":8.322,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"NAPA","label":"NAPA","x":1234.1086,"y":1058.6018,"size":8.3351,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"NAPRT","label":"NAPRT","x":1599.1343,"y":1240.423,"size":8.6382,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"NCKAP1","label":"NCKAP1","x":1433.7684,"y":1195.1142,"size":9.0448,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"NCL","label":"NCL","x":1267.5504,"y":1832.3684,"size":11.4238,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"NDRG2","label":"NDRG2","x":1981.9234,"y":1959.482,"size":9.6291,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"NDUFS2","label":"NDUFS2","x":458.1911,"y":879.9431,"size":11.8478,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"NEGR1","label":"NEGR1","x":1265.4006,"y":458.3161,"size":9.3671,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"NID1","label":"NID1","x":1728.3149,"y":1837.8618,"size":11.3033,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"NME1","label":"NME1","x":1141.1096,"y":379.4494,"size":9.8253,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"NME3","label":"NME3","x":1641.9472,"y":2227.9521,"size":15.3643,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"NNMT","label":"NNMT","x":1304.8197,"y":2391.0913,"size":12.2792,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"NNT","label":"NNT","x":169.1787,"y":1389.7172,"size":9.2907,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"NPM1","label":"NPM1","x":1796.0793,"y":2365.8107,"size":8.7666,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"NPNT","label":"NPNT","x":2284.7869,"y":507.661,"size":12.5386,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"NSF","label":"NSF","x":1222.1665,"y":1076.0281,"size":11.1042,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"NSFL1C","label":"NSFL1C","x":1245.4061,"y":1866.8266,"size":8.1552,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"NTN1","label":"NTN1","x":1692.0792,"y":2412.813,"size":10.0368,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"NUDC","label":"NUDC","x":2160.8328,"y":812.5435,"size":9.5123,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"NUTF2","label":"NUTF2","x":613.8896,"y":1249.8503,"size":8.6369,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"OGDH","label":"OGDH","x":622.0634,"y":238.7518,"size":12.406,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"OMD","label":"OMD","x":1494.4028,"y":2137.7446,"size":8.9,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"ORM1","label":"ORM1","x":1276.9649,"y":1332.0555,"size":8.3941,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"OXCT1","label":"OXCT1","x":599.9129,"y":220.5778,"size":8.3802,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"P4HB","label":"P4HB","x":351.3124,"y":1324.2779,"size":10.5651,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"PABPC1","label":"PABPC1","x":1867.1848,"y":1286.3817,"size":8.5577,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"PACSIN2","label":"PACSIN2","x":1537.262,"y":2344.1962,"size":9.202,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"PACSIN3","label":"PACSIN3","x":1382.868,"y":2053.9845,"size":8.2422,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"PALLD","label":"PALLD","x":1651.045,"y":1363.4451,"size":8.7831,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"PAPPA","label":"PAPPA","x":1148.8302,"y":291.2468,"size":5,"color":"#4DAF4A","shape":"triangle","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"PARP1","label":"PARP1","x":1587.7721,"y":1259.2504,"size":14.6901,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"PCBP2","label":"PCBP2","x":2717.0142,"y":870.3176,"size":10.6782,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"PCYOX1","label":"PCYOX1","x":1879.8151,"y":2448.4204,"size":10.1741,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"PDCD5","label":"PDCD5","x":1680.0328,"y":2342.0992,"size":8.8671,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"PDCD6","label":"PDCD6","x":1557.7744,"y":2111.7714,"size":17.7755,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"PDHB","label":"PDHB","x":1219.6632,"y":1592.7783,"size":12.4343,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"PDLIM1","label":"PDLIM1","x":1720.57,"y":960.6653,"size":9.188,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"PDLIM4","label":"PDLIM4","x":1975.191,"y":1955.285,"size":7.9226,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"PDLIM5","label":"PDLIM5","x":844.3041,"y":324.1075,"size":11.1766,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"PDLIM7","label":"PDLIM7","x":1844.7271,"y":751.1244,"size":13.6593,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"PEBP1","label":"PEBP1","x":1680.9714,"y":1406.906,"size":11.6568,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"PFN1","label":"PFN1","x":932.9054,"y":235.7667,"size":11.0603,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"PFN2","label":"PFN2","x":1115.2547,"y":454.9717,"size":10.5651,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"PGAM1","label":"PGAM1","x":1247.8547,"y":1599.1912,"size":8.0547,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"PGD","label":"PGD","x":708.8569,"y":293.8251,"size":8.29,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"PHGDH","label":"PHGDH","x":2262.0785,"y":517.3682,"size":11.8139,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"PHPT1","label":"PHPT1","x":1268.2385,"y":1613.9032,"size":9.0354,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"PLCD1","label":"PLCD1","x":1538.6734,"y":2275.1423,"size":9.044,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"PLD3","label":"PLD3","x":1865.7556,"y":805.6249,"size":9.0891,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"PLEC","label":"PLEC","x":1587.4762,"y":1978.5347,"size":9.4769,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"PLIN3","label":"PLIN3","x":1535.5748,"y":2254.0745,"size":9.6498,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"PLN","label":"PLN","x":799.6562,"y":100,"size":8.108,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"PLP1","label":"PLP1","x":1118.8224,"y":441.7043,"size":9.4575,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"PLP2","label":"PLP2","x":2743.4477,"y":873.2539,"size":8.9395,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"PLPBP","label":"PLPBP","x":2285.2553,"y":494.1226,"size":12.1863,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"POSTN","label":"POSTN","x":1514.7678,"y":2120.3096,"size":9.7375,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"POTEJ","label":"POTEJ","x":932.7543,"y":185.6044,"size":8.7342,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"PPIA","label":"PPIA","x":2898.6566,"y":886.1041,"size":8.6674,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"PPME1","label":"PPME1","x":2170.5678,"y":796.2107,"size":11.4647,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"PPP1CA","label":"PPP1CA","x":1518.133,"y":2293.7856,"size":8.2422,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"PPP1CB","label":"PPP1CB","x":1159.8699,"y":268.705,"size":9.6331,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"PPP1R12B","label":"PPP1R12B","x":1585.976,"y":2047.4161,"size":8.1524,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"PPP1R14A","label":"PPP1R14A","x":2031.4737,"y":1849.4978,"size":9.8293,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"PPP1R2B","label":"PPP1R2B","x":1561.7693,"y":2134.5309,"size":8.9705,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"PPP1R7","label":"PPP1R7","x":1565.7528,"y":2115.9517,"size":8.8168,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"PPP2CB","label":"PPP2CB","x":1494.342,"y":2360.9574,"size":11.9728,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"PPP5C","label":"PPP5C","x":2181.6744,"y":799.4827,"size":7.9866,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"PRDX3","label":"PRDX3","x":683.8831,"y":282.6958,"size":10.1715,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"PREP","label":"PREP","x":987.3023,"y":1151.939,"size":14.4759,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"PRKACB","label":"PRKACB","x":612.5428,"y":1237.513,"size":9.3225,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"PRKAG1","label":"PRKAG1","x":1473.7859,"y":927.333,"size":14.2139,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"PRKAR1A","label":"PRKAR1A","x":1504.2314,"y":2330.8674,"size":8.7072,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"PRKCSH","label":"PRKCSH","x":2652.4411,"y":745.6033,"size":8.3802,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"PRKG1","label":"PRKG1","x":2037.6174,"y":1822.695,"size":9.1182,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"PRNP","label":"PRNP","x":666.2579,"y":910.7828,"size":11.8971,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"PRPF8","label":"PRPF8","x":1831.0697,"y":2381.4765,"size":9.2501,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"PRPH","label":"PRPH","x":1669.0365,"y":1821.3894,"size":9.6291,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"PRXL2A","label":"PRXL2A","x":1523.9895,"y":2167.8393,"size":8.6674,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"PSMA1","label":"PSMA1","x":2118.8397,"y":663.9482,"size":9.2435,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"PSMA2","label":"PSMA2","x":1989.7243,"y":1397.5379,"size":9.5995,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"PSMA3","label":"PSMA3","x":1446.1512,"y":862.1072,"size":9.0433,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"PSMA4","label":"PSMA4","x":2041.671,"y":1393.001,"size":10.9754,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"PSMA5","label":"PSMA5","x":1124.4324,"y":357.6371,"size":8.9852,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"PSMA6","label":"PSMA6","x":2101.4278,"y":1378.5901,"size":13.2493,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"PSMA7","label":"PSMA7","x":1735.2188,"y":2319.589,"size":10.0512,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"PSMB1","label":"PSMB1","x":2010.1997,"y":787.1652,"size":9.7156,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"PSMB2","label":"PSMB2","x":2182.5746,"y":820.105,"size":9.3351,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"PSMB4","label":"PSMB4","x":2134.1988,"y":1398.881,"size":8.0123,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"PSMB5","label":"PSMB5","x":1103.243,"y":437.5076,"size":13.8305,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"PSMB7","label":"PSMB7","x":2665.4634,"y":855.2622,"size":11.1344,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"PSMB8","label":"PSMB8","x":1998.9012,"y":2036.9465,"size":9.0379,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"PSMD11","label":"PSMD11","x":2230.248,"y":787.6784,"size":9.4575,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"PSMD13","label":"PSMD13","x":963.464,"y":351.328,"size":8.123,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"PSMD3","label":"PSMD3","x":1072.4947,"y":1678.4472,"size":10.7959,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"PSMD4","label":"PSMD4","x":1705.1882,"y":2400.942,"size":10.4108,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"PSMD5","label":"PSMD5","x":1984.9045,"y":2037.0698,"size":9.4575,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"PSMD6","label":"PSMD6","x":1260.823,"y":1846.7556,"size":10.7319,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"PSMD9","label":"PSMD9","x":2019.1993,"y":2053.3166,"size":8.8168,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"PSME1","label":"PSME1","x":1940.4059,"y":1987.9718,"size":7.9772,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"PSME2","label":"PSME2","x":2202.3427,"y":574.2093,"size":8.1959,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"PTBP1","label":"PTBP1","x":1781.1266,"y":1371.3782,"size":8.4148,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"PTGIS","label":"PTGIS","x":1172.5143,"y":1732.5497,"size":7.8868,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"PTPN11","label":"PTPN11","x":960.4533,"y":961.9771,"size":10.3034,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"PTX3","label":"PTX3","x":1125.0372,"y":1649.3161,"size":13.5519,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"PURA","label":"PURA","x":2559.1878,"y":873.4297,"size":9.4445,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"PURB","label":"PURB","x":2578.4313,"y":878.6514,"size":9.2907,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"PXDN","label":"PXDN","x":868.0329,"y":193.5613,"size":12.1477,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"PYGB","label":"PYGB","x":1153.8262,"y":246.6518,"size":12.1682,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"PYGL","label":"PYGL","x":1612.1202,"y":821.1193,"size":9.4822,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"PYGM","label":"PYGM","x":1842.1181,"y":790.2527,"size":12.5232,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"QSOX1","label":"QSOX1","x":498.7006,"y":900.7861,"size":7.8051,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"RAB2A","label":"RAB2A","x":2067.7603,"y":1317.0893,"size":10.9599,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"RAB35","label":"RAB35","x":1529.1142,"y":2232.4036,"size":8.6766,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"RAB5A","label":"RAB5A","x":1242.1403,"y":1073.8799,"size":8.1503,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"RAB5B","label":"RAB5B","x":1907.9122,"y":1250.8533,"size":9.5374,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"RAB6A","label":"RAB6A","x":1536.6215,"y":2302.1978,"size":7.9772,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"RAB8B","label":"RAB8B","x":1582.6223,"y":2153.5789,"size":13.4136,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"RAD23B","label":"RAD23B","x":2190.8797,"y":587.7154,"size":11.0412,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"RAN","label":"RAN","x":1907.9078,"y":1395.8265,"size":9.8614,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"RANBP1","label":"RANBP1","x":1826.1676,"y":740.5377,"size":10.2198,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"RAP1A","label":"RAP1A","x":1485.8609,"y":2117.3307,"size":10.4121,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"RARRES2","label":"RARRES2","x":1859.1505,"y":1807.6313,"size":11.8656,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"RARS1","label":"RARS1","x":906.1263,"y":989.5265,"size":9.488,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"RBMX","label":"RBMX","x":979.2535,"y":1709.2311,"size":8.2458,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"RBP4","label":"RBP4","x":1280.7298,"y":2537.5601,"size":10.9807,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"RCN1","label":"RCN1","x":788.0936,"y":326.7446,"size":10.9807,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"RDX","label":"RDX","x":859.9205,"y":337.9243,"size":7.8604,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"RECQL","label":"RECQL","x":2271.0984,"y":498.1415,"size":8.2301,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"RHOG","label":"RHOG","x":1940.9015,"y":1237.5205,"size":9.1283,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"RILPL1","label":"RILPL1","x":1587.4692,"y":2185.0122,"size":12.0309,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"RNPEP","label":"RNPEP","x":2135.2456,"y":1284.0699,"size":17.8775,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"RO60","label":"RO60","x":2788.2925,"y":871.596,"size":15.1957,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"RPL12","label":"RPL12","x":2207.9259,"y":796.047,"size":9.6291,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"RPL14","label":"RPL14","x":2551.1119,"y":852.0489,"size":10.268,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"RPL18A","label":"RPL18A","x":1682.7304,"y":2319.0016,"size":9.2907,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"RPL27A","label":"RPL27A","x":1300.5178,"y":1843.8779,"size":8.0486,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"RPL30","label":"RPL30","x":1623.1248,"y":2107.3425,"size":9.728,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"RPL38","label":"RPL38","x":1631.8143,"y":2204.1895,"size":9.0492,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"RPL4","label":"RPL4","x":2226.1183,"y":549.6203,"size":8.014,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"RPL8","label":"RPL8","x":1714.6523,"y":2305.2956,"size":11.9746,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"RPN1","label":"RPN1","x":1157.8155,"y":208.8106,"size":10.3268,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"RPN2","label":"RPN2","x":1469.0245,"y":1493.5952,"size":11.8322,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"RPS10","label":"RPS10","x":2942.9049,"y":885.0239,"size":9.2765,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"RPS11","label":"RPS11","x":1018.8928,"y":1700.0906,"size":7.85,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"RPS12","label":"RPS12","x":2154.8603,"y":626.1189,"size":8.2422,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"RPS17","label":"RPS17","x":1743.7386,"y":2336.0251,"size":10.9807,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"RPS19","label":"RPS19","x":2265.9022,"y":771.3817,"size":7.8073,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"RPS25","label":"RPS25","x":2811.1174,"y":879.3209,"size":8.9807,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"RPS27L","label":"RPS27L","x":2758.6037,"y":839.8685,"size":11.6568,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"RPS9","label":"RPS9","x":1693.8994,"y":2351.4473,"size":9.9279,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"RRBP1","label":"RRBP1","x":2256.7191,"y":1285.2989,"size":10.9604,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"RTN4","label":"RTN4","x":1980.7254,"y":1947.2763,"size":11.8665,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"RTRAF","label":"RTRAF","x":1747.962,"y":1396.4031,"size":9.4344,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"RUVBL1","label":"RUVBL1","x":2088.1541,"y":713.7642,"size":7.9098,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"S100A11","label":"S100A11","x":1674.9693,"y":978.4993,"size":11.4623,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"S100A16","label":"S100A16","x":900.8677,"y":256.2357,"size":11.4233,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"S100A4","label":"S100A4","x":1253.7119,"y":539.1334,"size":10.261,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"S100A6","label":"S100A6","x":1647.0919,"y":1080.0889,"size":8.3206,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"SAA4","label":"SAA4","x":1702.2466,"y":784.7342,"size":8.1643,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"SBDS","label":"SBDS","x":1319.8412,"y":1868.1552,"size":8.0847,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"SCCPDH","label":"SCCPDH","x":2159.914,"y":1420.6748,"size":13.7268,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"SDCBP","label":"SDCBP","x":1479.1761,"y":2016.4071,"size":12.6788,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"SEC13","label":"SEC13","x":2081.4502,"y":702.7272,"size":11.2062,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"SEC23A","label":"SEC23A","x":1744.9434,"y":2543.6112,"size":12.438,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"SEC24C","label":"SEC24C","x":1676.4635,"y":1869.266,"size":9.1317,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"SEC31A","label":"SEC31A","x":1158.7003,"y":234.6315,"size":8.092,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"SELENOP","label":"SELENOP","x":1865.5183,"y":1265.7229,"size":9.8055,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"SERBP1","label":"SERBP1","x":1419.5061,"y":806.3057,"size":8.3802,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"SERPINA6","label":"SERPINA6","x":1695.316,"y":853.0765,"size":9.8846,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"SERPINC1","label":"SERPINC1","x":1493.4339,"y":703.9431,"size":8.5812,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"SERPINE1","label":"SERPINE1","x":1372.3576,"y":633.3565,"size":9.6291,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"SERPINE2","label":"SERPINE2","x":1213.1251,"y":178.9947,"size":8.2422,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"SERPINF2","label":"SERPINF2","x":1804.9597,"y":1816.3861,"size":10.367,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"SERPING1","label":"SERPING1","x":1312.3191,"y":2399.9299,"size":12.9541,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"SERPINH1","label":"SERPINH1","x":1673.8907,"y":1853.0027,"size":11.0668,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"SET","label":"SET","x":2008.7907,"y":1417.7732,"size":13.5519,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"SF3B3","label":"SF3B3","x":233.8776,"y":1297.1727,"size":8.1708,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"SGCA","label":"SGCA","x":1670.9435,"y":1381.5432,"size":5,"color":"#999999","shape":"triangle","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"SGCB","label":"SGCB","x":1746.5829,"y":1844.7437,"size":10.1939,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"SGCD","label":"SGCD","x":453.6202,"y":916.0054,"size":11.3957,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"SH3BGRL","label":"SH3BGRL","x":100,"y":1361.872,"size":11.6984,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"SH3GL1","label":"SH3GL1","x":1531.7164,"y":2369.7543,"size":13.796,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"SLC14A1","label":"SLC14A1","x":2213.5725,"y":1300.1942,"size":14.5599,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"SLC25A11","label":"SLC25A11","x":589.0836,"y":242.1028,"size":11.7009,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"SLC25A12","label":"SLC25A12","x":2493.8496,"y":836.4398,"size":8.1053,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"SLC25A4","label":"SLC25A4","x":1181.7973,"y":276.3688,"size":9.2698,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"SLC25A6","label":"SLC25A6","x":992.7252,"y":1703.5355,"size":13.6221,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"SLC2A1","label":"SLC2A1","x":1212.3476,"y":202.7275,"size":9.4575,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"SLMAP","label":"SLMAP","x":1805.6105,"y":747.2815,"size":10.3093,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"SND1","label":"SND1","x":1812.9698,"y":1345.2197,"size":8.7537,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"SNRPD2","label":"SNRPD2","x":2759.647,"y":872.5476,"size":10.4396,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"SNTB1","label":"SNTB1","x":1290.7702,"y":2437.6954,"size":10.5309,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"SNTB2","label":"SNTB2","x":1804.9637,"y":771.4587,"size":12.9654,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"SNX12","label":"SNX12","x":693.9493,"y":242.5949,"size":12.9541,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"SNX18","label":"SNX18","x":1018.6773,"y":998.3177,"size":10.0152,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"SNX3","label":"SNX3","x":1330.5923,"y":1883.1624,"size":11.4582,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"SOD1","label":"SOD1","x":267.4531,"y":1349.0751,"size":9.2453,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"SORBS1","label":"SORBS1","x":1717.3654,"y":1829.1042,"size":7.85,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"SORBS3","label":"SORBS3","x":2301.3383,"y":477.8311,"size":11.944,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"SPCS2","label":"SPCS2","x":1686.5902,"y":2289.7757,"size":10.2888,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"SPP2","label":"SPP2","x":1835.5353,"y":1810.7409,"size":9.8609,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"SQOR","label":"SQOR","x":1431.9442,"y":908.3506,"size":9.4971,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"SRC","label":"SRC","x":1199.6576,"y":237.8943,"size":8.9404,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"SRPX","label":"SRPX","x":1346.2456,"y":2516.1382,"size":9.3625,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"SSBP1","label":"SSBP1","x":1447.3601,"y":834.5979,"size":8.8271,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"ST13","label":"ST13","x":1720.2707,"y":2132.1769,"size":14.2139,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"STAB1","label":"STAB1","x":952.811,"y":971.593,"size":8.2422,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"STAT1","label":"STAT1","x":1330.756,"y":2382.7406,"size":10.1741,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"STAT3","label":"STAT3","x":1375.6536,"y":1344.6251,"size":10.7931,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"STIP1","label":"STIP1","x":210.7302,"y":1353.0388,"size":12.1477,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"STK38L","label":"STK38L","x":1413.4343,"y":2301.2805,"size":8.3802,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"STT3B","label":"STT3B","x":2676.0888,"y":732.3546,"size":8.6674,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"STX7","label":"STX7","x":1537.8344,"y":2211.8671,"size":8.5456,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"STXBP1","label":"STXBP1","x":682.2248,"y":916.3977,"size":8.8383,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"STXBP3","label":"STXBP3","x":1224.7664,"y":182.2607,"size":9.8785,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"SUCLA2","label":"SUCLA2","x":575.4817,"y":923.4067,"size":9.3459,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"SUN2","label":"SUN2","x":1552.5509,"y":1340.5691,"size":9.5452,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"SURF4","label":"SURF4","x":681.505,"y":967.2335,"size":8.8348,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"SUSD5","label":"SUSD5","x":906.3858,"y":1136.6484,"size":11.7654,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"SVIL","label":"SVIL","x":1652.8625,"y":2157.9596,"size":9.2489,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"SYNGR2","label":"SYNGR2","x":956.6839,"y":234.2226,"size":9.0314,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"SYNPO2","label":"SYNPO2","x":814.0155,"y":121.6293,"size":9.1628,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"TAGLN2","label":"TAGLN2","x":1759.6002,"y":1873.2073,"size":8.6346,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"TALDO1","label":"TALDO1","x":1255.5706,"y":1670.9517,"size":10.367,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"TARDBP","label":"TARDBP","x":2026.0025,"y":1429.6517,"size":9.5653,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"TCOF1","label":"TCOF1","x":1316.102,"y":1885.0592,"size":13.2493,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.695<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>AGL, AKR1A1, ALDH9A1, ATP5F1D, BST2, CBR1, DDX1, EOGT, FARSB, GALM, GSS, HLA-B, MAN2C1, NCL, NSFL1C, PSMD6, PTGIS, RPL27A, SBDS, SNX3, TALDO1, TCOF1<\/span><br><br><b>KEGG:<\/b><br> Glycolysis / Gluconeogenesis (p=4.00e-04)<br>Ascorbate and aldarate metabolism (p=2.06e-03)<br>Pyruvate metabolism (p=4.68e-03)<br><br><b>BP:<\/b><br>cyclooxygenase pathway (p=5.85e-05)<br>aldehyde metabolic process (p=9.24e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=2.95e-04)<br>alcohol dehydrogenase (NADP+) activity (p=5.67e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule lumen (p=8.22e-03)<br>phagocytic vesicle (p=1.11e-02)<\/div>"},{"id":"TCP1","label":"TCP1","x":1663.7036,"y":2112.5353,"size":8.5793,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"TECR","label":"TECR","x":631.6613,"y":250.2414,"size":15.5702,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"TES","label":"TES","x":1592.1148,"y":2106.6974,"size":9.3612,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"TF","label":"TF","x":1699.0549,"y":812.7073,"size":8.8168,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"TFG","label":"TFG","x":1214.4248,"y":2538.6736,"size":11.6568,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"TGFB1I1","label":"TGFB1I1","x":881.9205,"y":351.3402,"size":10.0287,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.829<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANOS1, CMAS, COL6A2, DMD, DSP, EFEMP1, FLOT1, FN1, HIBADH, HSD17B12, LIMS1, LIMS2, MFAP4, MGST3, OGDH, OXCT1, PDLIM5, PGD, PRDX3, RCN1, RDX, SLC25A11, SNX12, TECR, TGFB1I1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.08e-06)<br>Integrin signaling (p=2.08e-04)<br>Biosynthesis of unsaturated fatty acids (p=1.27e-03)<br><br><b>BP:<\/b><br>positive regulation of cell-substrate adhesion (p=2.99e-05)<br>positive regulation of integrin-mediated signaling pathway (p=1.30e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.85e-06)<br>collagen binding (p=1.51e-04) <br> <b>CC:<\/b><br>cell-substrate junction (p=1.37e-06)<br>focal adhesion (p=1.84e-05)<\/div>"},{"id":"TGFBI","label":"TGFBI","x":1270.5414,"y":501.7002,"size":8.5303,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"TIMP1","label":"TIMP1","x":1676.0192,"y":993.3878,"size":9.2641,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"TIMP2","label":"TIMP2","x":1769.1263,"y":1823.89,"size":12.4084,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"TIMP3","label":"TIMP3","x":1324.7589,"y":1345.0029,"size":11.8263,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"TKFC","label":"TKFC","x":1969.9554,"y":1971.8939,"size":9.5212,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"TLN1","label":"TLN1","x":1662.6895,"y":1393.6171,"size":9.1367,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"TMED10","label":"TMED10","x":2099.4035,"y":1310.008,"size":9.3959,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"TMED2","label":"TMED2","x":2143.9088,"y":1303.8865,"size":9.4455,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"TMEM109","label":"TMEM109","x":2066.769,"y":1823.0671,"size":8.5218,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"TMEM43","label":"TMEM43","x":482.8714,"y":918.9421,"size":8.4851,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"TMOD1","label":"TMOD1","x":1598.9215,"y":1363.6932,"size":10.7699,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"TMPO","label":"TMPO","x":1556.1681,"y":1353.1983,"size":8.2422,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"TMPRSS6","label":"TMPRSS6","x":3068.7173,"y":896.1413,"size":5,"color":"#C545E6","shape":"triangle","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"TMSB4X","label":"TMSB4X","x":1482.9199,"y":1340.4869,"size":12.9541,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"TMX4","label":"TMX4","x":2133.6808,"y":1412.6165,"size":13.4657,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"TNC","label":"TNC","x":1325.0037,"y":424.8106,"size":7.9568,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"TNS1","label":"TNS1","x":1130.6106,"y":424.2074,"size":8.6943,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"TNXB","label":"TNXB","x":1353.7211,"y":2456.8683,"size":11.8971,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.844<\/b><\/p><b>Genes (30):<\/b><br><span style='font-size:11px;'>A2M, ADAMTS4, ADAMTSL3, AHSG, APOA4, APOL1, AZGP1, C4BPA, CFHR1, CKB, CTNND1, DNAJB4, FERMT2, FTO, GSN, HLA-DRB1, HSPB1, ITGA8, MAPK1, MASP2, MMP2, NNMT, RBP4, SERPING1, SNTB1, SRPX, STAT1, STK38L, TFG, TNXB<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.07e-06)<br>Pertussis (p=6.25e-04)<br>Leishmaniasis (p=6.49e-04)<br><br><b>BP:<\/b><br>complement activation (p=5.62e-08)<br>complement activation, lectin pathway (p=5.99e-07) <br> <b>MF:<\/b><br>opsonin binding (p=5.16e-04)<br>complement binding (p=7.34e-04) <br> <b>CC:<\/b><br>blood microparticle (p=3.37e-11)<br>collagen-containing extracellular matrix (p=9.49e-09)<\/div>"},{"id":"TPI1","label":"TPI1","x":1846.9287,"y":1915.12,"size":11.4233,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"TPM2","label":"TPM2","x":779.0473,"y":1205.6511,"size":7.9439,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.765<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>A1BG, AGRN, ANK3, APOA2, ASAH1, CDH1, COL6A1, CTSB, ENTPD1, EPX, FCER1G, FCN1, HDGF, LRRC59, MRC1, NUTF2, PREP, PRKACB, SUSD5, TPM2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.84e-04)<br>Asthma (p=9.63e-04)<br>Renin secretion (p=4.42e-03)<br><br><b>BP:<\/b><br>positive regulation of phagocytosis (p=6.10e-05)<br>high-density lipoprotein particle assembly (p=8.32e-05) <br> <b>MF:<\/b><br>sialic acid binding (p=2.25e-04)<br>proteoglycan binding (p=6.42e-04) <br> <b>CC:<\/b><br>ficolin-1-rich granule (p=9.15e-07)<br>collagen-containing extracellular matrix (p=3.04e-06)<\/div>"},{"id":"TPM4","label":"TPM4","x":1828.8486,"y":773.7995,"size":8.9705,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.733<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AHNAK, AKT1, BLVRB, C1orf198, COMT, FHL1, FILIP1L, FLNC, GSTO1, HADH, HNRNPH1, LHPP, MARCKS, PDLIM7, PLD3, PYGL, PYGM, RANBP1, SERPINC1, SERPINE1, SLMAP, SNTB2, TPM4<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=7.24e-05)<br>Glucagon signaling pathway (p=1.16e-03)<br>Insulin resistance (p=1.22e-03)<br><br><b>BP:<\/b><br>glycogen metabolic process (p=2.41e-06)<br>glucan metabolic process (p=2.64e-06) <br> <b>MF:<\/b><br>actin binding (p=1.40e-04)<br>calmodulin binding (p=1.78e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.49e-07)<br>cell-substrate junction (p=4.08e-07)<\/div>"},{"id":"TRIM28","label":"TRIM28","x":1093.6246,"y":1668.1847,"size":8.9705,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"TRIP6","label":"TRIP6","x":1366.9429,"y":735.6519,"size":10.1585,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"TSN","label":"TSN","x":1107.147,"y":338.5471,"size":8.7819,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.797<\/b><\/p><b>Genes (35):<\/b><br><span style='font-size:11px;'>ABI3BP, ACTG2, AKR7A2, ALCAM, BST1, DDI2, DPT, FBLN5, HSPA5, IGFBP6, ITGB1, KANK2, LAMA2, MAMDC2, NEGR1, NME1, PAPPA, PFN2, PLP1, PPP1CB, PSMA5, PSMB5, PYGB, RPN1, S100A4, SEC31A, SERPINE2, SLC25A4, SLC2A1, SRC, STXBP3, TGFBI, TNC, TNS1, TSN<\/span><br><br><b>KEGG:<\/b><br> Focal adhesion (p=8.06e-05)<br>Integrin signaling (p=3.78e-04)<br>ECM-receptor interaction (p=1.06e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=2.88e-05)<br>extracellular structure organization (p=2.93e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=6.41e-07)<br>integrin binding (p=1.19e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=6.56e-07)<br>protein complex involved in cell adhesion (p=3.19e-06)<\/div>"},{"id":"TUBA1C","label":"TUBA1C","x":915.4805,"y":192.9898,"size":10.2553,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"TUBA4A","label":"TUBA4A","x":340.2241,"y":1336.6589,"size":9.2691,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"TUBB","label":"TUBB","x":1180.2388,"y":1635.6952,"size":8.1228,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"TUBB2A","label":"TUBB2A","x":1828.4511,"y":1355.7722,"size":14.6282,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"TUBB4B","label":"TUBB4B","x":484.8616,"y":889.6989,"size":8.5481,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 21 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.629<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ACSM4, ALDH4A1, ALDOA, AP2B1, BLVRA, CYTL1, DDOST, DNM1L, GPD1L, HADHB, ME2, NDUFS2, PRNP, QSOX1, SGCD, STXBP1, SUCLA2, SURF4, TMEM43, TUBB4B<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=1.07e-03)<br>Synaptic vesicle cycle (p=8.46e-03)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=8.66e-05)<br>dicarboxylic acid metabolic process (p=1.56e-04) <br> <b>MF:<\/b><br>NAD binding (p=2.16e-05)<br>C-acyltransferase activity (p=1.85e-04) <br> <b>CC:<\/b><br>platelet alpha granule (p=1.00e-04)<br>primary lysosome (p=4.81e-04)<\/div>"},{"id":"TWF1","label":"TWF1","x":1493.8975,"y":1348.9017,"size":7.9653,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.776<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ACTN2, ADD3, ANG, ANXA13, APOE, BASP1, BGN, CD74, COL12A1, COL4A2, ESYT1, FCGBP, FGL2, GNB4, HPX, ISLR, KTN1, LAMA4, MATN2, ORM1, PALLD, PEBP1, SGCA, STAT3, SUN2, TIMP3, TLN1, TMOD1, TMPO, TMSB4X, TWF1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.43e-08)<br>Integrin signaling (p=1.97e-03)<br>Focal adhesion (p=4.31e-03)<br><br><b>BP:<\/b><br>regulation of actin filament depolymerization (p=1.27e-06)<br>actin filament depolymerization (p=1.83e-06) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.43e-07)<br>actin binding (p=3.53e-07) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.57e-11)<br>basement membrane (p=3.83e-07)<\/div>"},{"id":"TXNL1","label":"TXNL1","x":2097.3612,"y":1400.4249,"size":9.4106,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"TXNRD1","label":"TXNRD1","x":1449.9996,"y":917.4033,"size":9.6601,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"TXNRD2","label":"TXNRD2","x":2051.997,"y":1993.6342,"size":8.3561,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"TYMP","label":"TYMP","x":1857.2535,"y":1937.8812,"size":9.3474,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"UBA2","label":"UBA2","x":1379.2197,"y":754.6205,"size":8.3802,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"UBA3","label":"UBA3","x":1728.3909,"y":2508.6638,"size":8.1615,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"UBA5","label":"UBA5","x":1737.233,"y":2518.4001,"size":11.1989,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.718<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>AIP, ATP1B3, CRYL1, DCD, DCXR, DHRS7, EIF3B, H1-4, H2AZ2, IPO7, LRRFIP1, MAGT1, MPST, NAE1, NME3, NPM1, NTN1, PCYOX1, PDCD5, PRPF8, PSMA7, PSMD4, RPL18A, RPL38, RPL8, RPS17, RPS9, SEC23A, SPCS2, UBA3, UBA5<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=2.14e-04)<br>Pentose and glucuronate interconversions (p=3.32e-03)<br>Proteasome (p=5.37e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=2.95e-07)<br>ribonucleoprotein complex biogenesis (p=1.34e-04) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.96e-07)<br>structural constituent of ribosome (p=9.61e-06) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.02e-06)<br>ribosomal subunit (p=9.47e-06)<\/div>"},{"id":"UBE2L3","label":"UBE2L3","x":1674.0889,"y":2191.4984,"size":8.5218,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.764<\/b><\/p><b>Genes (32):<\/b><br><span style='font-size:11px;'>ACOT9, ACTB, ATP2A2, CA1, CAPNS1, COPS2, CORO1B, CPNE1, DLGAP4, EIF4B, ERLIN2, FAM114A1, FLII, GNB2, HADHA, HSPA12A, IDH3B, IRGQ, LRRC17, OMD, PDCD6, POSTN, PRXL2A, RAB8B, RAP1A, RILPL1, RPL30, ST13, SVIL, TCP1, TES, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=1.08e-03)<br>Arrhythmogenic right ventricular cardiomyopathy (p=4.98e-03)<br>Adherens junction (p=5.80e-03)<br><br><b>BP:<\/b><br>actin filament severing (p=2.87e-04)<br>barbed-end actin filament capping (p=6.28e-04) <br> <b>MF:<\/b><br>NAD binding (p=3.40e-03)<br>hydro-lyase activity (p=4.32e-03) <br> <b>CC:<\/b><br>focal adhesion (p=3.23e-06)<br>cell-substrate junction (p=3.76e-06)<\/div>"},{"id":"UBXN1","label":"UBXN1","x":2162.9528,"y":1399.1005,"size":10.0139,"color":"#4585E6","shape":"dot","cluster":24,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 24<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.798<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>BUB3, CLTC, COPS4, COPS6, EIF2S2, HNRNPL, HNRNPU, PSMA2, PSMA4, PSMA6, PSMB4, SCCPDH, SET, TARDBP, TMX4, TXNL1, UBXN1<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=5.81e-08)<br>Huntington disease (p=3.99e-06)<br>Spinocerebellar ataxia (p=5.86e-06)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=2.26e-05)<br>protein deneddylation (p=3.25e-05) <br> <b>MF:<\/b><br>pre-mRNA binding (p=1.98e-05)<br>pre-mRNA intronic binding (p=6.07e-05) <br> <b>CC:<\/b><br>proteasome core complex (p=1.76e-09)<br>proteasome complex (p=1.77e-09)<\/div>"},{"id":"UGDH","label":"UGDH","x":913.8298,"y":166.9411,"size":9.3383,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ALB, ANO1, ANO6, ANXA3, ARPC4, CAP2, CNP, CTTN, DES, DYNLL1, EDNRA, GALNT2, GRB2, H1-0, HCLS1, HLA-DRB5, MAOA, PFN1, PLN, POTEJ, PSMD13, PXDN, S100A16, SYNGR2, SYNPO2, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Tight junction (p=3.04e-04)<br>Bacterial invasion of epithelial cells (p=4.61e-04)<br>Pathogenic Escherichia coli infection (p=5.95e-04)<br><br><b>BP:<\/b><br>actin filament polymerization (p=2.57e-06)<br>actin filament organization (p=3.04e-06) <br> <b>MF:<\/b><br>structural constituent of cytoskeleton (p=1.95e-05)<br>voltage-gated chloride channel activity (p=1.32e-04) <br> <b>CC:<\/b><br>COP9 signalosome (p=1.09e-03)<br>endocytic vesicle (p=1.31e-03)<\/div>"},{"id":"UGGT1","label":"UGGT1","x":2202.219,"y":1292.9379,"size":9.2907,"color":"#C5E645","shape":"dot","cluster":22,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 22<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.757<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ATL3, BCAP31, CAST, CD55, DDX3X, EEF1D, ELAVL1, ESYT2, ETF1, FLOT2, GNG12, HNRNPA0, IST1, LNPEP, RAB2A, RAN, RNPEP, RRBP1, SLC14A1, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.29e-03)<br>AMPK signaling pathway (p=1.52e-02)<br>Renin-angiotensin system (p=3.55e-02)<br><br><b>BP:<\/b><br>Golgi organization (p=2.97e-05)<br>Golgi vesicle budding (p=5.85e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.85e-06)<br>metalloaminopeptidase activity (p=4.25e-04) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.40e-11)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=2.47e-08)<\/div>"},{"id":"UNC45A","label":"UNC45A","x":184.5651,"y":1352.0316,"size":7.8229,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.656<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>ALDH16A1, CACYBP, COMP, CS, EEF1G, EIF2S3, FNDC1, G6PD, GAA, GYS1, HBE1, HSPH1, LRG1, ME1, MOGS, NAP1L4, NNT, P4HB, SF3B3, SH3BGRL, SOD1, STIP1, TUBA4A, UNC45A<\/span><br><br><b>KEGG:<\/b><br> Carbon metabolism (p=8.90e-04)<br>Starch and sucrose metabolism (p=1.97e-03)<br>Protein processing in endoplasmic reticulum (p=2.79e-03)<br><br><b>BP:<\/b><br>NADP metabolic process (p=2.04e-05)<br>hydrogen peroxide metabolic process (p=3.50e-05) <br> <b>MF:<\/b><br>NADP binding (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>haptoglobin-hemoglobin complex (p=1.32e-02)<br>endoplasmic reticulum chaperone complex (p=1.32e-02)<\/div>"},{"id":"UQCRC1","label":"UQCRC1","x":1280.0099,"y":1606.7416,"size":10.4467,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"USO1","label":"USO1","x":1579.2845,"y":1966.9136,"size":11.0718,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"UTRN","label":"UTRN","x":2582.7736,"y":808.0614,"size":7.9772,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 25 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.576<\/b><\/p><b>Genes (27):<\/b><br><span style='font-size:11px;'>ANXA11, APEH, APRT, DPP7, FUS, GSR, HNRNPC, HSPD1, ISYNA1, KARS1, L3HYPDH, MTHFD1, NAGK, NUDC, PPME1, PPP5C, PRKCSH, PSMB2, PSMD11, PURA, PURB, RPL12, RPL14, RPS19, SLC25A12, STT3B, UTRN<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=3.68e-03)<br>Amyotrophic lateral sclerosis (p=5.44e-03)<br>Coronavirus disease - COVID-19 (p=1.10e-02)<br><br><b>BP:<\/b><br>positive regulation of macrophage activation (p=7.81e-04)<br>nucleoside phosphate biosynthetic process (p=9.37e-04) <br> <b>MF:<\/b><br>mRNA regulatory element binding translation repressor activity (p=3.05e-04)<br>single-stranded DNA binding (p=6.97e-04) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.80e-04)<br>ribosomal subunit (p=1.79e-03)<\/div>"},{"id":"VAMP3","label":"VAMP3","x":1450.4744,"y":1193.7097,"size":11.7303,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"VAT1","label":"VAT1","x":1433.4922,"y":784.3218,"size":8.9925,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"VDAC1","label":"VDAC1","x":1470.998,"y":881.7646,"size":17.3536,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"},{"id":"VDAC2","label":"VDAC2","x":1626.8422,"y":1447.2803,"size":8.3932,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"VDAC3","label":"VDAC3","x":1661.2659,"y":1460.7571,"size":8.3285,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"VIM","label":"VIM","x":1671.6024,"y":1832.3073,"size":9.87,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.707<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ALDH1L1, ATP1A2, CALD1, CLTA, COL6A3, EFEMP2, HLA-DRA, ITGA6, LIX1, LTBP2, LXN, NID1, PPP1R14A, PRKG1, PRPH, RARRES2, SEC24C, SERPINF2, SERPINH1, SGCB, SORBS1, SPP2, TIMP2, TMEM109, VIM<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.28e-06)<br>Vascular smooth muscle contraction (p=1.32e-03)<br>Endocrine and other factor-regulated calcium reabsorption (p=3.44e-03)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=3.87e-05)<br>collagen biosynthetic process (p=4.10e-05) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=5.85e-08)<br>peptidase inhibitor activity (p=7.80e-08) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.49e-09)<br>sarcolemma (p=2.89e-05)<\/div>"},{"id":"VPS26B","label":"VPS26B","x":1009.6986,"y":981.7629,"size":11.5766,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"VPS29","label":"VPS29","x":1548.59,"y":2186.0365,"size":8.3032,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"VPS35","label":"VPS35","x":1030.2595,"y":1017.2429,"size":9.1064,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 22 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.623<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AHCYL1, CD14, DNM2, EFTUD2, EHD3, EHD4, M6PR, NAPA, NSF, PTPN11, RAB5A, RARS1, SNX18, STAB1, VPS26B, VPS35<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=2.03e-06)<br>Salmonella infection (p=4.13e-05)<br>Synaptic vesicle cycle (p=2.81e-04)<br><br><b>BP:<\/b><br>endosomal transport (p=9.55e-08)<br>receptor-mediated endocytosis (p=2.70e-06) <br> <b>MF:<\/b><br>GTP binding (p=1.21e-05)<br>guanyl nucleotide binding (p=1.60e-05) <br> <b>CC:<\/b><br>endocytic vesicle (p=5.76e-09)<br>recycling endosome (p=5.10e-07)<\/div>"},{"id":"WDR13","label":"WDR13","x":2088.6566,"y":2017.9871,"size":8.4694,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 24 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.584<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>ACAT1, ALDH2, CLIC1, ELOC, ENPP1, ERAP1, GFAP, GNPDA2, HSD17B10, HSD17B4, IVD, MVP, NDRG2, PDLIM4, PSMB8, PSMD5, PSMD9, PSME1, RTN4, TAGLN2, TKFC, TPI1, TXNRD2, TYMP, WDR13<\/span><br><br><b>KEGG:<\/b><br> Valine, leucine and isoleucine degradation (p=1.63e-06)<br>Proteasome (p=8.09e-05)<br>Pantothenate and CoA biosynthesis (p=6.88e-04)<br><br><b>BP:<\/b><br>small molecule catabolic process (p=1.68e-08)<br>fatty acid beta-oxidation (p=2.62e-06) <br> <b>MF:<\/b><br>estradiol 17-beta-dehydrogenase [NAD(P)+] activity (p=2.68e-04)<br>steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=7.70e-04) <br> <b>CC:<\/b><br>proteasome complex (p=1.17e-06)<br>proteasome accessory complex (p=3.97e-06)<\/div>"},{"id":"WDR77","label":"WDR77","x":887.05,"y":1761.5512,"size":8.5454,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"WFS1","label":"WFS1","x":1703.2869,"y":829.0963,"size":10.5663,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.732<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ANXA7, CD59, CDH13, COL4A1, CPNE3, EHD1, F10, FMOD, GC, HEXB, HP, ITGA1, ITIH2, LAMP1, MYADM, NADK2, NAPRT, PARP1, PDLIM1, S100A11, S100A6, SAA4, SERPINA6, TF, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Nicotinate and nicotinamide metabolism (p=2.26e-03)<br>Cornified envelope formation (p=7.31e-03)<br>Cytoskeleton in muscle cells (p=8.89e-03)<br><br><b>BP:<\/b><br>nicotinamide nucleotide biosynthetic process (p=6.80e-04)<br>pyridine nucleotide biosynthetic process (p=6.80e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=7.87e-08)<br>cell adhesion mediator activity (p=1.58e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.00e-06)<br>endoplasmic reticulum lumen (p=2.66e-06)<\/div>"},{"id":"WIPF1","label":"WIPF1","x":1542.67,"y":2370.7039,"size":13.2493,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 23 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.619<\/b><\/p><b>Genes (29):<\/b><br><span style='font-size:11px;'>AEBP1, CAVIN1, CNN1, ENSA, HAAO, HEBP2, ILK, LDB3, LGALS1, MBP, PACSIN2, PACSIN3, PLCD1, PLEC, PLIN3, PPP1CA, PPP1R12B, PPP1R2B, PPP1R7, PPP2CB, PRKAR1A, RAB35, RAB6A, SDCBP, SH3GL1, STX7, USO1, VPS29, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=5.11e-04)<br>Focal adhesion (p=3.55e-03)<br>mRNA surveillance pathway (p=1.10e-02)<br><br><b>BP:<\/b><br>sarcomere organization (p=5.25e-05)<br>plasma membrane raft assembly (p=8.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=1.06e-05)<br>protein phosphatase regulator activity (p=2.18e-05) <br> <b>CC:<\/b><br>sarcomere (p=2.51e-04)<br>focal adhesion (p=2.83e-04)<\/div>"},{"id":"XRCC5","label":"XRCC5","x":2072.5523,"y":730.1616,"size":11.5055,"color":"#E64545","shape":"dot","cluster":21,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 21<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.642<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>ARF3, CCT7, HDGFL3, HNRNPA2B1, HNRNPH3, MTERF2, NPNT, PHGDH, PLPBP, PSMA1, PSMB1, PSME2, RAD23B, RECQL, RPL4, RPS12, RUVBL1, SEC13, SORBS3, XRCC5<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=2.88e-05)<br>Amyotrophic lateral sclerosis (p=1.21e-03)<br>Spinocerebellar ataxia (p=1.58e-02)<br><br><b>BP:<\/b><br>regulation of telomere maintenance (p=5.37e-06)<br>telomere maintenance (p=2.31e-05) <br> <b>MF:<\/b><br>DNA helicase activity (p=6.52e-05)<br>single-stranded DNA binding (p=2.81e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.55e-07)<br>endopeptidase complex (p=2.53e-06)<\/div>"},{"id":"XRCC6","label":"XRCC6","x":951.2185,"y":1714.8707,"size":12.1509,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.68<\/b><\/p><b>Genes (31):<\/b><br><span style='font-size:11px;'>ANXA6, ARCN1, CCT3, COTL1, COX4I1, CTPS1, DHX9, DNPEP, ECH1, EML1, ERGIC1, GMPR2, H1-3, H2AC21, HEBP1, LAMC1, LMAN2, PDHB, PGAM1, PHPT1, PSMD3, PTX3, RBMX, RPN2, RPS11, SLC25A6, TRIM28, TUBB, UQCRC1, WDR77, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Prion disease (p=5.41e-06)<br>Parkinson disease (p=8.25e-05)<br>Huntington disease (p=1.58e-04)<br><br><b>BP:<\/b><br>retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (p=8.01e-05)<br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.29e-03) <br> <b>MF:<\/b><br>oxidoreduction-driven active transmembrane transporter activity (p=5.70e-03)<br>promoter-specific chromatin binding (p=5.70e-03) <br> <b>CC:<\/b><br>secretory granule lumen (p=9.34e-06)<br>cytoplasmic vesicle lumen (p=1.02e-05)<\/div>"},{"id":"YAP1","label":"YAP1","x":1896.6726,"y":1264.8871,"size":10.269,"color":"#45E685","shape":"dot","cluster":23,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 23<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.724<\/b><\/p><b>Genes (21):<\/b><br><span style='font-size:11px;'>ATP1A1, CCT2, CCT8, CP, CYB5R3, GLG1, HBG2, HNRNPM, IGLL5, ITGB2, PABPC1, PTBP1, RAB5B, RHOG, RTRAF, SELENOP, SND1, TUBB2A, VDAC2, VDAC3, YAP1<\/span><br><br><b>KEGG:<\/b><br> Ferroptosis (p=2.77e-05)<br>Phagosome (p=1.44e-03)<br>cGMP-PKG signaling pathway (p=1.63e-03)<br><br><b>BP:<\/b><br>binding of sperm to zona pellucida (p=1.07e-05)<br>sperm-egg recognition (p=2.41e-05) <br> <b>MF:<\/b><br>voltage-gated monoatomic anion channel activity (p=1.83e-04)<br>poly-pyrimidine tract binding (p=5.16e-04) <br> <b>CC:<\/b><br>chaperonin-containing T-complex (p=5.81e-05)<br>hemoglobin complex (p=6.97e-05)<\/div>"},{"id":"YBX3","label":"YBX3","x":2975.1106,"y":881.9297,"size":9.7185,"color":"#C545E6","shape":"dot","cluster":25,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 25<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.648<\/b><\/p><b>Genes (18):<\/b><br><span style='font-size:11px;'>COL18A1, CSRP2, EIF2S1, EIF4H, FN3K, GNAS, LAMA5, PCBP2, PLP2, PPIA, PSMB7, RO60, RPS10, RPS25, RPS27L, SNRPD2, TMPRSS6, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=4.52e-03)<br>Parkinson disease (p=6.50e-03)<br>Amoebiasis (p=9.61e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=1.75e-05)<br>regulation of translation (p=7.65e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=5.98e-04)<br>ribonucleoprotein complex binding (p=6.19e-04) <br> <b>CC:<\/b><br>cytosolic small ribosomal subunit (p=7.00e-06)<br>small ribosomal subunit (p=3.88e-05)<\/div>"},{"id":"YWHAB","label":"YWHAB","x":1425.3544,"y":853.3283,"size":9.7878,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.72<\/b><\/p><b>Genes (33):<\/b><br><span style='font-size:11px;'>ACLY, ACTN1, AKAP12, AMPD2, ARPC5, CD163, CD81, CLTB, CTNNB1, CYB5B, DDX17, DENR, GNA13, H1-2, HK1, HNRNPR, HSDL2, LSS, MYO1C, MYO1D, NCKAP1, PRKAG1, PSMA3, SERBP1, SQOR, SSBP1, TRIP6, TXNRD1, UBA2, VAMP3, VAT1, VDAC1, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Pathogenic Escherichia coli infection (p=1.01e-04)<br>Bacterial invasion of epithelial cells (p=8.22e-04)<br>Regulation of actin cytoskeleton (p=2.08e-03)<br><br><b>BP:<\/b><br>regulation of protein sumoylation (p=8.05e-04)<br>actin filament organization (p=1.19e-03) <br> <b>MF:<\/b><br>SUMO binding (p=3.82e-04)<br>actin filament binding (p=4.32e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.06e-08)<br>cell-substrate junction (p=2.51e-08)<\/div>"}],"aristas":[{"from":"AKAP12","to":"VAMP3","weight":0.405},{"from":"ACTN1","to":"VAMP3","weight":0.41},{"from":"STAT3","to":"TIMP3","weight":0.408},{"from":"COL12A1","to":"TIMP3","weight":0.415},{"from":"AKT1","to":"FHL1","weight":0.402},{"from":"FHL1","to":"FLNC","weight":0.405},{"from":"LTBP2","to":"TIMP2","weight":0.409},{"from":"COL6A3","to":"LTBP2","weight":0.408},{"from":"HLA-DRB1","to":"MMP2","weight":0.423},{"from":"HLA-DRB1","to":"TNXB","weight":0.413},{"from":"DMD","to":"FN1","weight":0.407},{"from":"ACTC1","to":"DMD","weight":0.401},{"from":"HSPA5","to":"PPP1CB","weight":0.402},{"from":"ACTG2","to":"PPP1CB","weight":0.411},{"from":"ADD3","to":"APOE","weight":0.402},{"from":"APOE","to":"VIM","weight":0.408},{"from":"CNN1","to":"VIM","weight":0.403},{"from":"ACTB","to":"CNN1","weight":0.403},{"from":"ITGB1","to":"S100A4","weight":0.401},{"from":"ITGB1","to":"TNS1","weight":0.408},{"from":"TUBB","to":"UQCRC1","weight":0.411},{"from":"ANXA6","to":"TUBB","weight":0.402},{"from":"CNN1","to":"PLEC","weight":0.401},{"from":"ECH1","to":"UQCRC1","weight":0.406},{"from":"CKB","to":"MMP2","weight":0.41},{"from":"CKB","to":"GSN","weight":0.413},{"from":"CDH1","to":"CTSB","weight":0.404},{"from":"COL6A1","to":"CTSB","weight":0.412},{"from":"ALDOA","to":"SUCLA2","weight":0.414},{"from":"ALDOA","to":"TUBB4B","weight":0.405},{"from":"FERMT2","to":"HLA-DRB1","weight":0.418},{"from":"ITGA6","to":"VIM","weight":0.414},{"from":"ITGA6","to":"SORBS1","weight":0.404},{"from":"HNRNPU","to":"SET","weight":0.404},{"from":"CLTC","to":"HNRNPU","weight":0.404},{"from":"ACTN2","to":"TLN1","weight":0.402},{"from":"ACTN2","to":"PALLD","weight":0.421},{"from":"PPP1CB","to":"PYGB","weight":0.402},{"from":"ITGB1","to":"NME1","weight":0.412},{"from":"HSPA5","to":"NME1","weight":0.412},{"from":"CCT8","to":"VDAC2","weight":0.405},{"from":"CYB5R3","to":"VDAC2","weight":0.485},{"from":"CTTN","to":"TGFB1I1","weight":0.41},{"from":"COL6A2","to":"TGFB1I1","weight":0.403},{"from":"AKAP12","to":"CTNNB1","weight":0.408},{"from":"CTNNB1","to":"MYO1D","weight":0.431},{"from":"PTBP1","to":"SND1","weight":0.405},{"from":"SND1","to":"TUBB2A","weight":0.42},{"from":"MYO1C","to":"MYO1D","weight":0.411},{"from":"LRRC59","to":"P4HB","weight":0.413},{"from":"P4HB","to":"TUBA4A","weight":0.413},{"from":"COL18A1","to":"PPIA","weight":0.404},{"from":"COL18A1","to":"LAMA5","weight":0.421},{"from":"ACTB","to":"CA1","weight":0.476},{"from":"PPIA","to":"RPS25","weight":0.405},{"from":"LAMA4","to":"TIMP3","weight":0.405},{"from":"BGN","to":"LAMA4","weight":0.401},{"from":"MAPK1","to":"MMP2","weight":0.408},{"from":"HSPB1","to":"MMP2","weight":0.407},{"from":"ALB","to":"PFN1","weight":0.404},{"from":"PFN1","to":"TUBA1C","weight":0.404},{"from":"DES","to":"PXDN","weight":0.421},{"from":"DES","to":"SYNPO2","weight":0.414},{"from":"AKT1","to":"TPM4","weight":0.409},{"from":"PDLIM7","to":"TPM4","weight":0.414},{"from":"COL6A2","to":"EFEMP1","weight":0.445},{"from":"HCLS1","to":"PXDN","weight":0.409},{"from":"ACTB","to":"POSTN","weight":0.404},{"from":"RDX","to":"TGFB1I1","weight":0.402},{"from":"GPD1L","to":"SUCLA2","weight":0.406},{"from":"GPD1L","to":"TMEM43","weight":0.401},{"from":"CCT3","to":"CTPS1","weight":0.422},{"from":"CCT3","to":"LAMC1","weight":0.415},{"from":"AHSG","to":"GSN","weight":0.402},{"from":"AHSG","to":"C4BPA","weight":0.404},{"from":"ACAT1","to":"TPI1","weight":0.405},{"from":"ACAT1","to":"ALDH2","weight":0.406},{"from":"ATP1A1","to":"VDAC2","weight":0.431},{"from":"COL6A3","to":"EFEMP2","weight":0.401},{"from":"EFEMP2","to":"PRKG1","weight":0.413},{"from":"CNN1","to":"ILK","weight":0.411},{"from":"MAMDC2","to":"TSN","weight":0.405},{"from":"ABI3BP","to":"MAMDC2","weight":0.427},{"from":"ILK","to":"SDCBP","weight":0.41},{"from":"CAVIN1","to":"SDCBP","weight":0.406},{"from":"AKT1","to":"PYGL","weight":0.406},{"from":"S100A4","to":"TGFBI","weight":0.41},{"from":"FBLN5","to":"TGFBI","weight":0.414},{"from":"PPP1CB","to":"SEC31A","weight":0.422},{"from":"RPN1","to":"SEC31A","weight":0.406},{"from":"ADD3","to":"TMPO","weight":0.408},{"from":"ADD3","to":"ESYT1","weight":0.435},{"from":"S100A4","to":"SERPINE1","weight":0.409},{"from":"ACTB","to":"HADHA","weight":0.404},{"from":"PDLIM5","to":"RDX","weight":0.411},{"from":"FMOD","to":"TIMP1","weight":0.414},{"from":"FMOD","to":"PDLIM1","weight":0.401},{"from":"ALDH9A1","to":"TALDO1","weight":0.418},{"from":"ALDH9A1","to":"CBR1","weight":0.405},{"from":"CTNNB1","to":"RAB5A","weight":0.407},{"from":"EHD4","to":"RAB5A","weight":0.431},{"from":"ACLY","to":"CTNNB1","weight":0.408},{"from":"ACLY","to":"HK1","weight":0.41},{"from":"ALB","to":"CTTN","weight":0.406},{"from":"ACTB","to":"CORO1B","weight":0.411},{"from":"CORO1B","to":"SVIL","weight":0.405},{"from":"DCD","to":"H1-4","weight":0.414},{"from":"DCD","to":"PCYOX1","weight":0.426},{"from":"P4HB","to":"SOD1","weight":0.404},{"from":"G6PD","to":"SOD1","weight":0.413},{"from":"TMOD1","to":"TMPO","weight":0.407},{"from":"CCT8","to":"TMPO","weight":0.406},{"from":"PTBP1","to":"RTRAF","weight":0.411},{"from":"SERPINH1","to":"VIM","weight":0.417},{"from":"EHD3","to":"EHD4","weight":0.622},{"from":"CBR1","to":"PTGIS","weight":0.419},{"from":"ALB","to":"ANXA3","weight":0.404},{"from":"FUS","to":"HSPD1","weight":0.416},{"from":"ANXA11","to":"FUS","weight":0.409},{"from":"PHGDH","to":"PLPBP","weight":0.415},{"from":"PLPBP","to":"SORBS3","weight":0.409},{"from":"ACTB","to":"CTNND1","weight":0.407},{"from":"CTNND1","to":"MAPK1","weight":0.41},{"from":"TPI1","to":"TYMP","weight":0.411},{"from":"MVP","to":"TYMP","weight":0.416},{"from":"ACTB","to":"TES","weight":0.455},{"from":"CTTN","to":"ITGB1","weight":0.407},{"from":"ATL3","to":"RRBP1","weight":0.421},{"from":"ATL3","to":"ESYT2","weight":0.49},{"from":"AKT1","to":"PYGM","weight":0.401},{"from":"PCBP2","to":"RPS25","weight":0.404},{"from":"AKT1","to":"HNRNPA2B1","weight":0.409},{"from":"LGALS1","to":"PLEC","weight":0.447},{"from":"ALDH9A1","to":"GALM","weight":0.413},{"from":"AKR1A1","to":"GALM","weight":0.419},{"from":"ACTB","to":"RPL30","weight":0.412},{"from":"GNB2","to":"RPL30","weight":0.429},{"from":"GSR","to":"HSPD1","weight":0.414},{"from":"GSR","to":"MTHFD1","weight":0.407},{"from":"COMP","to":"P4HB","weight":0.402},{"from":"COMP","to":"FNDC1","weight":0.421},{"from":"CDH13","to":"HP","weight":0.429},{"from":"CDH13","to":"CPNE3","weight":0.403},{"from":"PSMA5","to":"TSN","weight":0.408},{"from":"CTPS1","to":"GMPR2","weight":0.406},{"from":"AKT1","to":"SNTB2","weight":0.436},{"from":"SLMAP","to":"SNTB2","weight":0.434},{"from":"ALDOA","to":"AP2B1","weight":0.43},{"from":"ACTB","to":"ATP2A2","weight":0.402},{"from":"CCT2","to":"SND1","weight":0.413},{"from":"RPL30","to":"TCP1","weight":0.404},{"from":"GSTO1","to":"PYGL","weight":0.408},{"from":"BLVRB","to":"GSTO1","weight":0.407},{"from":"FBLN5","to":"LAMA2","weight":0.418},{"from":"HP","to":"LAMP1","weight":0.418},{"from":"EHD1","to":"LAMP1","weight":0.411},{"from":"PARP1","to":"TMPO","weight":0.407},{"from":"ANXA7","to":"PARP1","weight":0.404},{"from":"CAP2","to":"PFN1","weight":0.516},{"from":"HNRNPL","to":"SET","weight":0.405},{"from":"S100A6","to":"TIMP1","weight":0.401},{"from":"EIF4H","to":"RPS27L","weight":0.404},{"from":"CSRP2","to":"RPS27L","weight":0.424},{"from":"RPS11","to":"TRIM28","weight":0.407},{"from":"DHX9","to":"RPS11","weight":0.409},{"from":"ARCN1","to":"CCT8","weight":0.403},{"from":"ARCN1","to":"RPN2","weight":0.406},{"from":"ESYT1","to":"KTN1","weight":0.41},{"from":"COL4A2","to":"KTN1","weight":0.428},{"from":"PABPC1","to":"YAP1","weight":0.407},{"from":"RAB5B","to":"YAP1","weight":0.403},{"from":"AHCYL1","to":"EFTUD2","weight":0.411},{"from":"AHCYL1","to":"HADHB","weight":0.411},{"from":"LNPEP","to":"RAB2A","weight":0.422},{"from":"LNPEP","to":"RNPEP","weight":0.427},{"from":"CALD1","to":"COL6A3","weight":0.42},{"from":"ATP1A2","to":"CALD1","weight":0.434},{"from":"ITGA6","to":"NID1","weight":0.405},{"from":"EEF1G","to":"P4HB","weight":0.407},{"from":"GNPDA2","to":"TPI1","weight":0.406},{"from":"ENPP1","to":"GNPDA2","weight":0.505},{"from":"CAP2","to":"POTEJ","weight":0.627},{"from":"ACLY","to":"PYGL","weight":0.403},{"from":"DDX3X","to":"FLOT2","weight":0.401},{"from":"FLOT2","to":"RAB2A","weight":0.411},{"from":"M6PR","to":"RAB5A","weight":0.41},{"from":"M6PR","to":"VPS35","weight":0.407},{"from":"KANK2","to":"TNS1","weight":0.441},{"from":"ACLY","to":"VDAC1","weight":0.406},{"from":"HSPA5","to":"SLC25A4","weight":0.413},{"from":"RRBP1","to":"UGGT1","weight":0.401},{"from":"SNX18","to":"VPS35","weight":0.449},{"from":"COL4A1","to":"FMOD","weight":0.426},{"from":"DDX1","to":"RPL27A","weight":0.418},{"from":"RPL27A","to":"SBDS","weight":0.402},{"from":"HIBADH","to":"PGD","weight":0.413},{"from":"HIBADH","to":"OGDH","weight":0.408},{"from":"PLIN3","to":"VPS29","weight":0.405},{"from":"PLCD1","to":"PLIN3","weight":0.411},{"from":"PLIN3","to":"PPP1CA","weight":0.413},{"from":"PPP1CA","to":"PRKAR1A","weight":0.409},{"from":"CCT2","to":"PABPC1","weight":0.401},{"from":"RPS11","to":"SLC25A6","weight":0.401},{"from":"CCT7","to":"SEC13","weight":0.401},{"from":"ARF3","to":"SEC13","weight":0.407},{"from":"LDB3","to":"PLEC","weight":0.445},{"from":"RAB2A","to":"TMED2","weight":0.402},{"from":"TMED2","to":"UGGT1","weight":0.425},{"from":"ANXA7","to":"S100A6","weight":0.408},{"from":"MYADM","to":"S100A6","weight":0.45},{"from":"TUBA1C","to":"UGDH","weight":0.404},{"from":"CCT7","to":"HNRNPA2B1","weight":0.409},{"from":"CD74","to":"STAT3","weight":0.403},{"from":"GNB4","to":"STAT3","weight":0.433},{"from":"HADH","to":"PYGM","weight":0.419},{"from":"PRPH","to":"VIM","weight":0.457},{"from":"OGDH","to":"OXCT1","weight":0.401},{"from":"FN1","to":"TGFB1I1","weight":0.402},{"from":"ALDH2","to":"IVD","weight":0.402},{"from":"HSD17B10","to":"IVD","weight":0.418},{"from":"TAGLN2","to":"TPI1","weight":0.407},{"from":"DDX3X","to":"RTRAF","weight":0.406},{"from":"DDX3X","to":"HNRNPL","weight":0.403},{"from":"SGCD","to":"TMEM43","weight":0.456},{"from":"SLC25A4","to":"SRC","weight":0.407},{"from":"SLC2A1","to":"SRC","weight":0.414},{"from":"AKAP12","to":"TMPO","weight":0.401},{"from":"RBMX","to":"RPS11","weight":0.403},{"from":"RBMX","to":"XRCC6","weight":0.407},{"from":"TALDO1","to":"UQCRC1","weight":0.407},{"from":"AGL","to":"TALDO1","weight":0.406},{"from":"COL6A2","to":"MFAP4","weight":0.417},{"from":"AKR7A2","to":"HSPA5","weight":0.436},{"from":"CCT7","to":"XRCC5","weight":0.402},{"from":"CD81","to":"CTNNB1","weight":0.406},{"from":"CACYBP","to":"HSPH1","weight":0.471},{"from":"HSPH1","to":"SH3BGRL","weight":0.416},{"from":"EIF2S3","to":"P4HB","weight":0.408},{"from":"RAD23B","to":"RPS12","weight":0.409},{"from":"RAD23B","to":"RPL4","weight":0.406},{"from":"ARPC4","to":"CTTN","weight":0.416},{"from":"CLIC1","to":"GFAP","weight":0.412},{"from":"GFAP","to":"PDLIM4","weight":0.409},{"from":"EIF4H","to":"PSMB7","weight":0.409},{"from":"EIF4H","to":"GNAS","weight":0.403},{"from":"FILIP1L","to":"FLNC","weight":0.481},{"from":"DDX3X","to":"RAN","weight":0.401},{"from":"EIF2S1","to":"HSPD1","weight":0.406},{"from":"EIF2S1","to":"PCBP2","weight":0.401},{"from":"DDOST","to":"HADHB","weight":0.421},{"from":"PSMA3","to":"VDAC1","weight":0.403},{"from":"DDX17","to":"PSMA3","weight":0.405},{"from":"ALB","to":"MAOA","weight":0.406},{"from":"CTSB","to":"FCER1G","weight":0.407},{"from":"EPX","to":"FCER1G","weight":0.404},{"from":"POSTN","to":"RAP1A","weight":0.415},{"from":"SUN2","to":"TMPO","weight":0.425},{"from":"HNRNPA2B1","to":"NUDC","weight":0.408},{"from":"NUDC","to":"RPL12","weight":0.41},{"from":"CTSB","to":"PREP","weight":0.406},{"from":"ALB","to":"ANO6","weight":0.452},{"from":"HNRNPC","to":"RPL12","weight":0.411},{"from":"PHGDH","to":"RPL4","weight":0.403},{"from":"PPP2CB","to":"PRKAR1A","weight":0.483},{"from":"EFEMP1","to":"MGST3","weight":0.439},{"from":"GMPR2","to":"RPS11","weight":0.406},{"from":"CS","to":"EEF1G","weight":0.402},{"from":"HNRNPM","to":"PABPC1","weight":0.43},{"from":"ATP1A1","to":"VDAC3","weight":0.416},{"from":"CORO1B","to":"CPNE1","weight":0.415},{"from":"EFTUD2","to":"VPS35","weight":0.411},{"from":"MPST","to":"UBA5","weight":0.409},{"from":"SEC23A","to":"UBA5","weight":0.401},{"from":"ARCN1","to":"ECH1","weight":0.404},{"from":"AGRN","to":"ANK3","weight":0.409},{"from":"ANK3","to":"PRKACB","weight":0.412},{"from":"NID1","to":"SGCB","weight":0.425},{"from":"PRKAG1","to":"TXNRD1","weight":0.405},{"from":"SQOR","to":"TXNRD1","weight":0.426},{"from":"FN1","to":"LIMS1","weight":0.402},{"from":"NCKAP1","to":"VAMP3","weight":0.403},{"from":"PGAM1","to":"UQCRC1","weight":0.402},{"from":"PDHB","to":"PGAM1","weight":0.403},{"from":"CCT8","to":"RTRAF","weight":0.409},{"from":"DPT","to":"LAMA2","weight":0.411},{"from":"CD74","to":"TWF1","weight":0.405},{"from":"CD74","to":"FGL2","weight":0.404},{"from":"NAPA","to":"RAB5A","weight":0.404},{"from":"FLII","to":"SVIL","weight":0.423},{"from":"ACTC1","to":"FLOT1","weight":0.401},{"from":"CAVIN1","to":"PACSIN3","weight":0.403},{"from":"HAAO","to":"PACSIN3","weight":0.422},{"from":"LMAN2","to":"RPN2","weight":0.407},{"from":"ERGIC1","to":"LMAN2","weight":0.549},{"from":"HSD17B4","to":"IVD","weight":0.433},{"from":"LRRC17","to":"POSTN","weight":0.437},{"from":"ACTB","to":"RAB8B","weight":0.404},{"from":"FUS","to":"PURA","weight":0.44},{"from":"KARS1","to":"NUDC","weight":0.407},{"from":"HNRNPC","to":"RPS19","weight":0.411},{"from":"RPL38","to":"SPCS2","weight":0.403},{"from":"RPS9","to":"SPCS2","weight":0.401},{"from":"DNM1L","to":"PRNP","weight":0.409},{"from":"BLVRA","to":"PRNP","weight":0.402},{"from":"HSPD1","to":"KARS1","weight":0.404},{"from":"MMP2","to":"STAT1","weight":0.412},{"from":"NNMT","to":"STAT1","weight":0.404},{"from":"RPS17","to":"SPCS2","weight":0.411},{"from":"CRYL1","to":"RPS17","weight":0.403},{"from":"ILK","to":"MBP","weight":0.405},{"from":"HIBADH","to":"HSD17B12","weight":0.444},{"from":"ATP5F1D","to":"FARSB","weight":0.407},{"from":"DDX1","to":"FARSB","weight":0.407},{"from":"ITGB1","to":"PFN2","weight":0.401},{"from":"ACTN1","to":"HNRNPR","weight":0.41},{"from":"ATP2A2","to":"ERLIN2","weight":0.404},{"from":"HNRNPL","to":"PSMA4","weight":0.404},{"from":"COPS4","to":"PSMA4","weight":0.408},{"from":"FUS","to":"RPL14","weight":0.407},{"from":"PLEC","to":"USO1","weight":0.42},{"from":"ACTB","to":"PDCD6","weight":0.432},{"from":"DENR","to":"UBA2","weight":0.41},{"from":"TRIP6","to":"UBA2","weight":0.402},{"from":"NPNT","to":"PHGDH","weight":0.407},{"from":"MAGT1","to":"SPCS2","weight":0.404},{"from":"LRRFIP1","to":"MAGT1","weight":0.406},{"from":"HSD17B12","to":"SLC25A11","weight":0.473},{"from":"AKT1","to":"HNRNPH1","weight":0.412},{"from":"CNN1","to":"PPP1R12B","weight":0.403},{"from":"PPP1R12B","to":"PPP1R7","weight":0.405},{"from":"PLIN3","to":"RAB6A","weight":0.401},{"from":"AGRN","to":"TPM2","weight":0.41},{"from":"PSMD4","to":"RPS9","weight":0.404},{"from":"NAE1","to":"PSMD4","weight":0.413},{"from":"NPM1","to":"PRPF8","weight":0.415},{"from":"EIF3B","to":"PRPF8","weight":0.415},{"from":"PPP1R7","to":"VPS29","weight":0.406},{"from":"RUVBL1","to":"XRCC5","weight":0.406},{"from":"ACTN2","to":"TMOD1","weight":0.411},{"from":"IPO7","to":"RPS9","weight":0.41},{"from":"IPO7","to":"NTN1","weight":0.424},{"from":"RAB2A","to":"TMED10","weight":0.427},{"from":"SERPINF2","to":"TIMP2","weight":0.41},{"from":"SERPINF2","to":"SPP2","weight":0.414},{"from":"CS","to":"SF3B3","weight":0.414},{"from":"RPL8","to":"SPCS2","weight":0.405},{"from":"ACTC1","to":"DSP","weight":0.403},{"from":"SERPINE2","to":"SLC2A1","weight":0.423},{"from":"ADAMTS4","to":"SRPX","weight":0.406},{"from":"ADAMTS4","to":"TNXB","weight":0.417},{"from":"ALB","to":"CNP","weight":0.41},{"from":"RARRES2","to":"SPP2","weight":0.404},{"from":"PSMD11","to":"RPL12","weight":0.42},{"from":"TRIM28","to":"TUBB","weight":0.411},{"from":"DNAJB4","to":"HSPB1","weight":0.403},{"from":"DYNLL1","to":"TUBA1C","weight":0.438},{"from":"CLIC1","to":"TPI1","weight":0.402},{"from":"DDX3X","to":"ETF1","weight":0.412},{"from":"ELAVL1","to":"ETF1","weight":0.411},{"from":"ITGB1","to":"PSMB5","weight":0.41},{"from":"DDI2","to":"PSMB5","weight":0.437},{"from":"TMPO","to":"TWF1","weight":0.408},{"from":"FN1","to":"PGD","weight":0.404},{"from":"PGD","to":"PRDX3","weight":0.409},{"from":"CTSB","to":"MRC1","weight":0.404},{"from":"ENTPD1","to":"MRC1","weight":0.425},{"from":"STX7","to":"VPS29","weight":0.415},{"from":"RAB35","to":"STX7","weight":0.416},{"from":"ALDH4A1","to":"HADHB","weight":0.412},{"from":"ELOC","to":"PSME1","weight":0.414},{"from":"ELOC","to":"PSMD5","weight":0.421},{"from":"EFEMP1","to":"RCN1","weight":0.455},{"from":"ATP5F1D","to":"TALDO1","weight":0.408},{"from":"ALDH4A1","to":"SUCLA2","weight":0.412},{"from":"PCBP2","to":"SNRPD2","weight":0.418},{"from":"RO60","to":"SNRPD2","weight":0.449},{"from":"AHNAK","to":"PYGL","weight":0.404},{"from":"AHNAK","to":"LHPP","weight":0.406},{"from":"CRYL1","to":"DHRS7","weight":0.412},{"from":"CLIC1","to":"PSME1","weight":0.411},{"from":"ERAP1","to":"PSME1","weight":0.469},{"from":"COPS6","to":"PSMA4","weight":0.405},{"from":"HNRNPH3","to":"XRCC5","weight":0.406},{"from":"AKT1","to":"COMT","weight":0.406},{"from":"SSBP1","to":"VDAC1","weight":0.404},{"from":"HSDL2","to":"SSBP1","weight":0.407},{"from":"PHPT1","to":"UQCRC1","weight":0.512},{"from":"DDX1","to":"PSMD6","weight":0.408},{"from":"DENR","to":"SERBP1","weight":0.402},{"from":"TMX4","to":"TXNL1","weight":0.406},{"from":"SCCPDH","to":"TMX4","weight":0.469},{"from":"FN3K","to":"TMPRSS6","weight":0.409},{"from":"LAMA5","to":"TMPRSS6","weight":0.404},{"from":"DYNLL1","to":"GALNT2","weight":0.518},{"from":"DNM1L","to":"HADHB","weight":0.403},{"from":"DNM1L","to":"STXBP1","weight":0.526},{"from":"APEH","to":"L3HYPDH","weight":0.421},{"from":"L3HYPDH","to":"UTRN","weight":0.421},{"from":"NUDC","to":"PPP5C","weight":0.424},{"from":"HADHA","to":"PRXL2A","weight":0.44},{"from":"HP","to":"SERPINA6","weight":0.407},{"from":"SERPINA6","to":"WFS1","weight":0.418},{"from":"DNM2","to":"VPS35","weight":0.405},{"from":"ANOS1","to":"FN1","weight":0.489},{"from":"CRYL1","to":"DCXR","weight":0.439},{"from":"DNAJB4","to":"SNTB1","weight":0.424},{"from":"ACOT9","to":"HADHA","weight":0.521},{"from":"DDX3X","to":"HNRNPA0","weight":0.422},{"from":"NSF","to":"RAB5A","weight":0.403},{"from":"HSPA12A","to":"TCP1","weight":0.427},{"from":"NUDC","to":"PPME1","weight":0.492},{"from":"ALB","to":"HCLS1","weight":0.409},{"from":"COL6A1","to":"TPM2","weight":0.405},{"from":"PSMA1","to":"SEC13","weight":0.406},{"from":"PSMA1","to":"RPS12","weight":0.409},{"from":"ANXA6","to":"PTX3","weight":0.426},{"from":"HADHB","to":"ME2","weight":0.408},{"from":"ANO1","to":"CTTN","weight":0.406},{"from":"GFAP","to":"TKFC","weight":0.41},{"from":"SOD1","to":"STIP1","weight":0.413},{"from":"STIP1","to":"UNC45A","weight":0.412},{"from":"ITGB1","to":"PLP1","weight":0.401},{"from":"CACYBP","to":"STIP1","weight":0.418},{"from":"ACTB","to":"COPS2","weight":0.426},{"from":"FGL2","to":"MATN2","weight":0.445},{"from":"GRB2","to":"PXDN","weight":0.412},{"from":"COMT","to":"PLD3","weight":0.41},{"from":"CMAS","to":"LIMS1","weight":0.422},{"from":"RPL18A","to":"SPCS2","weight":0.406},{"from":"AGL","to":"MAN2C1","weight":0.411},{"from":"EOGT","to":"MAN2C1","weight":0.422},{"from":"AHSG","to":"FTO","weight":0.414},{"from":"ADAMTSL3","to":"FTO","weight":0.415},{"from":"DDOST","to":"SURF4","weight":0.506},{"from":"BUB3","to":"HNRNPU","weight":0.406},{"from":"GNA13","to":"VDAC1","weight":0.412},{"from":"PHGDH","to":"RECQL","weight":0.457},{"from":"G6PD","to":"GYS1","weight":0.414},{"from":"PSMD3","to":"TRIM28","weight":0.407},{"from":"ACTB","to":"RPL38","weight":0.408},{"from":"NDUFS2","to":"TUBB4B","weight":0.421},{"from":"ITGB2","to":"YAP1","weight":0.419},{"from":"ITGB2","to":"RHOG","weight":0.436},{"from":"NAPRT","to":"PARP1","weight":0.406},{"from":"NADK2","to":"NAPRT","weight":0.452},{"from":"ISYNA1","to":"PRKCSH","weight":0.402},{"from":"PRKCSH","to":"STT3B","weight":0.43},{"from":"SLC2A1","to":"STXBP3","weight":0.442},{"from":"NPM1","to":"RPS17","weight":0.406},{"from":"AIP","to":"NPM1","weight":0.402},{"from":"COL4A1","to":"F10","weight":0.449},{"from":"HSPD1","to":"SLC25A12","weight":0.516},{"from":"PSMA4","to":"TXNL1","weight":0.41},{"from":"G6PD","to":"NNT","weight":0.402},{"from":"SEC24C","to":"SERPINH1","weight":0.43},{"from":"PPIA","to":"RPS10","weight":0.416},{"from":"MPST","to":"NAE1","weight":0.406},{"from":"MPST","to":"UBA3","weight":0.407},{"from":"PURA","to":"PURB","weight":0.78},{"from":"CTPS1","to":"WDR77","weight":0.407},{"from":"ACLY","to":"PRKAG1","weight":0.408},{"from":"ARPC4","to":"PSMD13","weight":0.422},{"from":"H1-4","to":"H2AZ2","weight":0.413},{"from":"MAPK1","to":"STK38L","weight":0.472},{"from":"A2M","to":"RBP4","weight":0.42},{"from":"A2M","to":"MASP2","weight":0.411},{"from":"CDH1","to":"RAB5A","weight":0.404},{"from":"HADHA","to":"IDH3B","weight":0.422},{"from":"ACLY","to":"LSS","weight":0.46},{"from":"SNX18","to":"VPS26B","weight":0.404},{"from":"HIBADH","to":"TECR","weight":0.423},{"from":"EFTUD2","to":"RARS1","weight":0.413},{"from":"SET","to":"TARDBP","weight":0.415},{"from":"MOGS","to":"P4HB","weight":0.441},{"from":"EIF2S2","to":"PSMA4","weight":0.411},{"from":"ACLY","to":"AMPD2","weight":0.452},{"from":"GSN","to":"RBP4","weight":0.413},{"from":"SERPINA6","to":"TF","weight":0.406},{"from":"AEBP1","to":"CAVIN1","weight":0.407},{"from":"PABPC1","to":"SELENOP","weight":0.402},{"from":"CP","to":"SELENOP","weight":0.407},{"from":"HP","to":"TIMP1","weight":0.404},{"from":"TIMP2","to":"VIM","weight":0.411},{"from":"AZGP1","to":"GSN","weight":0.416},{"from":"APOA4","to":"AZGP1","weight":0.408},{"from":"CTNND1","to":"ITGA8","weight":0.479},{"from":"ITIH2","to":"TIMP1","weight":0.435},{"from":"HDGF","to":"LRRC59","weight":0.414},{"from":"ITGA1","to":"LAMP1","weight":0.401},{"from":"APOE","to":"HPX","weight":0.438},{"from":"GSTO1","to":"SERPINC1","weight":0.404},{"from":"TAGLN2","to":"VIM","weight":0.407},{"from":"LAMA2","to":"TNC","weight":0.401},{"from":"PEBP1","to":"TLN1","weight":0.411},{"from":"GC","to":"SERPINA6","weight":0.426},{"from":"HSDL2","to":"VAT1","weight":0.527},{"from":"SERPING1","to":"STAT1","weight":0.42},{"from":"CFHR1","to":"GSN","weight":0.429},{"from":"ISYNA1","to":"MTHFD1","weight":0.402},{"from":"DDX1","to":"NCL","weight":0.413},{"from":"A1BG","to":"COL6A1","weight":0.405},{"from":"PSMA3","to":"YWHAB","weight":0.405},{"from":"ALCAM","to":"TGFBI","weight":0.422},{"from":"CYB5R3","to":"HBG2","weight":0.56},{"from":"GFAP","to":"RTN4","weight":0.409},{"from":"APEH","to":"HSPD1","weight":0.429},{"from":"ANG","to":"APOE","weight":0.429},{"from":"NAGK","to":"NUDC","weight":0.41},{"from":"COPS6","to":"PSMA6","weight":0.409},{"from":"CTNNB1","to":"H1-2","weight":0.42},{"from":"H2AZ2","to":"NPM1","weight":0.416},{"from":"H2AC21","to":"TRIM28","weight":0.444},{"from":"H1-3","to":"H2AC21","weight":0.44},{"from":"COL12A1","to":"ORM1","weight":0.412},{"from":"FCN1","to":"MRC1","weight":0.408},{"from":"FCN1","to":"SUSD5","weight":0.422},{"from":"CYB5R3","to":"IGLL5","weight":0.429},{"from":"PSMA7","to":"RPL8","weight":0.413},{"from":"ALDOA","to":"QSOX1","weight":0.454},{"from":"CAST","to":"LNPEP","weight":0.505},{"from":"CD14","to":"DNM2","weight":0.412},{"from":"CD14","to":"PTPN11","weight":0.428},{"from":"PACSIN2","to":"RAB6A","weight":0.42},{"from":"BST2","to":"DDX1","weight":0.441},{"from":"BST2","to":"HLA-B","weight":0.471},{"from":"EEF1D","to":"RAN","weight":0.413},{"from":"ME1","to":"NNT","weight":0.427},{"from":"NME1","to":"PSMA5","weight":0.411},{"from":"GSTO1","to":"SERPINE1","weight":0.402},{"from":"HNRNPL","to":"PSMA2","weight":0.415},{"from":"BCAP31","to":"RRBP1","weight":0.419},{"from":"ACTB","to":"CAPNS1","weight":0.407},{"from":"EML1","to":"TUBB","weight":0.589},{"from":"ANK3","to":"NUTF2","weight":0.412},{"from":"GLG1","to":"TUBB2A","weight":0.401},{"from":"HSPA12A","to":"ST13","weight":0.439},{"from":"PSMB4","to":"TXNL1","weight":0.423},{"from":"CD55","to":"TMED2","weight":0.405},{"from":"HNRNPA2B1","to":"PSMB1","weight":0.406},{"from":"ADD3","to":"BASP1","weight":0.41},{"from":"CD14","to":"STAB1","weight":0.435},{"from":"HEXB","to":"LAMP1","weight":0.414},{"from":"COL6A3","to":"HLA-DRA","weight":0.407},{"from":"DES","to":"HLA-DRB5","weight":0.413},{"from":"APEH","to":"DPP7","weight":0.403},{"from":"SERBP1","to":"SSBP1","weight":0.408},{"from":"AFM","to":"FN1","weight":0.428},{"from":"A1BG","to":"APOA2","weight":0.434},{"from":"PDCD5","to":"RPL18A","weight":0.418},{"from":"COTL1","to":"TUBB","weight":0.401},{"from":"COTL1","to":"HEBP1","weight":0.422},{"from":"CD163","to":"CD81","weight":0.414},{"from":"GAA","to":"MOGS","weight":0.419},{"from":"EEF1G","to":"NAP1L4","weight":0.406},{"from":"ALCAM","to":"NEGR1","weight":0.47},{"from":"BST1","to":"NEGR1","weight":0.424},{"from":"ALB","to":"H1-0","weight":0.418},{"from":"ELOC","to":"PSMB8","weight":0.429},{"from":"BGN","to":"ISLR","weight":0.424},{"from":"FAM114A1","to":"POSTN","weight":0.425},{"from":"LIMS1","to":"LIMS2","weight":0.418},{"from":"COMP","to":"LRG1","weight":0.449},{"from":"SBDS","to":"SNX3","weight":0.448},{"from":"NUDC","to":"PSMB2","weight":0.402},{"from":"PSMB8","to":"PSMD9","weight":0.402},{"from":"AKR1A1","to":"GSS","weight":0.442},{"from":"CD74","to":"FCGBP","weight":0.448},{"from":"ACTB","to":"EIF4B","weight":0.406},{"from":"FLOT2","to":"GNG12","weight":0.418},{"from":"CD59","to":"HP","weight":0.424},{"from":"AGRN","to":"HDGF","weight":0.409},{"from":"APRT","to":"MTHFD1","weight":0.403},{"from":"ACSM4","to":"CYTL1","weight":0.435},{"from":"ACSM4","to":"ME2","weight":0.406},{"from":"ASAH1","to":"CTSB","weight":0.46},{"from":"PSME2","to":"RAD23B","weight":0.454},{"from":"PPP1R2B","to":"PPP1R7","weight":0.501},{"from":"CLTB","to":"VAMP3","weight":0.581},{"from":"G6PD","to":"HBE1","weight":0.44},{"from":"ATP1B3","to":"CRYL1","weight":0.412},{"from":"ALDH1L1","to":"VIM","weight":0.406},{"from":"AZGP1","to":"TFG","weight":0.414},{"from":"DNPEP","to":"ECH1","weight":0.426},{"from":"S100A11","to":"TIMP1","weight":0.446},{"from":"NSFL1C","to":"PSMD6","weight":0.41},{"from":"APOL1","to":"AZGP1","weight":0.436},{"from":"HSD17B10","to":"WDR13","weight":0.444},{"from":"HDGFL3","to":"MTERF2","weight":0.421},{"from":"MTERF2","to":"RPL4","weight":0.405},{"from":"ARPC5","to":"MYO1C","weight":0.506},{"from":"EDNRA","to":"SYNGR2","weight":0.414},{"from":"ALB","to":"EDNRA","weight":0.403},{"from":"EIF2S1","to":"PSMB7","weight":0.401},{"from":"CLTA","to":"HLA-DRA","weight":0.501},{"from":"OMD","to":"POSTN","weight":0.43},{"from":"AKT1","to":"MARCKS","weight":0.424},{"from":"CD55","to":"SLC14A1","weight":0.442},{"from":"ALDH16A1","to":"CS","weight":0.411},{"from":"RPS10","to":"YBX3","weight":0.41},{"from":"CPNE1","to":"UBE2L3","weight":0.415},{"from":"CPNE1","to":"IRGQ","weight":0.535},{"from":"IVD","to":"TXNRD2","weight":0.41},{"from":"LIX1","to":"LXN","weight":0.406},{"from":"ATP1A2","to":"LIX1","weight":0.417},{"from":"GFAP","to":"NDRG2","weight":0.413},{"from":"PCBP2","to":"PLP2","weight":0.405},{"from":"BLVRB","to":"C1orf198","weight":0.443},{"from":"CALD1","to":"PPP1R14A","weight":0.425},{"from":"IST1","to":"TMED10","weight":0.447},{"from":"PACSIN2","to":"SH3GL1","weight":0.429},{"from":"PACSIN2","to":"WIPF1","weight":0.423},{"from":"PRKG1","to":"TMEM109","weight":0.458},{"from":"COX4I1","to":"PDHB","weight":0.402},{"from":"IGFBP6","to":"PAPPA","weight":0.412},{"from":"HSPA5","to":"PAPPA","weight":0.408},{"from":"HEBP2","to":"PLIN3","weight":0.542},{"from":"SAA4","to":"TF","weight":0.409},{"from":"LIMS2","to":"SNX12","weight":0.418},{"from":"HNRNPH1","to":"RANBP1","weight":0.409},{"from":"NME3","to":"RPL38","weight":0.423},{"from":"TMSB4X","to":"TWF1","weight":0.42},{"from":"ANXA13","to":"SGCA","weight":0.41},{"from":"ACTN2","to":"SGCA","weight":0.412},{"from":"PSMB4","to":"UBXN1","weight":0.404},{"from":"RAB8B","to":"RILPL1","weight":0.427},{"from":"ENSA","to":"PPP2CB","weight":0.683},{"from":"SBDS","to":"TCOF1","weight":0.509},{"from":"PLN","to":"SYNPO2","weight":0.479},{"from":"CYB5B","to":"HSDL2","weight":0.414},{"from":"DLGAP4","to":"RILPL1","weight":0.421},{"from":"ANXA3","to":"S100A16","weight":0.43}],"clusters":[{"cluster":2,"color":"#377EB8","count":30,"mean_fc":0.844,"rank":1},{"cluster":8,"color":"#F781BF","count":27,"mean_fc":0.829,"rank":2},{"cluster":24,"color":"#4585E6","count":17,"mean_fc":0.798,"rank":3},{"cluster":3,"color":"#4DAF4A","count":35,"mean_fc":0.797,"rank":4},{"cluster":9,"color":"#999999","count":31,"mean_fc":0.776,"rank":5},{"cluster":1,"color":"#E41A1C","count":20,"mean_fc":0.765,"rank":6},{"cluster":6,"color":"#FFFF33","count":32,"mean_fc":0.764,"rank":7},{"cluster":22,"color":"#C5E645","count":22,"mean_fc":0.757,"rank":8},{"cluster":13,"color":"#E78AC3","count":23,"mean_fc":0.733,"rank":9},{"cluster":20,"color":"#E7298A","count":26,"mean_fc":0.732,"rank":10},{"cluster":23,"color":"#45E685","count":21,"mean_fc":0.724,"rank":11},{"cluster":5,"color":"#FF7F00","count":33,"mean_fc":0.72,"rank":12},{"cluster":14,"color":"#A6D854","count":31,"mean_fc":0.718,"rank":13},{"cluster":17,"color":"#1B9E77","count":25,"mean_fc":0.707,"rank":14},{"cluster":11,"color":"#FC8D62","count":22,"mean_fc":0.695,"rank":15},{"cluster":19,"color":"#7570B3","count":31,"mean_fc":0.68,"rank":16},{"cluster":16,"color":"#B3B3B3","count":24,"mean_fc":0.656,"rank":17},{"cluster":25,"color":"#C545E6","count":18,"mean_fc":0.648,"rank":18},{"cluster":15,"color":"#FFD92F","count":27,"mean_fc":0.648,"rank":19},{"cluster":21,"color":"#E64545","count":20,"mean_fc":0.642,"rank":20},{"cluster":7,"color":"#A65628","count":20,"mean_fc":0.629,"rank":21},{"cluster":12,"color":"#8DA0CB","count":16,"mean_fc":0.623,"rank":22},{"cluster":10,"color":"#66C2A5","count":29,"mean_fc":0.619,"rank":23},{"cluster":4,"color":"#984EA3","count":25,"mean_fc":0.584,"rank":24},{"cluster":18,"color":"#D95F02","count":27,"mean_fc":0.576,"rank":25}],"stats":{"nodos":632,"aristas":631,"clusters":25}},"P001":{"nodos":[{"id":"ACOT9","label":"ACOT9","x":1778.3234,"y":1300.9201,"size":10.5651,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.745<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT9, ALDH16A1, HADHA, HSD17B12, IDH3B, MTHFD1, MVP, PRDX3, SLC25A11, TPI1, TYMP, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Fatty acid elongation (p=1.72e-04)<br>Fatty acid metabolism (p=7.19e-04)<br>Biosynthesis of amino acids (p=1.24e-03)<br><br><b>BP:<\/b><br>NADH metabolic process (p=2.40e-04)<br>sulfur compound metabolic process (p=7.89e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=5.77e-05)<br>oxidoreductase activity, acting on CH-OH group of donors (p=7.29e-05) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.69e-03)<br>tricarboxylic acid cycle heteromeric enzyme complex (p=1.02e-02)<\/div>"},{"id":"ACTB","label":"ACTB","x":1956.7726,"y":1334.8319,"size":10.1971,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"ACTC1","label":"ACTC1","x":189.2973,"y":2567.1889,"size":9.6845,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"ACTG2","label":"ACTG2","x":1286.9565,"y":445.507,"size":20,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"ACTN1","label":"ACTN1","x":2064.3669,"y":1559.2923,"size":10.5806,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"ADAMTS4","label":"ADAMTS4","x":1369.3492,"y":1760.5566,"size":5,"color":"#FFFF33","shape":"triangle","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"ADAMTSL3","label":"ADAMTSL3","x":1114.7708,"y":1650.4499,"size":9.3375,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.948<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>ADAMTSL3, AHSG, APOL1, AZGP1, CFHR1, CKB, FTO, GSN, MASP2, RBP4, SVIL, TFG, TMOD1, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.26e-03)<br>African trypanosomiasis (p=3.06e-02)<br>Thyroid cancer (p=3.06e-02)<br><br><b>BP:<\/b><br>actin filament capping (p=3.19e-06)<br>negative regulation of actin filament depolymerization (p=4.27e-06) <br> <b>MF:<\/b><br>opsonin binding (p=1.09e-04)<br>complement binding (p=1.56e-04) <br> <b>CC:<\/b><br>blood microparticle (p=2.57e-06)<br>podosome (p=3.72e-04)<\/div>"},{"id":"ADD3","label":"ADD3","x":1953.7847,"y":1883.5472,"size":11.3124,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.706<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, AKAP12, BASP1, CD81, CLTB, CPNE1, CTNNB1, ESYT1, IRGQ, NDRG2, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=3.90e-04)<br>Hepatitis C (p=1.55e-03)<br>SNARE interactions in vesicular transport (p=1.37e-02)<br><br><b>BP:<\/b><br>midbrain development (p=1.37e-05)<br>mesenchymal to epithelial transition (p=4.33e-05) <br> <b>MF:<\/b><br>calmodulin binding (p=2.09e-04)<br>calcium-dependent phospholipid binding (p=4.29e-04) <br> <b>CC:<\/b><br>cell cortex (p=1.36e-05)<br>cell cortex region (p=1.34e-04)<\/div>"},{"id":"AFM","label":"AFM","x":296.316,"y":2516.0822,"size":13.0767,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"AGL","label":"AGL","x":2822.9543,"y":2023.6422,"size":10.5651,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"AGRN","label":"AGRN","x":2095.9213,"y":638.2159,"size":11.6568,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"AHSG","label":"AHSG","x":1221.9147,"y":1640.3749,"size":10.7699,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.948<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>ADAMTSL3, AHSG, APOL1, AZGP1, CFHR1, CKB, FTO, GSN, MASP2, RBP4, SVIL, TFG, TMOD1, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.26e-03)<br>African trypanosomiasis (p=3.06e-02)<br>Thyroid cancer (p=3.06e-02)<br><br><b>BP:<\/b><br>actin filament capping (p=3.19e-06)<br>negative regulation of actin filament depolymerization (p=4.27e-06) <br> <b>MF:<\/b><br>opsonin binding (p=1.09e-04)<br>complement binding (p=1.56e-04) <br> <b>CC:<\/b><br>blood microparticle (p=2.57e-06)<br>podosome (p=3.72e-04)<\/div>"},{"id":"AKAP12","label":"AKAP12","x":2098.294,"y":1818.958,"size":10.9807,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.706<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, AKAP12, BASP1, CD81, CLTB, CPNE1, CTNNB1, ESYT1, IRGQ, NDRG2, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=3.90e-04)<br>Hepatitis C (p=1.55e-03)<br>SNARE interactions in vesicular transport (p=1.37e-02)<br><br><b>BP:<\/b><br>midbrain development (p=1.37e-05)<br>mesenchymal to epithelial transition (p=4.33e-05) <br> <b>MF:<\/b><br>calmodulin binding (p=2.09e-04)<br>calcium-dependent phospholipid binding (p=4.29e-04) <br> <b>CC:<\/b><br>cell cortex (p=1.36e-05)<br>cell cortex region (p=1.34e-04)<\/div>"},{"id":"AKR7A2","label":"AKR7A2","x":1250.431,"y":369.4234,"size":11.1989,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"AKT1","label":"AKT1","x":1325.9773,"y":675.8869,"size":14.1235,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"ALB","label":"ALB","x":658.2741,"y":2338.9694,"size":11.251,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"ALCAM","label":"ALCAM","x":628.2911,"y":2296.3671,"size":10.6116,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"ALDH16A1","label":"ALDH16A1","x":1665.6483,"y":1296.8429,"size":11.8971,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.745<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT9, ALDH16A1, HADHA, HSD17B12, IDH3B, MTHFD1, MVP, PRDX3, SLC25A11, TPI1, TYMP, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Fatty acid elongation (p=1.72e-04)<br>Fatty acid metabolism (p=7.19e-04)<br>Biosynthesis of amino acids (p=1.24e-03)<br><br><b>BP:<\/b><br>NADH metabolic process (p=2.40e-04)<br>sulfur compound metabolic process (p=7.89e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=5.77e-05)<br>oxidoreductase activity, acting on CH-OH group of donors (p=7.29e-05) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.69e-03)<br>tricarboxylic acid cycle heteromeric enzyme complex (p=1.02e-02)<\/div>"},{"id":"ALDH4A1","label":"ALDH4A1","x":1777.7655,"y":976.8418,"size":9.9873,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"AMPD2","label":"AMPD2","x":999.7585,"y":512.4746,"size":11.3026,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"ANK3","label":"ANK3","x":2094.2105,"y":581.6841,"size":11.6568,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"ANO1","label":"ANO1","x":488.7202,"y":2400.267,"size":11.106,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"ANO6","label":"ANO6","x":681.3932,"y":2335.2033,"size":10.9807,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"ANOS1","label":"ANOS1","x":283.2407,"y":2501.5642,"size":10.8603,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"ANXA11","label":"ANXA11","x":2912.7496,"y":1054.8214,"size":11.9758,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"ANXA13","label":"ANXA13","x":198.4745,"y":2412.9188,"size":9.8055,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"ANXA6","label":"ANXA6","x":616.9411,"y":2330.559,"size":10.5696,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"ANXA7","label":"ANXA7","x":997.2376,"y":656.8202,"size":14.643,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"APEH","label":"APEH","x":2618.8375,"y":1897.4384,"size":9.36,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"APOE","label":"APOE","x":1853.9678,"y":2019.0923,"size":9.8858,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"APOL1","label":"APOL1","x":1212.1787,"y":1581.9914,"size":12.676,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.948<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>ADAMTSL3, AHSG, APOL1, AZGP1, CFHR1, CKB, FTO, GSN, MASP2, RBP4, SVIL, TFG, TMOD1, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.26e-03)<br>African trypanosomiasis (p=3.06e-02)<br>Thyroid cancer (p=3.06e-02)<br><br><b>BP:<\/b><br>actin filament capping (p=3.19e-06)<br>negative regulation of actin filament depolymerization (p=4.27e-06) <br> <b>MF:<\/b><br>opsonin binding (p=1.09e-04)<br>complement binding (p=1.56e-04) <br> <b>CC:<\/b><br>blood microparticle (p=2.57e-06)<br>podosome (p=3.72e-04)<\/div>"},{"id":"ARF3","label":"ARF3","x":2690.6997,"y":905.9639,"size":9.3784,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"ASAH1","label":"ASAH1","x":971.7091,"y":393.9299,"size":9.2527,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"ATL3","label":"ATL3","x":3065.216,"y":732.0283,"size":10.5899,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ATL3, ATP1B3, BCAP31, ERGIC1, ESYT2, LMAN2, RAB2A, RPN2, RRBP1, RTN4, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.24e-07)<br>Proximal tubule bicarbonate reclamation (p=2.15e-02)<br>Aldosterone-regulated sodium reabsorption (p=3.52e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.87e-08)<br>endoplasmic reticulum organization (p=5.40e-07) <br> <b>MF:<\/b><br>hexosyltransferase activity (p=8.03e-03)<br>UDP-glucosyltransferase activity (p=8.34e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.95e-13)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=6.35e-12)<\/div>"},{"id":"ATP1A2","label":"ATP1A2","x":2983.2645,"y":1058.7212,"size":17.012,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"ATP1B3","label":"ATP1B3","x":2899.2032,"y":824.0731,"size":9.3573,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ATL3, ATP1B3, BCAP31, ERGIC1, ESYT2, LMAN2, RAB2A, RPN2, RRBP1, RTN4, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.24e-07)<br>Proximal tubule bicarbonate reclamation (p=2.15e-02)<br>Aldosterone-regulated sodium reabsorption (p=3.52e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.87e-08)<br>endoplasmic reticulum organization (p=5.40e-07) <br> <b>MF:<\/b><br>hexosyltransferase activity (p=8.03e-03)<br>UDP-glucosyltransferase activity (p=8.34e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.95e-13)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=6.35e-12)<\/div>"},{"id":"ATP2A2","label":"ATP2A2","x":1917.0339,"y":1297.041,"size":10.119,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"ATP5F1D","label":"ATP5F1D","x":2697.517,"y":1910.3682,"size":14.5785,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"AZGP1","label":"AZGP1","x":1243.6247,"y":1603.4773,"size":11.8837,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.948<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>ADAMTSL3, AHSG, APOL1, AZGP1, CFHR1, CKB, FTO, GSN, MASP2, RBP4, SVIL, TFG, TMOD1, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.26e-03)<br>African trypanosomiasis (p=3.06e-02)<br>Thyroid cancer (p=3.06e-02)<br><br><b>BP:<\/b><br>actin filament capping (p=3.19e-06)<br>negative regulation of actin filament depolymerization (p=4.27e-06) <br> <b>MF:<\/b><br>opsonin binding (p=1.09e-04)<br>complement binding (p=1.56e-04) <br> <b>CC:<\/b><br>blood microparticle (p=2.57e-06)<br>podosome (p=3.72e-04)<\/div>"},{"id":"BASP1","label":"BASP1","x":1977.0595,"y":1909.3584,"size":11.5737,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.706<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, AKAP12, BASP1, CD81, CLTB, CPNE1, CTNNB1, ESYT1, IRGQ, NDRG2, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=3.90e-04)<br>Hepatitis C (p=1.55e-03)<br>SNARE interactions in vesicular transport (p=1.37e-02)<br><br><b>BP:<\/b><br>midbrain development (p=1.37e-05)<br>mesenchymal to epithelial transition (p=4.33e-05) <br> <b>MF:<\/b><br>calmodulin binding (p=2.09e-04)<br>calcium-dependent phospholipid binding (p=4.29e-04) <br> <b>CC:<\/b><br>cell cortex (p=1.36e-05)<br>cell cortex region (p=1.34e-04)<\/div>"},{"id":"BCAP31","label":"BCAP31","x":3052.2454,"y":710.1496,"size":11.5842,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ATL3, ATP1B3, BCAP31, ERGIC1, ESYT2, LMAN2, RAB2A, RPN2, RRBP1, RTN4, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.24e-07)<br>Proximal tubule bicarbonate reclamation (p=2.15e-02)<br>Aldosterone-regulated sodium reabsorption (p=3.52e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.87e-08)<br>endoplasmic reticulum organization (p=5.40e-07) <br> <b>MF:<\/b><br>hexosyltransferase activity (p=8.03e-03)<br>UDP-glucosyltransferase activity (p=8.34e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.95e-13)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=6.35e-12)<\/div>"},{"id":"BGN","label":"BGN","x":848.3453,"y":2338.4504,"size":11.8971,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"BLMH","label":"BLMH","x":861.8561,"y":285.7703,"size":5,"color":"#E78AC3","shape":"triangle","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"BST2","label":"BST2","x":614.8677,"y":2270.1738,"size":12.6571,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"BUB3","label":"BUB3","x":2730.5206,"y":1059.8035,"size":11.8971,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"CAVIN1","label":"CAVIN1","x":1488.742,"y":2462.4244,"size":9.2907,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"CCT2","label":"CCT2","x":2791.612,"y":1063.6278,"size":9.2907,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"CCT7","label":"CCT7","x":2586.0277,"y":1055.8556,"size":9.4575,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"CCT8","label":"CCT8","x":2740.7346,"y":1263.6472,"size":11.6568,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"CD14","label":"CD14","x":460.6114,"y":2468.0309,"size":11.8971,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"CD59","label":"CD59","x":1235.2192,"y":158.4402,"size":12.1477,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"CD74","label":"CD74","x":1405.7978,"y":2338.0087,"size":12.676,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"CD81","label":"CD81","x":2196.2131,"y":1958.7114,"size":10.0581,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.706<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, AKAP12, BASP1, CD81, CLTB, CPNE1, CTNNB1, ESYT1, IRGQ, NDRG2, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=3.90e-04)<br>Hepatitis C (p=1.55e-03)<br>SNARE interactions in vesicular transport (p=1.37e-02)<br><br><b>BP:<\/b><br>midbrain development (p=1.37e-05)<br>mesenchymal to epithelial transition (p=4.33e-05) <br> <b>MF:<\/b><br>calmodulin binding (p=2.09e-04)<br>calcium-dependent phospholipid binding (p=4.29e-04) <br> <b>CC:<\/b><br>cell cortex (p=1.36e-05)<br>cell cortex region (p=1.34e-04)<\/div>"},{"id":"CDH13","label":"CDH13","x":1193.946,"y":148.2558,"size":9.8369,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"CFHR1","label":"CFHR1","x":1270.7911,"y":1625.5682,"size":9.6291,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.948<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>ADAMTSL3, AHSG, APOL1, AZGP1, CFHR1, CKB, FTO, GSN, MASP2, RBP4, SVIL, TFG, TMOD1, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.26e-03)<br>African trypanosomiasis (p=3.06e-02)<br>Thyroid cancer (p=3.06e-02)<br><br><b>BP:<\/b><br>actin filament capping (p=3.19e-06)<br>negative regulation of actin filament depolymerization (p=4.27e-06) <br> <b>MF:<\/b><br>opsonin binding (p=1.09e-04)<br>complement binding (p=1.56e-04) <br> <b>CC:<\/b><br>blood microparticle (p=2.57e-06)<br>podosome (p=3.72e-04)<\/div>"},{"id":"CKB","label":"CKB","x":1423.3188,"y":1621.9694,"size":12.1477,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.948<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>ADAMTSL3, AHSG, APOL1, AZGP1, CFHR1, CKB, FTO, GSN, MASP2, RBP4, SVIL, TFG, TMOD1, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.26e-03)<br>African trypanosomiasis (p=3.06e-02)<br>Thyroid cancer (p=3.06e-02)<br><br><b>BP:<\/b><br>actin filament capping (p=3.19e-06)<br>negative regulation of actin filament depolymerization (p=4.27e-06) <br> <b>MF:<\/b><br>opsonin binding (p=1.09e-04)<br>complement binding (p=1.56e-04) <br> <b>CC:<\/b><br>blood microparticle (p=2.57e-06)<br>podosome (p=3.72e-04)<\/div>"},{"id":"CLTA","label":"CLTA","x":484.8256,"y":2373.9694,"size":11.2852,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"CLTB","label":"CLTB","x":2051.749,"y":1761.3017,"size":11.0331,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.706<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, AKAP12, BASP1, CD81, CLTB, CPNE1, CTNNB1, ESYT1, IRGQ, NDRG2, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=3.90e-04)<br>Hepatitis C (p=1.55e-03)<br>SNARE interactions in vesicular transport (p=1.37e-02)<br><br><b>BP:<\/b><br>midbrain development (p=1.37e-05)<br>mesenchymal to epithelial transition (p=4.33e-05) <br> <b>MF:<\/b><br>calmodulin binding (p=2.09e-04)<br>calcium-dependent phospholipid binding (p=4.29e-04) <br> <b>CC:<\/b><br>cell cortex (p=1.36e-05)<br>cell cortex region (p=1.34e-04)<\/div>"},{"id":"CLTC","label":"CLTC","x":1041.733,"y":2482.7612,"size":11.5965,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"CMAS","label":"CMAS","x":767.3132,"y":609.6619,"size":14.6205,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"CNP","label":"CNP","x":644.3484,"y":2326.1273,"size":9.7529,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"COL12A1","label":"COL12A1","x":1230.9959,"y":2374.3044,"size":11.9192,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"COL6A1","label":"COL6A1","x":1055.1756,"y":479.582,"size":9.4575,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"COL6A2","label":"COL6A2","x":303.1571,"y":2418.9245,"size":11.3857,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"COMP","label":"COMP","x":2110.2671,"y":819.3791,"size":11.6568,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"COPS6","label":"COPS6","x":2375.9317,"y":1036.5448,"size":16.9158,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.848<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GNA13, PDLIM5, PSMA4, PSMA6, PSMB1, RPL14, SCCPDH, TMX4, TXNL1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Spinocerebellar ataxia (p=1.67e-06)<br>Proteasome (p=3.60e-06)<br>Parkinson disease (p=2.07e-05)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=1.60e-03)<br>regulation of postsynapse organization (p=2.66e-03) <br> <b>MF:<\/b><br>disulfide oxidoreductase activity (p=2.92e-04)<br>oxidoreductase activity, acting on a sulfur group of donors (p=5.34e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.74e-08)<br>proteasome core complex (p=1.90e-07)<\/div>"},{"id":"COX4I1","label":"COX4I1","x":2062.8365,"y":989.8692,"size":9.9873,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"CPNE1","label":"CPNE1","x":2231.4414,"y":2010.6623,"size":9.3456,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.706<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, AKAP12, BASP1, CD81, CLTB, CPNE1, CTNNB1, ESYT1, IRGQ, NDRG2, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=3.90e-04)<br>Hepatitis C (p=1.55e-03)<br>SNARE interactions in vesicular transport (p=1.37e-02)<br><br><b>BP:<\/b><br>midbrain development (p=1.37e-05)<br>mesenchymal to epithelial transition (p=4.33e-05) <br> <b>MF:<\/b><br>calmodulin binding (p=2.09e-04)<br>calcium-dependent phospholipid binding (p=4.29e-04) <br> <b>CC:<\/b><br>cell cortex (p=1.36e-05)<br>cell cortex region (p=1.34e-04)<\/div>"},{"id":"CPNE3","label":"CPNE3","x":1167.2996,"y":121.2163,"size":13.2493,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"CSRP2","label":"CSRP2","x":2248.6794,"y":1609.6352,"size":9.3418,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"CTNNB1","label":"CTNNB1","x":2152.2652,"y":1894.927,"size":11.1161,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.706<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, AKAP12, BASP1, CD81, CLTB, CPNE1, CTNNB1, ESYT1, IRGQ, NDRG2, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=3.90e-04)<br>Hepatitis C (p=1.55e-03)<br>SNARE interactions in vesicular transport (p=1.37e-02)<br><br><b>BP:<\/b><br>midbrain development (p=1.37e-05)<br>mesenchymal to epithelial transition (p=4.33e-05) <br> <b>MF:<\/b><br>calmodulin binding (p=2.09e-04)<br>calcium-dependent phospholipid binding (p=4.29e-04) <br> <b>CC:<\/b><br>cell cortex (p=1.36e-05)<br>cell cortex region (p=1.34e-04)<\/div>"},{"id":"CTNND1","label":"CTNND1","x":1817.2416,"y":1432.048,"size":17.5177,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"CTSB","label":"CTSB","x":981.3913,"y":419.4185,"size":9.3318,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"CTTN","label":"CTTN","x":513.0454,"y":2385.266,"size":11.8971,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"CYB5B","label":"CYB5B","x":235.8402,"y":2215.5917,"size":9.8055,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"CYB5R3","label":"CYB5R3","x":599.4342,"y":2406.2496,"size":15.4563,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"DCD","label":"DCD","x":1981.6214,"y":1358.3428,"size":12.621,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"DCXR","label":"DCXR","x":2923.4404,"y":2095.4518,"size":10.5463,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"DDOST","label":"DDOST","x":1590.8053,"y":847.6941,"size":14.8444,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"DDX17","label":"DDX17","x":1851.1753,"y":2051.2608,"size":9.6428,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"DDX3X","label":"DDX3X","x":2640.7296,"y":1208.7228,"size":11.857,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"DES","label":"DES","x":639.9432,"y":2483.3724,"size":13.4832,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"DHX9","label":"DHX9","x":2830.9671,"y":1061.4364,"size":9.6693,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"DLGAP4","label":"DLGAP4","x":1911.4053,"y":1451.7083,"size":13.108,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"DMD","label":"DMD","x":249.1894,"y":2527.3645,"size":11.2374,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"DNM1L","label":"DNM1L","x":1624.3992,"y":824.4115,"size":11.8375,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"DPT","label":"DPT","x":832.4279,"y":2417.0854,"size":9.2907,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"DSP","label":"DSP","x":169.3746,"y":2599.9974,"size":12.9541,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"DYSF","label":"DYSF","x":243.8596,"y":2411.6243,"size":5,"color":"#4DAF4A","shape":"triangle","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"EEF1D","label":"EEF1D","x":2581.4621,"y":1204.7168,"size":9.6291,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"EEF1G","label":"EEF1G","x":2189.5859,"y":774.1889,"size":9.729,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"EFEMP1","label":"EFEMP1","x":249.8367,"y":2436.9065,"size":10.367,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"EFEMP2","label":"EFEMP2","x":1211.1899,"y":2346.0769,"size":11.1817,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"EFTUD2","label":"EFTUD2","x":2100.9184,"y":1181.3021,"size":9.9104,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"EHD1","label":"EHD1","x":1208.005,"y":100,"size":16.8642,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"EHD3","label":"EHD3","x":1494.3381,"y":2490.2184,"size":9.4071,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"EIF2S1","label":"EIF2S1","x":2487.6342,"y":1746.6543,"size":9.96,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"EIF2S2","label":"EIF2S2","x":2433.5359,"y":938.0607,"size":9.2907,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.848<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GNA13, PDLIM5, PSMA4, PSMA6, PSMB1, RPL14, SCCPDH, TMX4, TXNL1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Spinocerebellar ataxia (p=1.67e-06)<br>Proteasome (p=3.60e-06)<br>Parkinson disease (p=2.07e-05)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=1.60e-03)<br>regulation of postsynapse organization (p=2.66e-03) <br> <b>MF:<\/b><br>disulfide oxidoreductase activity (p=2.92e-04)<br>oxidoreductase activity, acting on a sulfur group of donors (p=5.34e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.74e-08)<br>proteasome core complex (p=1.90e-07)<\/div>"},{"id":"EIF2S3","label":"EIF2S3","x":2121.8979,"y":1019.2003,"size":10.4665,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"EIF3B","label":"EIF3B","x":2344.5565,"y":1204.2753,"size":10.5651,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"EIF4H","label":"EIF4H","x":2218.9521,"y":1549.348,"size":9.8626,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"ELAVL1","label":"ELAVL1","x":2781.1665,"y":1235.6775,"size":10.0652,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"ENPP1","label":"ENPP1","x":1035.9767,"y":459.5853,"size":10.7182,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"ENTPD1","label":"ENTPD1","x":1309.3785,"y":650.9281,"size":9.5736,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"EOGT","label":"EOGT","x":2886.0091,"y":2092.3517,"size":16.7273,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"EPX","label":"EPX","x":883.9733,"y":394.3768,"size":9.2907,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"ERGIC1","label":"ERGIC1","x":3046.578,"y":775.4474,"size":11.7166,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ATL3, ATP1B3, BCAP31, ERGIC1, ESYT2, LMAN2, RAB2A, RPN2, RRBP1, RTN4, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.24e-07)<br>Proximal tubule bicarbonate reclamation (p=2.15e-02)<br>Aldosterone-regulated sodium reabsorption (p=3.52e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.87e-08)<br>endoplasmic reticulum organization (p=5.40e-07) <br> <b>MF:<\/b><br>hexosyltransferase activity (p=8.03e-03)<br>UDP-glucosyltransferase activity (p=8.34e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.95e-13)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=6.35e-12)<\/div>"},{"id":"ERLIN2","label":"ERLIN2","x":1883.9072,"y":1263.8751,"size":12.8351,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"ESYT1","label":"ESYT1","x":1955.2117,"y":1914.1091,"size":12.8731,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.706<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, AKAP12, BASP1, CD81, CLTB, CPNE1, CTNNB1, ESYT1, IRGQ, NDRG2, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=3.90e-04)<br>Hepatitis C (p=1.55e-03)<br>SNARE interactions in vesicular transport (p=1.37e-02)<br><br><b>BP:<\/b><br>midbrain development (p=1.37e-05)<br>mesenchymal to epithelial transition (p=4.33e-05) <br> <b>MF:<\/b><br>calmodulin binding (p=2.09e-04)<br>calcium-dependent phospholipid binding (p=4.29e-04) <br> <b>CC:<\/b><br>cell cortex (p=1.36e-05)<br>cell cortex region (p=1.34e-04)<\/div>"},{"id":"ESYT2","label":"ESYT2","x":3099.997,"y":719.5348,"size":16.6216,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ATL3, ATP1B3, BCAP31, ERGIC1, ESYT2, LMAN2, RAB2A, RPN2, RRBP1, RTN4, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.24e-07)<br>Proximal tubule bicarbonate reclamation (p=2.15e-02)<br>Aldosterone-regulated sodium reabsorption (p=3.52e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.87e-08)<br>endoplasmic reticulum organization (p=5.40e-07) <br> <b>MF:<\/b><br>hexosyltransferase activity (p=8.03e-03)<br>UDP-glucosyltransferase activity (p=8.34e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.95e-13)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=6.35e-12)<\/div>"},{"id":"ETF1","label":"ETF1","x":2714.127,"y":1222.3324,"size":11.9722,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"F10","label":"F10","x":1871.7277,"y":2039.2336,"size":11.1989,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"FAM114A1","label":"FAM114A1","x":1863.5043,"y":1365.9677,"size":9.5008,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"FARSB","label":"FARSB","x":2759.8391,"y":1929.4638,"size":9.8403,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"FBLN5","label":"FBLN5","x":812.3053,"y":2410.4732,"size":12.2792,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"FCER1G","label":"FCER1G","x":925.553,"y":406.7954,"size":5,"color":"#E78AC3","shape":"triangle","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"FERMT2","label":"FERMT2","x":1450.8948,"y":1743.8261,"size":10.7699,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"FGL2","label":"FGL2","x":1395.7274,"y":2371.7035,"size":11.7354,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"FHL1","label":"FHL1","x":1227.994,"y":610.2232,"size":9.235,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"FLNC","label":"FLNC","x":1132.2096,"y":544.977,"size":9.872,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"FLOT1","label":"FLOT1","x":152.3437,"y":2589.815,"size":9.9873,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"FN1","label":"FN1","x":314.8641,"y":2482.804,"size":10.8082,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"FN3K","label":"FN3K","x":419.2054,"y":2400.8847,"size":15.0122,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"FOXRED1","label":"FOXRED1","x":2892.7258,"y":2063.9832,"size":5,"color":"#999999","shape":"triangle","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"FTO","label":"FTO","x":1159.5703,"y":1646.5686,"size":5,"color":"#A65628","shape":"triangle","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.948<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>ADAMTSL3, AHSG, APOL1, AZGP1, CFHR1, CKB, FTO, GSN, MASP2, RBP4, SVIL, TFG, TMOD1, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.26e-03)<br>African trypanosomiasis (p=3.06e-02)<br>Thyroid cancer (p=3.06e-02)<br><br><b>BP:<\/b><br>actin filament capping (p=3.19e-06)<br>negative regulation of actin filament depolymerization (p=4.27e-06) <br> <b>MF:<\/b><br>opsonin binding (p=1.09e-04)<br>complement binding (p=1.56e-04) <br> <b>CC:<\/b><br>blood microparticle (p=2.57e-06)<br>podosome (p=3.72e-04)<\/div>"},{"id":"G6PD","label":"G6PD","x":2157.6598,"y":696.6223,"size":10.1741,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"GALM","label":"GALM","x":2175.6316,"y":664.6221,"size":10.5577,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"GALNT2","label":"GALNT2","x":2682.6936,"y":876.4197,"size":9.5477,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"GC","label":"GC","x":1238.4829,"y":222.9903,"size":13.7822,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"GLG1","label":"GLG1","x":2949.3144,"y":2059.0457,"size":11.7046,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"GMPR2","label":"GMPR2","x":2851.8787,"y":1954.2217,"size":12.9567,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"GNA13","label":"GNA13","x":2294.7404,"y":1061.9728,"size":13.9168,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.848<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GNA13, PDLIM5, PSMA4, PSMA6, PSMB1, RPL14, SCCPDH, TMX4, TXNL1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Spinocerebellar ataxia (p=1.67e-06)<br>Proteasome (p=3.60e-06)<br>Parkinson disease (p=2.07e-05)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=1.60e-03)<br>regulation of postsynapse organization (p=2.66e-03) <br> <b>MF:<\/b><br>disulfide oxidoreductase activity (p=2.92e-04)<br>oxidoreductase activity, acting on a sulfur group of donors (p=5.34e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.74e-08)<br>proteasome core complex (p=1.90e-07)<\/div>"},{"id":"GNAS","label":"GNAS","x":2249.8138,"y":1559.1917,"size":9.2907,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"GNB2","label":"GNB2","x":2090.2094,"y":1470.8528,"size":17.8987,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"GNB4","label":"GNB4","x":1396.833,"y":2315.349,"size":13.4183,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"GNG12","label":"GNG12","x":2774.6375,"y":1279.4378,"size":9.8071,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"GRB2","label":"GRB2","x":619.5628,"y":2479.9869,"size":18.0661,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"GSN","label":"GSN","x":1303.9356,"y":1628.1792,"size":12.1477,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.948<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>ADAMTSL3, AHSG, APOL1, AZGP1, CFHR1, CKB, FTO, GSN, MASP2, RBP4, SVIL, TFG, TMOD1, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.26e-03)<br>African trypanosomiasis (p=3.06e-02)<br>Thyroid cancer (p=3.06e-02)<br><br><b>BP:<\/b><br>actin filament capping (p=3.19e-06)<br>negative regulation of actin filament depolymerization (p=4.27e-06) <br> <b>MF:<\/b><br>opsonin binding (p=1.09e-04)<br>complement binding (p=1.56e-04) <br> <b>CC:<\/b><br>blood microparticle (p=2.57e-06)<br>podosome (p=3.72e-04)<\/div>"},{"id":"GSS","label":"GSS","x":2262.8362,"y":670.0993,"size":10.2075,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"GYS1","label":"GYS1","x":2145.0717,"y":660.9957,"size":17.7076,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"H1-0","label":"H1-0","x":649.8103,"y":2396.2649,"size":9.4575,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"HAAO","label":"HAAO","x":2681.6828,"y":2037.2635,"size":15.5302,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"HADHA","label":"HADHA","x":1811.5601,"y":1304.098,"size":10.1609,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.745<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT9, ALDH16A1, HADHA, HSD17B12, IDH3B, MTHFD1, MVP, PRDX3, SLC25A11, TPI1, TYMP, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Fatty acid elongation (p=1.72e-04)<br>Fatty acid metabolism (p=7.19e-04)<br>Biosynthesis of amino acids (p=1.24e-03)<br><br><b>BP:<\/b><br>NADH metabolic process (p=2.40e-04)<br>sulfur compound metabolic process (p=7.89e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=5.77e-05)<br>oxidoreductase activity, acting on CH-OH group of donors (p=7.29e-05) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.69e-03)<br>tricarboxylic acid cycle heteromeric enzyme complex (p=1.02e-02)<\/div>"},{"id":"HADHB","label":"HADHB","x":1629.1472,"y":872.8417,"size":9.9967,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"HBG2","label":"HBG2","x":581.1179,"y":2430.0218,"size":9.2907,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"HDGF","label":"HDGF","x":2104.9141,"y":704.7996,"size":11.6568,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"HEBP2","label":"HEBP2","x":1911.8721,"y":2081.8662,"size":10.8393,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"HLA-DRB1","label":"HLA-DRB1","x":1478.8245,"y":1687.3475,"size":9.8055,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"HNRNPH1","label":"HNRNPH1","x":1205.8562,"y":676.0534,"size":13.9174,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"HNRNPH3","label":"HNRNPH3","x":2278.0018,"y":1158.8057,"size":10.0491,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"HNRNPM","label":"HNRNPM","x":2777.0305,"y":1805.8211,"size":12.1746,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"HNRNPR","label":"HNRNPR","x":2079.0924,"y":1374.7523,"size":9.3231,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"HP","label":"HP","x":1231.1734,"y":180.0401,"size":10.7699,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"HSD17B10","label":"HSD17B10","x":202.4461,"y":2214.3229,"size":9.8987,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"HSD17B12","label":"HSD17B12","x":1760.7293,"y":1275.7595,"size":9.7325,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.745<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT9, ALDH16A1, HADHA, HSD17B12, IDH3B, MTHFD1, MVP, PRDX3, SLC25A11, TPI1, TYMP, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Fatty acid elongation (p=1.72e-04)<br>Fatty acid metabolism (p=7.19e-04)<br>Biosynthesis of amino acids (p=1.24e-03)<br><br><b>BP:<\/b><br>NADH metabolic process (p=2.40e-04)<br>sulfur compound metabolic process (p=7.89e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=5.77e-05)<br>oxidoreductase activity, acting on CH-OH group of donors (p=7.29e-05) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.69e-03)<br>tricarboxylic acid cycle heteromeric enzyme complex (p=1.02e-02)<\/div>"},{"id":"HSD17B4","label":"HSD17B4","x":100,"y":2209.5522,"size":17.828,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"HSDL2","label":"HSDL2","x":273.7913,"y":2222.0903,"size":13.651,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"HSPA12A","label":"HSPA12A","x":2698.7115,"y":955.4242,"size":10.7699,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"HSPA5","label":"HSPA5","x":1279.7455,"y":384.5353,"size":10.1741,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"HSPD1","label":"HSPD1","x":2591.293,"y":1838.445,"size":10.7021,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"IDH3B","label":"IDH3B","x":1788.366,"y":1281.5788,"size":9.4575,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.745<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT9, ALDH16A1, HADHA, HSD17B12, IDH3B, MTHFD1, MVP, PRDX3, SLC25A11, TPI1, TYMP, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Fatty acid elongation (p=1.72e-04)<br>Fatty acid metabolism (p=7.19e-04)<br>Biosynthesis of amino acids (p=1.24e-03)<br><br><b>BP:<\/b><br>NADH metabolic process (p=2.40e-04)<br>sulfur compound metabolic process (p=7.89e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=5.77e-05)<br>oxidoreductase activity, acting on CH-OH group of donors (p=7.29e-05) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.69e-03)<br>tricarboxylic acid cycle heteromeric enzyme complex (p=1.02e-02)<\/div>"},{"id":"IGFBP6","label":"IGFBP6","x":1310.8602,"y":311.1069,"size":10.3928,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"IGLL5","label":"IGLL5","x":627.7651,"y":2372.7207,"size":9.2907,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"ILK","label":"ILK","x":1449.8508,"y":2357.4837,"size":10.0714,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"IRGQ","label":"IRGQ","x":2252.9039,"y":2044.833,"size":12.4732,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.706<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, AKAP12, BASP1, CD81, CLTB, CPNE1, CTNNB1, ESYT1, IRGQ, NDRG2, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=3.90e-04)<br>Hepatitis C (p=1.55e-03)<br>SNARE interactions in vesicular transport (p=1.37e-02)<br><br><b>BP:<\/b><br>midbrain development (p=1.37e-05)<br>mesenchymal to epithelial transition (p=4.33e-05) <br> <b>MF:<\/b><br>calmodulin binding (p=2.09e-04)<br>calcium-dependent phospholipid binding (p=4.29e-04) <br> <b>CC:<\/b><br>cell cortex (p=1.36e-05)<br>cell cortex region (p=1.34e-04)<\/div>"},{"id":"ISLR","label":"ISLR","x":825.499,"y":2346.8021,"size":10.5651,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"IVD","label":"IVD","x":142.9696,"y":2210.6486,"size":11.7409,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"KANK2","label":"KANK2","x":1443.2188,"y":1766.5942,"size":9.6291,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"L3HYPDH","label":"L3HYPDH","x":2642.7687,"y":1952.9778,"size":9.8469,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"LAMA2","label":"LAMA2","x":833.1457,"y":2383.9647,"size":14.1969,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"LAMA4","label":"LAMA4","x":1040.6343,"y":2337.4981,"size":10.831,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"LAMP1","label":"LAMP1","x":1217.6561,"y":133.9791,"size":11.1861,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"LDB3","label":"LDB3","x":1044.7588,"y":2423.737,"size":10.7098,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"LGALS1","label":"LGALS1","x":1006.0041,"y":2412.9647,"size":10.9853,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"LHPP","label":"LHPP","x":2722.9313,"y":1920.6156,"size":15.3059,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"LIMS2","label":"LIMS2","x":1424.8718,"y":1785.9301,"size":10.1741,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"LMAN2","label":"LMAN2","x":3016.196,"y":787.7382,"size":9.6458,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ATL3, ATP1B3, BCAP31, ERGIC1, ESYT2, LMAN2, RAB2A, RPN2, RRBP1, RTN4, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.24e-07)<br>Proximal tubule bicarbonate reclamation (p=2.15e-02)<br>Aldosterone-regulated sodium reabsorption (p=3.52e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.87e-08)<br>endoplasmic reticulum organization (p=5.40e-07) <br> <b>MF:<\/b><br>hexosyltransferase activity (p=8.03e-03)<br>UDP-glucosyltransferase activity (p=8.34e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.95e-13)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=6.35e-12)<\/div>"},{"id":"LRG1","label":"LRG1","x":2087.6105,"y":790.9668,"size":9.6291,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"LRRC59","label":"LRRC59","x":2121.7771,"y":777.9002,"size":11.4144,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"LRRFIP1","label":"LRRFIP1","x":1860.1865,"y":1238.3321,"size":16.8488,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"LSS","label":"LSS","x":1539.1663,"y":803.0148,"size":13.7571,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"LTBP2","label":"LTBP2","x":1575.2588,"y":2257.4484,"size":9.704,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"M6PR","label":"M6PR","x":943.3131,"y":390.7226,"size":10.5214,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"MAMDC2","label":"MAMDC2","x":1645.6364,"y":2286.0829,"size":12.818,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"MAN2C1","label":"MAN2C1","x":2858.6527,"y":2062.9511,"size":5,"color":"#999999","shape":"triangle","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"MAPK1","label":"MAPK1","x":1680.6323,"y":1525.0095,"size":12.1477,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"MARCKS","label":"MARCKS","x":1335.0584,"y":649.0888,"size":11.8971,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"MASP2","label":"MASP2","x":1183.5349,"y":1648.1272,"size":11.0021,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.948<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>ADAMTSL3, AHSG, APOL1, AZGP1, CFHR1, CKB, FTO, GSN, MASP2, RBP4, SVIL, TFG, TMOD1, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.26e-03)<br>African trypanosomiasis (p=3.06e-02)<br>Thyroid cancer (p=3.06e-02)<br><br><b>BP:<\/b><br>actin filament capping (p=3.19e-06)<br>negative regulation of actin filament depolymerization (p=4.27e-06) <br> <b>MF:<\/b><br>opsonin binding (p=1.09e-04)<br>complement binding (p=1.56e-04) <br> <b>CC:<\/b><br>blood microparticle (p=2.57e-06)<br>podosome (p=3.72e-04)<\/div>"},{"id":"MFAP4","label":"MFAP4","x":271.0523,"y":2416.4384,"size":9.8812,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"MMP2","label":"MMP2","x":1545.6891,"y":1616.2997,"size":9.4335,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"MOGS","label":"MOGS","x":2163.0227,"y":837.8484,"size":11.1989,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"MRGPRF","label":"MRGPRF","x":1621.8595,"y":2258.0462,"size":5,"color":"#FFD92F","shape":"triangle","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"MTHFD1","label":"MTHFD1","x":1667.7732,"y":1266.7702,"size":10.6772,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.745<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT9, ALDH16A1, HADHA, HSD17B12, IDH3B, MTHFD1, MVP, PRDX3, SLC25A11, TPI1, TYMP, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Fatty acid elongation (p=1.72e-04)<br>Fatty acid metabolism (p=7.19e-04)<br>Biosynthesis of amino acids (p=1.24e-03)<br><br><b>BP:<\/b><br>NADH metabolic process (p=2.40e-04)<br>sulfur compound metabolic process (p=7.89e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=5.77e-05)<br>oxidoreductase activity, acting on CH-OH group of donors (p=7.29e-05) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.69e-03)<br>tricarboxylic acid cycle heteromeric enzyme complex (p=1.02e-02)<\/div>"},{"id":"MVP","label":"MVP","x":1584.7941,"y":1261.2544,"size":11.2093,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.745<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT9, ALDH16A1, HADHA, HSD17B12, IDH3B, MTHFD1, MVP, PRDX3, SLC25A11, TPI1, TYMP, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Fatty acid elongation (p=1.72e-04)<br>Fatty acid metabolism (p=7.19e-04)<br>Biosynthesis of amino acids (p=1.24e-03)<br><br><b>BP:<\/b><br>NADH metabolic process (p=2.40e-04)<br>sulfur compound metabolic process (p=7.89e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=5.77e-05)<br>oxidoreductase activity, acting on CH-OH group of donors (p=7.29e-05) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.69e-03)<br>tricarboxylic acid cycle heteromeric enzyme complex (p=1.02e-02)<\/div>"},{"id":"NAE1","label":"NAE1","x":2018.129,"y":943.1708,"size":9.4097,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"NCL","label":"NCL","x":2498.3076,"y":1803.1348,"size":11.4238,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"NDRG2","label":"NDRG2","x":2168.459,"y":1923.3755,"size":9.6291,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.706<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, AKAP12, BASP1, CD81, CLTB, CPNE1, CTNNB1, ESYT1, IRGQ, NDRG2, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=3.90e-04)<br>Hepatitis C (p=1.55e-03)<br>SNARE interactions in vesicular transport (p=1.37e-02)<br><br><b>BP:<\/b><br>midbrain development (p=1.37e-05)<br>mesenchymal to epithelial transition (p=4.33e-05) <br> <b>MF:<\/b><br>calmodulin binding (p=2.09e-04)<br>calcium-dependent phospholipid binding (p=4.29e-04) <br> <b>CC:<\/b><br>cell cortex (p=1.36e-05)<br>cell cortex region (p=1.34e-04)<\/div>"},{"id":"NDUFS2","label":"NDUFS2","x":2075.6529,"y":1164.7833,"size":11.8478,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"NEGR1","label":"NEGR1","x":597.9561,"y":2280.4264,"size":9.3671,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"NID1","label":"NID1","x":1230.7898,"y":2419.1537,"size":11.3033,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"NME1","label":"NME1","x":1293.5372,"y":363.03,"size":9.8253,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"NME3","label":"NME3","x":2608.2689,"y":1225.5674,"size":15.3643,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"NNMT","label":"NNMT","x":1533.6079,"y":1755.8219,"size":12.2792,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"NNT","label":"NNT","x":2162.2891,"y":653.5616,"size":9.2907,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"NPNT","label":"NPNT","x":2531.422,"y":1881.1584,"size":12.5386,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"NSF","label":"NSF","x":914.1702,"y":371.5736,"size":11.1042,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"NTN1","label":"NTN1","x":449.8509,"y":2453.279,"size":10.0368,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"NUDC","label":"NUDC","x":2661.4486,"y":1775.2884,"size":9.5123,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"OGDH","label":"OGDH","x":2720.0238,"y":1940.6618,"size":12.406,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"P4HB","label":"P4HB","x":2143.5266,"y":856.9175,"size":10.5651,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"PAPPA","label":"PAPPA","x":1299.912,"y":343.9757,"size":5,"color":"#984EA3","shape":"triangle","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"PARP1","label":"PARP1","x":1099.7026,"y":668.6469,"size":14.6901,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"PCBP2","label":"PCBP2","x":2536.851,"y":1739.2069,"size":10.6782,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"PCYOX1","label":"PCYOX1","x":1999.314,"y":1378.7923,"size":10.1741,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"PDCD6","label":"PDCD6","x":1960.9202,"y":1313.0283,"size":17.7755,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"PDHB","label":"PDHB","x":2069.094,"y":957.0096,"size":12.4343,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"PDLIM5","label":"PDLIM5","x":2274.2692,"y":1051.5342,"size":11.1766,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.848<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GNA13, PDLIM5, PSMA4, PSMA6, PSMB1, RPL14, SCCPDH, TMX4, TXNL1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Spinocerebellar ataxia (p=1.67e-06)<br>Proteasome (p=3.60e-06)<br>Parkinson disease (p=2.07e-05)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=1.60e-03)<br>regulation of postsynapse organization (p=2.66e-03) <br> <b>MF:<\/b><br>disulfide oxidoreductase activity (p=2.92e-04)<br>oxidoreductase activity, acting on a sulfur group of donors (p=5.34e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.74e-08)<br>proteasome core complex (p=1.90e-07)<\/div>"},{"id":"PDLIM7","label":"PDLIM7","x":1012.7017,"y":2434.2148,"size":13.6593,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"PEBP1","label":"PEBP1","x":2580.9654,"y":1175.6902,"size":11.6568,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"PFN1","label":"PFN1","x":556.0228,"y":2296.1449,"size":11.0603,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"PFN2","label":"PFN2","x":1816.1266,"y":1398.3245,"size":10.5651,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"PHGDH","label":"PHGDH","x":2512.7108,"y":1856.4732,"size":11.8139,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"PIPOX","label":"PIPOX","x":2664.4137,"y":2001.3832,"size":5,"color":"#999999","shape":"triangle","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"PLEC","label":"PLEC","x":1032.3141,"y":2401.1255,"size":9.4769,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"PLIN3","label":"PLIN3","x":1891.2767,"y":2054.1893,"size":9.6498,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"PLP1","label":"PLP1","x":2940.7327,"y":1059.954,"size":9.4575,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"PLPBP","label":"PLPBP","x":2522.2268,"y":1901.4127,"size":12.1863,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"POSTN","label":"POSTN","x":1893.3338,"y":1359.8706,"size":9.7375,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"PPME1","label":"PPME1","x":2693.8,"y":1782.8131,"size":11.4647,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"PPP1CB","label":"PPP1CB","x":1294.0339,"y":475.6145,"size":9.6331,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"PPP1R14A","label":"PPP1R14A","x":1453.0629,"y":2388.61,"size":9.8293,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"PPP2CB","label":"PPP2CB","x":2878.6261,"y":1255.7041,"size":11.9728,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"PRDX3","label":"PRDX3","x":1776.5399,"y":1318.4884,"size":10.1715,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.745<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT9, ALDH16A1, HADHA, HSD17B12, IDH3B, MTHFD1, MVP, PRDX3, SLC25A11, TPI1, TYMP, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Fatty acid elongation (p=1.72e-04)<br>Fatty acid metabolism (p=7.19e-04)<br>Biosynthesis of amino acids (p=1.24e-03)<br><br><b>BP:<\/b><br>NADH metabolic process (p=2.40e-04)<br>sulfur compound metabolic process (p=7.89e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=5.77e-05)<br>oxidoreductase activity, acting on CH-OH group of donors (p=7.29e-05) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.69e-03)<br>tricarboxylic acid cycle heteromeric enzyme complex (p=1.02e-02)<\/div>"},{"id":"PREP","label":"PREP","x":936.7329,"y":362.7358,"size":14.4759,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"PRKACB","label":"PRKACB","x":2094.6646,"y":541.0953,"size":9.3225,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"PRKAG1","label":"PRKAG1","x":2256.3559,"y":655.5707,"size":14.2139,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"PRNP","label":"PRNP","x":1609.0423,"y":795.3971,"size":11.8971,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"PRPF8","label":"PRPF8","x":2313.2936,"y":1182.5029,"size":9.2501,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"PRPH","label":"PRPH","x":1753.9271,"y":2152.033,"size":9.6291,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"PSMA1","label":"PSMA1","x":2511.1024,"y":998.4977,"size":9.2435,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"PSMA2","label":"PSMA2","x":2838.2467,"y":1247.9311,"size":9.5995,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"PSMA4","label":"PSMA4","x":2424.0965,"y":968.8743,"size":10.9754,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.848<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GNA13, PDLIM5, PSMA4, PSMA6, PSMB1, RPL14, SCCPDH, TMX4, TXNL1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Spinocerebellar ataxia (p=1.67e-06)<br>Proteasome (p=3.60e-06)<br>Parkinson disease (p=2.07e-05)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=1.60e-03)<br>regulation of postsynapse organization (p=2.66e-03) <br> <b>MF:<\/b><br>disulfide oxidoreductase activity (p=2.92e-04)<br>oxidoreductase activity, acting on a sulfur group of donors (p=5.34e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.74e-08)<br>proteasome core complex (p=1.90e-07)<\/div>"},{"id":"PSMA6","label":"PSMA6","x":2228.2299,"y":1108.8992,"size":13.2493,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.848<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GNA13, PDLIM5, PSMA4, PSMA6, PSMB1, RPL14, SCCPDH, TMX4, TXNL1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Spinocerebellar ataxia (p=1.67e-06)<br>Proteasome (p=3.60e-06)<br>Parkinson disease (p=2.07e-05)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=1.60e-03)<br>regulation of postsynapse organization (p=2.66e-03) <br> <b>MF:<\/b><br>disulfide oxidoreductase activity (p=2.92e-04)<br>oxidoreductase activity, acting on a sulfur group of donors (p=5.34e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.74e-08)<br>proteasome core complex (p=1.90e-07)<\/div>"},{"id":"PSMA7","label":"PSMA7","x":2102.8082,"y":1204.5445,"size":10.0512,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"PSMB1","label":"PSMB1","x":2401.347,"y":1018.8127,"size":9.7156,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.848<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GNA13, PDLIM5, PSMA4, PSMA6, PSMB1, RPL14, SCCPDH, TMX4, TXNL1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Spinocerebellar ataxia (p=1.67e-06)<br>Proteasome (p=3.60e-06)<br>Parkinson disease (p=2.07e-05)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=1.60e-03)<br>regulation of postsynapse organization (p=2.66e-03) <br> <b>MF:<\/b><br>disulfide oxidoreductase activity (p=2.92e-04)<br>oxidoreductase activity, acting on a sulfur group of donors (p=5.34e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.74e-08)<br>proteasome core complex (p=1.90e-07)<\/div>"},{"id":"PSMB2","label":"PSMB2","x":2573.7866,"y":1761.5126,"size":9.3351,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"PSMB5","label":"PSMB5","x":2607.3672,"y":1040.3851,"size":13.8305,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"PSMB7","label":"PSMB7","x":2352.0802,"y":1648.1825,"size":11.1344,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"PSMD11","label":"PSMD11","x":2782.2837,"y":1779.5736,"size":9.4575,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"PSMD3","label":"PSMD3","x":2623.232,"y":1055.7681,"size":10.7959,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"PSMD4","label":"PSMD4","x":2028.5881,"y":979.2284,"size":10.4108,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"PSMD5","label":"PSMD5","x":2369.8969,"y":1663.2613,"size":9.4575,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"PSMD6","label":"PSMD6","x":2498.564,"y":1766.9366,"size":10.7319,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"PTPN11","label":"PTPN11","x":477.0702,"y":2432.1685,"size":10.3034,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"PTX3","label":"PTX3","x":583.0947,"y":2330.062,"size":13.5519,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"PURA","label":"PURA","x":2483.0795,"y":1135.4691,"size":9.4445,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"PURB","label":"PURB","x":2502.6479,"y":1142.1751,"size":9.2907,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"PXDN","label":"PXDN","x":638.8434,"y":2448.2742,"size":12.1477,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"PYGB","label":"PYGB","x":1308.5264,"y":573.0986,"size":12.1682,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"PYGL","label":"PYGL","x":1478.3037,"y":775.8587,"size":9.4822,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"PYGM","label":"PYGM","x":1308.1651,"y":682.968,"size":12.5232,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"RAB2A","label":"RAB2A","x":2760.2747,"y":900.7026,"size":10.9599,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ATL3, ATP1B3, BCAP31, ERGIC1, ESYT2, LMAN2, RAB2A, RPN2, RRBP1, RTN4, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.24e-07)<br>Proximal tubule bicarbonate reclamation (p=2.15e-02)<br>Aldosterone-regulated sodium reabsorption (p=3.52e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.87e-08)<br>endoplasmic reticulum organization (p=5.40e-07) <br> <b>MF:<\/b><br>hexosyltransferase activity (p=8.03e-03)<br>UDP-glucosyltransferase activity (p=8.34e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.95e-13)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=6.35e-12)<\/div>"},{"id":"RAB5B","label":"RAB5B","x":2729.414,"y":859.7436,"size":9.5374,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"RAB8B","label":"RAB8B","x":1936.098,"y":1381.3768,"size":13.4136,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"RAD23B","label":"RAD23B","x":2369.5599,"y":1221.4871,"size":11.0412,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"RAN","label":"RAN","x":2550.0359,"y":1174.5575,"size":9.8614,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"RANBP1","label":"RANBP1","x":1170.7798,"y":663.014,"size":10.2198,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"RAP1A","label":"RAP1A","x":1847.3171,"y":1383.8203,"size":10.4121,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"RARRES2","label":"RARRES2","x":1659.3966,"y":2363.2664,"size":11.8656,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"RARS1","label":"RARS1","x":2071.7311,"y":1197.678,"size":9.488,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"RBP4","label":"RBP4","x":1287.1634,"y":1605.0307,"size":10.9807,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.948<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>ADAMTSL3, AHSG, APOL1, AZGP1, CFHR1, CKB, FTO, GSN, MASP2, RBP4, SVIL, TFG, TMOD1, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.26e-03)<br>African trypanosomiasis (p=3.06e-02)<br>Thyroid cancer (p=3.06e-02)<br><br><b>BP:<\/b><br>actin filament capping (p=3.19e-06)<br>negative regulation of actin filament depolymerization (p=4.27e-06) <br> <b>MF:<\/b><br>opsonin binding (p=1.09e-04)<br>complement binding (p=1.56e-04) <br> <b>CC:<\/b><br>blood microparticle (p=2.57e-06)<br>podosome (p=3.72e-04)<\/div>"},{"id":"RCN1","label":"RCN1","x":208.8147,"y":2451.066,"size":10.9807,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"RILPL1","label":"RILPL1","x":1920.8333,"y":1421.0172,"size":12.0309,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"RNPEP","label":"RNPEP","x":900.1815,"y":324.2034,"size":17.8775,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"RO60","label":"RO60","x":2615.9096,"y":1731.1287,"size":15.1957,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"RPL12","label":"RPL12","x":2737.7655,"y":1786.3636,"size":9.6291,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"RPL14","label":"RPL14","x":2454.4791,"y":949.1058,"size":10.268,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.848<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GNA13, PDLIM5, PSMA4, PSMA6, PSMB1, RPL14, SCCPDH, TMX4, TXNL1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Spinocerebellar ataxia (p=1.67e-06)<br>Proteasome (p=3.60e-06)<br>Parkinson disease (p=2.07e-05)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=1.60e-03)<br>regulation of postsynapse organization (p=2.66e-03) <br> <b>MF:<\/b><br>disulfide oxidoreductase activity (p=2.92e-04)<br>oxidoreductase activity, acting on a sulfur group of donors (p=5.34e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.74e-08)<br>proteasome core complex (p=1.90e-07)<\/div>"},{"id":"RPL18A","label":"RPL18A","x":2084.694,"y":1082.8306,"size":9.2907,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"RPL30","label":"RPL30","x":2085.7843,"y":1444.8056,"size":9.728,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"RPL8","label":"RPL8","x":2075.5208,"y":1186.6719,"size":11.9746,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"RPN1","label":"RPN1","x":2770.9101,"y":1791.5892,"size":10.3268,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"RPN2","label":"RPN2","x":3062.7905,"y":784.3984,"size":11.8322,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ATL3, ATP1B3, BCAP31, ERGIC1, ESYT2, LMAN2, RAB2A, RPN2, RRBP1, RTN4, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.24e-07)<br>Proximal tubule bicarbonate reclamation (p=2.15e-02)<br>Aldosterone-regulated sodium reabsorption (p=3.52e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.87e-08)<br>endoplasmic reticulum organization (p=5.40e-07) <br> <b>MF:<\/b><br>hexosyltransferase activity (p=8.03e-03)<br>UDP-glucosyltransferase activity (p=8.34e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.95e-13)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=6.35e-12)<\/div>"},{"id":"RPS10","label":"RPS10","x":2122.5108,"y":1392.451,"size":9.2765,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"RPS17","label":"RPS17","x":2051.7554,"y":1082.4588,"size":10.9807,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"RPS27L","label":"RPS27L","x":2233.8222,"y":1584.0957,"size":11.6568,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"RPS9","label":"RPS9","x":2054.061,"y":1031.572,"size":9.9279,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"RRBP1","label":"RRBP1","x":3016.5434,"y":750.2615,"size":10.9604,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ATL3, ATP1B3, BCAP31, ERGIC1, ESYT2, LMAN2, RAB2A, RPN2, RRBP1, RTN4, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.24e-07)<br>Proximal tubule bicarbonate reclamation (p=2.15e-02)<br>Aldosterone-regulated sodium reabsorption (p=3.52e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.87e-08)<br>endoplasmic reticulum organization (p=5.40e-07) <br> <b>MF:<\/b><br>hexosyltransferase activity (p=8.03e-03)<br>UDP-glucosyltransferase activity (p=8.34e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.95e-13)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=6.35e-12)<\/div>"},{"id":"RTN1","label":"RTN1","x":2693.2598,"y":933.5653,"size":5,"color":"#A6D854","shape":"triangle","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"RTN4","label":"RTN4","x":3077.9702,"y":683.624,"size":11.8665,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ATL3, ATP1B3, BCAP31, ERGIC1, ESYT2, LMAN2, RAB2A, RPN2, RRBP1, RTN4, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.24e-07)<br>Proximal tubule bicarbonate reclamation (p=2.15e-02)<br>Aldosterone-regulated sodium reabsorption (p=3.52e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.87e-08)<br>endoplasmic reticulum organization (p=5.40e-07) <br> <b>MF:<\/b><br>hexosyltransferase activity (p=8.03e-03)<br>UDP-glucosyltransferase activity (p=8.34e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.95e-13)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=6.35e-12)<\/div>"},{"id":"RTRAF","label":"RTRAF","x":2693.0664,"y":1239.3676,"size":9.4344,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"S100A11","label":"S100A11","x":1258.8552,"y":103.9188,"size":11.4623,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"S100A16","label":"S100A16","x":1505.2218,"y":1895.6597,"size":11.4233,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"S100A4","label":"S100A4","x":1514.5353,"y":1862.7581,"size":10.261,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"SCCPDH","label":"SCCPDH","x":2503.9542,"y":840.7878,"size":13.7268,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.848<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GNA13, PDLIM5, PSMA4, PSMA6, PSMB1, RPL14, SCCPDH, TMX4, TXNL1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Spinocerebellar ataxia (p=1.67e-06)<br>Proteasome (p=3.60e-06)<br>Parkinson disease (p=2.07e-05)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=1.60e-03)<br>regulation of postsynapse organization (p=2.66e-03) <br> <b>MF:<\/b><br>disulfide oxidoreductase activity (p=2.92e-04)<br>oxidoreductase activity, acting on a sulfur group of donors (p=5.34e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.74e-08)<br>proteasome core complex (p=1.90e-07)<\/div>"},{"id":"SDCBP","label":"SDCBP","x":1473.5823,"y":2413.4228,"size":12.6788,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"SEC13","label":"SEC13","x":2645.2523,"y":960.6001,"size":11.2062,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"SEC23A","label":"SEC23A","x":2180.0742,"y":821.5932,"size":12.438,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"SELENOP","label":"SELENOP","x":1385.2849,"y":1740.5843,"size":9.8055,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"SERPINA6","label":"SERPINA6","x":1247.1844,"y":249.1863,"size":9.8846,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"SERPINE1","label":"SERPINE1","x":1524.8744,"y":1814.2471,"size":9.6291,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"SERPINF2","label":"SERPINF2","x":1617.1944,"y":2280.9256,"size":10.367,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"SERPING1","label":"SERPING1","x":1542.912,"y":1713.728,"size":12.9541,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"SERPINH1","label":"SERPINH1","x":1720.5358,"y":2164.0655,"size":11.0668,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"SET","label":"SET","x":2923.2276,"y":1073.1756,"size":13.5519,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"SGCB","label":"SGCB","x":1228.6059,"y":2454.1515,"size":10.1939,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"SGCD","label":"SGCD","x":154.7372,"y":2573.4528,"size":11.3957,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"SH3BGRL","label":"SH3BGRL","x":832.6745,"y":257.1703,"size":11.6984,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"SH3GL1","label":"SH3GL1","x":1629.783,"y":794.0548,"size":13.796,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"SLC14A1","label":"SLC14A1","x":2730.4954,"y":912.9587,"size":14.5599,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"SLC25A11","label":"SLC25A11","x":1726.2424,"y":1253.7229,"size":11.7009,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.745<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT9, ALDH16A1, HADHA, HSD17B12, IDH3B, MTHFD1, MVP, PRDX3, SLC25A11, TPI1, TYMP, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Fatty acid elongation (p=1.72e-04)<br>Fatty acid metabolism (p=7.19e-04)<br>Biosynthesis of amino acids (p=1.24e-03)<br><br><b>BP:<\/b><br>NADH metabolic process (p=2.40e-04)<br>sulfur compound metabolic process (p=7.89e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=5.77e-05)<br>oxidoreductase activity, acting on CH-OH group of donors (p=7.29e-05) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.69e-03)<br>tricarboxylic acid cycle heteromeric enzyme complex (p=1.02e-02)<\/div>"},{"id":"SLC25A4","label":"SLC25A4","x":1264.636,"y":354.7852,"size":9.2698,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"SLC25A6","label":"SLC25A6","x":1742.0787,"y":2165.1141,"size":13.6221,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"SLC2A1","label":"SLC2A1","x":1292.7547,"y":537.5881,"size":9.4575,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"SLMAP","label":"SLMAP","x":1256.4818,"y":691.6215,"size":10.3093,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"SNRPD2","label":"SNRPD2","x":2581.5937,"y":1733.4123,"size":10.4396,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"SNTB1","label":"SNTB1","x":1083.9319,"y":531.7497,"size":10.5309,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"SNTB2","label":"SNTB2","x":1287.0581,"y":687.3311,"size":12.9654,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"SNX12","label":"SNX12","x":1403.2983,"y":1816.8644,"size":12.9541,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"SNX18","label":"SNX18","x":908.14,"y":642.8201,"size":10.0152,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"SNX3","label":"SNX3","x":871.5359,"y":638.1968,"size":11.4582,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"SNX32","label":"SNX32","x":709.467,"y":593.3833,"size":5,"color":"#FC8D62","shape":"triangle","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"SOD1","label":"SOD1","x":2151.2092,"y":769.4785,"size":9.2453,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"SORBS3","label":"SORBS3","x":2531.8421,"y":1934.5124,"size":11.944,"color":"#E7298A","shape":"dot","cluster":20,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 18 - Cluster 20<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.715<\/b><\/p><b>Genes (25):<\/b><br><span style='font-size:11px;'>CSRP2, EIF2S1, EIF4H, GNAS, GNB2, HNRNPM, NCL, NPNT, NUDC, PCBP2, PHGDH, PLPBP, PPME1, PSMB2, PSMB7, PSMD11, PSMD5, PSMD6, RO60, RPL12, RPL30, RPN1, RPS27L, SNRPD2, SORBS3<\/span><br><br><b>KEGG:<\/b><br> Proteasome (p=1.72e-06)<br>Parkinson disease (p=9.76e-06)<br>Spinocerebellar ataxia (p=1.60e-04)<br><br><b>BP:<\/b><br>proteasome assembly (p=1.53e-04)<br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=3.26e-04) <br> <b>MF:<\/b><br>lncRNA binding (p=6.86e-04)<br>structural constituent of ribosome (p=1.61e-03) <br> <b>CC:<\/b><br>proteasome complex (p=1.49e-08)<br>endopeptidase complex (p=1.29e-07)<\/div>"},{"id":"SPCS2","label":"SPCS2","x":2067.4824,"y":1104.9117,"size":10.2888,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"SPP2","label":"SPP2","x":1643.6622,"y":2327.014,"size":9.8609,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"SQOR","label":"SQOR","x":2239.569,"y":657.1543,"size":9.4971,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"SRPX","label":"SRPX","x":1334.734,"y":1784.8524,"size":9.3625,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"ST13","label":"ST13","x":2740.5693,"y":949.1305,"size":14.2139,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"STAT1","label":"STAT1","x":1540.3641,"y":1689.2126,"size":10.1741,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"STAT3","label":"STAT3","x":1414.7339,"y":2294.4788,"size":10.7931,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"STIP1","label":"STIP1","x":2155.565,"y":734.0411,"size":12.1477,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"STXBP3","label":"STXBP3","x":1278.4216,"y":511.6801,"size":9.8785,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"SUCLA2","label":"SUCLA2","x":1926.5056,"y":1081.5077,"size":9.3459,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"SUN2","label":"SUN2","x":1174.3612,"y":684.0279,"size":9.5452,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"SVIL","label":"SVIL","x":1263.8711,"y":1657.6895,"size":9.2489,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.948<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>ADAMTSL3, AHSG, APOL1, AZGP1, CFHR1, CKB, FTO, GSN, MASP2, RBP4, SVIL, TFG, TMOD1, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.26e-03)<br>African trypanosomiasis (p=3.06e-02)<br>Thyroid cancer (p=3.06e-02)<br><br><b>BP:<\/b><br>actin filament capping (p=3.19e-06)<br>negative regulation of actin filament depolymerization (p=4.27e-06) <br> <b>MF:<\/b><br>opsonin binding (p=1.09e-04)<br>complement binding (p=1.56e-04) <br> <b>CC:<\/b><br>blood microparticle (p=2.57e-06)<br>podosome (p=3.72e-04)<\/div>"},{"id":"TALDO1","label":"TALDO1","x":2780.6429,"y":1977.1033,"size":10.367,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"TARDBP","label":"TARDBP","x":2878.9052,"y":1064.3202,"size":9.5653,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"TCOF1","label":"TCOF1","x":2105.603,"y":1161.5623,"size":13.2493,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"TECR","label":"TECR","x":1561.8773,"y":824.5261,"size":15.5702,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"TES","label":"TES","x":1934.5591,"y":1337.5655,"size":9.3612,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.906<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>ACTB, ATP2A2, CTNND1, DCD, DLGAP4, ERLIN2, FAM114A1, LRRFIP1, MAPK1, PCYOX1, PDCD6, PFN2, POSTN, RAB8B, RAP1A, RILPL1, TES<\/span><br><br><b>KEGG:<\/b><br> Rap1 signaling pathway (p=2.71e-07)<br>Adherens junction (p=5.70e-07)<br>Leukocyte transendothelial migration (p=9.32e-05)<br><br><b>BP:<\/b><br>regulation of synaptic vesicle exocytosis (p=8.54e-06)<br>synaptic vesicle cycle (p=3.08e-05) <br> <b>MF:<\/b><br>GDP binding (p=2.09e-03)<br>cadherin binding (p=3.22e-03) <br> <b>CC:<\/b><br>Schaffer collateral - CA1 synapse (p=7.51e-05)<br>neuromuscular junction (p=1.99e-03)<\/div>"},{"id":"TFG","label":"TFG","x":1200.0978,"y":1596.7225,"size":11.6568,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.948<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>ADAMTSL3, AHSG, APOL1, AZGP1, CFHR1, CKB, FTO, GSN, MASP2, RBP4, SVIL, TFG, TMOD1, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.26e-03)<br>African trypanosomiasis (p=3.06e-02)<br>Thyroid cancer (p=3.06e-02)<br><br><b>BP:<\/b><br>actin filament capping (p=3.19e-06)<br>negative regulation of actin filament depolymerization (p=4.27e-06) <br> <b>MF:<\/b><br>opsonin binding (p=1.09e-04)<br>complement binding (p=1.56e-04) <br> <b>CC:<\/b><br>blood microparticle (p=2.57e-06)<br>podosome (p=3.72e-04)<\/div>"},{"id":"TGFB1I1","label":"TGFB1I1","x":391.3405,"y":2423.5632,"size":10.0287,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"TIMP1","label":"TIMP1","x":1251.1192,"y":138.2939,"size":9.2641,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"TIMP2","label":"TIMP2","x":1583.8802,"y":2228.7054,"size":12.4084,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"TIMP3","label":"TIMP3","x":1229.2292,"y":2323.3119,"size":11.8263,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"TKFC","label":"TKFC","x":667.1465,"y":580.7518,"size":9.5212,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"TMED10","label":"TMED10","x":2800.7699,"y":879.2164,"size":9.3959,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ATL3, ATP1B3, BCAP31, ERGIC1, ESYT2, LMAN2, RAB2A, RPN2, RRBP1, RTN4, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.24e-07)<br>Proximal tubule bicarbonate reclamation (p=2.15e-02)<br>Aldosterone-regulated sodium reabsorption (p=3.52e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.87e-08)<br>endoplasmic reticulum organization (p=5.40e-07) <br> <b>MF:<\/b><br>hexosyltransferase activity (p=8.03e-03)<br>UDP-glucosyltransferase activity (p=8.34e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.95e-13)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=6.35e-12)<\/div>"},{"id":"TMED2","label":"TMED2","x":2863.7859,"y":845.8433,"size":9.4455,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ATL3, ATP1B3, BCAP31, ERGIC1, ESYT2, LMAN2, RAB2A, RPN2, RRBP1, RTN4, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.24e-07)<br>Proximal tubule bicarbonate reclamation (p=2.15e-02)<br>Aldosterone-regulated sodium reabsorption (p=3.52e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.87e-08)<br>endoplasmic reticulum organization (p=5.40e-07) <br> <b>MF:<\/b><br>hexosyltransferase activity (p=8.03e-03)<br>UDP-glucosyltransferase activity (p=8.34e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.95e-13)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=6.35e-12)<\/div>"},{"id":"TMOD1","label":"TMOD1","x":1232.25,"y":1678.278,"size":10.7699,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.948<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>ADAMTSL3, AHSG, APOL1, AZGP1, CFHR1, CKB, FTO, GSN, MASP2, RBP4, SVIL, TFG, TMOD1, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.26e-03)<br>African trypanosomiasis (p=3.06e-02)<br>Thyroid cancer (p=3.06e-02)<br><br><b>BP:<\/b><br>actin filament capping (p=3.19e-06)<br>negative regulation of actin filament depolymerization (p=4.27e-06) <br> <b>MF:<\/b><br>opsonin binding (p=1.09e-04)<br>complement binding (p=1.56e-04) <br> <b>CC:<\/b><br>blood microparticle (p=2.57e-06)<br>podosome (p=3.72e-04)<\/div>"},{"id":"TMSB4X","label":"TMSB4X","x":2076.3925,"y":1585.8121,"size":12.9541,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"TMX4","label":"TMX4","x":2486.0537,"y":870.9337,"size":13.4657,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.848<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GNA13, PDLIM5, PSMA4, PSMA6, PSMB1, RPL14, SCCPDH, TMX4, TXNL1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Spinocerebellar ataxia (p=1.67e-06)<br>Proteasome (p=3.60e-06)<br>Parkinson disease (p=2.07e-05)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=1.60e-03)<br>regulation of postsynapse organization (p=2.66e-03) <br> <b>MF:<\/b><br>disulfide oxidoreductase activity (p=2.92e-04)<br>oxidoreductase activity, acting on a sulfur group of donors (p=5.34e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.74e-08)<br>proteasome core complex (p=1.90e-07)<\/div>"},{"id":"TNXB","label":"TNXB","x":1416.488,"y":1727.1075,"size":11.8971,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.817<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>ADAMTS4, FERMT2, HLA-DRB1, KANK2, LIMS2, MMP2, NNMT, S100A16, S100A4, SELENOP, SERPINE1, SERPING1, SNX12, SRPX, STAT1, TNXB<\/span><br><br><b>KEGG:<\/b><br> AGE-RAGE signaling pathway in diabetic complications (p=2.35e-04)<br>Integrin signaling (p=8.10e-04)<br>Inflammatory bowel disease (p=2.96e-03)<br><br><b>BP:<\/b><br>mesenchymal cell differentiation (p=7.09e-05)<br>mesenchyme development (p=1.65e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=2.10e-03)<br>serine-type endopeptidase inhibitor activity (p=2.94e-03) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>platelet alpha granule lumen (p=1.30e-03)<\/div>"},{"id":"TPI1","label":"TPI1","x":1700.7213,"y":1286.421,"size":11.4233,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.745<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT9, ALDH16A1, HADHA, HSD17B12, IDH3B, MTHFD1, MVP, PRDX3, SLC25A11, TPI1, TYMP, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Fatty acid elongation (p=1.72e-04)<br>Fatty acid metabolism (p=7.19e-04)<br>Biosynthesis of amino acids (p=1.24e-03)<br><br><b>BP:<\/b><br>NADH metabolic process (p=2.40e-04)<br>sulfur compound metabolic process (p=7.89e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=5.77e-05)<br>oxidoreductase activity, acting on CH-OH group of donors (p=7.29e-05) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.69e-03)<br>tricarboxylic acid cycle heteromeric enzyme complex (p=1.02e-02)<\/div>"},{"id":"TRIP6","label":"TRIP6","x":999.6451,"y":2457.0585,"size":10.1585,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"TTC5","label":"TTC5","x":2811.4697,"y":1943.0988,"size":5,"color":"#999999","shape":"triangle","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"TUBA1C","label":"TUBA1C","x":456.9703,"y":2262.9761,"size":10.2553,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"TUBA4A","label":"TUBA4A","x":2138.5202,"y":828.7511,"size":9.2691,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"TUBB2A","label":"TUBB2A","x":2907.3825,"y":2041.7356,"size":14.6282,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"TUBGCP3","label":"TUBGCP3","x":458.116,"y":2393.8034,"size":5,"color":"#4DAF4A","shape":"triangle","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.913<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ACTC1, AFM, ANO1, ANOS1, ANXA13, CD14, CLTA, COL6A2, CTTN, DMD, DSP, DYSF, EFEMP1, FLOT1, FN1, FN3K, MFAP4, NTN1, PTPN11, RCN1, SGCD, TGFB1I1, TUBGCP3<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=1.61e-07)<br>Bacterial invasion of epithelial cells (p=1.09e-04)<br>Arrhythmogenic right ventricular cardiomyopathy (p=1.46e-04)<br><br><b>BP:<\/b><br>substrate-dependent cell migration (p=4.59e-06)<br>axonogenesis (p=1.45e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>structural constituent of cytoskeleton (p=2.99e-04) <br> <b>CC:<\/b><br>sarcolemma (p=5.44e-07)<br>collagen-containing extracellular matrix (p=7.50e-06)<\/div>"},{"id":"TXNL1","label":"TXNL1","x":2458.4559,"y":915.2688,"size":9.4106,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.848<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GNA13, PDLIM5, PSMA4, PSMA6, PSMB1, RPL14, SCCPDH, TMX4, TXNL1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Spinocerebellar ataxia (p=1.67e-06)<br>Proteasome (p=3.60e-06)<br>Parkinson disease (p=2.07e-05)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=1.60e-03)<br>regulation of postsynapse organization (p=2.66e-03) <br> <b>MF:<\/b><br>disulfide oxidoreductase activity (p=2.92e-04)<br>oxidoreductase activity, acting on a sulfur group of donors (p=5.34e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.74e-08)<br>proteasome core complex (p=1.90e-07)<\/div>"},{"id":"TXNRD1","label":"TXNRD1","x":2231.5142,"y":699.1529,"size":9.6601,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"TYMP","label":"TYMP","x":1632.3783,"y":1271.3031,"size":9.3474,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.745<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT9, ALDH16A1, HADHA, HSD17B12, IDH3B, MTHFD1, MVP, PRDX3, SLC25A11, TPI1, TYMP, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Fatty acid elongation (p=1.72e-04)<br>Fatty acid metabolism (p=7.19e-04)<br>Biosynthesis of amino acids (p=1.24e-03)<br><br><b>BP:<\/b><br>NADH metabolic process (p=2.40e-04)<br>sulfur compound metabolic process (p=7.89e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=5.77e-05)<br>oxidoreductase activity, acting on CH-OH group of donors (p=7.29e-05) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.69e-03)<br>tricarboxylic acid cycle heteromeric enzyme complex (p=1.02e-02)<\/div>"},{"id":"UBA5","label":"UBA5","x":2209.7019,"y":795.494,"size":11.1989,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 14 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.805<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>AGRN, ANK3, COMP, EEF1G, G6PD, GALM, GSS, GYS1, HDGF, LRG1, LRRC59, MOGS, NNT, P4HB, PRKACB, PRKAG1, SEC23A, SOD1, SQOR, STIP1, TUBA4A, TXNRD1, UBA5<\/span><br><br><b>KEGG:<\/b><br> Longevity regulating pathway - multiple species (p=2.34e-04)<br>Glucagon signaling pathway (p=1.16e-03)<br>Prion disease (p=1.92e-03)<br><br><b>BP:<\/b><br>glutathione metabolic process (p=4.48e-05)<br>modified amino acid metabolic process (p=6.79e-05) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on a sulfur group of donors (p=3.91e-05)<br>D-glucose binding (p=7.96e-05) <br> <b>CC:<\/b><br>cAMP-dependent protein kinase complex (p=1.27e-02)<br>nucleotide-activated protein kinase complex (p=1.27e-02)<\/div>"},{"id":"UBXN1","label":"UBXN1","x":2007.0199,"y":957.4761,"size":10.0139,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"UGDH","label":"UGDH","x":362.1236,"y":2238.8404,"size":9.3383,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.892<\/b><\/p><b>Genes (28):<\/b><br><span style='font-size:11px;'>ALB, ALCAM, ANO6, ANXA6, BGN, BST2, CNP, CYB5B, CYB5R3, DES, DPT, FBLN5, GRB2, H1-0, HBG2, HSD17B10, HSD17B4, HSDL2, IGLL5, ISLR, IVD, LAMA2, NEGR1, PFN1, PTX3, PXDN, TUBA1C, UGDH<\/span><br><br><b>KEGG:<\/b><br> Biosynthesis of various nucleotide sugars (p=4.90e-04)<br>Valine, leucine and isoleucine degradation (p=2.83e-03)<br>Cytoskeleton in muscle cells (p=6.33e-03)<br><br><b>BP:<\/b><br>cellular oxidant detoxification (p=1.34e-05)<br>cellular detoxification (p=3.37e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.16e-06)<br>oxidoreductase activity, acting on other nitrogenous compounds as donors (p=1.45e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.55e-05)<br>hemoglobin complex (p=1.25e-04)<\/div>"},{"id":"UGGT1","label":"UGGT1","x":2954.1159,"y":799.2593,"size":9.2907,"color":"#B3B3B3","shape":"dot","cluster":16,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 20 - Cluster 16<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.673<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ATL3, ATP1B3, BCAP31, ERGIC1, ESYT2, LMAN2, RAB2A, RPN2, RRBP1, RTN4, TMED10, TMED2, UGGT1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=2.24e-07)<br>Proximal tubule bicarbonate reclamation (p=2.15e-02)<br>Aldosterone-regulated sodium reabsorption (p=3.52e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.87e-08)<br>endoplasmic reticulum organization (p=5.40e-07) <br> <b>MF:<\/b><br>hexosyltransferase activity (p=8.03e-03)<br>UDP-glucosyltransferase activity (p=8.34e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-Golgi intermediate compartment (p=9.95e-13)<br>endoplasmic reticulum-Golgi intermediate compartment membrane (p=6.35e-12)<\/div>"},{"id":"UQCRC1","label":"UQCRC1","x":2853.9502,"y":2023.4118,"size":10.4467,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.877<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AGL, APEH, ATP5F1D, DCXR, EOGT, FARSB, FOXRED1, GLG1, GMPR2, HAAO, HSPD1, L3HYPDH, LHPP, MAN2C1, OGDH, PIPOX, TALDO1, TTC5, TUBB2A, UQCRC1<\/span><br><br><b>KEGG:<\/b><br> Oxidative phosphorylation (p=1.73e-03)<br>Parkinson disease (p=1.14e-02)<br>Prion disease (p=1.22e-02)<br><br><b>BP:<\/b><br>purine nucleotide metabolic process (p=3.69e-06)<br>pyridine nucleotide metabolic process (p=2.81e-05) <br> <b>MF:<\/b><br>carbohydrate binding (p=3.16e-03)<br>hydrolase activity, hydrolyzing O-glycosyl compounds (p=4.23e-03) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.96e-04)<br>respiratory chain complex (p=4.79e-03)<\/div>"},{"id":"USO1","label":"USO1","x":1039.4028,"y":2447.9465,"size":11.0718,"color":"#1B9E77","shape":"dot","cluster":17,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 17<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.854<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>CAVIN1, CD74, CLTC, COL12A1, EFEMP2, EHD3, FGL2, GNB4, ILK, LAMA4, LDB3, LGALS1, NID1, PDLIM7, PLEC, PPP1R14A, SDCBP, SGCB, STAT3, TIMP3, TRIP6, USO1<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.89e-05)<br>Bacterial invasion of epithelial cells (p=7.32e-03)<br>Toxoplasmosis (p=1.47e-02)<br><br><b>BP:<\/b><br>T cell activation involved in immune response (p=1.60e-05)<br>positive T cell selection (p=2.41e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.30e-06)<br>muscle alpha-actinin binding (p=1.38e-04) <br> <b>CC:<\/b><br>focal adhesion (p=2.47e-07)<br>collagen-containing extracellular matrix (p=2.80e-07)<\/div>"},{"id":"VAMP3","label":"VAMP3","x":2037.855,"y":1738.5317,"size":11.7303,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 19 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.706<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, AKAP12, BASP1, CD81, CLTB, CPNE1, CTNNB1, ESYT1, IRGQ, NDRG2, VAMP3<\/span><br><br><b>KEGG:<\/b><br> Bacterial invasion of epithelial cells (p=3.90e-04)<br>Hepatitis C (p=1.55e-03)<br>SNARE interactions in vesicular transport (p=1.37e-02)<br><br><b>BP:<\/b><br>midbrain development (p=1.37e-05)<br>mesenchymal to epithelial transition (p=4.33e-05) <br> <b>MF:<\/b><br>calmodulin binding (p=2.09e-04)<br>calcium-dependent phospholipid binding (p=4.29e-04) <br> <b>CC:<\/b><br>cell cortex (p=1.36e-05)<br>cell cortex region (p=1.34e-04)<\/div>"},{"id":"VDAC1","label":"VDAC1","x":2264.1942,"y":1076.4078,"size":17.3536,"color":"#7570B3","shape":"dot","cluster":19,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 19<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.848<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>COPS6, EIF2S2, GNA13, PDLIM5, PSMA4, PSMA6, PSMB1, RPL14, SCCPDH, TMX4, TXNL1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Spinocerebellar ataxia (p=1.67e-06)<br>Proteasome (p=3.60e-06)<br>Parkinson disease (p=2.07e-05)<br><br><b>BP:<\/b><br>proteasome-mediated ubiquitin-dependent protein catabolic process (p=1.60e-03)<br>regulation of postsynapse organization (p=2.66e-03) <br> <b>MF:<\/b><br>disulfide oxidoreductase activity (p=2.92e-04)<br>oxidoreductase activity, acting on a sulfur group of donors (p=5.34e-04) <br> <b>CC:<\/b><br>proteasome complex (p=4.74e-08)<br>proteasome core complex (p=1.90e-07)<\/div>"},{"id":"VIM","label":"VIM","x":1727.0964,"y":2132.351,"size":9.87,"color":"#FFD92F","shape":"dot","cluster":15,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 15<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.849<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>APOE, DDX17, F10, HEBP2, LTBP2, MAMDC2, MRGPRF, PLIN3, PRPH, RARRES2, SERPINF2, SERPINH1, SLC25A6, SPP2, TIMP2, VIM<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=1.23e-03)<br>Alzheimer disease (p=2.24e-02)<br>Cholesterol metabolism (p=3.22e-02)<br><br><b>BP:<\/b><br>negative regulation of peptidase activity (p=7.10e-06)<br>collagen biosynthetic process (p=7.53e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=9.00e-06)<br>peptidase inhibitor activity (p=1.09e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>secretory granule lumen (p=4.20e-06)<\/div>"},{"id":"VPS26B","label":"VPS26B","x":828.14,"y":625.0719,"size":11.5766,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.815<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AKT1, ANXA7, CMAS, ENTPD1, HNRNPH1, MARCKS, PARP1, PYGM, RANBP1, SLMAP, SNTB2, SNX18, SNX3, SNX32, SUN2, TKFC, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Endocytosis (p=6.51e-03)<br>Fc gamma R-mediated phagocytosis (p=1.02e-02)<br>Glucagon signaling pathway (p=1.18e-02)<br><br><b>BP:<\/b><br>negative regulation of cytoplasmic pattern recognition receptor signaling pathway (p=1.60e-05)<br>regulation of macroautophagy (p=1.71e-05) <br> <b>MF:<\/b><br>phospholipid binding (p=6.27e-05)<br>phosphatidylinositol binding (p=1.07e-04) <br> <b>CC:<\/b><br>retromer complex (p=1.43e-04)<br>phagocytic vesicle (p=6.69e-03)<\/div>"},{"id":"WASHC5","label":"WASHC5","x":1035.8391,"y":520.5034,"size":5,"color":"#E78AC3","shape":"triangle","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AMPD2, ASAH1, BLMH, COL6A1, CTSB, ENPP1, EPX, FCER1G, FHL1, FLNC, M6PR, NSF, PREP, RNPEP, SH3BGRL, SNTB1, WASHC5<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=2.03e-05)<br>Asthma (p=1.11e-03)<br>Lysosome (p=6.30e-03)<br><br><b>BP:<\/b><br>positive regulation of interleukin-4 production (p=2.66e-04)<br>interleukin-4 production (p=4.50e-04) <br> <b>MF:<\/b><br>aminopeptidase activity (p=5.98e-04)<br>collagen binding (p=1.93e-03) <br> <b>CC:<\/b><br>sarcolemma (p=2.30e-04)<br>ficolin-1-rich granule (p=4.90e-04)<\/div>"},{"id":"WFS1","label":"WFS1","x":1262.073,"y":315.0949,"size":10.5663,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.941<\/b><\/p><b>Genes (22):<\/b><br><span style='font-size:11px;'>ACTG2, AKR7A2, CD59, CDH13, CPNE3, EHD1, GC, HP, HSPA5, IGFBP6, LAMP1, NME1, PAPPA, PPP1CB, PYGB, S100A11, SERPINA6, SLC25A4, SLC2A1, STXBP3, TIMP1, WFS1<\/span><br><br><b>KEGG:<\/b><br> Insulin resistance (p=4.79e-04)<br>Diabetic cardiomyopathy (p=2.97e-03)<br>Glucagon signaling pathway (p=1.03e-02)<br><br><b>BP:<\/b><br>ER overload response (p=7.14e-05)<br>negative regulation of endoplasmic reticulum unfolded protein response (p=2.71e-04) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=1.11e-04)<br>cadherin binding (p=5.74e-04) <br> <b>CC:<\/b><br>blood microparticle (p=1.79e-05)<br>tertiary granule (p=2.91e-05)<\/div>"},{"id":"WIPF1","label":"WIPF1","x":1295.5152,"y":1647.7682,"size":13.2493,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.948<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>ADAMTSL3, AHSG, APOL1, AZGP1, CFHR1, CKB, FTO, GSN, MASP2, RBP4, SVIL, TFG, TMOD1, WIPF1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=2.26e-03)<br>African trypanosomiasis (p=3.06e-02)<br>Thyroid cancer (p=3.06e-02)<br><br><b>BP:<\/b><br>actin filament capping (p=3.19e-06)<br>negative regulation of actin filament depolymerization (p=4.27e-06) <br> <b>MF:<\/b><br>opsonin binding (p=1.09e-04)<br>complement binding (p=1.56e-04) <br> <b>CC:<\/b><br>blood microparticle (p=2.57e-06)<br>podosome (p=3.72e-04)<\/div>"},{"id":"XRCC5","label":"XRCC5","x":2453.2683,"y":1128.4506,"size":11.5055,"color":"#D95F02","shape":"dot","cluster":18,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 16 - Cluster 18<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.79<\/b><\/p><b>Genes (24):<\/b><br><span style='font-size:11px;'>CCT8, DDX3X, EEF1D, EFTUD2, EIF2S3, EIF3B, ELAVL1, ETF1, GNG12, HNRNPH3, NDUFS2, NME3, PEBP1, PPP2CB, PRPF8, PSMA2, PURA, PURB, RAD23B, RAN, RARS1, RTRAF, TCOF1, XRCC5<\/span><br><br><b>KEGG:<\/b><br> mRNA surveillance pathway (p=1.10e-02)<br>AMPK signaling pathway (p=1.52e-02)<br>Dopaminergic synapse (p=1.79e-02)<br><br><b>BP:<\/b><br>regulation of translation (p=1.06e-06)<br>ribonucleoprotein complex biogenesis (p=2.87e-05) <br> <b>MF:<\/b><br>cadherin binding (p=3.24e-06)<br>translation factor activity, RNA binding (p=3.63e-06) <br> <b>CC:<\/b><br>eukaryotic translation initiation factor 3 complex (p=1.66e-04)<br>cytoplasmic stress granule (p=2.05e-04)<\/div>"},{"id":"XRCC6","label":"XRCC6","x":2692.7781,"y":1060.9454,"size":12.1509,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"YAP1","label":"YAP1","x":2759.3631,"y":825.3196,"size":10.269,"color":"#A6D854","shape":"dot","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"},{"id":"YBX3","label":"YBX3","x":2155.4276,"y":1406.1988,"size":9.7185,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 15 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.794<\/b><\/p><b>Genes (26):<\/b><br><span style='font-size:11px;'>ACTN1, ALDH4A1, COX4I1, DDOST, DNM1L, HADHB, HNRNPR, LSS, NAE1, PDHB, PRNP, PSMA7, PSMD4, PYGL, RPL18A, RPL8, RPS10, RPS17, RPS9, SH3GL1, SPCS2, SUCLA2, TECR, TMSB4X, UBXN1, YBX3<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=3.24e-04)<br>Fatty acid elongation (p=2.38e-03)<br>Citrate cycle (TCA cycle) (p=2.73e-03)<br><br><b>BP:<\/b><br>cytoplasmic translation (p=9.56e-08)<br>acyl-CoA metabolic process (p=3.47e-04) <br> <b>MF:<\/b><br>structural constituent of ribosome (p=3.86e-06)<br>oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (p=1.41e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=4.03e-07)<br>ribosomal subunit (p=3.81e-06)<\/div>"},{"id":"YWHAB","label":"YWHAB","x":1653.2279,"y":1282.5584,"size":9.7878,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 17 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.745<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ACOT9, ALDH16A1, HADHA, HSD17B12, IDH3B, MTHFD1, MVP, PRDX3, SLC25A11, TPI1, TYMP, YWHAB<\/span><br><br><b>KEGG:<\/b><br> Fatty acid elongation (p=1.72e-04)<br>Fatty acid metabolism (p=7.19e-04)<br>Biosynthesis of amino acids (p=1.24e-03)<br><br><b>BP:<\/b><br>NADH metabolic process (p=2.40e-04)<br>sulfur compound metabolic process (p=7.89e-04) <br> <b>MF:<\/b><br>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (p=5.77e-05)<br>oxidoreductase activity, acting on CH-OH group of donors (p=7.29e-05) <br> <b>CC:<\/b><br>oxidoreductase complex (p=3.69e-03)<br>tricarboxylic acid cycle heteromeric enzyme complex (p=1.02e-02)<\/div>"},{"id":"ZFPL1","label":"ZFPL1","x":2664.359,"y":913.3603,"size":5,"color":"#A6D854","shape":"triangle","cluster":14,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 14<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.825<\/b><\/p><b>Genes (23):<\/b><br><span style='font-size:11px;'>ANXA11, ARF3, ATP1A2, BUB3, CCT2, CCT7, DHX9, GALNT2, HSPA12A, PLP1, PSMA1, PSMB5, PSMD3, RAB5B, RTN1, SEC13, SET, SLC14A1, ST13, TARDBP, XRCC6, YAP1, ZFPL1<\/span><br><br><b>KEGG:<\/b><br> Amyotrophic lateral sclerosis (p=4.46e-06)<br>Proteasome (p=2.88e-05)<br>Spinocerebellar ataxia (p=8.57e-04)<br><br><b>BP:<\/b><br>positive regulation of protein localization to nucleus (p=4.00e-06)<br>'de novo' post-translational protein folding (p=1.78e-05) <br> <b>MF:<\/b><br>ATP hydrolysis activity (p=1.32e-04)<br>ATP-dependent protein folding chaperone (p=1.10e-03) <br> <b>CC:<\/b><br>proteasome complex (p=5.38e-05)<br>chaperonin-containing T-complex (p=7.00e-05)<\/div>"}],"aristas":[{"from":"STAT3","to":"TIMP3","weight":0.408},{"from":"COL12A1","to":"TIMP3","weight":0.415},{"from":"AKT1","to":"FHL1","weight":0.402},{"from":"FHL1","to":"FLNC","weight":0.405},{"from":"HLA-DRB1","to":"MMP2","weight":0.423},{"from":"HLA-DRB1","to":"TNXB","weight":0.413},{"from":"DMD","to":"FN1","weight":0.407},{"from":"ACTC1","to":"DMD","weight":0.401},{"from":"PPP1CB","to":"PYGB","weight":0.402},{"from":"ACTG2","to":"PPP1CB","weight":0.411},{"from":"ADD3","to":"APOE","weight":0.402},{"from":"APOE","to":"VIM","weight":0.408},{"from":"EFTUD2","to":"HNRNPH3","weight":0.413},{"from":"ACTB","to":"EFTUD2","weight":0.413},{"from":"ALB","to":"BGN","weight":0.414},{"from":"ALB","to":"ANXA6","weight":0.416},{"from":"LAMA4","to":"TIMP3","weight":0.405},{"from":"LAMA4","to":"PLEC","weight":0.416},{"from":"CKB","to":"MMP2","weight":0.41},{"from":"CKB","to":"GSN","weight":0.413},{"from":"COL6A1","to":"FLNC","weight":0.415},{"from":"FERMT2","to":"HLA-DRB1","weight":0.418},{"from":"PLEC","to":"USO1","weight":0.42},{"from":"CLTC","to":"USO1","weight":0.423},{"from":"AKT1","to":"PYGL","weight":0.406},{"from":"AKT1","to":"PYGB","weight":0.415},{"from":"HSPA5","to":"PPP1CB","weight":0.402},{"from":"ALB","to":"IGLL5","weight":0.491},{"from":"CYB5R3","to":"IGLL5","weight":0.429},{"from":"TALDO1","to":"UQCRC1","weight":0.407},{"from":"TUBB2A","to":"UQCRC1","weight":0.431},{"from":"CTTN","to":"TGFB1I1","weight":0.41},{"from":"COL6A2","to":"TGFB1I1","weight":0.403},{"from":"EIF2S3","to":"P4HB","weight":0.408},{"from":"P4HB","to":"TUBA4A","weight":0.413},{"from":"BGN","to":"LAMA4","weight":0.401},{"from":"ALB","to":"PFN1","weight":0.404},{"from":"PFN1","to":"TUBA1C","weight":0.404},{"from":"PDLIM7","to":"PLEC","weight":0.503},{"from":"H1-0","to":"PXDN","weight":0.419},{"from":"DES","to":"PXDN","weight":0.421},{"from":"ACTB","to":"POSTN","weight":0.404},{"from":"COL6A2","to":"EFEMP1","weight":0.445},{"from":"STAT3","to":"TIMP2","weight":0.411},{"from":"ILK","to":"STAT3","weight":0.417},{"from":"ILK","to":"SDCBP","weight":0.41},{"from":"CAVIN1","to":"SDCBP","weight":0.406},{"from":"BGN","to":"LAMA2","weight":0.42},{"from":"FBLN5","to":"LAMA2","weight":0.418},{"from":"NUDC","to":"RPL12","weight":0.41},{"from":"RPL12","to":"RPN1","weight":0.513},{"from":"ADD3","to":"VAMP3","weight":0.408},{"from":"ADD3","to":"ESYT1","weight":0.435},{"from":"ACTB","to":"HADHA","weight":0.404},{"from":"PSMA6","to":"VDAC1","weight":0.41},{"from":"PDLIM5","to":"VDAC1","weight":0.512},{"from":"GSN","to":"SVIL","weight":0.421},{"from":"ACTB","to":"DCD","weight":0.42},{"from":"DCD","to":"PCYOX1","weight":0.426},{"from":"P4HB","to":"SOD1","weight":0.404},{"from":"G6PD","to":"SOD1","weight":0.413},{"from":"DDX3X","to":"RTRAF","weight":0.406},{"from":"CCT8","to":"RTRAF","weight":0.409},{"from":"SERPINH1","to":"VIM","weight":0.417},{"from":"CAVIN1","to":"EHD3","weight":0.785},{"from":"CCT2","to":"TARDBP","weight":0.428},{"from":"ANXA11","to":"TARDBP","weight":0.419},{"from":"PHGDH","to":"PLPBP","weight":0.415},{"from":"PLPBP","to":"SORBS3","weight":0.409},{"from":"ACTB","to":"CTNND1","weight":0.407},{"from":"CTNND1","to":"MAPK1","weight":0.41},{"from":"TPI1","to":"TYMP","weight":0.411},{"from":"MVP","to":"TYMP","weight":0.416},{"from":"ACTB","to":"TES","weight":0.455},{"from":"ALB","to":"CTTN","weight":0.406},{"from":"ATL3","to":"RRBP1","weight":0.421},{"from":"ATL3","to":"ESYT2","weight":0.49},{"from":"AKT1","to":"PYGM","weight":0.401},{"from":"LGALS1","to":"PLEC","weight":0.447},{"from":"ACTB","to":"RPL30","weight":0.412},{"from":"GNB2","to":"RPL30","weight":0.429},{"from":"HADHA","to":"TPI1","weight":0.411},{"from":"MTHFD1","to":"TPI1","weight":0.477},{"from":"MAPK1","to":"MMP2","weight":0.408},{"from":"CDH13","to":"HP","weight":0.429},{"from":"CDH13","to":"CPNE3","weight":0.403},{"from":"TIMP2","to":"VIM","weight":0.411},{"from":"MRGPRF","to":"TIMP2","weight":0.402},{"from":"MAMDC2","to":"MRGPRF","weight":0.419},{"from":"AKT1","to":"SNTB2","weight":0.436},{"from":"SLMAP","to":"SNTB2","weight":0.434},{"from":"ACTB","to":"ATP2A2","weight":0.402},{"from":"CCT7","to":"XRCC6","weight":0.423},{"from":"CCT2","to":"XRCC6","weight":0.422},{"from":"HP","to":"LAMP1","weight":0.418},{"from":"EHD1","to":"LAMP1","weight":0.411},{"from":"HNRNPH1","to":"PARP1","weight":0.422},{"from":"ANXA7","to":"PARP1","weight":0.404},{"from":"EIF4H","to":"RPS27L","weight":0.404},{"from":"CSRP2","to":"RPS27L","weight":0.424},{"from":"CCT2","to":"DHX9","weight":0.429},{"from":"LMAN2","to":"UGGT1","weight":0.442},{"from":"LMAN2","to":"RPN2","weight":0.407},{"from":"ARF3","to":"SEC13","weight":0.407},{"from":"ARF3","to":"RAB5B","weight":0.423},{"from":"ALDH4A1","to":"SUCLA2","weight":0.412},{"from":"ALDH4A1","to":"HADHB","weight":0.412},{"from":"CTSB","to":"PREP","weight":0.406},{"from":"PREP","to":"RNPEP","weight":0.614},{"from":"PLP1","to":"TARDBP","weight":0.454},{"from":"ATP1A2","to":"PLP1","weight":0.435},{"from":"COL12A1","to":"NID1","weight":0.418},{"from":"EEF1G","to":"P4HB","weight":0.407},{"from":"COL6A1","to":"ENPP1","weight":0.529},{"from":"HADHB","to":"PYGL","weight":0.415},{"from":"PSMA1","to":"SEC13","weight":0.406},{"from":"RAB2A","to":"SEC13","weight":0.412},{"from":"FERMT2","to":"KANK2","weight":0.621},{"from":"PSMA6","to":"RPL8","weight":0.414},{"from":"HSPA5","to":"SLC25A4","weight":0.413},{"from":"RRBP1","to":"UGGT1","weight":0.401},{"from":"ANXA7","to":"SNX18","weight":0.468},{"from":"ATP5F1D","to":"HSPD1","weight":0.417},{"from":"ATP5F1D","to":"OGDH","weight":0.415},{"from":"SLC25A6","to":"VIM","weight":0.438},{"from":"LDB3","to":"PLEC","weight":0.445},{"from":"RAB2A","to":"TMED2","weight":0.402},{"from":"TMED2","to":"UGGT1","weight":0.425},{"from":"TUBA1C","to":"UGDH","weight":0.404},{"from":"CCT7","to":"SEC13","weight":0.401},{"from":"GNB4","to":"STAT3","weight":0.433},{"from":"PRPH","to":"VIM","weight":0.457},{"from":"FN1","to":"TGFB1I1","weight":0.402},{"from":"HSDL2","to":"UGDH","weight":0.41},{"from":"HSD17B10","to":"HSDL2","weight":0.426},{"from":"ACTC1","to":"SGCD","weight":0.504},{"from":"PYGB","to":"SLC2A1","weight":0.416},{"from":"AKAP12","to":"VAMP3","weight":0.405},{"from":"AKAP12","to":"CTNNB1","weight":0.408},{"from":"ATP5F1D","to":"TALDO1","weight":0.408},{"from":"AGL","to":"TALDO1","weight":0.406},{"from":"COL6A2","to":"MFAP4","weight":0.417},{"from":"AKR7A2","to":"HSPA5","weight":0.436},{"from":"CCT7","to":"XRCC5","weight":0.402},{"from":"CD81","to":"CTNNB1","weight":0.406},{"from":"BLMH","to":"SH3BGRL","weight":0.404},{"from":"BLMH","to":"RNPEP","weight":0.407},{"from":"EFTUD2","to":"EIF2S3","weight":0.416},{"from":"EIF4H","to":"RPL30","weight":0.413},{"from":"EIF4H","to":"GNAS","weight":0.403},{"from":"RAN","to":"XRCC5","weight":0.415},{"from":"EIF2S1","to":"PSMB7","weight":0.401},{"from":"EIF2S1","to":"PCBP2","weight":0.401},{"from":"DDOST","to":"HADHB","weight":0.421},{"from":"APOE","to":"DDX17","weight":0.432},{"from":"ACTN1","to":"VAMP3","weight":0.41},{"from":"COL6A1","to":"CTSB","weight":0.412},{"from":"CTSB","to":"FCER1G","weight":0.407},{"from":"EPX","to":"FCER1G","weight":0.404},{"from":"POSTN","to":"RAP1A","weight":0.415},{"from":"AKT1","to":"HNRNPH1","weight":0.412},{"from":"HNRNPH1","to":"SUN2","weight":0.51},{"from":"NUDC","to":"PSMB2","weight":0.402},{"from":"EFEMP2","to":"TIMP3","weight":0.415},{"from":"ALB","to":"ANO6","weight":0.452},{"from":"EIF2S1","to":"NCL","weight":0.414},{"from":"NCL","to":"PHGDH","weight":0.415},{"from":"ELAVL1","to":"PSMA2","weight":0.418},{"from":"PPP2CB","to":"PSMA2","weight":0.502},{"from":"HNRNPM","to":"RPL12","weight":0.435},{"from":"CD81","to":"CPNE1","weight":0.439},{"from":"P4HB","to":"SEC23A","weight":0.431},{"from":"AGRN","to":"ANK3","weight":0.409},{"from":"ANK3","to":"PRKACB","weight":0.412},{"from":"NID1","to":"SGCB","weight":0.425},{"from":"EEF1G","to":"TXNRD1","weight":0.422},{"from":"SQOR","to":"TXNRD1","weight":0.426},{"from":"COX4I1","to":"RPS9","weight":0.413},{"from":"COX4I1","to":"PDHB","weight":0.402},{"from":"DDX3X","to":"RAN","weight":0.401},{"from":"DPT","to":"LAMA2","weight":0.411},{"from":"CD74","to":"STAT3","weight":0.403},{"from":"CD74","to":"FGL2","weight":0.404},{"from":"ACTC1","to":"FLOT1","weight":0.401},{"from":"APEH","to":"L3HYPDH","weight":0.421},{"from":"L3HYPDH","to":"PIPOX","weight":0.404},{"from":"HAAO","to":"PIPOX","weight":0.407},{"from":"ERGIC1","to":"LMAN2","weight":0.549},{"from":"HSD17B10","to":"IVD","weight":0.418},{"from":"HSD17B4","to":"IVD","weight":0.433},{"from":"ACTB","to":"RAB8B","weight":0.404},{"from":"PURA","to":"XRCC5","weight":0.524},{"from":"RPL8","to":"SPCS2","weight":0.405},{"from":"RPS9","to":"SPCS2","weight":0.401},{"from":"G6PD","to":"GALM","weight":0.434},{"from":"EIF4H","to":"PSMB7","weight":0.409},{"from":"MMP2","to":"STAT1","weight":0.412},{"from":"NNMT","to":"STAT1","weight":0.404},{"from":"HADHA","to":"HSD17B12","weight":0.447},{"from":"PFN2","to":"RAP1A","weight":0.515},{"from":"ACTN1","to":"HNRNPR","weight":0.41},{"from":"ATP2A2","to":"ERLIN2","weight":0.404},{"from":"COPS6","to":"PSMA4","weight":0.405},{"from":"PSMA4","to":"RPL14","weight":0.419},{"from":"ACTB","to":"PDCD6","weight":0.432},{"from":"PDLIM7","to":"TRIP6","weight":0.472},{"from":"NPNT","to":"PHGDH","weight":0.407},{"from":"ERLIN2","to":"LRRFIP1","weight":0.415},{"from":"HSD17B12","to":"SLC25A11","weight":0.473},{"from":"AGRN","to":"HDGF","weight":0.409},{"from":"PSMD4","to":"RPS9","weight":0.404},{"from":"NAE1","to":"PSMD4","weight":0.413},{"from":"HNRNPH3","to":"PRPF8","weight":0.416},{"from":"EIF3B","to":"PRPF8","weight":0.415},{"from":"SVIL","to":"TMOD1","weight":0.448},{"from":"CTTN","to":"PTPN11","weight":0.438},{"from":"NTN1","to":"PTPN11","weight":0.527},{"from":"RAB2A","to":"TMED10","weight":0.427},{"from":"SERPINF2","to":"TIMP2","weight":0.41},{"from":"SERPINF2","to":"SPP2","weight":0.414},{"from":"HNRNPR","to":"RPL8","weight":0.412},{"from":"ACTC1","to":"DSP","weight":0.403},{"from":"ADAMTS4","to":"SRPX","weight":0.406},{"from":"ADAMTS4","to":"TNXB","weight":0.417},{"from":"ALB","to":"CNP","weight":0.41},{"from":"RARRES2","to":"SPP2","weight":0.404},{"from":"PSMD11","to":"RPL12","weight":0.42},{"from":"DDX3X","to":"ETF1","weight":0.412},{"from":"ELAVL1","to":"ETF1","weight":0.411},{"from":"HADHA","to":"PRDX3","weight":0.425},{"from":"AKT1","to":"ENTPD1","weight":0.428},{"from":"HNRNPH3","to":"XRCC5","weight":0.406},{"from":"RPL8","to":"SUCLA2","weight":0.415},{"from":"PSMB7","to":"PSMD5","weight":0.623},{"from":"EFEMP1","to":"RCN1","weight":0.455},{"from":"ATP5F1D","to":"FARSB","weight":0.407},{"from":"PCBP2","to":"SNRPD2","weight":0.418},{"from":"RO60","to":"SNRPD2","weight":0.449},{"from":"ATP5F1D","to":"LHPP","weight":0.698},{"from":"COPS6","to":"PSMA6","weight":0.409},{"from":"EIF2S1","to":"PSMD6","weight":0.417},{"from":"TMX4","to":"TXNL1","weight":0.406},{"from":"SCCPDH","to":"TMX4","weight":0.469},{"from":"CTTN","to":"TUBGCP3","weight":0.404},{"from":"FN3K","to":"TUBGCP3","weight":0.416},{"from":"SEC13","to":"ZFPL1","weight":0.402},{"from":"GALNT2","to":"ZFPL1","weight":0.409},{"from":"HSPA5","to":"WFS1","weight":0.429},{"from":"ANOS1","to":"FN1","weight":0.489},{"from":"DCXR","to":"FOXRED1","weight":0.416},{"from":"FOXRED1","to":"UQCRC1","weight":0.413},{"from":"FLNC","to":"SNTB1","weight":0.505},{"from":"ACOT9","to":"HADHA","weight":0.521},{"from":"CTSB","to":"M6PR","weight":0.417},{"from":"M6PR","to":"NSF","weight":0.503},{"from":"HSPA12A","to":"SEC13","weight":0.435},{"from":"NUDC","to":"PPME1","weight":0.492},{"from":"ALB","to":"H1-0","weight":0.418},{"from":"HDGF","to":"LRRC59","weight":0.414},{"from":"ANXA6","to":"PTX3","weight":0.426},{"from":"ANO1","to":"CTTN","weight":0.406},{"from":"CMAS","to":"VPS26B","weight":0.527},{"from":"CMAS","to":"SNX32","weight":0.401},{"from":"SNX32","to":"TKFC","weight":0.402},{"from":"GRB2","to":"PXDN","weight":0.412},{"from":"COPS6","to":"PSMA1","weight":0.412},{"from":"SNX18","to":"VPS26B","weight":0.404},{"from":"RPL18A","to":"SPCS2","weight":0.406},{"from":"EOGT","to":"MAN2C1","weight":0.422},{"from":"AGL","to":"MAN2C1","weight":0.411},{"from":"RPS17","to":"SPCS2","weight":0.411},{"from":"AHSG","to":"GSN","weight":0.402},{"from":"AHSG","to":"FTO","weight":0.414},{"from":"ADAMTSL3","to":"FTO","weight":0.415},{"from":"BUB3","to":"XRCC6","weight":0.431},{"from":"GNA13","to":"VDAC1","weight":0.412},{"from":"G6PD","to":"GYS1","weight":0.414},{"from":"CCT7","to":"PSMD3","weight":0.412},{"from":"EFTUD2","to":"NDUFS2","weight":0.458},{"from":"SLC2A1","to":"STXBP3","weight":0.442},{"from":"DNM1L","to":"HADHB","weight":0.403},{"from":"APOE","to":"F10","weight":0.526},{"from":"PSMA4","to":"TXNL1","weight":0.41},{"from":"G6PD","to":"NNT","weight":0.402},{"from":"HNRNPR","to":"RPS10","weight":0.416},{"from":"PURA","to":"PURB","weight":0.78},{"from":"PRKAG1","to":"TXNRD1","weight":0.405},{"from":"AHSG","to":"MASP2","weight":0.45},{"from":"HADHA","to":"IDH3B","weight":0.422},{"from":"DDOST","to":"TECR","weight":0.527},{"from":"LSS","to":"TECR","weight":0.461},{"from":"SEC23A","to":"UBA5","weight":0.401},{"from":"EFTUD2","to":"RARS1","weight":0.413},{"from":"MOGS","to":"P4HB","weight":0.441},{"from":"EIF2S2","to":"PSMA4","weight":0.411},{"from":"AMPD2","to":"WASHC5","weight":0.418},{"from":"SNTB1","to":"WASHC5","weight":0.402},{"from":"SERPINA6","to":"WFS1","weight":0.418},{"from":"HP","to":"SERPINA6","weight":0.407},{"from":"LTBP2","to":"TIMP2","weight":0.409},{"from":"COMP","to":"P4HB","weight":0.402},{"from":"SOD1","to":"STIP1","weight":0.413},{"from":"PEBP1","to":"RAN","weight":0.425},{"from":"GC","to":"SERPINA6","weight":0.426},{"from":"SERPING1","to":"STAT1","weight":0.42},{"from":"EIF2S1","to":"HSPD1","weight":0.406},{"from":"CFHR1","to":"GSN","weight":0.429},{"from":"APOE","to":"PLIN3","weight":0.496},{"from":"TPI1","to":"YWHAB","weight":0.418},{"from":"ALB","to":"ALCAM","weight":0.445},{"from":"CYB5R3","to":"HBG2","weight":0.56},{"from":"BCAP31","to":"RRBP1","weight":0.419},{"from":"BCAP31","to":"RTN4","weight":0.45},{"from":"APEH","to":"HSPD1","weight":0.429},{"from":"HSPA5","to":"NME1","weight":0.412},{"from":"PSMA7","to":"RPL8","weight":0.413},{"from":"CCT7","to":"PSMB5","weight":0.55},{"from":"EEF1D","to":"RAN","weight":0.413},{"from":"NNMT","to":"SERPINE1","weight":0.413},{"from":"S100A4","to":"SERPINE1","weight":0.409},{"from":"GLG1","to":"TUBB2A","weight":0.401},{"from":"EIF3B","to":"RAD23B","weight":0.419},{"from":"HSPA12A","to":"ST13","weight":0.439},{"from":"COPS6","to":"PSMB1","weight":0.412},{"from":"ADD3","to":"BASP1","weight":0.41},{"from":"RAB5B","to":"YAP1","weight":0.403},{"from":"AFM","to":"FN1","weight":0.428},{"from":"BGN","to":"ISLR","weight":0.424},{"from":"FAM114A1","to":"POSTN","weight":0.425},{"from":"FERMT2","to":"LIMS2","weight":0.449},{"from":"COMP","to":"LRG1","weight":0.449},{"from":"SNX18","to":"SNX3","weight":0.478},{"from":"AZGP1","to":"GSN","weight":0.416},{"from":"EIF2S1","to":"PSMB2","weight":0.414},{"from":"GSS","to":"TXNRD1","weight":0.449},{"from":"CCT8","to":"GNG12","weight":0.501},{"from":"CD59","to":"HP","weight":0.424},{"from":"LRRC59","to":"P4HB","weight":0.413},{"from":"HP","to":"TIMP1","weight":0.404},{"from":"ASAH1","to":"CTSB","weight":0.46},{"from":"ALCAM","to":"NEGR1","weight":0.47},{"from":"CLTB","to":"VAMP3","weight":0.581},{"from":"ATP1B3","to":"TMED2","weight":0.447},{"from":"AZGP1","to":"TFG","weight":0.414},{"from":"S100A11","to":"TIMP1","weight":0.446},{"from":"APOL1","to":"AZGP1","weight":0.436},{"from":"SET","to":"TARDBP","weight":0.415},{"from":"CLTA","to":"CTTN","weight":0.502},{"from":"AKT1","to":"MARCKS","weight":0.424},{"from":"RTN1","to":"SLC14A1","weight":0.412},{"from":"RTN1","to":"SEC13","weight":0.404},{"from":"ALDH16A1","to":"TPI1","weight":0.48},{"from":"RPS10","to":"YBX3","weight":0.41},{"from":"CPNE1","to":"IRGQ","weight":0.535},{"from":"ALCAM","to":"BST2","weight":0.475},{"from":"CTNNB1","to":"NDRG2","weight":0.495},{"from":"CD14","to":"PTPN11","weight":0.428},{"from":"GMPR2","to":"TTC5","weight":0.403},{"from":"FARSB","to":"TTC5","weight":0.405},{"from":"ILK","to":"PPP1R14A","weight":0.473},{"from":"DNM1L","to":"PRNP","weight":0.409},{"from":"DNM1L","to":"SH3GL1","weight":0.461},{"from":"GSN","to":"WIPF1","weight":0.536},{"from":"IGFBP6","to":"PAPPA","weight":0.412},{"from":"HSPA5","to":"PAPPA","weight":0.408},{"from":"GSN","to":"RBP4","weight":0.413},{"from":"HEBP2","to":"PLIN3","weight":0.542},{"from":"SELENOP","to":"TNXB","weight":0.436},{"from":"LIMS2","to":"SNX12","weight":0.418},{"from":"HNRNPH1","to":"RANBP1","weight":0.409},{"from":"EEF1D","to":"NME3","weight":0.428},{"from":"ACTN1","to":"TMSB4X","weight":0.492},{"from":"ANXA13","to":"DYSF","weight":0.416},{"from":"COL6A2","to":"DYSF","weight":0.408},{"from":"PSMD4","to":"UBXN1","weight":0.552},{"from":"RAB8B","to":"RILPL1","weight":0.427},{"from":"EFTUD2","to":"TCOF1","weight":0.564},{"from":"CYB5B","to":"HSDL2","weight":0.414},{"from":"DLGAP4","to":"RILPL1","weight":0.421},{"from":"S100A16","to":"S100A4","weight":0.453}],"clusters":[{"cluster":7,"color":"#A65628","count":14,"mean_fc":0.948,"rank":1},{"cluster":4,"color":"#984EA3","count":22,"mean_fc":0.941,"rank":2},{"cluster":3,"color":"#4DAF4A","count":23,"mean_fc":0.913,"rank":3},{"cluster":2,"color":"#377EB8","count":17,"mean_fc":0.906,"rank":4},{"cluster":12,"color":"#8DA0CB","count":28,"mean_fc":0.892,"rank":5},{"cluster":9,"color":"#999999","count":20,"mean_fc":0.877,"rank":6},{"cluster":17,"color":"#1B9E77","count":22,"mean_fc":0.854,"rank":7},{"cluster":15,"color":"#FFD92F","count":16,"mean_fc":0.849,"rank":8},{"cluster":19,"color":"#7570B3","count":12,"mean_fc":0.848,"rank":9},{"cluster":13,"color":"#E78AC3","count":17,"mean_fc":0.825,"rank":10},{"cluster":14,"color":"#A6D854","count":23,"mean_fc":0.825,"rank":11},{"cluster":6,"color":"#FFFF33","count":16,"mean_fc":0.817,"rank":12},{"cluster":11,"color":"#FC8D62","count":17,"mean_fc":0.815,"rank":13},{"cluster":10,"color":"#66C2A5","count":23,"mean_fc":0.805,"rank":14},{"cluster":5,"color":"#FF7F00","count":26,"mean_fc":0.794,"rank":15},{"cluster":18,"color":"#D95F02","count":24,"mean_fc":0.79,"rank":16},{"cluster":1,"color":"#E41A1C","count":12,"mean_fc":0.745,"rank":17},{"cluster":20,"color":"#E7298A","count":25,"mean_fc":0.715,"rank":18},{"cluster":8,"color":"#F781BF","count":11,"mean_fc":0.706,"rank":19},{"cluster":16,"color":"#B3B3B3","count":13,"mean_fc":0.673,"rank":20}],"stats":{"nodos":381,"aristas":380,"clusters":20}}},"MIXTO":{"P005":{"nodos":[{"id":"ABCC12","label":"ABCC12","x":1174.0916,"y":305.3535,"size":5,"color":"#E41A1C","shape":"triangle","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.614<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ABCC12, ANOS1, ATP1A2, DDOST, DUSP6, ERP29, LRRFIP1, LSS, NOTCH3, TECR, TMED2, TMX1<\/span><br><br><b>KEGG:<\/b><br> Thyroid hormone signaling pathway (p=4.30e-03)<br>Protein processing in endoplasmic reticulum (p=8.58e-03)<br>Steroid biosynthesis (p=1.66e-02)<br><br><b>BP:<\/b><br>response to endoplasmic reticulum stress (p=6.71e-04)<br>regulation of response to endoplasmic reticulum stress (p=1.51e-03) <br> <b>MF:<\/b><br>ATPase-coupled transmembrane transporter activity (p=1.75e-03)<br>protein-folding chaperone binding (p=3.23e-03) <br> <b>CC:<\/b><br>sodium:potassium-exchanging ATPase complex (p=7.22e-03)<br>oligosaccharyltransferase complex (p=8.42e-03)<\/div>"},{"id":"ACADVL","label":"ACADVL","x":657.2644,"y":1840.3407,"size":10.1906,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.711<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACADVL, ANO1, BCAP31, EHD1, HSD17B4, IVD, LAMP1, LMNA, NTRK3, PCYOX1, PRXL2A<\/span><br><br><b>KEGG:<\/b><br> Fatty acid metabolism (p=1.22e-03)<br>Primary bile acid biosynthesis (p=1.59e-02)<br>Virion - Lassa virus and SFTS virus (p=1.59e-02)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=9.44e-06)<br>fatty acid beta-oxidation using acyl-CoA dehydrogenase (p=2.05e-05) <br> <b>MF:<\/b><br>flavin adenine dinucleotide binding (p=1.52e-05)<br>acyl-CoA dehydrogenase activity (p=2.08e-05) <br> <b>CC:<\/b><br>lipid droplet (p=1.50e-03)<br>platelet dense tubular network (p=6.07e-03)<\/div>"},{"id":"ADAMTSL3","label":"ADAMTSL3","x":1802.6193,"y":1222.3995,"size":12.2492,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.659<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, B4GALT1, BGN, COL12A1, EOGT, ISLR, LAMA2, LAMA4, MGP, OMD, SERPINE2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=9.16e-06)<br>ECM-receptor interaction (p=2.96e-03)<br>Small cell lung cancer (p=3.22e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.52e-05)<br>extracellular structure organization (p=6.60e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.48e-08)<br>UDP-glycosyltransferase activity (p=7.27e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.34e-09)<br>basement membrane (p=3.11e-05)<\/div>"},{"id":"ADD3","label":"ADD3","x":1551.337,"y":822.3925,"size":11.0841,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.596<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, BASP1, BUB3, DEK, ESYT1, HNRNPH1, HNRNPU, PTPRA, RPL18A, WBP2, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Non-homologous end-joining (p=5.43e-03)<br>Cell cycle (p=6.45e-02)<br>Human T-cell leukemia virus 1 infection (p=9.05e-02)<br><br><b>BP:<\/b><br>attachment of spindle microtubules to kinetochore (p=4.38e-04)<br>regulation of mitotic sister chromatid segregation (p=5.05e-04) <br> <b>MF:<\/b><br>poly-pyrimidine tract binding (p=1.37e-04)<br>single-stranded RNA binding (p=1.21e-03) <br> <b>CC:<\/b><br>condensed chromosome (p=4.42e-04)<br>catalytic step 2 spliceosome (p=1.09e-03)<\/div>"},{"id":"AFM","label":"AFM","x":1167.4698,"y":1209.0709,"size":9.8671,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"AGL","label":"AGL","x":2630.451,"y":1618.7201,"size":16.5979,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"AGRN","label":"AGRN","x":2677.9837,"y":1519.9268,"size":14.7802,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"AIP","label":"AIP","x":2050.221,"y":844.5854,"size":15.5076,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"AKT1","label":"AKT1","x":1585.0263,"y":1053.2378,"size":10.2561,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"ANAPC1","label":"ANAPC1","x":568.4083,"y":2293.5642,"size":5,"color":"#999999","shape":"triangle","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"ANGPTL4","label":"ANGPTL4","x":1571.074,"y":1095.6057,"size":5,"color":"#F781BF","shape":"triangle","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"ANK3","label":"ANK3","x":2787.6008,"y":1539.2792,"size":11.3035,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"ANO1","label":"ANO1","x":557.1408,"y":1731.6366,"size":14.434,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.711<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACADVL, ANO1, BCAP31, EHD1, HSD17B4, IVD, LAMP1, LMNA, NTRK3, PCYOX1, PRXL2A<\/span><br><br><b>KEGG:<\/b><br> Fatty acid metabolism (p=1.22e-03)<br>Primary bile acid biosynthesis (p=1.59e-02)<br>Virion - Lassa virus and SFTS virus (p=1.59e-02)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=9.44e-06)<br>fatty acid beta-oxidation using acyl-CoA dehydrogenase (p=2.05e-05) <br> <b>MF:<\/b><br>flavin adenine dinucleotide binding (p=1.52e-05)<br>acyl-CoA dehydrogenase activity (p=2.08e-05) <br> <b>CC:<\/b><br>lipid droplet (p=1.50e-03)<br>platelet dense tubular network (p=6.07e-03)<\/div>"},{"id":"ANOS1","label":"ANOS1","x":992.0417,"y":385.9351,"size":11.3449,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.614<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ABCC12, ANOS1, ATP1A2, DDOST, DUSP6, ERP29, LRRFIP1, LSS, NOTCH3, TECR, TMED2, TMX1<\/span><br><br><b>KEGG:<\/b><br> Thyroid hormone signaling pathway (p=4.30e-03)<br>Protein processing in endoplasmic reticulum (p=8.58e-03)<br>Steroid biosynthesis (p=1.66e-02)<br><br><b>BP:<\/b><br>response to endoplasmic reticulum stress (p=6.71e-04)<br>regulation of response to endoplasmic reticulum stress (p=1.51e-03) <br> <b>MF:<\/b><br>ATPase-coupled transmembrane transporter activity (p=1.75e-03)<br>protein-folding chaperone binding (p=3.23e-03) <br> <b>CC:<\/b><br>sodium:potassium-exchanging ATPase complex (p=7.22e-03)<br>oligosaccharyltransferase complex (p=8.42e-03)<\/div>"},{"id":"ANXA11","label":"ANXA11","x":1132.6353,"y":998.6364,"size":9.7329,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"ANXA7","label":"ANXA7","x":2072.8425,"y":945.1183,"size":11.1408,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"AQP1","label":"AQP1","x":597.6473,"y":1952.6173,"size":5,"color":"#66C2A5","shape":"triangle","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.687<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>AQP1, BLMH, CDH1, CTSB, GFAP, HSPH1, ITGB3, MASP1, NDRG2, PREP, RNPEP, RPS17, SH3BGRL, SLC14A1<\/span><br><br><b>KEGG:<\/b><br> Renin secretion (p=2.23e-03)<br>Integrin signaling (p=1.07e-02)<br>Rap1 signaling pathway (p=1.96e-02)<br><br><b>BP:<\/b><br>positive regulation of fibroblast migration (p=5.37e-05)<br>regulation of neurotransmitter uptake (p=9.70e-05) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=7.96e-05)<br>endopeptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>melanosome (p=2.69e-03)<br>pigment granule (p=2.69e-03)<\/div>"},{"id":"ARFGEF1","label":"ARFGEF1","x":1044.018,"y":184.1286,"size":5,"color":"#FC8D62","shape":"triangle","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"ATP1A2","label":"ATP1A2","x":1133.0833,"y":374.0316,"size":9.6592,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.614<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ABCC12, ANOS1, ATP1A2, DDOST, DUSP6, ERP29, LRRFIP1, LSS, NOTCH3, TECR, TMED2, TMX1<\/span><br><br><b>KEGG:<\/b><br> Thyroid hormone signaling pathway (p=4.30e-03)<br>Protein processing in endoplasmic reticulum (p=8.58e-03)<br>Steroid biosynthesis (p=1.66e-02)<br><br><b>BP:<\/b><br>response to endoplasmic reticulum stress (p=6.71e-04)<br>regulation of response to endoplasmic reticulum stress (p=1.51e-03) <br> <b>MF:<\/b><br>ATPase-coupled transmembrane transporter activity (p=1.75e-03)<br>protein-folding chaperone binding (p=3.23e-03) <br> <b>CC:<\/b><br>sodium:potassium-exchanging ATPase complex (p=7.22e-03)<br>oligosaccharyltransferase complex (p=8.42e-03)<\/div>"},{"id":"B3GLCT","label":"B3GLCT","x":1782.2211,"y":1193.297,"size":5,"color":"#4DAF4A","shape":"triangle","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.659<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, B4GALT1, BGN, COL12A1, EOGT, ISLR, LAMA2, LAMA4, MGP, OMD, SERPINE2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=9.16e-06)<br>ECM-receptor interaction (p=2.96e-03)<br>Small cell lung cancer (p=3.22e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.52e-05)<br>extracellular structure organization (p=6.60e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.48e-08)<br>UDP-glycosyltransferase activity (p=7.27e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.34e-09)<br>basement membrane (p=3.11e-05)<\/div>"},{"id":"B4GALT1","label":"B4GALT1","x":2343.178,"y":1412.7693,"size":5,"color":"#4DAF4A","shape":"triangle","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.659<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, B4GALT1, BGN, COL12A1, EOGT, ISLR, LAMA2, LAMA4, MGP, OMD, SERPINE2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=9.16e-06)<br>ECM-receptor interaction (p=2.96e-03)<br>Small cell lung cancer (p=3.22e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.52e-05)<br>extracellular structure organization (p=6.60e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.48e-08)<br>UDP-glycosyltransferase activity (p=7.27e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.34e-09)<br>basement membrane (p=3.11e-05)<\/div>"},{"id":"BAG2","label":"BAG2","x":2701.8643,"y":1667.8809,"size":9.4631,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"BASP1","label":"BASP1","x":1515.5521,"y":861.3711,"size":10.213,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.596<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, BASP1, BUB3, DEK, ESYT1, HNRNPH1, HNRNPU, PTPRA, RPL18A, WBP2, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Non-homologous end-joining (p=5.43e-03)<br>Cell cycle (p=6.45e-02)<br>Human T-cell leukemia virus 1 infection (p=9.05e-02)<br><br><b>BP:<\/b><br>attachment of spindle microtubules to kinetochore (p=4.38e-04)<br>regulation of mitotic sister chromatid segregation (p=5.05e-04) <br> <b>MF:<\/b><br>poly-pyrimidine tract binding (p=1.37e-04)<br>single-stranded RNA binding (p=1.21e-03) <br> <b>CC:<\/b><br>condensed chromosome (p=4.42e-04)<br>catalytic step 2 spliceosome (p=1.09e-03)<\/div>"},{"id":"BCAP31","label":"BCAP31","x":725.052,"y":1488.648,"size":10.1754,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.711<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACADVL, ANO1, BCAP31, EHD1, HSD17B4, IVD, LAMP1, LMNA, NTRK3, PCYOX1, PRXL2A<\/span><br><br><b>KEGG:<\/b><br> Fatty acid metabolism (p=1.22e-03)<br>Primary bile acid biosynthesis (p=1.59e-02)<br>Virion - Lassa virus and SFTS virus (p=1.59e-02)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=9.44e-06)<br>fatty acid beta-oxidation using acyl-CoA dehydrogenase (p=2.05e-05) <br> <b>MF:<\/b><br>flavin adenine dinucleotide binding (p=1.52e-05)<br>acyl-CoA dehydrogenase activity (p=2.08e-05) <br> <b>CC:<\/b><br>lipid droplet (p=1.50e-03)<br>platelet dense tubular network (p=6.07e-03)<\/div>"},{"id":"BGN","label":"BGN","x":2109.5862,"y":1328.1837,"size":13.9956,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.659<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, B4GALT1, BGN, COL12A1, EOGT, ISLR, LAMA2, LAMA4, MGP, OMD, SERPINE2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=9.16e-06)<br>ECM-receptor interaction (p=2.96e-03)<br>Small cell lung cancer (p=3.22e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.52e-05)<br>extracellular structure organization (p=6.60e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.48e-08)<br>UDP-glycosyltransferase activity (p=7.27e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.34e-09)<br>basement membrane (p=3.11e-05)<\/div>"},{"id":"BLMH","label":"BLMH","x":235.1793,"y":2036.6024,"size":5,"color":"#66C2A5","shape":"triangle","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.687<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>AQP1, BLMH, CDH1, CTSB, GFAP, HSPH1, ITGB3, MASP1, NDRG2, PREP, RNPEP, RPS17, SH3BGRL, SLC14A1<\/span><br><br><b>KEGG:<\/b><br> Renin secretion (p=2.23e-03)<br>Integrin signaling (p=1.07e-02)<br>Rap1 signaling pathway (p=1.96e-02)<br><br><b>BP:<\/b><br>positive regulation of fibroblast migration (p=5.37e-05)<br>regulation of neurotransmitter uptake (p=9.70e-05) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=7.96e-05)<br>endopeptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>melanosome (p=2.69e-03)<br>pigment granule (p=2.69e-03)<\/div>"},{"id":"BUB3","label":"BUB3","x":1255.5968,"y":597.4691,"size":14.243,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.596<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, BASP1, BUB3, DEK, ESYT1, HNRNPH1, HNRNPU, PTPRA, RPL18A, WBP2, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Non-homologous end-joining (p=5.43e-03)<br>Cell cycle (p=6.45e-02)<br>Human T-cell leukemia virus 1 infection (p=9.05e-02)<br><br><b>BP:<\/b><br>attachment of spindle microtubules to kinetochore (p=4.38e-04)<br>regulation of mitotic sister chromatid segregation (p=5.05e-04) <br> <b>MF:<\/b><br>poly-pyrimidine tract binding (p=1.37e-04)<br>single-stranded RNA binding (p=1.21e-03) <br> <b>CC:<\/b><br>condensed chromosome (p=4.42e-04)<br>catalytic step 2 spliceosome (p=1.09e-03)<\/div>"},{"id":"CAVIN1","label":"CAVIN1","x":972.6987,"y":2236.6731,"size":5,"color":"#8DA0CB","shape":"triangle","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.755<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CAVIN1, CPNE3, GRB2, KLF6, PACSIN3, PDCD6, PPP1CA, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=6.15e-04)<br>Alcoholism (p=1.18e-03)<br>Focal adhesion (p=1.33e-03)<br><br><b>BP:<\/b><br>response to metal ion (p=6.79e-04)<br>negative regulation of endocytosis (p=7.10e-04) <br> <b>MF:<\/b><br>ephrin receptor binding (p=9.72e-05)<br>calcium-dependent protein binding (p=8.01e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.03e-03)<br>cell-substrate junction (p=1.11e-03)<\/div>"},{"id":"CBR3","label":"CBR3","x":272.8709,"y":1494.9249,"size":15.0807,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.608<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CBR3, CNP, CYB5R3, EFTUD2, HBE1, HBG2, NDUFS2, PRDX3, RARS1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Diabetic cardiomyopathy (p=6.48e-03)<br>Chemical carcinogenesis - reactive oxygen species (p=7.90e-03)<br>Parkinson disease (p=1.11e-02)<br><br><b>BP:<\/b><br>hydrogen peroxide catabolic process (p=4.83e-07)<br>hydrogen peroxide metabolic process (p=2.80e-06) <br> <b>MF:<\/b><br>peroxidase activity (p=3.20e-06)<br>oxidoreductase activity, acting on peroxide as acceptor (p=3.56e-06) <br> <b>CC:<\/b><br>hemoglobin complex (p=2.01e-08)<br>haptoglobin-hemoglobin complex (p=1.25e-05)<\/div>"},{"id":"CD14","label":"CD14","x":1812.0616,"y":978.5014,"size":10.2404,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"CD59","label":"CD59","x":1839.9272,"y":997.5967,"size":9.7914,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"CD74","label":"CD74","x":912.5997,"y":231.4371,"size":10.5151,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"CDH1","label":"CDH1","x":652.8758,"y":1963.3214,"size":13.4688,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.687<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>AQP1, BLMH, CDH1, CTSB, GFAP, HSPH1, ITGB3, MASP1, NDRG2, PREP, RNPEP, RPS17, SH3BGRL, SLC14A1<\/span><br><br><b>KEGG:<\/b><br> Renin secretion (p=2.23e-03)<br>Integrin signaling (p=1.07e-02)<br>Rap1 signaling pathway (p=1.96e-02)<br><br><b>BP:<\/b><br>positive regulation of fibroblast migration (p=5.37e-05)<br>regulation of neurotransmitter uptake (p=9.70e-05) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=7.96e-05)<br>endopeptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>melanosome (p=2.69e-03)<br>pigment granule (p=2.69e-03)<\/div>"},{"id":"CMAS","label":"CMAS","x":2321.8554,"y":895.9431,"size":14.6915,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"CNP","label":"CNP","x":369.5042,"y":1459.3711,"size":11.9023,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.608<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CBR3, CNP, CYB5R3, EFTUD2, HBE1, HBG2, NDUFS2, PRDX3, RARS1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Diabetic cardiomyopathy (p=6.48e-03)<br>Chemical carcinogenesis - reactive oxygen species (p=7.90e-03)<br>Parkinson disease (p=1.11e-02)<br><br><b>BP:<\/b><br>hydrogen peroxide catabolic process (p=4.83e-07)<br>hydrogen peroxide metabolic process (p=2.80e-06) <br> <b>MF:<\/b><br>peroxidase activity (p=3.20e-06)<br>oxidoreductase activity, acting on peroxide as acceptor (p=3.56e-06) <br> <b>CC:<\/b><br>hemoglobin complex (p=2.01e-08)<br>haptoglobin-hemoglobin complex (p=1.25e-05)<\/div>"},{"id":"COL12A1","label":"COL12A1","x":1829.4827,"y":1171.3321,"size":13.5556,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.659<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, B4GALT1, BGN, COL12A1, EOGT, ISLR, LAMA2, LAMA4, MGP, OMD, SERPINE2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=9.16e-06)<br>ECM-receptor interaction (p=2.96e-03)<br>Small cell lung cancer (p=3.22e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.52e-05)<br>extracellular structure organization (p=6.60e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.48e-08)<br>UDP-glycosyltransferase activity (p=7.27e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.34e-09)<br>basement membrane (p=3.11e-05)<\/div>"},{"id":"COL18A1","label":"COL18A1","x":1012.1158,"y":225.7886,"size":10.7068,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"COL4A2","label":"COL4A2","x":441.4082,"y":1275.1653,"size":10.5151,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"COPS6","label":"COPS6","x":589.456,"y":2341.5681,"size":9.4709,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"CPNE3","label":"CPNE3","x":1048.5766,"y":2228.8545,"size":11.7193,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.755<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CAVIN1, CPNE3, GRB2, KLF6, PACSIN3, PDCD6, PPP1CA, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=6.15e-04)<br>Alcoholism (p=1.18e-03)<br>Focal adhesion (p=1.33e-03)<br><br><b>BP:<\/b><br>response to metal ion (p=6.79e-04)<br>negative regulation of endocytosis (p=7.10e-04) <br> <b>MF:<\/b><br>ephrin receptor binding (p=9.72e-05)<br>calcium-dependent protein binding (p=8.01e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.03e-03)<br>cell-substrate junction (p=1.11e-03)<\/div>"},{"id":"CTBP1","label":"CTBP1","x":2600.6487,"y":1505.5949,"size":9.5559,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"CTNND1","label":"CTNND1","x":2880.3326,"y":1555.9088,"size":12.7947,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"CTSB","label":"CTSB","x":524.8964,"y":1987.7095,"size":9.312,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.687<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>AQP1, BLMH, CDH1, CTSB, GFAP, HSPH1, ITGB3, MASP1, NDRG2, PREP, RNPEP, RPS17, SH3BGRL, SLC14A1<\/span><br><br><b>KEGG:<\/b><br> Renin secretion (p=2.23e-03)<br>Integrin signaling (p=1.07e-02)<br>Rap1 signaling pathway (p=1.96e-02)<br><br><b>BP:<\/b><br>positive regulation of fibroblast migration (p=5.37e-05)<br>regulation of neurotransmitter uptake (p=9.70e-05) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=7.96e-05)<br>endopeptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>melanosome (p=2.69e-03)<br>pigment granule (p=2.69e-03)<\/div>"},{"id":"CTSZ","label":"CTSZ","x":1950.6583,"y":970.5815,"size":10.7431,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"CXCL12","label":"CXCL12","x":1010.7336,"y":293.4468,"size":9.3086,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"CYB5R3","label":"CYB5R3","x":491.2575,"y":1503.134,"size":9.99,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.608<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CBR3, CNP, CYB5R3, EFTUD2, HBE1, HBG2, NDUFS2, PRDX3, RARS1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Diabetic cardiomyopathy (p=6.48e-03)<br>Chemical carcinogenesis - reactive oxygen species (p=7.90e-03)<br>Parkinson disease (p=1.11e-02)<br><br><b>BP:<\/b><br>hydrogen peroxide catabolic process (p=4.83e-07)<br>hydrogen peroxide metabolic process (p=2.80e-06) <br> <b>MF:<\/b><br>peroxidase activity (p=3.20e-06)<br>oxidoreductase activity, acting on peroxide as acceptor (p=3.56e-06) <br> <b>CC:<\/b><br>hemoglobin complex (p=2.01e-08)<br>haptoglobin-hemoglobin complex (p=1.25e-05)<\/div>"},{"id":"CYC1","label":"CYC1","x":2592.3343,"y":1598.7717,"size":9.8064,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"DDOST","label":"DDOST","x":1249.5879,"y":298.5281,"size":11.9318,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.614<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ABCC12, ANOS1, ATP1A2, DDOST, DUSP6, ERP29, LRRFIP1, LSS, NOTCH3, TECR, TMED2, TMX1<\/span><br><br><b>KEGG:<\/b><br> Thyroid hormone signaling pathway (p=4.30e-03)<br>Protein processing in endoplasmic reticulum (p=8.58e-03)<br>Steroid biosynthesis (p=1.66e-02)<br><br><b>BP:<\/b><br>response to endoplasmic reticulum stress (p=6.71e-04)<br>regulation of response to endoplasmic reticulum stress (p=1.51e-03) <br> <b>MF:<\/b><br>ATPase-coupled transmembrane transporter activity (p=1.75e-03)<br>protein-folding chaperone binding (p=3.23e-03) <br> <b>CC:<\/b><br>sodium:potassium-exchanging ATPase complex (p=7.22e-03)<br>oligosaccharyltransferase complex (p=8.42e-03)<\/div>"},{"id":"DEK","label":"DEK","x":1379.8849,"y":783.0211,"size":11.0219,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.596<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, BASP1, BUB3, DEK, ESYT1, HNRNPH1, HNRNPU, PTPRA, RPL18A, WBP2, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Non-homologous end-joining (p=5.43e-03)<br>Cell cycle (p=6.45e-02)<br>Human T-cell leukemia virus 1 infection (p=9.05e-02)<br><br><b>BP:<\/b><br>attachment of spindle microtubules to kinetochore (p=4.38e-04)<br>regulation of mitotic sister chromatid segregation (p=5.05e-04) <br> <b>MF:<\/b><br>poly-pyrimidine tract binding (p=1.37e-04)<br>single-stranded RNA binding (p=1.21e-03) <br> <b>CC:<\/b><br>condensed chromosome (p=4.42e-04)<br>catalytic step 2 spliceosome (p=1.09e-03)<\/div>"},{"id":"DSP","label":"DSP","x":1047.5744,"y":1197.469,"size":14.0357,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"DUSP6","label":"DUSP6","x":1045.9022,"y":389.2096,"size":5,"color":"#E41A1C","shape":"triangle","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.614<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ABCC12, ANOS1, ATP1A2, DDOST, DUSP6, ERP29, LRRFIP1, LSS, NOTCH3, TECR, TMED2, TMX1<\/span><br><br><b>KEGG:<\/b><br> Thyroid hormone signaling pathway (p=4.30e-03)<br>Protein processing in endoplasmic reticulum (p=8.58e-03)<br>Steroid biosynthesis (p=1.66e-02)<br><br><b>BP:<\/b><br>response to endoplasmic reticulum stress (p=6.71e-04)<br>regulation of response to endoplasmic reticulum stress (p=1.51e-03) <br> <b>MF:<\/b><br>ATPase-coupled transmembrane transporter activity (p=1.75e-03)<br>protein-folding chaperone binding (p=3.23e-03) <br> <b>CC:<\/b><br>sodium:potassium-exchanging ATPase complex (p=7.22e-03)<br>oligosaccharyltransferase complex (p=8.42e-03)<\/div>"},{"id":"EDIL3","label":"EDIL3","x":1816.6329,"y":943.0383,"size":11.7939,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"EFTUD2","label":"EFTUD2","x":322.0942,"y":1460.2219,"size":12.0035,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.608<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CBR3, CNP, CYB5R3, EFTUD2, HBE1, HBG2, NDUFS2, PRDX3, RARS1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Diabetic cardiomyopathy (p=6.48e-03)<br>Chemical carcinogenesis - reactive oxygen species (p=7.90e-03)<br>Parkinson disease (p=1.11e-02)<br><br><b>BP:<\/b><br>hydrogen peroxide catabolic process (p=4.83e-07)<br>hydrogen peroxide metabolic process (p=2.80e-06) <br> <b>MF:<\/b><br>peroxidase activity (p=3.20e-06)<br>oxidoreductase activity, acting on peroxide as acceptor (p=3.56e-06) <br> <b>CC:<\/b><br>hemoglobin complex (p=2.01e-08)<br>haptoglobin-hemoglobin complex (p=1.25e-05)<\/div>"},{"id":"EHD1","label":"EHD1","x":677.9864,"y":1598.9263,"size":12.2883,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.711<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACADVL, ANO1, BCAP31, EHD1, HSD17B4, IVD, LAMP1, LMNA, NTRK3, PCYOX1, PRXL2A<\/span><br><br><b>KEGG:<\/b><br> Fatty acid metabolism (p=1.22e-03)<br>Primary bile acid biosynthesis (p=1.59e-02)<br>Virion - Lassa virus and SFTS virus (p=1.59e-02)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=9.44e-06)<br>fatty acid beta-oxidation using acyl-CoA dehydrogenase (p=2.05e-05) <br> <b>MF:<\/b><br>flavin adenine dinucleotide binding (p=1.52e-05)<br>acyl-CoA dehydrogenase activity (p=2.08e-05) <br> <b>CC:<\/b><br>lipid droplet (p=1.50e-03)<br>platelet dense tubular network (p=6.07e-03)<\/div>"},{"id":"EIF2S1","label":"EIF2S1","x":634.5349,"y":2289.3106,"size":9.9171,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"ELOC","label":"ELOC","x":1436.5173,"y":1001.8835,"size":10.5506,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"ENTPD1","label":"ENTPD1","x":1547.3866,"y":1067.0764,"size":11.0516,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"EOGT","label":"EOGT","x":2398.9337,"y":1417.0032,"size":11.263,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.659<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, B4GALT1, BGN, COL12A1, EOGT, ISLR, LAMA2, LAMA4, MGP, OMD, SERPINE2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=9.16e-06)<br>ECM-receptor interaction (p=2.96e-03)<br>Small cell lung cancer (p=3.22e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.52e-05)<br>extracellular structure organization (p=6.60e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.48e-08)<br>UDP-glycosyltransferase activity (p=7.27e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.34e-09)<br>basement membrane (p=3.11e-05)<\/div>"},{"id":"ERP29","label":"ERP29","x":1297.6007,"y":229.6874,"size":13.5828,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.614<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ABCC12, ANOS1, ATP1A2, DDOST, DUSP6, ERP29, LRRFIP1, LSS, NOTCH3, TECR, TMED2, TMX1<\/span><br><br><b>KEGG:<\/b><br> Thyroid hormone signaling pathway (p=4.30e-03)<br>Protein processing in endoplasmic reticulum (p=8.58e-03)<br>Steroid biosynthesis (p=1.66e-02)<br><br><b>BP:<\/b><br>response to endoplasmic reticulum stress (p=6.71e-04)<br>regulation of response to endoplasmic reticulum stress (p=1.51e-03) <br> <b>MF:<\/b><br>ATPase-coupled transmembrane transporter activity (p=1.75e-03)<br>protein-folding chaperone binding (p=3.23e-03) <br> <b>CC:<\/b><br>sodium:potassium-exchanging ATPase complex (p=7.22e-03)<br>oligosaccharyltransferase complex (p=8.42e-03)<\/div>"},{"id":"ESYT1","label":"ESYT1","x":1576.9316,"y":793.1514,"size":10.0782,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.596<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, BASP1, BUB3, DEK, ESYT1, HNRNPH1, HNRNPU, PTPRA, RPL18A, WBP2, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Non-homologous end-joining (p=5.43e-03)<br>Cell cycle (p=6.45e-02)<br>Human T-cell leukemia virus 1 infection (p=9.05e-02)<br><br><b>BP:<\/b><br>attachment of spindle microtubules to kinetochore (p=4.38e-04)<br>regulation of mitotic sister chromatid segregation (p=5.05e-04) <br> <b>MF:<\/b><br>poly-pyrimidine tract binding (p=1.37e-04)<br>single-stranded RNA binding (p=1.21e-03) <br> <b>CC:<\/b><br>condensed chromosome (p=4.42e-04)<br>catalytic step 2 spliceosome (p=1.09e-03)<\/div>"},{"id":"ESYT2","label":"ESYT2","x":1272.0516,"y":1027.0363,"size":20,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"FAM184B","label":"FAM184B","x":2170.8437,"y":780.1585,"size":10.4557,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"FBLN2","label":"FBLN2","x":517.0064,"y":1301.9855,"size":11.465,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"FBLN7","label":"FBLN7","x":526.1894,"y":2317.6885,"size":11.8194,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"FGL2","label":"FGL2","x":860.0396,"y":212.8507,"size":16.4686,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"GFAP","label":"GFAP","x":658.6485,"y":1996.1336,"size":10.0275,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.687<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>AQP1, BLMH, CDH1, CTSB, GFAP, HSPH1, ITGB3, MASP1, NDRG2, PREP, RNPEP, RPS17, SH3BGRL, SLC14A1<\/span><br><br><b>KEGG:<\/b><br> Renin secretion (p=2.23e-03)<br>Integrin signaling (p=1.07e-02)<br>Rap1 signaling pathway (p=1.96e-02)<br><br><b>BP:<\/b><br>positive regulation of fibroblast migration (p=5.37e-05)<br>regulation of neurotransmitter uptake (p=9.70e-05) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=7.96e-05)<br>endopeptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>melanosome (p=2.69e-03)<br>pigment granule (p=2.69e-03)<\/div>"},{"id":"GLG1","label":"GLG1","x":1875.6587,"y":943.247,"size":10.7431,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"GNB2","label":"GNB2","x":939.9076,"y":284.5952,"size":14.7814,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"GPC6","label":"GPC6","x":1854.8431,"y":915.5661,"size":11.6403,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"GRB2","label":"GRB2","x":816.6587,"y":2132.1826,"size":19.4385,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.755<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CAVIN1, CPNE3, GRB2, KLF6, PACSIN3, PDCD6, PPP1CA, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=6.15e-04)<br>Alcoholism (p=1.18e-03)<br>Focal adhesion (p=1.33e-03)<br><br><b>BP:<\/b><br>response to metal ion (p=6.79e-04)<br>negative regulation of endocytosis (p=7.10e-04) <br> <b>MF:<\/b><br>ephrin receptor binding (p=9.72e-05)<br>calcium-dependent protein binding (p=8.01e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.03e-03)<br>cell-substrate junction (p=1.11e-03)<\/div>"},{"id":"GSN","label":"GSN","x":1371.516,"y":1133.232,"size":12.2492,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"GYS1","label":"GYS1","x":1649.538,"y":1067.3836,"size":11.907,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"HAPLN3","label":"HAPLN3","x":1821.5659,"y":908.6577,"size":9.4631,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"HBE1","label":"HBE1","x":447.423,"y":1511.6319,"size":11.465,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.608<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CBR3, CNP, CYB5R3, EFTUD2, HBE1, HBG2, NDUFS2, PRDX3, RARS1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Diabetic cardiomyopathy (p=6.48e-03)<br>Chemical carcinogenesis - reactive oxygen species (p=7.90e-03)<br>Parkinson disease (p=1.11e-02)<br><br><b>BP:<\/b><br>hydrogen peroxide catabolic process (p=4.83e-07)<br>hydrogen peroxide metabolic process (p=2.80e-06) <br> <b>MF:<\/b><br>peroxidase activity (p=3.20e-06)<br>oxidoreductase activity, acting on peroxide as acceptor (p=3.56e-06) <br> <b>CC:<\/b><br>hemoglobin complex (p=2.01e-08)<br>haptoglobin-hemoglobin complex (p=1.25e-05)<\/div>"},{"id":"HBG2","label":"HBG2","x":478.5399,"y":1525.4433,"size":11.465,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.608<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CBR3, CNP, CYB5R3, EFTUD2, HBE1, HBG2, NDUFS2, PRDX3, RARS1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Diabetic cardiomyopathy (p=6.48e-03)<br>Chemical carcinogenesis - reactive oxygen species (p=7.90e-03)<br>Parkinson disease (p=1.11e-02)<br><br><b>BP:<\/b><br>hydrogen peroxide catabolic process (p=4.83e-07)<br>hydrogen peroxide metabolic process (p=2.80e-06) <br> <b>MF:<\/b><br>peroxidase activity (p=3.20e-06)<br>oxidoreductase activity, acting on peroxide as acceptor (p=3.56e-06) <br> <b>CC:<\/b><br>hemoglobin complex (p=2.01e-08)<br>haptoglobin-hemoglobin complex (p=1.25e-05)<\/div>"},{"id":"HDGF","label":"HDGF","x":2556.7935,"y":1499.854,"size":9.902,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"HDGFL3","label":"HDGFL3","x":2114.6377,"y":975.8545,"size":13.1026,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"HNRNPH1","label":"HNRNPH1","x":1504.6511,"y":921.144,"size":9.7241,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.596<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, BASP1, BUB3, DEK, ESYT1, HNRNPH1, HNRNPU, PTPRA, RPL18A, WBP2, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Non-homologous end-joining (p=5.43e-03)<br>Cell cycle (p=6.45e-02)<br>Human T-cell leukemia virus 1 infection (p=9.05e-02)<br><br><b>BP:<\/b><br>attachment of spindle microtubules to kinetochore (p=4.38e-04)<br>regulation of mitotic sister chromatid segregation (p=5.05e-04) <br> <b>MF:<\/b><br>poly-pyrimidine tract binding (p=1.37e-04)<br>single-stranded RNA binding (p=1.21e-03) <br> <b>CC:<\/b><br>condensed chromosome (p=4.42e-04)<br>catalytic step 2 spliceosome (p=1.09e-03)<\/div>"},{"id":"HNRNPU","label":"HNRNPU","x":1332.9101,"y":704.1828,"size":12.5255,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.596<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, BASP1, BUB3, DEK, ESYT1, HNRNPH1, HNRNPU, PTPRA, RPL18A, WBP2, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Non-homologous end-joining (p=5.43e-03)<br>Cell cycle (p=6.45e-02)<br>Human T-cell leukemia virus 1 infection (p=9.05e-02)<br><br><b>BP:<\/b><br>attachment of spindle microtubules to kinetochore (p=4.38e-04)<br>regulation of mitotic sister chromatid segregation (p=5.05e-04) <br> <b>MF:<\/b><br>poly-pyrimidine tract binding (p=1.37e-04)<br>single-stranded RNA binding (p=1.21e-03) <br> <b>CC:<\/b><br>condensed chromosome (p=4.42e-04)<br>catalytic step 2 spliceosome (p=1.09e-03)<\/div>"},{"id":"HSD17B4","label":"HSD17B4","x":547.2298,"y":1839.7174,"size":12.06,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.711<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACADVL, ANO1, BCAP31, EHD1, HSD17B4, IVD, LAMP1, LMNA, NTRK3, PCYOX1, PRXL2A<\/span><br><br><b>KEGG:<\/b><br> Fatty acid metabolism (p=1.22e-03)<br>Primary bile acid biosynthesis (p=1.59e-02)<br>Virion - Lassa virus and SFTS virus (p=1.59e-02)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=9.44e-06)<br>fatty acid beta-oxidation using acyl-CoA dehydrogenase (p=2.05e-05) <br> <b>MF:<\/b><br>flavin adenine dinucleotide binding (p=1.52e-05)<br>acyl-CoA dehydrogenase activity (p=2.08e-05) <br> <b>CC:<\/b><br>lipid droplet (p=1.50e-03)<br>platelet dense tubular network (p=6.07e-03)<\/div>"},{"id":"HSPB1","label":"HSPB1","x":2655.782,"y":1639.6276,"size":5,"color":"#FFFF33","shape":"triangle","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"HSPH1","label":"HSPH1","x":100,"y":2062.8859,"size":11.345,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.687<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>AQP1, BLMH, CDH1, CTSB, GFAP, HSPH1, ITGB3, MASP1, NDRG2, PREP, RNPEP, RPS17, SH3BGRL, SLC14A1<\/span><br><br><b>KEGG:<\/b><br> Renin secretion (p=2.23e-03)<br>Integrin signaling (p=1.07e-02)<br>Rap1 signaling pathway (p=1.96e-02)<br><br><b>BP:<\/b><br>positive regulation of fibroblast migration (p=5.37e-05)<br>regulation of neurotransmitter uptake (p=9.70e-05) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=7.96e-05)<br>endopeptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>melanosome (p=2.69e-03)<br>pigment granule (p=2.69e-03)<\/div>"},{"id":"IGFBP2","label":"IGFBP2","x":992.3363,"y":178.8877,"size":5,"color":"#FC8D62","shape":"triangle","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"IGFBP4","label":"IGFBP4","x":423.2758,"y":1295.3736,"size":5,"color":"#FF7F00","shape":"triangle","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"IGFBP6","label":"IGFBP6","x":352.6989,"y":1288.2431,"size":11.2179,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"INSIG2","label":"INSIG2","x":797.4411,"y":132.5473,"size":5,"color":"#FC8D62","shape":"triangle","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"ISLR","label":"ISLR","x":2163.6517,"y":1330.3933,"size":9.8671,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.659<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, B4GALT1, BGN, COL12A1, EOGT, ISLR, LAMA2, LAMA4, MGP, OMD, SERPINE2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=9.16e-06)<br>ECM-receptor interaction (p=2.96e-03)<br>Small cell lung cancer (p=3.22e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.52e-05)<br>extracellular structure organization (p=6.60e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.48e-08)<br>UDP-glycosyltransferase activity (p=7.27e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.34e-09)<br>basement membrane (p=3.11e-05)<\/div>"},{"id":"ITGB2","label":"ITGB2","x":1786.518,"y":989.9016,"size":11.7193,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"ITGB3","label":"ITGB3","x":697.7785,"y":1955.0435,"size":11.465,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.687<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>AQP1, BLMH, CDH1, CTSB, GFAP, HSPH1, ITGB3, MASP1, NDRG2, PREP, RNPEP, RPS17, SH3BGRL, SLC14A1<\/span><br><br><b>KEGG:<\/b><br> Renin secretion (p=2.23e-03)<br>Integrin signaling (p=1.07e-02)<br>Rap1 signaling pathway (p=1.96e-02)<br><br><b>BP:<\/b><br>positive regulation of fibroblast migration (p=5.37e-05)<br>regulation of neurotransmitter uptake (p=9.70e-05) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=7.96e-05)<br>endopeptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>melanosome (p=2.69e-03)<br>pigment granule (p=2.69e-03)<\/div>"},{"id":"IVD","label":"IVD","x":598.3635,"y":1838.3231,"size":13.8534,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.711<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACADVL, ANO1, BCAP31, EHD1, HSD17B4, IVD, LAMP1, LMNA, NTRK3, PCYOX1, PRXL2A<\/span><br><br><b>KEGG:<\/b><br> Fatty acid metabolism (p=1.22e-03)<br>Primary bile acid biosynthesis (p=1.59e-02)<br>Virion - Lassa virus and SFTS virus (p=1.59e-02)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=9.44e-06)<br>fatty acid beta-oxidation using acyl-CoA dehydrogenase (p=2.05e-05) <br> <b>MF:<\/b><br>flavin adenine dinucleotide binding (p=1.52e-05)<br>acyl-CoA dehydrogenase activity (p=2.08e-05) <br> <b>CC:<\/b><br>lipid droplet (p=1.50e-03)<br>platelet dense tubular network (p=6.07e-03)<\/div>"},{"id":"KLF6","label":"KLF6","x":993.6342,"y":2209.5655,"size":5,"color":"#8DA0CB","shape":"triangle","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.755<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CAVIN1, CPNE3, GRB2, KLF6, PACSIN3, PDCD6, PPP1CA, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=6.15e-04)<br>Alcoholism (p=1.18e-03)<br>Focal adhesion (p=1.33e-03)<br><br><b>BP:<\/b><br>response to metal ion (p=6.79e-04)<br>negative regulation of endocytosis (p=7.10e-04) <br> <b>MF:<\/b><br>ephrin receptor binding (p=9.72e-05)<br>calcium-dependent protein binding (p=8.01e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.03e-03)<br>cell-substrate junction (p=1.11e-03)<\/div>"},{"id":"LAMA2","label":"LAMA2","x":2135.2167,"y":1351.8189,"size":10.0813,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.659<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, B4GALT1, BGN, COL12A1, EOGT, ISLR, LAMA2, LAMA4, MGP, OMD, SERPINE2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=9.16e-06)<br>ECM-receptor interaction (p=2.96e-03)<br>Small cell lung cancer (p=3.22e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.52e-05)<br>extracellular structure organization (p=6.60e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.48e-08)<br>UDP-glycosyltransferase activity (p=7.27e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.34e-09)<br>basement membrane (p=3.11e-05)<\/div>"},{"id":"LAMA4","label":"LAMA4","x":1934.0408,"y":1242.2808,"size":9.7983,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.659<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, B4GALT1, BGN, COL12A1, EOGT, ISLR, LAMA2, LAMA4, MGP, OMD, SERPINE2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=9.16e-06)<br>ECM-receptor interaction (p=2.96e-03)<br>Small cell lung cancer (p=3.22e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.52e-05)<br>extracellular structure organization (p=6.60e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.48e-08)<br>UDP-glycosyltransferase activity (p=7.27e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.34e-09)<br>basement membrane (p=3.11e-05)<\/div>"},{"id":"LAMA5","label":"LAMA5","x":991.8684,"y":201.3376,"size":10.2525,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"LAMP1","label":"LAMP1","x":688.3677,"y":1478.3133,"size":9.5219,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.711<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACADVL, ANO1, BCAP31, EHD1, HSD17B4, IVD, LAMP1, LMNA, NTRK3, PCYOX1, PRXL2A<\/span><br><br><b>KEGG:<\/b><br> Fatty acid metabolism (p=1.22e-03)<br>Primary bile acid biosynthesis (p=1.59e-02)<br>Virion - Lassa virus and SFTS virus (p=1.59e-02)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=9.44e-06)<br>fatty acid beta-oxidation using acyl-CoA dehydrogenase (p=2.05e-05) <br> <b>MF:<\/b><br>flavin adenine dinucleotide binding (p=1.52e-05)<br>acyl-CoA dehydrogenase activity (p=2.08e-05) <br> <b>CC:<\/b><br>lipid droplet (p=1.50e-03)<br>platelet dense tubular network (p=6.07e-03)<\/div>"},{"id":"LEFTY1","label":"LEFTY1","x":381.27,"y":1255.0324,"size":19.3656,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"LGALS3BP","label":"LGALS3BP","x":783.6156,"y":1367.5168,"size":10.5151,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"LIMS1","label":"LIMS1","x":527.8443,"y":2528.5889,"size":5,"color":"#999999","shape":"triangle","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"LIMS2","label":"LIMS2","x":510.3488,"y":2569.272,"size":10.6905,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"LMNA","label":"LMNA","x":664.192,"y":1721.5954,"size":17.1209,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.711<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACADVL, ANO1, BCAP31, EHD1, HSD17B4, IVD, LAMP1, LMNA, NTRK3, PCYOX1, PRXL2A<\/span><br><br><b>KEGG:<\/b><br> Fatty acid metabolism (p=1.22e-03)<br>Primary bile acid biosynthesis (p=1.59e-02)<br>Virion - Lassa virus and SFTS virus (p=1.59e-02)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=9.44e-06)<br>fatty acid beta-oxidation using acyl-CoA dehydrogenase (p=2.05e-05) <br> <b>MF:<\/b><br>flavin adenine dinucleotide binding (p=1.52e-05)<br>acyl-CoA dehydrogenase activity (p=2.08e-05) <br> <b>CC:<\/b><br>lipid droplet (p=1.50e-03)<br>platelet dense tubular network (p=6.07e-03)<\/div>"},{"id":"LRRC59","label":"LRRC59","x":2424.5588,"y":1477.4611,"size":10.2697,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"LRRFIP1","label":"LRRFIP1","x":1167.4067,"y":278.9089,"size":10.2383,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.614<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ABCC12, ANOS1, ATP1A2, DDOST, DUSP6, ERP29, LRRFIP1, LSS, NOTCH3, TECR, TMED2, TMX1<\/span><br><br><b>KEGG:<\/b><br> Thyroid hormone signaling pathway (p=4.30e-03)<br>Protein processing in endoplasmic reticulum (p=8.58e-03)<br>Steroid biosynthesis (p=1.66e-02)<br><br><b>BP:<\/b><br>response to endoplasmic reticulum stress (p=6.71e-04)<br>regulation of response to endoplasmic reticulum stress (p=1.51e-03) <br> <b>MF:<\/b><br>ATPase-coupled transmembrane transporter activity (p=1.75e-03)<br>protein-folding chaperone binding (p=3.23e-03) <br> <b>CC:<\/b><br>sodium:potassium-exchanging ATPase complex (p=7.22e-03)<br>oligosaccharyltransferase complex (p=8.42e-03)<\/div>"},{"id":"LSS","label":"LSS","x":1357.8842,"y":264.584,"size":10.4381,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.614<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ABCC12, ANOS1, ATP1A2, DDOST, DUSP6, ERP29, LRRFIP1, LSS, NOTCH3, TECR, TMED2, TMX1<\/span><br><br><b>KEGG:<\/b><br> Thyroid hormone signaling pathway (p=4.30e-03)<br>Protein processing in endoplasmic reticulum (p=8.58e-03)<br>Steroid biosynthesis (p=1.66e-02)<br><br><b>BP:<\/b><br>response to endoplasmic reticulum stress (p=6.71e-04)<br>regulation of response to endoplasmic reticulum stress (p=1.51e-03) <br> <b>MF:<\/b><br>ATPase-coupled transmembrane transporter activity (p=1.75e-03)<br>protein-folding chaperone binding (p=3.23e-03) <br> <b>CC:<\/b><br>sodium:potassium-exchanging ATPase complex (p=7.22e-03)<br>oligosaccharyltransferase complex (p=8.42e-03)<\/div>"},{"id":"LTBP2","label":"LTBP2","x":642.5247,"y":1325.3286,"size":10.2934,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"MAMDC2","label":"MAMDC2","x":500.1294,"y":1228.183,"size":11.7193,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"MASP1","label":"MASP1","x":481.8329,"y":2004.5561,"size":11.866,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.687<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>AQP1, BLMH, CDH1, CTSB, GFAP, HSPH1, ITGB3, MASP1, NDRG2, PREP, RNPEP, RPS17, SH3BGRL, SLC14A1<\/span><br><br><b>KEGG:<\/b><br> Renin secretion (p=2.23e-03)<br>Integrin signaling (p=1.07e-02)<br>Rap1 signaling pathway (p=1.96e-02)<br><br><b>BP:<\/b><br>positive regulation of fibroblast migration (p=5.37e-05)<br>regulation of neurotransmitter uptake (p=9.70e-05) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=7.96e-05)<br>endopeptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>melanosome (p=2.69e-03)<br>pigment granule (p=2.69e-03)<\/div>"},{"id":"MASP2","label":"MASP2","x":1049.5286,"y":1221.1721,"size":12.8796,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"MBP","label":"MBP","x":1603.3129,"y":1073.8392,"size":10.0773,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"METAP2","label":"METAP2","x":591.3851,"y":2192.1732,"size":10.9772,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"MGP","label":"MGP","x":2291.5221,"y":1430.4958,"size":11.2179,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.659<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, B4GALT1, BGN, COL12A1, EOGT, ISLR, LAMA2, LAMA4, MGP, OMD, SERPINE2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=9.16e-06)<br>ECM-receptor interaction (p=2.96e-03)<br>Small cell lung cancer (p=3.22e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.52e-05)<br>extracellular structure organization (p=6.60e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.48e-08)<br>UDP-glycosyltransferase activity (p=7.27e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.34e-09)<br>basement membrane (p=3.11e-05)<\/div>"},{"id":"MRGPRF","label":"MRGPRF","x":539.6113,"y":1253.4381,"size":5,"color":"#FF7F00","shape":"triangle","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"NDRG2","label":"NDRG2","x":662.3089,"y":2023.3584,"size":9.8671,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.687<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>AQP1, BLMH, CDH1, CTSB, GFAP, HSPH1, ITGB3, MASP1, NDRG2, PREP, RNPEP, RPS17, SH3BGRL, SLC14A1<\/span><br><br><b>KEGG:<\/b><br> Renin secretion (p=2.23e-03)<br>Integrin signaling (p=1.07e-02)<br>Rap1 signaling pathway (p=1.96e-02)<br><br><b>BP:<\/b><br>positive regulation of fibroblast migration (p=5.37e-05)<br>regulation of neurotransmitter uptake (p=9.70e-05) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=7.96e-05)<br>endopeptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>melanosome (p=2.69e-03)<br>pigment granule (p=2.69e-03)<\/div>"},{"id":"NDUFS2","label":"NDUFS2","x":409.5525,"y":1471.9315,"size":12.1448,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.608<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CBR3, CNP, CYB5R3, EFTUD2, HBE1, HBG2, NDUFS2, PRDX3, RARS1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Diabetic cardiomyopathy (p=6.48e-03)<br>Chemical carcinogenesis - reactive oxygen species (p=7.90e-03)<br>Parkinson disease (p=1.11e-02)<br><br><b>BP:<\/b><br>hydrogen peroxide catabolic process (p=4.83e-07)<br>hydrogen peroxide metabolic process (p=2.80e-06) <br> <b>MF:<\/b><br>peroxidase activity (p=3.20e-06)<br>oxidoreductase activity, acting on peroxide as acceptor (p=3.56e-06) <br> <b>CC:<\/b><br>hemoglobin complex (p=2.01e-08)<br>haptoglobin-hemoglobin complex (p=1.25e-05)<\/div>"},{"id":"NEGR1","label":"NEGR1","x":763.1099,"y":100,"size":10.3878,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"NOTCH3","label":"NOTCH3","x":1112.2279,"y":388.0223,"size":9.9576,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.614<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ABCC12, ANOS1, ATP1A2, DDOST, DUSP6, ERP29, LRRFIP1, LSS, NOTCH3, TECR, TMED2, TMX1<\/span><br><br><b>KEGG:<\/b><br> Thyroid hormone signaling pathway (p=4.30e-03)<br>Protein processing in endoplasmic reticulum (p=8.58e-03)<br>Steroid biosynthesis (p=1.66e-02)<br><br><b>BP:<\/b><br>response to endoplasmic reticulum stress (p=6.71e-04)<br>regulation of response to endoplasmic reticulum stress (p=1.51e-03) <br> <b>MF:<\/b><br>ATPase-coupled transmembrane transporter activity (p=1.75e-03)<br>protein-folding chaperone binding (p=3.23e-03) <br> <b>CC:<\/b><br>sodium:potassium-exchanging ATPase complex (p=7.22e-03)<br>oligosaccharyltransferase complex (p=8.42e-03)<\/div>"},{"id":"NPNT","label":"NPNT","x":1522.2725,"y":986.5676,"size":18.2408,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"NTRK3","label":"NTRK3","x":607.2698,"y":1726.6017,"size":5,"color":"#377EB8","shape":"triangle","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.711<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACADVL, ANO1, BCAP31, EHD1, HSD17B4, IVD, LAMP1, LMNA, NTRK3, PCYOX1, PRXL2A<\/span><br><br><b>KEGG:<\/b><br> Fatty acid metabolism (p=1.22e-03)<br>Primary bile acid biosynthesis (p=1.59e-02)<br>Virion - Lassa virus and SFTS virus (p=1.59e-02)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=9.44e-06)<br>fatty acid beta-oxidation using acyl-CoA dehydrogenase (p=2.05e-05) <br> <b>MF:<\/b><br>flavin adenine dinucleotide binding (p=1.52e-05)<br>acyl-CoA dehydrogenase activity (p=2.08e-05) <br> <b>CC:<\/b><br>lipid droplet (p=1.50e-03)<br>platelet dense tubular network (p=6.07e-03)<\/div>"},{"id":"NUP54","label":"NUP54","x":1372.2466,"y":1041.7062,"size":5,"color":"#F781BF","shape":"triangle","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"OMD","label":"OMD","x":2272.8097,"y":1405.6523,"size":10.0424,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.659<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, B4GALT1, BGN, COL12A1, EOGT, ISLR, LAMA2, LAMA4, MGP, OMD, SERPINE2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=9.16e-06)<br>ECM-receptor interaction (p=2.96e-03)<br>Small cell lung cancer (p=3.22e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.52e-05)<br>extracellular structure organization (p=6.60e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.48e-08)<br>UDP-glycosyltransferase activity (p=7.27e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.34e-09)<br>basement membrane (p=3.11e-05)<\/div>"},{"id":"PACSIN3","label":"PACSIN3","x":1023.2956,"y":2278.187,"size":13.1026,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.755<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CAVIN1, CPNE3, GRB2, KLF6, PACSIN3, PDCD6, PPP1CA, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=6.15e-04)<br>Alcoholism (p=1.18e-03)<br>Focal adhesion (p=1.33e-03)<br><br><b>BP:<\/b><br>response to metal ion (p=6.79e-04)<br>negative regulation of endocytosis (p=7.10e-04) <br> <b>MF:<\/b><br>ephrin receptor binding (p=9.72e-05)<br>calcium-dependent protein binding (p=8.01e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.03e-03)<br>cell-substrate junction (p=1.11e-03)<\/div>"},{"id":"PCYOX1","label":"PCYOX1","x":666.499,"y":1489.9795,"size":11.2179,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.711<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACADVL, ANO1, BCAP31, EHD1, HSD17B4, IVD, LAMP1, LMNA, NTRK3, PCYOX1, PRXL2A<\/span><br><br><b>KEGG:<\/b><br> Fatty acid metabolism (p=1.22e-03)<br>Primary bile acid biosynthesis (p=1.59e-02)<br>Virion - Lassa virus and SFTS virus (p=1.59e-02)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=9.44e-06)<br>fatty acid beta-oxidation using acyl-CoA dehydrogenase (p=2.05e-05) <br> <b>MF:<\/b><br>flavin adenine dinucleotide binding (p=1.52e-05)<br>acyl-CoA dehydrogenase activity (p=2.08e-05) <br> <b>CC:<\/b><br>lipid droplet (p=1.50e-03)<br>platelet dense tubular network (p=6.07e-03)<\/div>"},{"id":"PDCD6","label":"PDCD6","x":917.5904,"y":2210.9461,"size":12.397,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.755<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CAVIN1, CPNE3, GRB2, KLF6, PACSIN3, PDCD6, PPP1CA, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=6.15e-04)<br>Alcoholism (p=1.18e-03)<br>Focal adhesion (p=1.33e-03)<br><br><b>BP:<\/b><br>response to metal ion (p=6.79e-04)<br>negative regulation of endocytosis (p=7.10e-04) <br> <b>MF:<\/b><br>ephrin receptor binding (p=9.72e-05)<br>calcium-dependent protein binding (p=8.01e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.03e-03)<br>cell-substrate junction (p=1.11e-03)<\/div>"},{"id":"PDLIM7","label":"PDLIM7","x":536.4054,"y":2506.1432,"size":10.2542,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"PGM2L1","label":"PGM2L1","x":1715.705,"y":1082.4283,"size":10.2937,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"PHGDH","label":"PHGDH","x":1508.3477,"y":1012.2284,"size":10.1818,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"PLAG1","label":"PLAG1","x":2119.2876,"y":807.3528,"size":5,"color":"#A65628","shape":"triangle","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"PLBD2","label":"PLBD2","x":1967.5477,"y":890.5015,"size":5,"color":"#A65628","shape":"triangle","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"PLPBP","label":"PLPBP","x":1466.4718,"y":976.6751,"size":5,"color":"#F781BF","shape":"triangle","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"PML","label":"PML","x":1489.1922,"y":1051.0802,"size":14.3436,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"PON3","label":"PON3","x":2044.0394,"y":974.5486,"size":5,"color":"#A65628","shape":"triangle","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"PPP1CA","label":"PPP1CA","x":701.622,"y":2077.9534,"size":11.0651,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.755<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CAVIN1, CPNE3, GRB2, KLF6, PACSIN3, PDCD6, PPP1CA, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=6.15e-04)<br>Alcoholism (p=1.18e-03)<br>Focal adhesion (p=1.33e-03)<br><br><b>BP:<\/b><br>response to metal ion (p=6.79e-04)<br>negative regulation of endocytosis (p=7.10e-04) <br> <b>MF:<\/b><br>ephrin receptor binding (p=9.72e-05)<br>calcium-dependent protein binding (p=8.01e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.03e-03)<br>cell-substrate junction (p=1.11e-03)<\/div>"},{"id":"PRDX3","label":"PRDX3","x":335.108,"y":1485.581,"size":10.1486,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.608<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CBR3, CNP, CYB5R3, EFTUD2, HBE1, HBG2, NDUFS2, PRDX3, RARS1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Diabetic cardiomyopathy (p=6.48e-03)<br>Chemical carcinogenesis - reactive oxygen species (p=7.90e-03)<br>Parkinson disease (p=1.11e-02)<br><br><b>BP:<\/b><br>hydrogen peroxide catabolic process (p=4.83e-07)<br>hydrogen peroxide metabolic process (p=2.80e-06) <br> <b>MF:<\/b><br>peroxidase activity (p=3.20e-06)<br>oxidoreductase activity, acting on peroxide as acceptor (p=3.56e-06) <br> <b>CC:<\/b><br>hemoglobin complex (p=2.01e-08)<br>haptoglobin-hemoglobin complex (p=1.25e-05)<\/div>"},{"id":"PREP","label":"PREP","x":410.5764,"y":2005.7892,"size":11.8771,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.687<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>AQP1, BLMH, CDH1, CTSB, GFAP, HSPH1, ITGB3, MASP1, NDRG2, PREP, RNPEP, RPS17, SH3BGRL, SLC14A1<\/span><br><br><b>KEGG:<\/b><br> Renin secretion (p=2.23e-03)<br>Integrin signaling (p=1.07e-02)<br>Rap1 signaling pathway (p=1.96e-02)<br><br><b>BP:<\/b><br>positive regulation of fibroblast migration (p=5.37e-05)<br>regulation of neurotransmitter uptake (p=9.70e-05) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=7.96e-05)<br>endopeptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>melanosome (p=2.69e-03)<br>pigment granule (p=2.69e-03)<\/div>"},{"id":"PRKAG1","label":"PRKAG1","x":894.3881,"y":278.4904,"size":9.6624,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"PRXL2A","label":"PRXL2A","x":696.9418,"y":1844.7138,"size":13.2174,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.711<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACADVL, ANO1, BCAP31, EHD1, HSD17B4, IVD, LAMP1, LMNA, NTRK3, PCYOX1, PRXL2A<\/span><br><br><b>KEGG:<\/b><br> Fatty acid metabolism (p=1.22e-03)<br>Primary bile acid biosynthesis (p=1.59e-02)<br>Virion - Lassa virus and SFTS virus (p=1.59e-02)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=9.44e-06)<br>fatty acid beta-oxidation using acyl-CoA dehydrogenase (p=2.05e-05) <br> <b>MF:<\/b><br>flavin adenine dinucleotide binding (p=1.52e-05)<br>acyl-CoA dehydrogenase activity (p=2.08e-05) <br> <b>CC:<\/b><br>lipid droplet (p=1.50e-03)<br>platelet dense tubular network (p=6.07e-03)<\/div>"},{"id":"PSMB7","label":"PSMB7","x":617.5051,"y":2260.9229,"size":9.4631,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"PSMD3","label":"PSMD3","x":1383.678,"y":989.6551,"size":10.3887,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"PTPRA","label":"PTPRA","x":1501.2935,"y":817.9472,"size":5,"color":"#984EA3","shape":"triangle","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.596<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, BASP1, BUB3, DEK, ESYT1, HNRNPH1, HNRNPU, PTPRA, RPL18A, WBP2, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Non-homologous end-joining (p=5.43e-03)<br>Cell cycle (p=6.45e-02)<br>Human T-cell leukemia virus 1 infection (p=9.05e-02)<br><br><b>BP:<\/b><br>attachment of spindle microtubules to kinetochore (p=4.38e-04)<br>regulation of mitotic sister chromatid segregation (p=5.05e-04) <br> <b>MF:<\/b><br>poly-pyrimidine tract binding (p=1.37e-04)<br>single-stranded RNA binding (p=1.21e-03) <br> <b>CC:<\/b><br>condensed chromosome (p=4.42e-04)<br>catalytic step 2 spliceosome (p=1.09e-03)<\/div>"},{"id":"PTX3","label":"PTX3","x":980.3166,"y":144.9652,"size":12.5255,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"RAB8B","label":"RAB8B","x":475.5468,"y":2226.3951,"size":10.6897,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"RAI14","label":"RAI14","x":1052.056,"y":2303.2712,"size":12.788,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.755<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CAVIN1, CPNE3, GRB2, KLF6, PACSIN3, PDCD6, PPP1CA, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=6.15e-04)<br>Alcoholism (p=1.18e-03)<br>Focal adhesion (p=1.33e-03)<br><br><b>BP:<\/b><br>response to metal ion (p=6.79e-04)<br>negative regulation of endocytosis (p=7.10e-04) <br> <b>MF:<\/b><br>ephrin receptor binding (p=9.72e-05)<br>calcium-dependent protein binding (p=8.01e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.03e-03)<br>cell-substrate junction (p=1.11e-03)<\/div>"},{"id":"RAN","label":"RAN","x":2524.3478,"y":1584.2508,"size":9.3357,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"RARS1","label":"RARS1","x":251.8662,"y":1454.0988,"size":11.3086,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.608<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CBR3, CNP, CYB5R3, EFTUD2, HBE1, HBG2, NDUFS2, PRDX3, RARS1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Diabetic cardiomyopathy (p=6.48e-03)<br>Chemical carcinogenesis - reactive oxygen species (p=7.90e-03)<br>Parkinson disease (p=1.11e-02)<br><br><b>BP:<\/b><br>hydrogen peroxide catabolic process (p=4.83e-07)<br>hydrogen peroxide metabolic process (p=2.80e-06) <br> <b>MF:<\/b><br>peroxidase activity (p=3.20e-06)<br>oxidoreductase activity, acting on peroxide as acceptor (p=3.56e-06) <br> <b>CC:<\/b><br>hemoglobin complex (p=2.01e-08)<br>haptoglobin-hemoglobin complex (p=1.25e-05)<\/div>"},{"id":"RHOB","label":"RHOB","x":3007.8042,"y":1570.4167,"size":13.715,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"RNPEP","label":"RNPEP","x":326.4756,"y":2020.0488,"size":10.4149,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.687<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>AQP1, BLMH, CDH1, CTSB, GFAP, HSPH1, ITGB3, MASP1, NDRG2, PREP, RNPEP, RPS17, SH3BGRL, SLC14A1<\/span><br><br><b>KEGG:<\/b><br> Renin secretion (p=2.23e-03)<br>Integrin signaling (p=1.07e-02)<br>Rap1 signaling pathway (p=1.96e-02)<br><br><b>BP:<\/b><br>positive regulation of fibroblast migration (p=5.37e-05)<br>regulation of neurotransmitter uptake (p=9.70e-05) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=7.96e-05)<br>endopeptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>melanosome (p=2.69e-03)<br>pigment granule (p=2.69e-03)<\/div>"},{"id":"RO60","label":"RO60","x":505.541,"y":2400.9447,"size":9.8494,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"RPL14","label":"RPL14","x":650.8726,"y":2168.9071,"size":10.6521,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"RPL18A","label":"RPL18A","x":1413.0472,"y":811.6617,"size":9.4631,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.596<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, BASP1, BUB3, DEK, ESYT1, HNRNPH1, HNRNPU, PTPRA, RPL18A, WBP2, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Non-homologous end-joining (p=5.43e-03)<br>Cell cycle (p=6.45e-02)<br>Human T-cell leukemia virus 1 infection (p=9.05e-02)<br><br><b>BP:<\/b><br>attachment of spindle microtubules to kinetochore (p=4.38e-04)<br>regulation of mitotic sister chromatid segregation (p=5.05e-04) <br> <b>MF:<\/b><br>poly-pyrimidine tract binding (p=1.37e-04)<br>single-stranded RNA binding (p=1.21e-03) <br> <b>CC:<\/b><br>condensed chromosome (p=4.42e-04)<br>catalytic step 2 spliceosome (p=1.09e-03)<\/div>"},{"id":"RPL29","label":"RPL29","x":588.0542,"y":2211.2305,"size":11.4408,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"RPL8","label":"RPL8","x":2506.3048,"y":1546.0207,"size":13.9475,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"RPS17","label":"RPS17","x":683.6468,"y":1972.6377,"size":18.8981,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.687<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>AQP1, BLMH, CDH1, CTSB, GFAP, HSPH1, ITGB3, MASP1, NDRG2, PREP, RNPEP, RPS17, SH3BGRL, SLC14A1<\/span><br><br><b>KEGG:<\/b><br> Renin secretion (p=2.23e-03)<br>Integrin signaling (p=1.07e-02)<br>Rap1 signaling pathway (p=1.96e-02)<br><br><b>BP:<\/b><br>positive regulation of fibroblast migration (p=5.37e-05)<br>regulation of neurotransmitter uptake (p=9.70e-05) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=7.96e-05)<br>endopeptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>melanosome (p=2.69e-03)<br>pigment granule (p=2.69e-03)<\/div>"},{"id":"RPS27L","label":"RPS27L","x":526.4572,"y":2209.9358,"size":12.0761,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"RTKN","label":"RTKN","x":3040.3031,"y":1586.7931,"size":5,"color":"#FFFF33","shape":"triangle","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"RTRAF","label":"RTRAF","x":2535.1397,"y":1615.3339,"size":11.3653,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"S100A16","label":"S100A16","x":1562.1009,"y":1126.4004,"size":12.8101,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"SAE1","label":"SAE1","x":546.0597,"y":2375.9986,"size":5,"color":"#999999","shape":"triangle","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"SARAF","label":"SARAF","x":1191.9073,"y":1011.8246,"size":5,"color":"#F781BF","shape":"triangle","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"SDCBP","label":"SDCBP","x":915.887,"y":2185.8394,"size":15.8009,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.755<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CAVIN1, CPNE3, GRB2, KLF6, PACSIN3, PDCD6, PPP1CA, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=6.15e-04)<br>Alcoholism (p=1.18e-03)<br>Focal adhesion (p=1.33e-03)<br><br><b>BP:<\/b><br>response to metal ion (p=6.79e-04)<br>negative regulation of endocytosis (p=7.10e-04) <br> <b>MF:<\/b><br>ephrin receptor binding (p=9.72e-05)<br>calcium-dependent protein binding (p=8.01e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.03e-03)<br>cell-substrate junction (p=1.11e-03)<\/div>"},{"id":"SEC23A","label":"SEC23A","x":845.382,"y":179.2779,"size":12.2714,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"SEPTIN8","label":"SEPTIN8","x":3099.9949,"y":1598.0518,"size":12.7821,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"SERPINE2","label":"SERPINE2","x":1881.1011,"y":1183.9038,"size":10.848,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.659<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, B4GALT1, BGN, COL12A1, EOGT, ISLR, LAMA2, LAMA4, MGP, OMD, SERPINE2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=9.16e-06)<br>ECM-receptor interaction (p=2.96e-03)<br>Small cell lung cancer (p=3.22e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.52e-05)<br>extracellular structure organization (p=6.60e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.48e-08)<br>UDP-glycosyltransferase activity (p=7.27e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.34e-09)<br>basement membrane (p=3.11e-05)<\/div>"},{"id":"SH3BGRL","label":"SH3BGRL","x":157.5031,"y":2051.5294,"size":12.9778,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.687<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>AQP1, BLMH, CDH1, CTSB, GFAP, HSPH1, ITGB3, MASP1, NDRG2, PREP, RNPEP, RPS17, SH3BGRL, SLC14A1<\/span><br><br><b>KEGG:<\/b><br> Renin secretion (p=2.23e-03)<br>Integrin signaling (p=1.07e-02)<br>Rap1 signaling pathway (p=1.96e-02)<br><br><b>BP:<\/b><br>positive regulation of fibroblast migration (p=5.37e-05)<br>regulation of neurotransmitter uptake (p=9.70e-05) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=7.96e-05)<br>endopeptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>melanosome (p=2.69e-03)<br>pigment granule (p=2.69e-03)<\/div>"},{"id":"SLC14A1","label":"SLC14A1","x":547.1692,"y":1948.1716,"size":15.9792,"color":"#66C2A5","shape":"dot","cluster":10,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 10<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.687<\/b><\/p><b>Genes (14):<\/b><br><span style='font-size:11px;'>AQP1, BLMH, CDH1, CTSB, GFAP, HSPH1, ITGB3, MASP1, NDRG2, PREP, RNPEP, RPS17, SH3BGRL, SLC14A1<\/span><br><br><b>KEGG:<\/b><br> Renin secretion (p=2.23e-03)<br>Integrin signaling (p=1.07e-02)<br>Rap1 signaling pathway (p=1.96e-02)<br><br><b>BP:<\/b><br>positive regulation of fibroblast migration (p=5.37e-05)<br>regulation of neurotransmitter uptake (p=9.70e-05) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=7.96e-05)<br>endopeptidase activity (p=1.85e-04) <br> <b>CC:<\/b><br>melanosome (p=2.69e-03)<br>pigment granule (p=2.69e-03)<\/div>"},{"id":"SNTB1","label":"SNTB1","x":958.449,"y":2191.7016,"size":13.4126,"color":"#8DA0CB","shape":"dot","cluster":12,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 12<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.755<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CAVIN1, CPNE3, GRB2, KLF6, PACSIN3, PDCD6, PPP1CA, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Insulin signaling pathway (p=6.15e-04)<br>Alcoholism (p=1.18e-03)<br>Focal adhesion (p=1.33e-03)<br><br><b>BP:<\/b><br>response to metal ion (p=6.79e-04)<br>negative regulation of endocytosis (p=7.10e-04) <br> <b>MF:<\/b><br>ephrin receptor binding (p=9.72e-05)<br>calcium-dependent protein binding (p=8.01e-04) <br> <b>CC:<\/b><br>focal adhesion (p=1.03e-03)<br>cell-substrate junction (p=1.11e-03)<\/div>"},{"id":"SNX12","label":"SNX12","x":496.636,"y":2599.9974,"size":18.8981,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"SNX18","label":"SNX18","x":2172.6161,"y":925.875,"size":9.7902,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"SORBS3","label":"SORBS3","x":1430.4733,"y":950.1679,"size":10.0518,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"SPP2","label":"SPP2","x":977.6869,"y":1286.8084,"size":12.5255,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"TECR","label":"TECR","x":1310.0504,"y":281.8161,"size":17.3116,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.614<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ABCC12, ANOS1, ATP1A2, DDOST, DUSP6, ERP29, LRRFIP1, LSS, NOTCH3, TECR, TMED2, TMX1<\/span><br><br><b>KEGG:<\/b><br> Thyroid hormone signaling pathway (p=4.30e-03)<br>Protein processing in endoplasmic reticulum (p=8.58e-03)<br>Steroid biosynthesis (p=1.66e-02)<br><br><b>BP:<\/b><br>response to endoplasmic reticulum stress (p=6.71e-04)<br>regulation of response to endoplasmic reticulum stress (p=1.51e-03) <br> <b>MF:<\/b><br>ATPase-coupled transmembrane transporter activity (p=1.75e-03)<br>protein-folding chaperone binding (p=3.23e-03) <br> <b>CC:<\/b><br>sodium:potassium-exchanging ATPase complex (p=7.22e-03)<br>oligosaccharyltransferase complex (p=8.42e-03)<\/div>"},{"id":"TIMP2","label":"TIMP2","x":588.7689,"y":1287.4922,"size":15.5081,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"TIMP3","label":"TIMP3","x":1758.8631,"y":1152.4412,"size":12.5194,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.659<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, B4GALT1, BGN, COL12A1, EOGT, ISLR, LAMA2, LAMA4, MGP, OMD, SERPINE2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=9.16e-06)<br>ECM-receptor interaction (p=2.96e-03)<br>Small cell lung cancer (p=3.22e-03)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.52e-05)<br>extracellular structure organization (p=6.60e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=2.48e-08)<br>UDP-glycosyltransferase activity (p=7.27e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.34e-09)<br>basement membrane (p=3.11e-05)<\/div>"},{"id":"TJP2","label":"TJP2","x":2963.183,"y":1569.8015,"size":11.6148,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.609<\/b><\/p><b>Genes (17):<\/b><br><span style='font-size:11px;'>AGL, AGRN, ANK3, BAG2, CTBP1, CTNND1, CYC1, HDGF, HSPB1, LRRC59, RAN, RHOB, RPL8, RTKN, RTRAF, SEPTIN8, TJP2<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=3.87e-02)<br>Starch and sucrose metabolism (p=5.31e-02)<br>IgSF CAM signaling (p=6.17e-02)<br><br><b>BP:<\/b><br>cytoskeleton-dependent cytokinesis (p=4.27e-06)<br>cytokinesis (p=2.35e-05) <br> <b>MF:<\/b><br>cadherin binding (p=9.30e-06)<br>transmembrane transporter binding (p=2.40e-04) <br> <b>CC:<\/b><br>cell division site (p=2.41e-05)<br>presynaptic active zone cytoplasmic component (p=9.29e-05)<\/div>"},{"id":"TMED2","label":"TMED2","x":1180.4695,"y":336.8124,"size":13.7501,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.614<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ABCC12, ANOS1, ATP1A2, DDOST, DUSP6, ERP29, LRRFIP1, LSS, NOTCH3, TECR, TMED2, TMX1<\/span><br><br><b>KEGG:<\/b><br> Thyroid hormone signaling pathway (p=4.30e-03)<br>Protein processing in endoplasmic reticulum (p=8.58e-03)<br>Steroid biosynthesis (p=1.66e-02)<br><br><b>BP:<\/b><br>response to endoplasmic reticulum stress (p=6.71e-04)<br>regulation of response to endoplasmic reticulum stress (p=1.51e-03) <br> <b>MF:<\/b><br>ATPase-coupled transmembrane transporter activity (p=1.75e-03)<br>protein-folding chaperone binding (p=3.23e-03) <br> <b>CC:<\/b><br>sodium:potassium-exchanging ATPase complex (p=7.22e-03)<br>oligosaccharyltransferase complex (p=8.42e-03)<\/div>"},{"id":"TMX1","label":"TMX1","x":1275.7503,"y":259.3942,"size":5,"color":"#E41A1C","shape":"triangle","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.614<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>ABCC12, ANOS1, ATP1A2, DDOST, DUSP6, ERP29, LRRFIP1, LSS, NOTCH3, TECR, TMED2, TMX1<\/span><br><br><b>KEGG:<\/b><br> Thyroid hormone signaling pathway (p=4.30e-03)<br>Protein processing in endoplasmic reticulum (p=8.58e-03)<br>Steroid biosynthesis (p=1.66e-02)<br><br><b>BP:<\/b><br>response to endoplasmic reticulum stress (p=6.71e-04)<br>regulation of response to endoplasmic reticulum stress (p=1.51e-03) <br> <b>MF:<\/b><br>ATPase-coupled transmembrane transporter activity (p=1.75e-03)<br>protein-folding chaperone binding (p=3.23e-03) <br> <b>CC:<\/b><br>sodium:potassium-exchanging ATPase complex (p=7.22e-03)<br>oligosaccharyltransferase complex (p=8.42e-03)<\/div>"},{"id":"TNS1","label":"TNS1","x":1614.3127,"y":1032.9189,"size":13.4593,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"TRIP6","label":"TRIP6","x":548.2921,"y":2478.2645,"size":11.1671,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"TYMP","label":"TYMP","x":1755.9187,"y":1090.6239,"size":11.4495,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.672<\/b><\/p><b>Genes (20):<\/b><br><span style='font-size:11px;'>AKT1, ANGPTL4, ANXA11, ELOC, ENTPD1, ESYT2, GYS1, MBP, NPNT, NUP54, PGM2L1, PHGDH, PLPBP, PML, PSMD3, S100A16, SARAF, SORBS3, TNS1, TYMP<\/span><br><br><b>KEGG:<\/b><br> Starch and sucrose metabolism (p=1.73e-03)<br>Pyrimidine metabolism (p=3.61e-03)<br>Epstein-Barr virus infection (p=3.65e-03)<br><br><b>BP:<\/b><br>fibroblast migration (p=2.75e-05)<br>myelination (p=5.97e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=1.47e-04)<br>calcium-dependent phospholipid binding (p=1.46e-03) <br> <b>CC:<\/b><br>endoplasmic reticulum-plasma membrane contact site (p=6.31e-05)<br>organelle membrane contact site (p=1.43e-03)<\/div>"},{"id":"UBA2","label":"UBA2","x":573.3642,"y":2414.2385,"size":10.0773,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"UBA5","label":"UBA5","x":800.4396,"y":155.8445,"size":10.0636,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"UBE2L3","label":"UBE2L3","x":575.7357,"y":2444.0948,"size":10.2934,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 12 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.6<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>ANAPC1, COPS6, EIF2S1, FBLN7, LIMS1, LIMS2, METAP2, PDLIM7, PSMB7, RAB8B, RO60, RPL14, RPL29, RPS27L, SAE1, SNX12, TRIP6, UBA2, UBE2L3<\/span><br><br><b>KEGG:<\/b><br> Ubiquitin mediated proteolysis (p=7.39e-05)<br>Coronavirus disease - COVID-19 (p=6.71e-03)<br>Parkinson disease (p=9.59e-03)<br><br><b>BP:<\/b><br>positive regulation of integrin-mediated signaling pathway (p=6.34e-05)<br>positive regulation of protein sumoylation (p=7.49e-05) <br> <b>MF:<\/b><br>ubiquitin-like modifier activating enzyme activity (p=4.41e-05)<br>structural constituent of ribosome (p=7.06e-04) <br> <b>CC:<\/b><br>focal adhesion (p=3.92e-05)<br>cell-substrate junction (p=4.38e-05)<\/div>"},{"id":"USO1","label":"USO1","x":2000.6494,"y":959.2945,"size":12.6087,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"VDAC1","label":"VDAC1","x":540.1262,"y":1479.5051,"size":10.212,"color":"#E78AC3","shape":"dot","cluster":13,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 10 - Cluster 13<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.608<\/b><\/p><b>Genes (10):<\/b><br><span style='font-size:11px;'>CBR3, CNP, CYB5R3, EFTUD2, HBE1, HBG2, NDUFS2, PRDX3, RARS1, VDAC1<\/span><br><br><b>KEGG:<\/b><br> Diabetic cardiomyopathy (p=6.48e-03)<br>Chemical carcinogenesis - reactive oxygen species (p=7.90e-03)<br>Parkinson disease (p=1.11e-02)<br><br><b>BP:<\/b><br>hydrogen peroxide catabolic process (p=4.83e-07)<br>hydrogen peroxide metabolic process (p=2.80e-06) <br> <b>MF:<\/b><br>peroxidase activity (p=3.20e-06)<br>oxidoreductase activity, acting on peroxide as acceptor (p=3.56e-06) <br> <b>CC:<\/b><br>hemoglobin complex (p=2.01e-08)<br>haptoglobin-hemoglobin complex (p=1.25e-05)<\/div>"},{"id":"VPS26B","label":"VPS26B","x":2262.3253,"y":908.2139,"size":14.0893,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 11 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.601<\/b><\/p><b>Genes (19):<\/b><br><span style='font-size:11px;'>AIP, ANXA7, CD14, CD59, CMAS, CTSZ, EDIL3, FAM184B, GLG1, GPC6, HAPLN3, HDGFL3, ITGB2, PLAG1, PLBD2, PON3, SNX18, USO1, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Legionellosis (p=1.47e-03)<br>Pertussis (p=2.83e-03)<br>Complement and coagulation cascades (p=3.59e-03)<br><br><b>BP:<\/b><br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=1.47e-04)<br>negative regulation of protein processing (p=2.16e-04) <br> <b>MF:<\/b><br>complement binding (p=2.61e-04)<br>integrin binding (p=4.69e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=3.21e-05)<br>COPII-coated ER to Golgi transport vesicle (p=8.19e-05)<\/div>"},{"id":"VTN","label":"VTN","x":1093.2903,"y":1209.7281,"size":14.7075,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.796<\/b><\/p><b>Genes (16):<\/b><br><span style='font-size:11px;'>AFM, COL4A2, DSP, FBLN2, GSN, IGFBP4, IGFBP6, LEFTY1, LGALS3BP, LTBP2, MAMDC2, MASP2, MRGPRF, SPP2, TIMP2, VTN<\/span><br><br><b>KEGG:<\/b><br> Cytoskeleton in muscle cells (p=4.65e-04)<br>Complement and coagulation cascades (p=1.71e-03)<br>ECM-receptor interaction (p=1.75e-03)<br><br><b>BP:<\/b><br>regulation of insulin-like growth factor receptor signaling pathway (p=1.76e-04)<br>negative regulation of peptidase activity (p=7.70e-04) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=1.07e-05)<br>extracellular matrix binding (p=2.40e-05) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.11e-08)<br>blood microparticle (p=4.62e-06)<\/div>"},{"id":"WBP2","label":"WBP2","x":1496.0148,"y":783.9592,"size":11.1321,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.596<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, BASP1, BUB3, DEK, ESYT1, HNRNPH1, HNRNPU, PTPRA, RPL18A, WBP2, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Non-homologous end-joining (p=5.43e-03)<br>Cell cycle (p=6.45e-02)<br>Human T-cell leukemia virus 1 infection (p=9.05e-02)<br><br><b>BP:<\/b><br>attachment of spindle microtubules to kinetochore (p=4.38e-04)<br>regulation of mitotic sister chromatid segregation (p=5.05e-04) <br> <b>MF:<\/b><br>poly-pyrimidine tract binding (p=1.37e-04)<br>single-stranded RNA binding (p=1.21e-03) <br> <b>CC:<\/b><br>condensed chromosome (p=4.42e-04)<br>catalytic step 2 spliceosome (p=1.09e-03)<\/div>"},{"id":"WDR44","label":"WDR44","x":1064.0515,"y":150.5492,"size":11.1588,"color":"#FC8D62","shape":"dot","cluster":11,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 11<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.725<\/b><\/p><b>Genes (15):<\/b><br><span style='font-size:11px;'>ARFGEF1, CD74, COL18A1, CXCL12, FGL2, GNB2, IGFBP2, INSIG2, LAMA5, NEGR1, PRKAG1, PTX3, SEC23A, UBA5, WDR44<\/span><br><br><b>KEGG:<\/b><br> Apelin signaling pathway (p=7.16e-03)<br>Chemokine signaling pathway (p=1.33e-02)<br>Human cytomegalovirus infection (p=1.81e-02)<br><br><b>BP:<\/b><br>regulation of dendritic cell antigen processing and presentation (p=3.25e-05)<br>dendritic cell antigen processing and presentation (p=7.08e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=3.02e-04)<br>molecular sequestering activity (p=8.76e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=2.48e-04)<br>ER to Golgi transport vesicle membrane (p=1.04e-03)<\/div>"},{"id":"XRCC6","label":"XRCC6","x":1182.81,"y":494.0387,"size":10.3671,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 13 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.596<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ADD3, BASP1, BUB3, DEK, ESYT1, HNRNPH1, HNRNPU, PTPRA, RPL18A, WBP2, XRCC6<\/span><br><br><b>KEGG:<\/b><br> Non-homologous end-joining (p=5.43e-03)<br>Cell cycle (p=6.45e-02)<br>Human T-cell leukemia virus 1 infection (p=9.05e-02)<br><br><b>BP:<\/b><br>attachment of spindle microtubules to kinetochore (p=4.38e-04)<br>regulation of mitotic sister chromatid segregation (p=5.05e-04) <br> <b>MF:<\/b><br>poly-pyrimidine tract binding (p=1.37e-04)<br>single-stranded RNA binding (p=1.21e-03) <br> <b>CC:<\/b><br>condensed chromosome (p=4.42e-04)<br>catalytic step 2 spliceosome (p=1.09e-03)<\/div>"}],"aristas":[{"from":"AKT1","to":"TIMP3","weight":0.453},{"from":"AKT1","to":"TNS1","weight":0.435},{"from":"EHD1","to":"LAMP1","weight":0.411},{"from":"EHD1","to":"LMNA","weight":0.402},{"from":"AKT1","to":"GSN","weight":0.43},{"from":"LAMP1","to":"VDAC1","weight":0.429},{"from":"CYB5R3","to":"VDAC1","weight":0.497},{"from":"COL18A1","to":"CXCL12","weight":0.444},{"from":"COL18A1","to":"LAMA5","weight":0.421},{"from":"CXCL12","to":"NOTCH3","weight":0.402},{"from":"LAMA4","to":"TIMP3","weight":0.405},{"from":"BGN","to":"LAMA4","weight":0.401},{"from":"TRIP6","to":"UBA2","weight":0.402},{"from":"PDLIM7","to":"TRIP6","weight":0.472},{"from":"LGALS3BP","to":"LTBP2","weight":0.431},{"from":"FBLN2","to":"LTBP2","weight":0.45},{"from":"AFM","to":"SPP2","weight":0.445},{"from":"LGALS3BP","to":"SPP2","weight":0.412},{"from":"ADD3","to":"BASP1","weight":0.41},{"from":"ADD3","to":"ESYT1","weight":0.435},{"from":"AFM","to":"GSN","weight":0.448},{"from":"AFM","to":"VTN","weight":0.416},{"from":"LAMP1","to":"LGALS3BP","weight":0.444},{"from":"LAMP1","to":"PCYOX1","weight":0.781},{"from":"ESYT2","to":"NUP54","weight":0.408},{"from":"ESYT2","to":"SARAF","weight":0.427},{"from":"ANXA11","to":"SARAF","weight":0.411},{"from":"AKT1","to":"PHGDH","weight":0.452},{"from":"PHGDH","to":"PLPBP","weight":0.415},{"from":"PLPBP","to":"SORBS3","weight":0.409},{"from":"AKT1","to":"PML","weight":0.732},{"from":"NUP54","to":"PML","weight":0.403},{"from":"CXCL12","to":"GNB2","weight":0.419},{"from":"GRB2","to":"SDCBP","weight":0.501},{"from":"KLF6","to":"SDCBP","weight":0.409},{"from":"CPNE3","to":"KLF6","weight":0.416},{"from":"LTBP2","to":"TIMP2","weight":0.409},{"from":"MRGPRF","to":"TIMP2","weight":0.402},{"from":"MAMDC2","to":"MRGPRF","weight":0.419},{"from":"BGN","to":"LAMA2","weight":0.42},{"from":"AKT1","to":"ITGB2","weight":0.456},{"from":"EDIL3","to":"ITGB2","weight":0.481},{"from":"CTSZ","to":"ITGB2","weight":0.446},{"from":"ANXA7","to":"CTSZ","weight":0.407},{"from":"HNRNPH1","to":"RPL18A","weight":0.433},{"from":"HNRNPU","to":"RPL18A","weight":0.414},{"from":"COL4A2","to":"FBLN2","weight":0.418},{"from":"CTSB","to":"PREP","weight":0.406},{"from":"PREP","to":"RNPEP","weight":0.614},{"from":"NOTCH3","to":"XRCC6","weight":0.43},{"from":"ATP1A2","to":"NOTCH3","weight":0.403},{"from":"ANXA7","to":"SNX18","weight":0.468},{"from":"ACADVL","to":"CDH1","weight":0.432},{"from":"CDH1","to":"PPP1CA","weight":0.442},{"from":"CDH1","to":"ITGB3","weight":0.462},{"from":"BUB3","to":"HNRNPU","weight":0.406},{"from":"BUB3","to":"XRCC6","weight":0.431},{"from":"CYC1","to":"RPL8","weight":0.401},{"from":"AGL","to":"CYC1","weight":0.545},{"from":"BLMH","to":"SH3BGRL","weight":0.404},{"from":"BLMH","to":"RNPEP","weight":0.407},{"from":"EDIL3","to":"GPC6","weight":0.423},{"from":"LRRC59","to":"RPL8","weight":0.431},{"from":"RAN","to":"RPL8","weight":0.45},{"from":"NOTCH3","to":"TMED2","weight":0.444},{"from":"DDOST","to":"TMED2","weight":0.508},{"from":"BASP1","to":"HNRNPH1","weight":0.461},{"from":"CDH1","to":"CTSB","weight":0.404},{"from":"NDUFS2","to":"PRDX3","weight":0.529},{"from":"CBR3","to":"PRDX3","weight":0.444},{"from":"COL12A1","to":"TIMP3","weight":0.415},{"from":"EDIL3","to":"HAPLN3","weight":0.419},{"from":"CD74","to":"CXCL12","weight":0.411},{"from":"CD74","to":"SEC23A","weight":0.499},{"from":"CD74","to":"FGL2","weight":0.404},{"from":"ACADVL","to":"IVD","weight":0.437},{"from":"HSD17B4","to":"IVD","weight":0.433},{"from":"METAP2","to":"RPS27L","weight":0.466},{"from":"RAB8B","to":"RPS27L","weight":0.45},{"from":"PSMB7","to":"RPL14","weight":0.436},{"from":"EIF2S1","to":"PSMB7","weight":0.401},{"from":"AKT1","to":"MBP","weight":0.456},{"from":"PPP1CA","to":"RPL14","weight":0.482},{"from":"CTSZ","to":"USO1","weight":0.499},{"from":"PDCD6","to":"SDCBP","weight":0.539},{"from":"COPS6","to":"UBA2","weight":0.423},{"from":"NPNT","to":"PHGDH","weight":0.407},{"from":"ABCC12","to":"TMED2","weight":0.422},{"from":"ABCC12","to":"LRRFIP1","weight":0.405},{"from":"AKT1","to":"HNRNPH1","weight":0.412},{"from":"BGN","to":"OMD","weight":0.432},{"from":"MGP","to":"OMD","weight":0.407},{"from":"AGRN","to":"HDGF","weight":0.409},{"from":"AGRN","to":"ANK3","weight":0.409},{"from":"LRRC59","to":"OMD","weight":0.43},{"from":"DSP","to":"VTN","weight":0.448},{"from":"COL12A1","to":"SERPINE2","weight":0.487},{"from":"NDUFS2","to":"VDAC1","weight":0.459},{"from":"CNP","to":"NDUFS2","weight":0.528},{"from":"CTNND1","to":"TJP2","weight":0.588},{"from":"RHOB","to":"TJP2","weight":0.626},{"from":"CDH1","to":"GFAP","weight":0.479},{"from":"AKT1","to":"ENTPD1","weight":0.428},{"from":"EFTUD2","to":"NDUFS2","weight":0.458},{"from":"CTSB","to":"MASP1","weight":0.452},{"from":"COPS6","to":"PSMB7","weight":0.447},{"from":"COPS6","to":"SAE1","weight":0.415},{"from":"RO60","to":"SAE1","weight":0.408},{"from":"RAN","to":"RTRAF","weight":0.443},{"from":"ELOC","to":"PHGDH","weight":0.448},{"from":"COL4A2","to":"LEFTY1","weight":0.407},{"from":"ACADVL","to":"LMNA","weight":0.442},{"from":"ACADVL","to":"PRXL2A","weight":0.429},{"from":"CAVIN1","to":"PACSIN3","weight":0.403},{"from":"PACSIN3","to":"RAI14","weight":0.643},{"from":"DUSP6","to":"NOTCH3","weight":0.406},{"from":"ANOS1","to":"DUSP6","weight":0.401},{"from":"SDCBP","to":"SNTB1","weight":0.518},{"from":"HDGF","to":"LRRC59","weight":0.414},{"from":"METAP2","to":"RPL14","weight":0.544},{"from":"METAP2","to":"RPL29","weight":0.588},{"from":"IGFBP2","to":"PTX3","weight":0.404},{"from":"COL18A1","to":"IGFBP2","weight":0.406},{"from":"ANO1","to":"NTRK3","weight":0.403},{"from":"LMNA","to":"NTRK3","weight":0.412},{"from":"BASP1","to":"PTPRA","weight":0.403},{"from":"PTPRA","to":"WBP2","weight":0.404},{"from":"CAVIN1","to":"SDCBP","weight":0.406},{"from":"GRB2","to":"PPP1CA","weight":0.452},{"from":"SNX18","to":"VPS26B","weight":0.404},{"from":"CMAS","to":"VPS26B","weight":0.527},{"from":"B4GALT1","to":"OMD","weight":0.418},{"from":"B4GALT1","to":"EOGT","weight":0.404},{"from":"CDH1","to":"RPS17","weight":0.804},{"from":"ADAMTSL3","to":"B3GLCT","weight":0.438},{"from":"B3GLCT","to":"TIMP3","weight":0.401},{"from":"AKT1","to":"GYS1","weight":0.623},{"from":"GYS1","to":"PGM2L1","weight":0.412},{"from":"ELOC","to":"PSMD3","weight":0.472},{"from":"GLG1","to":"ITGB2","weight":0.568},{"from":"GLG1","to":"PLBD2","weight":0.414},{"from":"AIP","to":"PLBD2","weight":0.41},{"from":"ARFGEF1","to":"WDR44","weight":0.404},{"from":"ARFGEF1","to":"COL18A1","weight":0.428},{"from":"ANK3","to":"CTNND1","weight":0.486},{"from":"DEK","to":"RPL18A","weight":0.408},{"from":"HSPH1","to":"SH3BGRL","weight":0.416},{"from":"CTBP1","to":"HDGF","weight":0.511},{"from":"GNB2","to":"PRKAG1","weight":0.685},{"from":"MASP2","to":"VTN","weight":0.454},{"from":"ANAPC1","to":"PSMB7","weight":0.409},{"from":"ANAPC1","to":"FBLN7","weight":0.407},{"from":"DDOST","to":"TECR","weight":0.527},{"from":"LSS","to":"TECR","weight":0.461},{"from":"SEC23A","to":"UBA5","weight":0.401},{"from":"EFTUD2","to":"RARS1","weight":0.413},{"from":"CYB5R3","to":"HBG2","weight":0.56},{"from":"RTKN","to":"TJP2","weight":0.411},{"from":"RTKN","to":"SEPTIN8","weight":0.414},{"from":"BCAP31","to":"LAMP1","weight":0.441},{"from":"PGM2L1","to":"TYMP","weight":0.738},{"from":"BGN","to":"ISLR","weight":0.424},{"from":"LIMS1","to":"LIMS2","weight":0.418},{"from":"LIMS1","to":"TRIP6","weight":0.413},{"from":"CD59","to":"ITGB2","weight":0.443},{"from":"INSIG2","to":"NEGR1","weight":0.425},{"from":"INSIG2","to":"SEC23A","weight":0.404},{"from":"CYB5R3","to":"HBE1","weight":0.561},{"from":"HDGFL3","to":"PON3","weight":0.41},{"from":"CTSZ","to":"PON3","weight":0.412},{"from":"BAG2","to":"HSPB1","weight":0.408},{"from":"CYC1","to":"HSPB1","weight":0.402},{"from":"ERP29","to":"TMX1","weight":0.413},{"from":"DDOST","to":"TMX1","weight":0.403},{"from":"AQP1","to":"SLC14A1","weight":0.404},{"from":"AQP1","to":"CDH1","weight":0.411},{"from":"UBA2","to":"UBE2L3","weight":0.429},{"from":"GFAP","to":"NDRG2","weight":0.413},{"from":"CD14","to":"ITGB2","weight":0.805},{"from":"IGFBP4","to":"IGFBP6","weight":0.416},{"from":"FBLN2","to":"IGFBP4","weight":0.417},{"from":"LIMS2","to":"SNX12","weight":0.418},{"from":"FAM184B","to":"PLAG1","weight":0.412},{"from":"AIP","to":"PLAG1","weight":0.418},{"from":"ANGPTL4","to":"S100A16","weight":0.417},{"from":"AKT1","to":"ANGPTL4","weight":0.41}],"clusters":[{"cluster":5,"color":"#FF7F00","count":16,"mean_fc":0.796,"rank":1},{"cluster":12,"color":"#8DA0CB","count":10,"mean_fc":0.755,"rank":2},{"cluster":11,"color":"#FC8D62","count":15,"mean_fc":0.725,"rank":3},{"cluster":2,"color":"#377EB8","count":11,"mean_fc":0.711,"rank":4},{"cluster":10,"color":"#66C2A5","count":14,"mean_fc":0.687,"rank":5},{"cluster":8,"color":"#F781BF","count":20,"mean_fc":0.672,"rank":6},{"cluster":3,"color":"#4DAF4A","count":13,"mean_fc":0.659,"rank":7},{"cluster":1,"color":"#E41A1C","count":12,"mean_fc":0.614,"rank":8},{"cluster":6,"color":"#FFFF33","count":17,"mean_fc":0.609,"rank":9},{"cluster":13,"color":"#E78AC3","count":10,"mean_fc":0.608,"rank":10},{"cluster":7,"color":"#A65628","count":19,"mean_fc":0.601,"rank":11},{"cluster":9,"color":"#999999","count":19,"mean_fc":0.6,"rank":12},{"cluster":4,"color":"#984EA3","count":11,"mean_fc":0.596,"rank":13}],"stats":{"nodos":187,"aristas":186,"clusters":13}},"P001":{"nodos":[{"id":"ACACB","label":"ACACB","x":2934.7283,"y":998.3655,"size":5,"color":"#E41A1C","shape":"triangle","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.639<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACACB, BUB3, CNP, DECR1, EFTUD2, GYS1, HNRNPU, HSD17B4, IVD, NDUFS2, RPS27L<\/span><br><br><b>KEGG:<\/b><br> Glucagon signaling pathway (p=4.24e-03)<br>Insulin resistance (p=4.40e-03)<br>AMPK signaling pathway (p=5.48e-03)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=7.14e-08)<br>fatty acid catabolic process (p=2.94e-07) <br> <b>MF:<\/b><br>snRNA binding (p=4.46e-04)<br>oxidoreductase activity, acting on the CH-CH group of donors (p=5.50e-04) <br> <b>CC:<\/b><br>catalytic step 2 spliceosome (p=1.09e-03)<br>oxidoreductase complex (p=3.09e-03)<\/div>"},{"id":"ADAMTSL3","label":"ADAMTSL3","x":935.155,"y":851.2641,"size":12.2492,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.025<\/b><\/p><b>Genes (8):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, COL12A1, FAM3C, PLG, PTX3, SPP2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=1.95e-02)<br>Complement and coagulation cascades (p=3.63e-02)<br>Staphylococcus aureus infection (p=4.20e-02)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.86e-06)<br>extracellular structure organization (p=6.94e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=2.01e-03)<br>peptidase inhibitor activity (p=2.21e-03) <br> <b>CC:<\/b><br>platelet dense granule lumen (p=1.55e-08)<br>platelet dense granule (p=5.67e-08)<\/div>"},{"id":"AGRN","label":"AGRN","x":325.3156,"y":1409.0383,"size":14.7802,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.752<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AGRN, BGN, CMAS, EDIL3, FGL2, GPC6, HLA-DMB, ITGB2, MAMDC2, MRGPRF, NCAPD3, TIMP2, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Viral myocarditis (p=7.78e-04)<br>Leishmaniasis (p=9.90e-04)<br>Rheumatoid arthritis (p=1.43e-03)<br><br><b>BP:<\/b><br>T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (p=3.38e-05)<br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=6.34e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=4.27e-06)<br>extracellular matrix binding (p=9.68e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.53e-07)<br>lysosomal lumen (p=3.21e-05)<\/div>"},{"id":"AIP","label":"AIP","x":2229.2131,"y":994.2603,"size":15.5076,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.046<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>AIP, ANO1, AQP1, CDH1, EHD1, LMNA, NTRK3, RPL8, RPS17, SLC14A1, TDGF1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=1.56e-02)<br>Proximal tubule bicarbonate reclamation (p=1.91e-02)<br>IgSF CAM signaling (p=2.45e-02)<br><br><b>BP:<\/b><br>one-carbon compound transport (p=8.22e-05)<br>water transport (p=1.03e-04) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=3.95e-05)<br>ligand-gated monoatomic cation channel activity (p=2.29e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.52e-03)<br>ribosomal subunit (p=3.73e-03)<\/div>"},{"id":"ANO1","label":"ANO1","x":2469.7648,"y":1968.3158,"size":14.434,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.046<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>AIP, ANO1, AQP1, CDH1, EHD1, LMNA, NTRK3, RPL8, RPS17, SLC14A1, TDGF1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=1.56e-02)<br>Proximal tubule bicarbonate reclamation (p=1.91e-02)<br>IgSF CAM signaling (p=2.45e-02)<br><br><b>BP:<\/b><br>one-carbon compound transport (p=8.22e-05)<br>water transport (p=1.03e-04) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=3.95e-05)<br>ligand-gated monoatomic cation channel activity (p=2.29e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.52e-03)<br>ribosomal subunit (p=3.73e-03)<\/div>"},{"id":"AQP1","label":"AQP1","x":1525.5204,"y":1184.168,"size":5,"color":"#984EA3","shape":"triangle","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.046<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>AIP, ANO1, AQP1, CDH1, EHD1, LMNA, NTRK3, RPL8, RPS17, SLC14A1, TDGF1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=1.56e-02)<br>Proximal tubule bicarbonate reclamation (p=1.91e-02)<br>IgSF CAM signaling (p=2.45e-02)<br><br><b>BP:<\/b><br>one-carbon compound transport (p=8.22e-05)<br>water transport (p=1.03e-04) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=3.95e-05)<br>ligand-gated monoatomic cation channel activity (p=2.29e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.52e-03)<br>ribosomal subunit (p=3.73e-03)<\/div>"},{"id":"B3GLCT","label":"B3GLCT","x":1052.2046,"y":1068.1691,"size":5,"color":"#377EB8","shape":"triangle","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.025<\/b><\/p><b>Genes (8):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, COL12A1, FAM3C, PLG, PTX3, SPP2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=1.95e-02)<br>Complement and coagulation cascades (p=3.63e-02)<br>Staphylococcus aureus infection (p=4.20e-02)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.86e-06)<br>extracellular structure organization (p=6.94e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=2.01e-03)<br>peptidase inhibitor activity (p=2.21e-03) <br> <b>CC:<\/b><br>platelet dense granule lumen (p=1.55e-08)<br>platelet dense granule (p=5.67e-08)<\/div>"},{"id":"BGN","label":"BGN","x":401.9367,"y":1236.9714,"size":13.9956,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.752<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AGRN, BGN, CMAS, EDIL3, FGL2, GPC6, HLA-DMB, ITGB2, MAMDC2, MRGPRF, NCAPD3, TIMP2, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Viral myocarditis (p=7.78e-04)<br>Leishmaniasis (p=9.90e-04)<br>Rheumatoid arthritis (p=1.43e-03)<br><br><b>BP:<\/b><br>T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (p=3.38e-05)<br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=6.34e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=4.27e-06)<br>extracellular matrix binding (p=9.68e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.53e-07)<br>lysosomal lumen (p=3.21e-05)<\/div>"},{"id":"BUB3","label":"BUB3","x":2793.3762,"y":2079.618,"size":14.243,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.639<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACACB, BUB3, CNP, DECR1, EFTUD2, GYS1, HNRNPU, HSD17B4, IVD, NDUFS2, RPS27L<\/span><br><br><b>KEGG:<\/b><br> Glucagon signaling pathway (p=4.24e-03)<br>Insulin resistance (p=4.40e-03)<br>AMPK signaling pathway (p=5.48e-03)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=7.14e-08)<br>fatty acid catabolic process (p=2.94e-07) <br> <b>MF:<\/b><br>snRNA binding (p=4.46e-04)<br>oxidoreductase activity, acting on the CH-CH group of donors (p=5.50e-04) <br> <b>CC:<\/b><br>catalytic step 2 spliceosome (p=1.09e-03)<br>oxidoreductase complex (p=3.09e-03)<\/div>"},{"id":"CAVIN1","label":"CAVIN1","x":1722.0475,"y":316.5293,"size":5,"color":"#FF7F00","shape":"triangle","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.743<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>CAVIN1, CBR3, CPNE3, GRB2, KLF6, MIPEP, PACSIN3, PDCD6, PREP, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Renin-angiotensin system (p=9.59e-03)<br>Endometrial cancer (p=2.45e-02)<br>Arachidonic acid metabolism (p=2.61e-02)<br><br><b>BP:<\/b><br>negative regulation of endocytosis (p=1.04e-03)<br>Ras protein signal transduction (p=2.47e-03) <br> <b>MF:<\/b><br>ephrin receptor binding (p=1.42e-04)<br>calcium-dependent protein binding (p=1.17e-03) <br> <b>CC:<\/b><br>focal adhesion (p=1.84e-03)<br>cell-substrate junction (p=1.96e-03)<\/div>"},{"id":"CBR3","label":"CBR3","x":1838.1399,"y":522.0866,"size":15.0807,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.743<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>CAVIN1, CBR3, CPNE3, GRB2, KLF6, MIPEP, PACSIN3, PDCD6, PREP, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Renin-angiotensin system (p=9.59e-03)<br>Endometrial cancer (p=2.45e-02)<br>Arachidonic acid metabolism (p=2.61e-02)<br><br><b>BP:<\/b><br>negative regulation of endocytosis (p=1.04e-03)<br>Ras protein signal transduction (p=2.47e-03) <br> <b>MF:<\/b><br>ephrin receptor binding (p=1.42e-04)<br>calcium-dependent protein binding (p=1.17e-03) <br> <b>CC:<\/b><br>focal adhesion (p=1.84e-03)<br>cell-substrate junction (p=1.96e-03)<\/div>"},{"id":"CDH1","label":"CDH1","x":1722.3733,"y":1380.0601,"size":13.4688,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.046<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>AIP, ANO1, AQP1, CDH1, EHD1, LMNA, NTRK3, RPL8, RPS17, SLC14A1, TDGF1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=1.56e-02)<br>Proximal tubule bicarbonate reclamation (p=1.91e-02)<br>IgSF CAM signaling (p=2.45e-02)<br><br><b>BP:<\/b><br>one-carbon compound transport (p=8.22e-05)<br>water transport (p=1.03e-04) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=3.95e-05)<br>ligand-gated monoatomic cation channel activity (p=2.29e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.52e-03)<br>ribosomal subunit (p=3.73e-03)<\/div>"},{"id":"CMAS","label":"CMAS","x":682.0801,"y":378.3944,"size":14.6915,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.752<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AGRN, BGN, CMAS, EDIL3, FGL2, GPC6, HLA-DMB, ITGB2, MAMDC2, MRGPRF, NCAPD3, TIMP2, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Viral myocarditis (p=7.78e-04)<br>Leishmaniasis (p=9.90e-04)<br>Rheumatoid arthritis (p=1.43e-03)<br><br><b>BP:<\/b><br>T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (p=3.38e-05)<br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=6.34e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=4.27e-06)<br>extracellular matrix binding (p=9.68e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.53e-07)<br>lysosomal lumen (p=3.21e-05)<\/div>"},{"id":"CNP","label":"CNP","x":2549.7429,"y":1217.1532,"size":11.9023,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.639<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACACB, BUB3, CNP, DECR1, EFTUD2, GYS1, HNRNPU, HSD17B4, IVD, NDUFS2, RPS27L<\/span><br><br><b>KEGG:<\/b><br> Glucagon signaling pathway (p=4.24e-03)<br>Insulin resistance (p=4.40e-03)<br>AMPK signaling pathway (p=5.48e-03)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=7.14e-08)<br>fatty acid catabolic process (p=2.94e-07) <br> <b>MF:<\/b><br>snRNA binding (p=4.46e-04)<br>oxidoreductase activity, acting on the CH-CH group of donors (p=5.50e-04) <br> <b>CC:<\/b><br>catalytic step 2 spliceosome (p=1.09e-03)<br>oxidoreductase complex (p=3.09e-03)<\/div>"},{"id":"COL12A1","label":"COL12A1","x":914.064,"y":1461.6969,"size":13.5556,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.025<\/b><\/p><b>Genes (8):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, COL12A1, FAM3C, PLG, PTX3, SPP2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=1.95e-02)<br>Complement and coagulation cascades (p=3.63e-02)<br>Staphylococcus aureus infection (p=4.20e-02)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.86e-06)<br>extracellular structure organization (p=6.94e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=2.01e-03)<br>peptidase inhibitor activity (p=2.21e-03) <br> <b>CC:<\/b><br>platelet dense granule lumen (p=1.55e-08)<br>platelet dense granule (p=5.67e-08)<\/div>"},{"id":"CPNE3","label":"CPNE3","x":1003.4988,"y":544.2942,"size":11.7193,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.743<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>CAVIN1, CBR3, CPNE3, GRB2, KLF6, MIPEP, PACSIN3, PDCD6, PREP, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Renin-angiotensin system (p=9.59e-03)<br>Endometrial cancer (p=2.45e-02)<br>Arachidonic acid metabolism (p=2.61e-02)<br><br><b>BP:<\/b><br>negative regulation of endocytosis (p=1.04e-03)<br>Ras protein signal transduction (p=2.47e-03) <br> <b>MF:<\/b><br>ephrin receptor binding (p=1.42e-04)<br>calcium-dependent protein binding (p=1.17e-03) <br> <b>CC:<\/b><br>focal adhesion (p=1.84e-03)<br>cell-substrate junction (p=1.96e-03)<\/div>"},{"id":"CTNND1","label":"CTNND1","x":1798.7826,"y":2163.5875,"size":12.7947,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.851<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>CTNND1, DSP, LEFTY1, MASP1, MASP2, RHOB, RTKN, SEPTIN8, TJP2, VTN, ZEB1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=8.63e-05)<br>Staphylococcus aureus infection (p=4.80e-03)<br>Coronavirus disease - COVID-19 (p=2.43e-02)<br><br><b>BP:<\/b><br>protein localization to cell-cell junction (p=3.40e-07)<br>complement activation, lectin pathway (p=1.71e-05) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=9.76e-04)<br>GTP binding (p=1.21e-03) <br> <b>CC:<\/b><br>cell division site (p=5.92e-06)<br>adherens junction (p=1.32e-04)<\/div>"},{"id":"DDOST","label":"DDOST","x":774.9648,"y":2230.4427,"size":11.9318,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.637<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>DDOST, ERP29, GSN, MPP5, SEC23A, TECR, TMED2, TMX1, USO1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=5.77e-05)<br>Biosynthesis of unsaturated fatty acids (p=1.40e-02)<br>Fatty acid elongation (p=1.46e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.80e-05)<br>vesicle cargo loading (p=9.91e-05) <br> <b>MF:<\/b><br>acyl-CoA dehydrogenase activity (p=5.14e-03)<br>oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor (p=5.14e-03) <br> <b>CC:<\/b><br>ER to Golgi transport vesicle membrane (p=1.76e-06)<br>COPII-coated ER to Golgi transport vesicle (p=5.82e-06)<\/div>"},{"id":"DECR1","label":"DECR1","x":2794.3984,"y":1354.3067,"size":5,"color":"#E41A1C","shape":"triangle","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.639<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACACB, BUB3, CNP, DECR1, EFTUD2, GYS1, HNRNPU, HSD17B4, IVD, NDUFS2, RPS27L<\/span><br><br><b>KEGG:<\/b><br> Glucagon signaling pathway (p=4.24e-03)<br>Insulin resistance (p=4.40e-03)<br>AMPK signaling pathway (p=5.48e-03)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=7.14e-08)<br>fatty acid catabolic process (p=2.94e-07) <br> <b>MF:<\/b><br>snRNA binding (p=4.46e-04)<br>oxidoreductase activity, acting on the CH-CH group of donors (p=5.50e-04) <br> <b>CC:<\/b><br>catalytic step 2 spliceosome (p=1.09e-03)<br>oxidoreductase complex (p=3.09e-03)<\/div>"},{"id":"DSP","label":"DSP","x":1539.9233,"y":2004.5348,"size":14.0357,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.851<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>CTNND1, DSP, LEFTY1, MASP1, MASP2, RHOB, RTKN, SEPTIN8, TJP2, VTN, ZEB1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=8.63e-05)<br>Staphylococcus aureus infection (p=4.80e-03)<br>Coronavirus disease - COVID-19 (p=2.43e-02)<br><br><b>BP:<\/b><br>protein localization to cell-cell junction (p=3.40e-07)<br>complement activation, lectin pathway (p=1.71e-05) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=9.76e-04)<br>GTP binding (p=1.21e-03) <br> <b>CC:<\/b><br>cell division site (p=5.92e-06)<br>adherens junction (p=1.32e-04)<\/div>"},{"id":"EDIL3","label":"EDIL3","x":324.9504,"y":1587.6587,"size":11.7939,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.752<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AGRN, BGN, CMAS, EDIL3, FGL2, GPC6, HLA-DMB, ITGB2, MAMDC2, MRGPRF, NCAPD3, TIMP2, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Viral myocarditis (p=7.78e-04)<br>Leishmaniasis (p=9.90e-04)<br>Rheumatoid arthritis (p=1.43e-03)<br><br><b>BP:<\/b><br>T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (p=3.38e-05)<br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=6.34e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=4.27e-06)<br>extracellular matrix binding (p=9.68e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.53e-07)<br>lysosomal lumen (p=3.21e-05)<\/div>"},{"id":"EFTUD2","label":"EFTUD2","x":2755.166,"y":1657.6085,"size":12.0035,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.639<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACACB, BUB3, CNP, DECR1, EFTUD2, GYS1, HNRNPU, HSD17B4, IVD, NDUFS2, RPS27L<\/span><br><br><b>KEGG:<\/b><br> Glucagon signaling pathway (p=4.24e-03)<br>Insulin resistance (p=4.40e-03)<br>AMPK signaling pathway (p=5.48e-03)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=7.14e-08)<br>fatty acid catabolic process (p=2.94e-07) <br> <b>MF:<\/b><br>snRNA binding (p=4.46e-04)<br>oxidoreductase activity, acting on the CH-CH group of donors (p=5.50e-04) <br> <b>CC:<\/b><br>catalytic step 2 spliceosome (p=1.09e-03)<br>oxidoreductase complex (p=3.09e-03)<\/div>"},{"id":"EHD1","label":"EHD1","x":2301.1051,"y":1609.055,"size":12.2883,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.046<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>AIP, ANO1, AQP1, CDH1, EHD1, LMNA, NTRK3, RPL8, RPS17, SLC14A1, TDGF1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=1.56e-02)<br>Proximal tubule bicarbonate reclamation (p=1.91e-02)<br>IgSF CAM signaling (p=2.45e-02)<br><br><b>BP:<\/b><br>one-carbon compound transport (p=8.22e-05)<br>water transport (p=1.03e-04) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=3.95e-05)<br>ligand-gated monoatomic cation channel activity (p=2.29e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.52e-03)<br>ribosomal subunit (p=3.73e-03)<\/div>"},{"id":"ERP29","label":"ERP29","x":365.8435,"y":2104.7616,"size":13.5828,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.637<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>DDOST, ERP29, GSN, MPP5, SEC23A, TECR, TMED2, TMX1, USO1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=5.77e-05)<br>Biosynthesis of unsaturated fatty acids (p=1.40e-02)<br>Fatty acid elongation (p=1.46e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.80e-05)<br>vesicle cargo loading (p=9.91e-05) <br> <b>MF:<\/b><br>acyl-CoA dehydrogenase activity (p=5.14e-03)<br>oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor (p=5.14e-03) <br> <b>CC:<\/b><br>ER to Golgi transport vesicle membrane (p=1.76e-06)<br>COPII-coated ER to Golgi transport vesicle (p=5.82e-06)<\/div>"},{"id":"ESYT2","label":"ESYT2","x":2667.2777,"y":479.6769,"size":20,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.938<\/b><\/p><b>Genes (3):<\/b><br><span style='font-size:11px;'>ESYT2, NUP54, PML<\/span><br><br><b>KEGG:<\/b><br> Acute myeloid leukemia (p=1.42e-02)<br>Nucleocytoplasmic transport (p=2.25e-02)<br>Ubiquitin mediated proteolysis (p=2.95e-02)<br><br><b>BP:<\/b><br>nucleus organization (p=1.99e-04)<br>protein import into nucleus (p=2.34e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=2.73e-03)<br>SUMO binding (p=2.73e-03) <br> <b>CC:<\/b><br>nuclear membrane (p=7.29e-04)<br>endoplasmic reticulum-plasma membrane contact site (p=1.81e-03)<\/div>"},{"id":"FAM3C","label":"FAM3C","x":1065.4888,"y":1647.173,"size":5,"color":"#377EB8","shape":"triangle","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.025<\/b><\/p><b>Genes (8):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, COL12A1, FAM3C, PLG, PTX3, SPP2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=1.95e-02)<br>Complement and coagulation cascades (p=3.63e-02)<br>Staphylococcus aureus infection (p=4.20e-02)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.86e-06)<br>extracellular structure organization (p=6.94e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=2.01e-03)<br>peptidase inhibitor activity (p=2.21e-03) <br> <b>CC:<\/b><br>platelet dense granule lumen (p=1.55e-08)<br>platelet dense granule (p=5.67e-08)<\/div>"},{"id":"FGL2","label":"FGL2","x":393.4366,"y":1859.5593,"size":16.4686,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.752<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AGRN, BGN, CMAS, EDIL3, FGL2, GPC6, HLA-DMB, ITGB2, MAMDC2, MRGPRF, NCAPD3, TIMP2, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Viral myocarditis (p=7.78e-04)<br>Leishmaniasis (p=9.90e-04)<br>Rheumatoid arthritis (p=1.43e-03)<br><br><b>BP:<\/b><br>T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (p=3.38e-05)<br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=6.34e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=4.27e-06)<br>extracellular matrix binding (p=9.68e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.53e-07)<br>lysosomal lumen (p=3.21e-05)<\/div>"},{"id":"GPC6","label":"GPC6","x":100,"y":1653.8429,"size":11.6403,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.752<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AGRN, BGN, CMAS, EDIL3, FGL2, GPC6, HLA-DMB, ITGB2, MAMDC2, MRGPRF, NCAPD3, TIMP2, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Viral myocarditis (p=7.78e-04)<br>Leishmaniasis (p=9.90e-04)<br>Rheumatoid arthritis (p=1.43e-03)<br><br><b>BP:<\/b><br>T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (p=3.38e-05)<br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=6.34e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=4.27e-06)<br>extracellular matrix binding (p=9.68e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.53e-07)<br>lysosomal lumen (p=3.21e-05)<\/div>"},{"id":"GRB2","label":"GRB2","x":1712.4004,"y":995.1769,"size":19.4385,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.743<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>CAVIN1, CBR3, CPNE3, GRB2, KLF6, MIPEP, PACSIN3, PDCD6, PREP, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Renin-angiotensin system (p=9.59e-03)<br>Endometrial cancer (p=2.45e-02)<br>Arachidonic acid metabolism (p=2.61e-02)<br><br><b>BP:<\/b><br>negative regulation of endocytosis (p=1.04e-03)<br>Ras protein signal transduction (p=2.47e-03) <br> <b>MF:<\/b><br>ephrin receptor binding (p=1.42e-04)<br>calcium-dependent protein binding (p=1.17e-03) <br> <b>CC:<\/b><br>focal adhesion (p=1.84e-03)<br>cell-substrate junction (p=1.96e-03)<\/div>"},{"id":"GSN","label":"GSN","x":1324.7624,"y":2599.9666,"size":12.2492,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.637<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>DDOST, ERP29, GSN, MPP5, SEC23A, TECR, TMED2, TMX1, USO1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=5.77e-05)<br>Biosynthesis of unsaturated fatty acids (p=1.40e-02)<br>Fatty acid elongation (p=1.46e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.80e-05)<br>vesicle cargo loading (p=9.91e-05) <br> <b>MF:<\/b><br>acyl-CoA dehydrogenase activity (p=5.14e-03)<br>oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor (p=5.14e-03) <br> <b>CC:<\/b><br>ER to Golgi transport vesicle membrane (p=1.76e-06)<br>COPII-coated ER to Golgi transport vesicle (p=5.82e-06)<\/div>"},{"id":"GYS1","label":"GYS1","x":2921.7941,"y":821.4583,"size":11.907,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.639<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACACB, BUB3, CNP, DECR1, EFTUD2, GYS1, HNRNPU, HSD17B4, IVD, NDUFS2, RPS27L<\/span><br><br><b>KEGG:<\/b><br> Glucagon signaling pathway (p=4.24e-03)<br>Insulin resistance (p=4.40e-03)<br>AMPK signaling pathway (p=5.48e-03)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=7.14e-08)<br>fatty acid catabolic process (p=2.94e-07) <br> <b>MF:<\/b><br>snRNA binding (p=4.46e-04)<br>oxidoreductase activity, acting on the CH-CH group of donors (p=5.50e-04) <br> <b>CC:<\/b><br>catalytic step 2 spliceosome (p=1.09e-03)<br>oxidoreductase complex (p=3.09e-03)<\/div>"},{"id":"HLA-DMB","label":"HLA-DMB","x":564.635,"y":1703.3521,"size":5,"color":"#4DAF4A","shape":"triangle","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.752<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AGRN, BGN, CMAS, EDIL3, FGL2, GPC6, HLA-DMB, ITGB2, MAMDC2, MRGPRF, NCAPD3, TIMP2, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Viral myocarditis (p=7.78e-04)<br>Leishmaniasis (p=9.90e-04)<br>Rheumatoid arthritis (p=1.43e-03)<br><br><b>BP:<\/b><br>T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (p=3.38e-05)<br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=6.34e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=4.27e-06)<br>extracellular matrix binding (p=9.68e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.53e-07)<br>lysosomal lumen (p=3.21e-05)<\/div>"},{"id":"HNRNPU","label":"HNRNPU","x":2817.6102,"y":1879.7358,"size":12.5255,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.639<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACACB, BUB3, CNP, DECR1, EFTUD2, GYS1, HNRNPU, HSD17B4, IVD, NDUFS2, RPS27L<\/span><br><br><b>KEGG:<\/b><br> Glucagon signaling pathway (p=4.24e-03)<br>Insulin resistance (p=4.40e-03)<br>AMPK signaling pathway (p=5.48e-03)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=7.14e-08)<br>fatty acid catabolic process (p=2.94e-07) <br> <b>MF:<\/b><br>snRNA binding (p=4.46e-04)<br>oxidoreductase activity, acting on the CH-CH group of donors (p=5.50e-04) <br> <b>CC:<\/b><br>catalytic step 2 spliceosome (p=1.09e-03)<br>oxidoreductase complex (p=3.09e-03)<\/div>"},{"id":"HSD17B4","label":"HSD17B4","x":3099.9601,"y":1346.3078,"size":12.06,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.639<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACACB, BUB3, CNP, DECR1, EFTUD2, GYS1, HNRNPU, HSD17B4, IVD, NDUFS2, RPS27L<\/span><br><br><b>KEGG:<\/b><br> Glucagon signaling pathway (p=4.24e-03)<br>Insulin resistance (p=4.40e-03)<br>AMPK signaling pathway (p=5.48e-03)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=7.14e-08)<br>fatty acid catabolic process (p=2.94e-07) <br> <b>MF:<\/b><br>snRNA binding (p=4.46e-04)<br>oxidoreductase activity, acting on the CH-CH group of donors (p=5.50e-04) <br> <b>CC:<\/b><br>catalytic step 2 spliceosome (p=1.09e-03)<br>oxidoreductase complex (p=3.09e-03)<\/div>"},{"id":"ILK","label":"ILK","x":1978.6211,"y":670.5095,"size":5,"color":"#999999","shape":"triangle","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.803<\/b><\/p><b>Genes (4):<\/b><br><span style='font-size:11px;'>ILK, NPNT, PPT2, TNS1<\/span><br><br><b>KEGG:<\/b><br> Integrin signaling (p=7.65e-04)<br>Fatty acid elongation (p=8.76e-03)<br>Fatty acid metabolism (p=1.78e-02)<br><br><b>BP:<\/b><br>fibroblast migration (p=5.21e-05)<br>branching involved in ureteric bud morphogenesis (p=6.18e-05) <br> <b>MF:<\/b><br>integrin binding (p=4.40e-04)<br>palmitoyl-(protein) hydrolase activity (p=3.00e-03) <br> <b>CC:<\/b><br>contractile muscle fiber (p=9.59e-04)<br>focal adhesion (p=2.65e-03)<\/div>"},{"id":"ITGB2","label":"ITGB2","x":610.7898,"y":1441.8719,"size":11.7193,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.752<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AGRN, BGN, CMAS, EDIL3, FGL2, GPC6, HLA-DMB, ITGB2, MAMDC2, MRGPRF, NCAPD3, TIMP2, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Viral myocarditis (p=7.78e-04)<br>Leishmaniasis (p=9.90e-04)<br>Rheumatoid arthritis (p=1.43e-03)<br><br><b>BP:<\/b><br>T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (p=3.38e-05)<br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=6.34e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=4.27e-06)<br>extracellular matrix binding (p=9.68e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.53e-07)<br>lysosomal lumen (p=3.21e-05)<\/div>"},{"id":"IVD","label":"IVD","x":2960.6991,"y":1196.4662,"size":13.8534,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.639<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACACB, BUB3, CNP, DECR1, EFTUD2, GYS1, HNRNPU, HSD17B4, IVD, NDUFS2, RPS27L<\/span><br><br><b>KEGG:<\/b><br> Glucagon signaling pathway (p=4.24e-03)<br>Insulin resistance (p=4.40e-03)<br>AMPK signaling pathway (p=5.48e-03)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=7.14e-08)<br>fatty acid catabolic process (p=2.94e-07) <br> <b>MF:<\/b><br>snRNA binding (p=4.46e-04)<br>oxidoreductase activity, acting on the CH-CH group of donors (p=5.50e-04) <br> <b>CC:<\/b><br>catalytic step 2 spliceosome (p=1.09e-03)<br>oxidoreductase complex (p=3.09e-03)<\/div>"},{"id":"KLF6","label":"KLF6","x":1265.042,"y":617.6368,"size":5,"color":"#FF7F00","shape":"triangle","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.743<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>CAVIN1, CBR3, CPNE3, GRB2, KLF6, MIPEP, PACSIN3, PDCD6, PREP, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Renin-angiotensin system (p=9.59e-03)<br>Endometrial cancer (p=2.45e-02)<br>Arachidonic acid metabolism (p=2.61e-02)<br><br><b>BP:<\/b><br>negative regulation of endocytosis (p=1.04e-03)<br>Ras protein signal transduction (p=2.47e-03) <br> <b>MF:<\/b><br>ephrin receptor binding (p=1.42e-04)<br>calcium-dependent protein binding (p=1.17e-03) <br> <b>CC:<\/b><br>focal adhesion (p=1.84e-03)<br>cell-substrate junction (p=1.96e-03)<\/div>"},{"id":"LEFTY1","label":"LEFTY1","x":2418.6002,"y":2244.3329,"size":19.3656,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.851<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>CTNND1, DSP, LEFTY1, MASP1, MASP2, RHOB, RTKN, SEPTIN8, TJP2, VTN, ZEB1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=8.63e-05)<br>Staphylococcus aureus infection (p=4.80e-03)<br>Coronavirus disease - COVID-19 (p=2.43e-02)<br><br><b>BP:<\/b><br>protein localization to cell-cell junction (p=3.40e-07)<br>complement activation, lectin pathway (p=1.71e-05) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=9.76e-04)<br>GTP binding (p=1.21e-03) <br> <b>CC:<\/b><br>cell division site (p=5.92e-06)<br>adherens junction (p=1.32e-04)<\/div>"},{"id":"LMNA","label":"LMNA","x":2017.0369,"y":1586.1326,"size":17.1209,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.046<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>AIP, ANO1, AQP1, CDH1, EHD1, LMNA, NTRK3, RPL8, RPS17, SLC14A1, TDGF1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=1.56e-02)<br>Proximal tubule bicarbonate reclamation (p=1.91e-02)<br>IgSF CAM signaling (p=2.45e-02)<br><br><b>BP:<\/b><br>one-carbon compound transport (p=8.22e-05)<br>water transport (p=1.03e-04) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=3.95e-05)<br>ligand-gated monoatomic cation channel activity (p=2.29e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.52e-03)<br>ribosomal subunit (p=3.73e-03)<\/div>"},{"id":"MAMDC2","label":"MAMDC2","x":284.9671,"y":793.2902,"size":11.7193,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.752<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AGRN, BGN, CMAS, EDIL3, FGL2, GPC6, HLA-DMB, ITGB2, MAMDC2, MRGPRF, NCAPD3, TIMP2, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Viral myocarditis (p=7.78e-04)<br>Leishmaniasis (p=9.90e-04)<br>Rheumatoid arthritis (p=1.43e-03)<br><br><b>BP:<\/b><br>T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (p=3.38e-05)<br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=6.34e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=4.27e-06)<br>extracellular matrix binding (p=9.68e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.53e-07)<br>lysosomal lumen (p=3.21e-05)<\/div>"},{"id":"MASP1","label":"MASP1","x":1429.7677,"y":1821.6635,"size":11.866,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.851<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>CTNND1, DSP, LEFTY1, MASP1, MASP2, RHOB, RTKN, SEPTIN8, TJP2, VTN, ZEB1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=8.63e-05)<br>Staphylococcus aureus infection (p=4.80e-03)<br>Coronavirus disease - COVID-19 (p=2.43e-02)<br><br><b>BP:<\/b><br>protein localization to cell-cell junction (p=3.40e-07)<br>complement activation, lectin pathway (p=1.71e-05) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=9.76e-04)<br>GTP binding (p=1.21e-03) <br> <b>CC:<\/b><br>cell division site (p=5.92e-06)<br>adherens junction (p=1.32e-04)<\/div>"},{"id":"MASP2","label":"MASP2","x":1933.0582,"y":1933.1848,"size":12.8796,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.851<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>CTNND1, DSP, LEFTY1, MASP1, MASP2, RHOB, RTKN, SEPTIN8, TJP2, VTN, ZEB1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=8.63e-05)<br>Staphylococcus aureus infection (p=4.80e-03)<br>Coronavirus disease - COVID-19 (p=2.43e-02)<br><br><b>BP:<\/b><br>protein localization to cell-cell junction (p=3.40e-07)<br>complement activation, lectin pathway (p=1.71e-05) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=9.76e-04)<br>GTP binding (p=1.21e-03) <br> <b>CC:<\/b><br>cell division site (p=5.92e-06)<br>adherens junction (p=1.32e-04)<\/div>"},{"id":"MIPEP","label":"MIPEP","x":1196.3791,"y":205.6225,"size":5,"color":"#FF7F00","shape":"triangle","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.743<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>CAVIN1, CBR3, CPNE3, GRB2, KLF6, MIPEP, PACSIN3, PDCD6, PREP, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Renin-angiotensin system (p=9.59e-03)<br>Endometrial cancer (p=2.45e-02)<br>Arachidonic acid metabolism (p=2.61e-02)<br><br><b>BP:<\/b><br>negative regulation of endocytosis (p=1.04e-03)<br>Ras protein signal transduction (p=2.47e-03) <br> <b>MF:<\/b><br>ephrin receptor binding (p=1.42e-04)<br>calcium-dependent protein binding (p=1.17e-03) <br> <b>CC:<\/b><br>focal adhesion (p=1.84e-03)<br>cell-substrate junction (p=1.96e-03)<\/div>"},{"id":"MPP5","label":"MPP5","x":1504.8478,"y":2288.0954,"size":5,"color":"#A65628","shape":"triangle","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.637<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>DDOST, ERP29, GSN, MPP5, SEC23A, TECR, TMED2, TMX1, USO1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=5.77e-05)<br>Biosynthesis of unsaturated fatty acids (p=1.40e-02)<br>Fatty acid elongation (p=1.46e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.80e-05)<br>vesicle cargo loading (p=9.91e-05) <br> <b>MF:<\/b><br>acyl-CoA dehydrogenase activity (p=5.14e-03)<br>oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor (p=5.14e-03) <br> <b>CC:<\/b><br>ER to Golgi transport vesicle membrane (p=1.76e-06)<br>COPII-coated ER to Golgi transport vesicle (p=5.82e-06)<\/div>"},{"id":"MRGPRF","label":"MRGPRF","x":171.4778,"y":962.8781,"size":5,"color":"#4DAF4A","shape":"triangle","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.752<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AGRN, BGN, CMAS, EDIL3, FGL2, GPC6, HLA-DMB, ITGB2, MAMDC2, MRGPRF, NCAPD3, TIMP2, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Viral myocarditis (p=7.78e-04)<br>Leishmaniasis (p=9.90e-04)<br>Rheumatoid arthritis (p=1.43e-03)<br><br><b>BP:<\/b><br>T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (p=3.38e-05)<br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=6.34e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=4.27e-06)<br>extracellular matrix binding (p=9.68e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.53e-07)<br>lysosomal lumen (p=3.21e-05)<\/div>"},{"id":"NCAPD3","label":"NCAPD3","x":422.4536,"y":648.2894,"size":5,"color":"#4DAF4A","shape":"triangle","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.752<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AGRN, BGN, CMAS, EDIL3, FGL2, GPC6, HLA-DMB, ITGB2, MAMDC2, MRGPRF, NCAPD3, TIMP2, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Viral myocarditis (p=7.78e-04)<br>Leishmaniasis (p=9.90e-04)<br>Rheumatoid arthritis (p=1.43e-03)<br><br><b>BP:<\/b><br>T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (p=3.38e-05)<br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=6.34e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=4.27e-06)<br>extracellular matrix binding (p=9.68e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.53e-07)<br>lysosomal lumen (p=3.21e-05)<\/div>"},{"id":"NDUFS2","label":"NDUFS2","x":2526.3558,"y":1426.5738,"size":12.1448,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.639<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACACB, BUB3, CNP, DECR1, EFTUD2, GYS1, HNRNPU, HSD17B4, IVD, NDUFS2, RPS27L<\/span><br><br><b>KEGG:<\/b><br> Glucagon signaling pathway (p=4.24e-03)<br>Insulin resistance (p=4.40e-03)<br>AMPK signaling pathway (p=5.48e-03)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=7.14e-08)<br>fatty acid catabolic process (p=2.94e-07) <br> <b>MF:<\/b><br>snRNA binding (p=4.46e-04)<br>oxidoreductase activity, acting on the CH-CH group of donors (p=5.50e-04) <br> <b>CC:<\/b><br>catalytic step 2 spliceosome (p=1.09e-03)<br>oxidoreductase complex (p=3.09e-03)<\/div>"},{"id":"NPNT","label":"NPNT","x":2267.2768,"y":237.8238,"size":18.2408,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.803<\/b><\/p><b>Genes (4):<\/b><br><span style='font-size:11px;'>ILK, NPNT, PPT2, TNS1<\/span><br><br><b>KEGG:<\/b><br> Integrin signaling (p=7.65e-04)<br>Fatty acid elongation (p=8.76e-03)<br>Fatty acid metabolism (p=1.78e-02)<br><br><b>BP:<\/b><br>fibroblast migration (p=5.21e-05)<br>branching involved in ureteric bud morphogenesis (p=6.18e-05) <br> <b>MF:<\/b><br>integrin binding (p=4.40e-04)<br>palmitoyl-(protein) hydrolase activity (p=3.00e-03) <br> <b>CC:<\/b><br>contractile muscle fiber (p=9.59e-04)<br>focal adhesion (p=2.65e-03)<\/div>"},{"id":"NTRK3","label":"NTRK3","x":2266.6701,"y":1821.3231,"size":5,"color":"#984EA3","shape":"triangle","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.046<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>AIP, ANO1, AQP1, CDH1, EHD1, LMNA, NTRK3, RPL8, RPS17, SLC14A1, TDGF1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=1.56e-02)<br>Proximal tubule bicarbonate reclamation (p=1.91e-02)<br>IgSF CAM signaling (p=2.45e-02)<br><br><b>BP:<\/b><br>one-carbon compound transport (p=8.22e-05)<br>water transport (p=1.03e-04) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=3.95e-05)<br>ligand-gated monoatomic cation channel activity (p=2.29e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.52e-03)<br>ribosomal subunit (p=3.73e-03)<\/div>"},{"id":"NUP54","label":"NUP54","x":2646.1897,"y":651.9014,"size":5,"color":"#F781BF","shape":"triangle","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.938<\/b><\/p><b>Genes (3):<\/b><br><span style='font-size:11px;'>ESYT2, NUP54, PML<\/span><br><br><b>KEGG:<\/b><br> Acute myeloid leukemia (p=1.42e-02)<br>Nucleocytoplasmic transport (p=2.25e-02)<br>Ubiquitin mediated proteolysis (p=2.95e-02)<br><br><b>BP:<\/b><br>nucleus organization (p=1.99e-04)<br>protein import into nucleus (p=2.34e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=2.73e-03)<br>SUMO binding (p=2.73e-03) <br> <b>CC:<\/b><br>nuclear membrane (p=7.29e-04)<br>endoplasmic reticulum-plasma membrane contact site (p=1.81e-03)<\/div>"},{"id":"PACSIN3","label":"PACSIN3","x":1678.2729,"y":111.9551,"size":13.1026,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.743<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>CAVIN1, CBR3, CPNE3, GRB2, KLF6, MIPEP, PACSIN3, PDCD6, PREP, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Renin-angiotensin system (p=9.59e-03)<br>Endometrial cancer (p=2.45e-02)<br>Arachidonic acid metabolism (p=2.61e-02)<br><br><b>BP:<\/b><br>negative regulation of endocytosis (p=1.04e-03)<br>Ras protein signal transduction (p=2.47e-03) <br> <b>MF:<\/b><br>ephrin receptor binding (p=1.42e-04)<br>calcium-dependent protein binding (p=1.17e-03) <br> <b>CC:<\/b><br>focal adhesion (p=1.84e-03)<br>cell-substrate junction (p=1.96e-03)<\/div>"},{"id":"PDCD6","label":"PDCD6","x":1544.7502,"y":446.2139,"size":12.397,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.743<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>CAVIN1, CBR3, CPNE3, GRB2, KLF6, MIPEP, PACSIN3, PDCD6, PREP, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Renin-angiotensin system (p=9.59e-03)<br>Endometrial cancer (p=2.45e-02)<br>Arachidonic acid metabolism (p=2.61e-02)<br><br><b>BP:<\/b><br>negative regulation of endocytosis (p=1.04e-03)<br>Ras protein signal transduction (p=2.47e-03) <br> <b>MF:<\/b><br>ephrin receptor binding (p=1.42e-04)<br>calcium-dependent protein binding (p=1.17e-03) <br> <b>CC:<\/b><br>focal adhesion (p=1.84e-03)<br>cell-substrate junction (p=1.96e-03)<\/div>"},{"id":"PLG","label":"PLG","x":818.2186,"y":1163.5032,"size":5,"color":"#377EB8","shape":"triangle","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.025<\/b><\/p><b>Genes (8):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, COL12A1, FAM3C, PLG, PTX3, SPP2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=1.95e-02)<br>Complement and coagulation cascades (p=3.63e-02)<br>Staphylococcus aureus infection (p=4.20e-02)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.86e-06)<br>extracellular structure organization (p=6.94e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=2.01e-03)<br>peptidase inhibitor activity (p=2.21e-03) <br> <b>CC:<\/b><br>platelet dense granule lumen (p=1.55e-08)<br>platelet dense granule (p=5.67e-08)<\/div>"},{"id":"PML","label":"PML","x":2570.418,"y":822.4211,"size":14.3436,"color":"#F781BF","shape":"dot","cluster":8,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 3 - Cluster 8<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.938<\/b><\/p><b>Genes (3):<\/b><br><span style='font-size:11px;'>ESYT2, NUP54, PML<\/span><br><br><b>KEGG:<\/b><br> Acute myeloid leukemia (p=1.42e-02)<br>Nucleocytoplasmic transport (p=2.25e-02)<br>Ubiquitin mediated proteolysis (p=2.95e-02)<br><br><b>BP:<\/b><br>nucleus organization (p=1.99e-04)<br>protein import into nucleus (p=2.34e-04) <br> <b>MF:<\/b><br>phosphatidylethanolamine binding (p=2.73e-03)<br>SUMO binding (p=2.73e-03) <br> <b>CC:<\/b><br>nuclear membrane (p=7.29e-04)<br>endoplasmic reticulum-plasma membrane contact site (p=1.81e-03)<\/div>"},{"id":"PPT2","label":"PPT2","x":2329.0323,"y":405.3866,"size":5,"color":"#999999","shape":"triangle","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.803<\/b><\/p><b>Genes (4):<\/b><br><span style='font-size:11px;'>ILK, NPNT, PPT2, TNS1<\/span><br><br><b>KEGG:<\/b><br> Integrin signaling (p=7.65e-04)<br>Fatty acid elongation (p=8.76e-03)<br>Fatty acid metabolism (p=1.78e-02)<br><br><b>BP:<\/b><br>fibroblast migration (p=5.21e-05)<br>branching involved in ureteric bud morphogenesis (p=6.18e-05) <br> <b>MF:<\/b><br>integrin binding (p=4.40e-04)<br>palmitoyl-(protein) hydrolase activity (p=3.00e-03) <br> <b>CC:<\/b><br>contractile muscle fiber (p=9.59e-04)<br>focal adhesion (p=2.65e-03)<\/div>"},{"id":"PREP","label":"PREP","x":972.4862,"y":202.7497,"size":11.8771,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.743<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>CAVIN1, CBR3, CPNE3, GRB2, KLF6, MIPEP, PACSIN3, PDCD6, PREP, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Renin-angiotensin system (p=9.59e-03)<br>Endometrial cancer (p=2.45e-02)<br>Arachidonic acid metabolism (p=2.61e-02)<br><br><b>BP:<\/b><br>negative regulation of endocytosis (p=1.04e-03)<br>Ras protein signal transduction (p=2.47e-03) <br> <b>MF:<\/b><br>ephrin receptor binding (p=1.42e-04)<br>calcium-dependent protein binding (p=1.17e-03) <br> <b>CC:<\/b><br>focal adhesion (p=1.84e-03)<br>cell-substrate junction (p=1.96e-03)<\/div>"},{"id":"PTX3","label":"PTX3","x":633.167,"y":972.8715,"size":12.5255,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.025<\/b><\/p><b>Genes (8):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, COL12A1, FAM3C, PLG, PTX3, SPP2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=1.95e-02)<br>Complement and coagulation cascades (p=3.63e-02)<br>Staphylococcus aureus infection (p=4.20e-02)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.86e-06)<br>extracellular structure organization (p=6.94e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=2.01e-03)<br>peptidase inhibitor activity (p=2.21e-03) <br> <b>CC:<\/b><br>platelet dense granule lumen (p=1.55e-08)<br>platelet dense granule (p=5.67e-08)<\/div>"},{"id":"RAI14","label":"RAI14","x":1886.9695,"y":100,"size":12.788,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.743<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>CAVIN1, CBR3, CPNE3, GRB2, KLF6, MIPEP, PACSIN3, PDCD6, PREP, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Renin-angiotensin system (p=9.59e-03)<br>Endometrial cancer (p=2.45e-02)<br>Arachidonic acid metabolism (p=2.61e-02)<br><br><b>BP:<\/b><br>negative regulation of endocytosis (p=1.04e-03)<br>Ras protein signal transduction (p=2.47e-03) <br> <b>MF:<\/b><br>ephrin receptor binding (p=1.42e-04)<br>calcium-dependent protein binding (p=1.17e-03) <br> <b>CC:<\/b><br>focal adhesion (p=1.84e-03)<br>cell-substrate junction (p=1.96e-03)<\/div>"},{"id":"RHOB","label":"RHOB","x":1721.0056,"y":2571.3418,"size":13.715,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.851<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>CTNND1, DSP, LEFTY1, MASP1, MASP2, RHOB, RTKN, SEPTIN8, TJP2, VTN, ZEB1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=8.63e-05)<br>Staphylococcus aureus infection (p=4.80e-03)<br>Coronavirus disease - COVID-19 (p=2.43e-02)<br><br><b>BP:<\/b><br>protein localization to cell-cell junction (p=3.40e-07)<br>complement activation, lectin pathway (p=1.71e-05) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=9.76e-04)<br>GTP binding (p=1.21e-03) <br> <b>CC:<\/b><br>cell division site (p=5.92e-06)<br>adherens junction (p=1.32e-04)<\/div>"},{"id":"RPL8","label":"RPL8","x":2097.4103,"y":1372.2081,"size":13.9475,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.046<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>AIP, ANO1, AQP1, CDH1, EHD1, LMNA, NTRK3, RPL8, RPS17, SLC14A1, TDGF1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=1.56e-02)<br>Proximal tubule bicarbonate reclamation (p=1.91e-02)<br>IgSF CAM signaling (p=2.45e-02)<br><br><b>BP:<\/b><br>one-carbon compound transport (p=8.22e-05)<br>water transport (p=1.03e-04) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=3.95e-05)<br>ligand-gated monoatomic cation channel activity (p=2.29e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.52e-03)<br>ribosomal subunit (p=3.73e-03)<\/div>"},{"id":"RPS17","label":"RPS17","x":1560.9289,"y":1490.9032,"size":18.8981,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.046<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>AIP, ANO1, AQP1, CDH1, EHD1, LMNA, NTRK3, RPL8, RPS17, SLC14A1, TDGF1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=1.56e-02)<br>Proximal tubule bicarbonate reclamation (p=1.91e-02)<br>IgSF CAM signaling (p=2.45e-02)<br><br><b>BP:<\/b><br>one-carbon compound transport (p=8.22e-05)<br>water transport (p=1.03e-04) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=3.95e-05)<br>ligand-gated monoatomic cation channel activity (p=2.29e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.52e-03)<br>ribosomal subunit (p=3.73e-03)<\/div>"},{"id":"RPS27L","label":"RPS27L","x":2981.8746,"y":1677.2551,"size":12.0761,"color":"#E41A1C","shape":"dot","cluster":1,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 8 - Cluster 1<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.639<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>ACACB, BUB3, CNP, DECR1, EFTUD2, GYS1, HNRNPU, HSD17B4, IVD, NDUFS2, RPS27L<\/span><br><br><b>KEGG:<\/b><br> Glucagon signaling pathway (p=4.24e-03)<br>Insulin resistance (p=4.40e-03)<br>AMPK signaling pathway (p=5.48e-03)<br><br><b>BP:<\/b><br>fatty acid beta-oxidation (p=7.14e-08)<br>fatty acid catabolic process (p=2.94e-07) <br> <b>MF:<\/b><br>snRNA binding (p=4.46e-04)<br>oxidoreductase activity, acting on the CH-CH group of donors (p=5.50e-04) <br> <b>CC:<\/b><br>catalytic step 2 spliceosome (p=1.09e-03)<br>oxidoreductase complex (p=3.09e-03)<\/div>"},{"id":"RTKN","label":"RTKN","x":2070.9303,"y":2504.1507,"size":5,"color":"#FFFF33","shape":"triangle","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.851<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>CTNND1, DSP, LEFTY1, MASP1, MASP2, RHOB, RTKN, SEPTIN8, TJP2, VTN, ZEB1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=8.63e-05)<br>Staphylococcus aureus infection (p=4.80e-03)<br>Coronavirus disease - COVID-19 (p=2.43e-02)<br><br><b>BP:<\/b><br>protein localization to cell-cell junction (p=3.40e-07)<br>complement activation, lectin pathway (p=1.71e-05) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=9.76e-04)<br>GTP binding (p=1.21e-03) <br> <b>CC:<\/b><br>cell division site (p=5.92e-06)<br>adherens junction (p=1.32e-04)<\/div>"},{"id":"SDCBP","label":"SDCBP","x":1621.95,"y":616.8194,"size":15.8009,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.743<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>CAVIN1, CBR3, CPNE3, GRB2, KLF6, MIPEP, PACSIN3, PDCD6, PREP, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Renin-angiotensin system (p=9.59e-03)<br>Endometrial cancer (p=2.45e-02)<br>Arachidonic acid metabolism (p=2.61e-02)<br><br><b>BP:<\/b><br>negative regulation of endocytosis (p=1.04e-03)<br>Ras protein signal transduction (p=2.47e-03) <br> <b>MF:<\/b><br>ephrin receptor binding (p=1.42e-04)<br>calcium-dependent protein binding (p=1.17e-03) <br> <b>CC:<\/b><br>focal adhesion (p=1.84e-03)<br>cell-substrate junction (p=1.96e-03)<\/div>"},{"id":"SEC23A","label":"SEC23A","x":1166.8012,"y":2484.0875,"size":12.2714,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.637<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>DDOST, ERP29, GSN, MPP5, SEC23A, TECR, TMED2, TMX1, USO1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=5.77e-05)<br>Biosynthesis of unsaturated fatty acids (p=1.40e-02)<br>Fatty acid elongation (p=1.46e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.80e-05)<br>vesicle cargo loading (p=9.91e-05) <br> <b>MF:<\/b><br>acyl-CoA dehydrogenase activity (p=5.14e-03)<br>oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor (p=5.14e-03) <br> <b>CC:<\/b><br>ER to Golgi transport vesicle membrane (p=1.76e-06)<br>COPII-coated ER to Golgi transport vesicle (p=5.82e-06)<\/div>"},{"id":"SEPTIN8","label":"SEPTIN8","x":2305.7287,"y":2472.1356,"size":12.7821,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.851<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>CTNND1, DSP, LEFTY1, MASP1, MASP2, RHOB, RTKN, SEPTIN8, TJP2, VTN, ZEB1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=8.63e-05)<br>Staphylococcus aureus infection (p=4.80e-03)<br>Coronavirus disease - COVID-19 (p=2.43e-02)<br><br><b>BP:<\/b><br>protein localization to cell-cell junction (p=3.40e-07)<br>complement activation, lectin pathway (p=1.71e-05) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=9.76e-04)<br>GTP binding (p=1.21e-03) <br> <b>CC:<\/b><br>cell division site (p=5.92e-06)<br>adherens junction (p=1.32e-04)<\/div>"},{"id":"SLC14A1","label":"SLC14A1","x":1394.8942,"y":981.0891,"size":15.9792,"color":"#984EA3","shape":"dot","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.046<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>AIP, ANO1, AQP1, CDH1, EHD1, LMNA, NTRK3, RPL8, RPS17, SLC14A1, TDGF1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=1.56e-02)<br>Proximal tubule bicarbonate reclamation (p=1.91e-02)<br>IgSF CAM signaling (p=2.45e-02)<br><br><b>BP:<\/b><br>one-carbon compound transport (p=8.22e-05)<br>water transport (p=1.03e-04) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=3.95e-05)<br>ligand-gated monoatomic cation channel activity (p=2.29e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.52e-03)<br>ribosomal subunit (p=3.73e-03)<\/div>"},{"id":"SNTB1","label":"SNTB1","x":1351.7297,"y":389.3307,"size":13.4126,"color":"#FF7F00","shape":"dot","cluster":5,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 7 - Cluster 5<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.743<\/b><\/p><b>Genes (12):<\/b><br><span style='font-size:11px;'>CAVIN1, CBR3, CPNE3, GRB2, KLF6, MIPEP, PACSIN3, PDCD6, PREP, RAI14, SDCBP, SNTB1<\/span><br><br><b>KEGG:<\/b><br> Renin-angiotensin system (p=9.59e-03)<br>Endometrial cancer (p=2.45e-02)<br>Arachidonic acid metabolism (p=2.61e-02)<br><br><b>BP:<\/b><br>negative regulation of endocytosis (p=1.04e-03)<br>Ras protein signal transduction (p=2.47e-03) <br> <b>MF:<\/b><br>ephrin receptor binding (p=1.42e-04)<br>calcium-dependent protein binding (p=1.17e-03) <br> <b>CC:<\/b><br>focal adhesion (p=1.84e-03)<br>cell-substrate junction (p=1.96e-03)<\/div>"},{"id":"SPP2","label":"SPP2","x":959.7604,"y":1856.9289,"size":12.5255,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.025<\/b><\/p><b>Genes (8):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, COL12A1, FAM3C, PLG, PTX3, SPP2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=1.95e-02)<br>Complement and coagulation cascades (p=3.63e-02)<br>Staphylococcus aureus infection (p=4.20e-02)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.86e-06)<br>extracellular structure organization (p=6.94e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=2.01e-03)<br>peptidase inhibitor activity (p=2.21e-03) <br> <b>CC:<\/b><br>platelet dense granule lumen (p=1.55e-08)<br>platelet dense granule (p=5.67e-08)<\/div>"},{"id":"TDGF1","label":"TDGF1","x":2002.3831,"y":1145.3967,"size":5,"color":"#984EA3","shape":"triangle","cluster":4,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 1 - Cluster 4<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.046<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>AIP, ANO1, AQP1, CDH1, EHD1, LMNA, NTRK3, RPL8, RPS17, SLC14A1, TDGF1<\/span><br><br><b>KEGG:<\/b><br> Coronavirus disease - COVID-19 (p=1.56e-02)<br>Proximal tubule bicarbonate reclamation (p=1.91e-02)<br>IgSF CAM signaling (p=2.45e-02)<br><br><b>BP:<\/b><br>one-carbon compound transport (p=8.22e-05)<br>water transport (p=1.03e-04) <br> <b>MF:<\/b><br>water transmembrane transporter activity (p=3.95e-05)<br>ligand-gated monoatomic cation channel activity (p=2.29e-03) <br> <b>CC:<\/b><br>cytosolic ribosome (p=1.52e-03)<br>ribosomal subunit (p=3.73e-03)<\/div>"},{"id":"TECR","label":"TECR","x":736.6308,"y":2404.7737,"size":17.3116,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.637<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>DDOST, ERP29, GSN, MPP5, SEC23A, TECR, TMED2, TMX1, USO1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=5.77e-05)<br>Biosynthesis of unsaturated fatty acids (p=1.40e-02)<br>Fatty acid elongation (p=1.46e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.80e-05)<br>vesicle cargo loading (p=9.91e-05) <br> <b>MF:<\/b><br>acyl-CoA dehydrogenase activity (p=5.14e-03)<br>oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor (p=5.14e-03) <br> <b>CC:<\/b><br>ER to Golgi transport vesicle membrane (p=1.76e-06)<br>COPII-coated ER to Golgi transport vesicle (p=5.82e-06)<\/div>"},{"id":"TIMP2","label":"TIMP2","x":171.3547,"y":1155.6952,"size":15.5081,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.752<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AGRN, BGN, CMAS, EDIL3, FGL2, GPC6, HLA-DMB, ITGB2, MAMDC2, MRGPRF, NCAPD3, TIMP2, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Viral myocarditis (p=7.78e-04)<br>Leishmaniasis (p=9.90e-04)<br>Rheumatoid arthritis (p=1.43e-03)<br><br><b>BP:<\/b><br>T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (p=3.38e-05)<br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=6.34e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=4.27e-06)<br>extracellular matrix binding (p=9.68e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.53e-07)<br>lysosomal lumen (p=3.21e-05)<\/div>"},{"id":"TIMP3","label":"TIMP3","x":1118.4008,"y":1359.9196,"size":12.5194,"color":"#377EB8","shape":"dot","cluster":2,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 2 - Cluster 2<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>1.025<\/b><\/p><b>Genes (8):<\/b><br><span style='font-size:11px;'>ADAMTSL3, B3GLCT, COL12A1, FAM3C, PLG, PTX3, SPP2, TIMP3<\/span><br><br><b>KEGG:<\/b><br> Other types of O-glycan biosynthesis (p=1.95e-02)<br>Complement and coagulation cascades (p=3.63e-02)<br>Staphylococcus aureus infection (p=4.20e-02)<br><br><b>BP:<\/b><br>extracellular matrix organization (p=6.86e-06)<br>extracellular structure organization (p=6.94e-06) <br> <b>MF:<\/b><br>endopeptidase inhibitor activity (p=2.01e-03)<br>peptidase inhibitor activity (p=2.21e-03) <br> <b>CC:<\/b><br>platelet dense granule lumen (p=1.55e-08)<br>platelet dense granule (p=5.67e-08)<\/div>"},{"id":"TJP2","label":"TJP2","x":1839.5837,"y":2407.0243,"size":11.6148,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.851<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>CTNND1, DSP, LEFTY1, MASP1, MASP2, RHOB, RTKN, SEPTIN8, TJP2, VTN, ZEB1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=8.63e-05)<br>Staphylococcus aureus infection (p=4.80e-03)<br>Coronavirus disease - COVID-19 (p=2.43e-02)<br><br><b>BP:<\/b><br>protein localization to cell-cell junction (p=3.40e-07)<br>complement activation, lectin pathway (p=1.71e-05) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=9.76e-04)<br>GTP binding (p=1.21e-03) <br> <b>CC:<\/b><br>cell division site (p=5.92e-06)<br>adherens junction (p=1.32e-04)<\/div>"},{"id":"TMED2","label":"TMED2","x":1007.7979,"y":2219.0787,"size":13.7501,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.637<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>DDOST, ERP29, GSN, MPP5, SEC23A, TECR, TMED2, TMX1, USO1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=5.77e-05)<br>Biosynthesis of unsaturated fatty acids (p=1.40e-02)<br>Fatty acid elongation (p=1.46e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.80e-05)<br>vesicle cargo loading (p=9.91e-05) <br> <b>MF:<\/b><br>acyl-CoA dehydrogenase activity (p=5.14e-03)<br>oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor (p=5.14e-03) <br> <b>CC:<\/b><br>ER to Golgi transport vesicle membrane (p=1.76e-06)<br>COPII-coated ER to Golgi transport vesicle (p=5.82e-06)<\/div>"},{"id":"TMX1","label":"TMX1","x":580.644,"y":2122.2036,"size":5,"color":"#A65628","shape":"triangle","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.637<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>DDOST, ERP29, GSN, MPP5, SEC23A, TECR, TMED2, TMX1, USO1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=5.77e-05)<br>Biosynthesis of unsaturated fatty acids (p=1.40e-02)<br>Fatty acid elongation (p=1.46e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.80e-05)<br>vesicle cargo loading (p=9.91e-05) <br> <b>MF:<\/b><br>acyl-CoA dehydrogenase activity (p=5.14e-03)<br>oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor (p=5.14e-03) <br> <b>CC:<\/b><br>ER to Golgi transport vesicle membrane (p=1.76e-06)<br>COPII-coated ER to Golgi transport vesicle (p=5.82e-06)<\/div>"},{"id":"TNS1","label":"TNS1","x":2226.5338,"y":583.8208,"size":13.4593,"color":"#999999","shape":"dot","cluster":9,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 5 - Cluster 9<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.803<\/b><\/p><b>Genes (4):<\/b><br><span style='font-size:11px;'>ILK, NPNT, PPT2, TNS1<\/span><br><br><b>KEGG:<\/b><br> Integrin signaling (p=7.65e-04)<br>Fatty acid elongation (p=8.76e-03)<br>Fatty acid metabolism (p=1.78e-02)<br><br><b>BP:<\/b><br>fibroblast migration (p=5.21e-05)<br>branching involved in ureteric bud morphogenesis (p=6.18e-05) <br> <b>MF:<\/b><br>integrin binding (p=4.40e-04)<br>palmitoyl-(protein) hydrolase activity (p=3.00e-03) <br> <b>CC:<\/b><br>contractile muscle fiber (p=9.59e-04)<br>focal adhesion (p=2.65e-03)<\/div>"},{"id":"USO1","label":"USO1","x":1219.6298,"y":2310.5269,"size":12.6087,"color":"#A65628","shape":"dot","cluster":7,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 9 - Cluster 7<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.637<\/b><\/p><b>Genes (9):<\/b><br><span style='font-size:11px;'>DDOST, ERP29, GSN, MPP5, SEC23A, TECR, TMED2, TMX1, USO1<\/span><br><br><b>KEGG:<\/b><br> Protein processing in endoplasmic reticulum (p=5.77e-05)<br>Biosynthesis of unsaturated fatty acids (p=1.40e-02)<br>Fatty acid elongation (p=1.46e-02)<br><br><b>BP:<\/b><br>endoplasmic reticulum to Golgi vesicle-mediated transport (p=1.80e-05)<br>vesicle cargo loading (p=9.91e-05) <br> <b>MF:<\/b><br>acyl-CoA dehydrogenase activity (p=5.14e-03)<br>oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor (p=5.14e-03) <br> <b>CC:<\/b><br>ER to Golgi transport vesicle membrane (p=1.76e-06)<br>COPII-coated ER to Golgi transport vesicle (p=5.82e-06)<\/div>"},{"id":"VPS26B","label":"VPS26B","x":574.8213,"y":521.9529,"size":14.0893,"color":"#4DAF4A","shape":"dot","cluster":3,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 6 - Cluster 3<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.752<\/b><\/p><b>Genes (13):<\/b><br><span style='font-size:11px;'>AGRN, BGN, CMAS, EDIL3, FGL2, GPC6, HLA-DMB, ITGB2, MAMDC2, MRGPRF, NCAPD3, TIMP2, VPS26B<\/span><br><br><b>KEGG:<\/b><br> Viral myocarditis (p=7.78e-04)<br>Leishmaniasis (p=9.90e-04)<br>Rheumatoid arthritis (p=1.43e-03)<br><br><b>BP:<\/b><br>T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (p=3.38e-05)<br>regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (p=6.34e-05) <br> <b>MF:<\/b><br>extracellular matrix structural constituent (p=4.27e-06)<br>extracellular matrix binding (p=9.68e-04) <br> <b>CC:<\/b><br>collagen-containing extracellular matrix (p=1.53e-07)<br>lysosomal lumen (p=3.21e-05)<\/div>"},{"id":"VTN","label":"VTN","x":1708.4532,"y":1811.044,"size":14.7075,"color":"#FFFF33","shape":"dot","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.851<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>CTNND1, DSP, LEFTY1, MASP1, MASP2, RHOB, RTKN, SEPTIN8, TJP2, VTN, ZEB1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=8.63e-05)<br>Staphylococcus aureus infection (p=4.80e-03)<br>Coronavirus disease - COVID-19 (p=2.43e-02)<br><br><b>BP:<\/b><br>protein localization to cell-cell junction (p=3.40e-07)<br>complement activation, lectin pathway (p=1.71e-05) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=9.76e-04)<br>GTP binding (p=1.21e-03) <br> <b>CC:<\/b><br>cell division site (p=5.92e-06)<br>adherens junction (p=1.32e-04)<\/div>"},{"id":"ZEB1","label":"ZEB1","x":2139.2514,"y":2211.9895,"size":5,"color":"#FFFF33","shape":"triangle","cluster":6,"title":"<div style='max-width:320px; padding:12px; background:#fff; color:#333; border-radius:10px; box-shadow:0 4px 15px rgba(0,0,0,0.2);'><h4 style='margin:0 0 8px 0; color:#2E86C1; border-bottom:2px solid #eee; padding-bottom:6px;'>Rank 4 - Cluster 6<\/h4><p style='margin:0 0 8px 0; color:#666; font-size:11px;'>|log2FC| promedio: <b>0.851<\/b><\/p><b>Genes (11):<\/b><br><span style='font-size:11px;'>CTNND1, DSP, LEFTY1, MASP1, MASP2, RHOB, RTKN, SEPTIN8, TJP2, VTN, ZEB1<\/span><br><br><b>KEGG:<\/b><br> Complement and coagulation cascades (p=8.63e-05)<br>Staphylococcus aureus infection (p=4.80e-03)<br>Coronavirus disease - COVID-19 (p=2.43e-02)<br><br><b>BP:<\/b><br>protein localization to cell-cell junction (p=3.40e-07)<br>complement activation, lectin pathway (p=1.71e-05) <br> <b>MF:<\/b><br>calcium-dependent protein binding (p=9.76e-04)<br>GTP binding (p=1.21e-03) <br> <b>CC:<\/b><br>cell division site (p=5.92e-06)<br>adherens junction (p=1.32e-04)<\/div>"}],"aristas":[{"from":"GRB2","to":"SDCBP","weight":0.501},{"from":"ILK","to":"SDCBP","weight":0.41},{"from":"ILK","to":"TNS1","weight":0.418},{"from":"CDH1","to":"TIMP3","weight":0.523},{"from":"CDH1","to":"LMNA","weight":0.632},{"from":"SEC23A","to":"USO1","weight":0.704},{"from":"GSN","to":"SEC23A","weight":0.512},{"from":"ITGB2","to":"TIMP3","weight":0.472},{"from":"BGN","to":"ITGB2","weight":0.502},{"from":"CDH1","to":"VTN","weight":0.535},{"from":"KLF6","to":"SDCBP","weight":0.409},{"from":"CPNE3","to":"KLF6","weight":0.416},{"from":"BGN","to":"TIMP2","weight":0.515},{"from":"MRGPRF","to":"TIMP2","weight":0.402},{"from":"MAMDC2","to":"MRGPRF","weight":0.419},{"from":"EDIL3","to":"ITGB2","weight":0.481},{"from":"EHD1","to":"LMNA","weight":0.402},{"from":"EFTUD2","to":"NDUFS2","weight":0.458},{"from":"EFTUD2","to":"HNRNPU","weight":0.51},{"from":"EDIL3","to":"GPC6","weight":0.423},{"from":"TMED2","to":"USO1","weight":0.583},{"from":"DDOST","to":"TMED2","weight":0.508},{"from":"SDCBP","to":"SNTB1","weight":0.518},{"from":"MIPEP","to":"SNTB1","weight":0.422},{"from":"MIPEP","to":"PREP","weight":0.403},{"from":"CBR3","to":"SDCBP","weight":0.615},{"from":"COL12A1","to":"TIMP3","weight":0.415},{"from":"MPP5","to":"USO1","weight":0.422},{"from":"HLA-DMB","to":"ITGB2","weight":0.426},{"from":"FGL2","to":"HLA-DMB","weight":0.405},{"from":"DECR1","to":"IVD","weight":0.413},{"from":"HSD17B4","to":"IVD","weight":0.433},{"from":"CTNND1","to":"VTN","weight":0.534},{"from":"CTNND1","to":"MPP5","weight":0.408},{"from":"PDCD6","to":"SDCBP","weight":0.539},{"from":"NPNT","to":"PPT2","weight":0.418},{"from":"PPT2","to":"TNS1","weight":0.418},{"from":"FAM3C","to":"SPP2","weight":0.408},{"from":"FAM3C","to":"TIMP3","weight":0.413},{"from":"CDH1","to":"RPL8","weight":0.8},{"from":"DSP","to":"VTN","weight":0.448},{"from":"NDUFS2","to":"RPL8","weight":0.462},{"from":"CNP","to":"NDUFS2","weight":0.528},{"from":"CTNND1","to":"TJP2","weight":0.588},{"from":"RHOB","to":"TJP2","weight":0.626},{"from":"MASP1","to":"VTN","weight":0.459},{"from":"CTNND1","to":"ZEB1","weight":0.404},{"from":"LEFTY1","to":"ZEB1","weight":0.403},{"from":"CAVIN1","to":"PACSIN3","weight":0.403},{"from":"PACSIN3","to":"RAI14","weight":0.643},{"from":"AGRN","to":"ITGB2","weight":0.489},{"from":"PLG","to":"PTX3","weight":0.407},{"from":"PLG","to":"TIMP3","weight":0.401},{"from":"ANO1","to":"NTRK3","weight":0.403},{"from":"LMNA","to":"NTRK3","weight":0.412},{"from":"CAVIN1","to":"SDCBP","weight":0.406},{"from":"CDH1","to":"GRB2","weight":0.632},{"from":"NCAPD3","to":"VPS26B","weight":0.414},{"from":"CMAS","to":"VPS26B","weight":0.527},{"from":"CDH1","to":"RPS17","weight":0.804},{"from":"DECR1","to":"NDUFS2","weight":0.426},{"from":"ADAMTSL3","to":"B3GLCT","weight":0.438},{"from":"B3GLCT","to":"TIMP3","weight":0.401},{"from":"BUB3","to":"HNRNPU","weight":0.406},{"from":"ACACB","to":"GYS1","weight":0.415},{"from":"ACACB","to":"IVD","weight":0.402},{"from":"CDH1","to":"TDGF1","weight":0.404},{"from":"AIP","to":"TDGF1","weight":0.416},{"from":"EFTUD2","to":"RPS27L","weight":0.558},{"from":"MASP2","to":"VTN","weight":0.454},{"from":"MAMDC2","to":"NCAPD3","weight":0.409},{"from":"DDOST","to":"TECR","weight":0.527},{"from":"RTKN","to":"TJP2","weight":0.411},{"from":"RTKN","to":"SEPTIN8","weight":0.414},{"from":"ERP29","to":"TMX1","weight":0.413},{"from":"DDOST","to":"TMX1","weight":0.403},{"from":"AQP1","to":"SLC14A1","weight":0.404},{"from":"AQP1","to":"CDH1","weight":0.411},{"from":"NUP54","to":"PML","weight":0.403},{"from":"ESYT2","to":"NUP54","weight":0.408}],"clusters":[{"cluster":4,"color":"#984EA3","count":11,"mean_fc":1.046,"rank":1},{"cluster":2,"color":"#377EB8","count":8,"mean_fc":1.025,"rank":2},{"cluster":8,"color":"#F781BF","count":3,"mean_fc":0.938,"rank":3},{"cluster":6,"color":"#FFFF33","count":11,"mean_fc":0.851,"rank":4},{"cluster":9,"color":"#999999","count":4,"mean_fc":0.803,"rank":5},{"cluster":3,"color":"#4DAF4A","count":13,"mean_fc":0.752,"rank":6},{"cluster":5,"color":"#FF7F00","count":12,"mean_fc":0.743,"rank":7},{"cluster":1,"color":"#E41A1C","count":11,"mean_fc":0.639,"rank":8},{"cluster":7,"color":"#A65628","count":9,"mean_fc":0.637,"rank":9}],"stats":{"nodos":82,"aristas":80,"clusters":9}}}};
let network = null, currentCond = "TUBULAR", currentPval = "P005", highlightedCluster = null;

document.addEventListener("DOMContentLoaded", function() {
  cargarVisualizacion();
  
  document.querySelectorAll(".cond-btn").forEach(btn => {
    btn.addEventListener("click", function() {
      currentCond = this.dataset.cond;
      document.querySelectorAll(".cond-btn").forEach(b => b.classList.remove("active"));
      this.classList.add("active");
      cargarVisualizacion();
    });
  });
  
  document.querySelectorAll(".pval-btn").forEach(btn => {
    btn.addEventListener("click", function() {
      currentPval = this.dataset.pval;
      document.querySelectorAll(".pval-btn").forEach(b => b.classList.remove("active"));
      this.classList.add("active");
      cargarVisualizacion();
    });
  });
});

function cargarVisualizacion() {
  highlightedCluster = null;
  
  if (!datosCompletos[currentCond] || !datosCompletos[currentCond][currentPval]) {
    document.getElementById("stat-nodos").textContent = "0";
    document.getElementById("stat-aristas").textContent = "0";
    document.getElementById("stat-clusters").textContent = "0";
    if (network) network.destroy();
    document.getElementById("network").innerHTML = "<div class=\"no-data\">No hay datos disponibles</div>";
    document.getElementById("cluster-legend").innerHTML = "";
    return;
  }
  
  const datos = datosCompletos[currentCond][currentPval];
  
  document.getElementById("stat-nodos").textContent = datos.stats.nodos;
  document.getElementById("stat-aristas").textContent = datos.stats.aristas;
  document.getElementById("stat-clusters").textContent = datos.stats.clusters;
  
  const nodes = new vis.DataSet(datos.nodos.map(n => ({
    id: n.id, label: n.label, x: n.x, y: n.y, size: n.size,
    color: { background: n.color, border: n.color },
    shape: n.shape, font: { size: 8, color: "#333" },
    cluster: n.cluster
  })));
  
  const edges = new vis.DataSet(datos.aristas.map((e, i) => ({
    id: i, from: e.from, to: e.to,
    width: Math.max(1, Math.min(3, e.weight / 200)),
    color: { color: "#ccc" }
  })));
  
  if (network) network.destroy();
  network = new vis.Network(document.getElementById("network"), { nodes, edges }, {
    physics: false,
    interaction: { hover: true, zoomView: true, dragView: true, dragNodes: true }
  });
  
  network.on("hoverNode", function(params) {
    const node = datos.nodos.find(n => String(n.id) === String(params.node));
    if (node && node.title) {
      const tooltip = document.getElementById("tooltip");
      tooltip.innerHTML = node.title;
      tooltip.style.display = "block";
      tooltip.style.left = (params.event.pageX + 10) + "px";
      tooltip.style.top = (params.event.pageY + 10) + "px";
    }
  });
  
  network.on("blurNode", () => document.getElementById("tooltip").style.display = "none");
  
  const legendContainer = document.getElementById("cluster-legend");
  legendContainer.innerHTML = "";
  datos.clusters.forEach(c => {
    const item = document.createElement("div");
    item.className = "legend-item";
    item.dataset.cluster = c.cluster;
    item.innerHTML = "<div class=\"legend-color\" style=\"background:" + c.color + "\"></div><div class=\"legend-info\"><div class=\"cluster-name\">Cluster " + c.cluster + "</div><div class=\"cluster-meta\">" + c.count + " genes - |FC|=" + c.mean_fc + "</div></div><div class=\"legend-rank\">#" + c.rank + "</div>";
    item.onclick = () => filtrarCluster(c.cluster);
    legendContainer.appendChild(item);
  });
}

function filtrarCluster(clusterId) {
  const datos = datosCompletos[currentCond][currentPval];
  
  if (highlightedCluster === clusterId) {
    highlightedCluster = null;
    network.body.data.nodes.update(datos.nodos.map(n => ({ id: n.id, color: { background: n.color, border: n.color } })));
    document.querySelectorAll(".legend-item").forEach(item => item.classList.remove("dimmed"));
  } else {
    highlightedCluster = clusterId;
    network.body.data.nodes.update(datos.nodos.map(n => ({
      id: n.id,
      color: n.cluster === clusterId ? { background: n.color, border: n.color } : { background: "#ddd", border: "#ccc" }
    })));
    document.querySelectorAll(".legend-item").forEach(item => {
      item.classList.toggle("dimmed", parseInt(item.dataset.cluster) !== clusterId);
    });
  }
}
</script>
</body>
</html>
